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Abstract 
Hippocampal neurogenesis is the process by which new neurons are born within the 
dentate gyrus (DG). This process begins during embryonic development and persists 
throughout life. Neurogenesis encompasses proliferation, differentiation and 
integration of neural progenitor cells (NPCs) into the surrounding neural network. 
Each stage is regulated by a host of intrinsic and extrinsic factor such as intracellular 
signalling molecules, exercise, environmental enrichment, diet and learning. TLX is 
an orphan nuclear receptor and transcription factor, which promotes the proliferation 
of NPCs, maintains the neurogenic pool of cells within the DG, and has been shown 
to promote hippocampal neurogenesis-associated cognition. Conversely, the pro-
inflammatory cytokine IL-1β is a major mediator of the anti-neurogenic effects of 
hippocampal neuroinflammation, and previous work from the group has shown that 
IL-1β can suppress the expression of TLX within proliferating NPCs. 
 
The aims of this thesis were to investigate the interactions between TLX and IL-1β 
both in vitro and in vivo, and to determine the behavioural outcome of enhancing 
TLX and IL-1β, as well as well as in response to dietary intervention in vivo. We 
demonstrate that IL-1β suppresses TLX expression and neurogenesis (neurosphere 
expansion) in vitro, and that these effects are mediated by the NF-κB pathway. 
Restoration of TLX expression is sufficient to attenuate the negative effects of IL-1β 
on neurogenesis. We have shown using an RNA sequencing approach that TLX 
expression maintains a reduced inflammatory transcriptional profile in the 
hippocampus at baseline, and regulates the transcriptional response to IL-1β in vivo. 
We demonstrate that lentiviral-mediated overexpression of TLX does not enhance 
hippocampal neurogenesis-associated cognitive processes in vivo but that it impairs 
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object recognition memory in rats. This suggests that enhancing cell proliferation is 
not sufficient to promote certain hippocampal-associated cognitive processes, and 
may even have a detrimental effect on cognitive behaviour. Finally, we show that an 
adolescent cafeteria diet which induces negative effects on hippocampal-associated 
memory, does not induce lasting cognitive defects when rats are switched to standard 
chow diet in adulthood. Lentiviral-mediated overexpression of IL-1β does not impact 
upon cognitive behaviours in rats fed a cafeteria diet throughout adolescence. 
However, we show that this chronic low-grade hippocampal IL-1β-mediated 
inflammation promotes fear memory in adulthood. 
 
In summary, TLX and IL-1β can enhance and repress hippocampal neurogenesis 
respectively. Determining the role that TLX has on neurogenesis-associated 
cognition and how it can interact with IL-1β may position TLX as a novel 
therapeutic target for the treatment of neuroinflammatory-associated disorders where 
hippocampal neurogenesis is impaired.   
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1.1: The hippocampus 
The limbic system is a group of forebrain structures that are involved in motivation, 
emotion, learning and memory. The hippocampus, a component of the limbic 
system, is a bilateral curved structure situated within the medial temporal lobe. The 
hippocampus consists of three main regions which as a whole constitute the 
hippocampal formation. These three regions are the hippocampus proper or Cornu 
ammonis (CA), the subiculum and the dentate gyrus (DG). The hippocampus proper 
can be subdivided transversely into 4 main layers, the Stratum Oriens which consists 
of basal dendrites and axon collaterals of pyramidal neurons (the main excitatory 
neurons of the hippocampus), the Stratum Pyramidae which consists of the cell 
bodies of the pyramidal neurons, the Stratum Radiatum which consists of dendrites 
and recurrent axon collaterals of the pyramidal cells and finally the Stratum 
Moleculare containing distal dendrites of the pyramidal cells and some incoming 
axons from the perforent pathway (see figure 1.1 for diagram of hippocampal 
substructure locations) (Nolte & Sundsten 2002). The Stratum Moleculare faces the 
DG and it is within the DG that neurogenesis occurs. The DG consists of three main 
layers, the Stratum Granulare, the Stratum Moleculare and the Stratum Multiforme. 
It is within the Stratum Granular, specifically the Subgranular Zone (SGZ) of the 
DG, that neural precursor cells reside and proliferate throughout adulthood (Altman 
& Das 1965). 
 
 
 
 
 
Chapter 1 
9 
 
 
 
Figure 1.1: Hippocampal Structure (Kandel et al. 2000). A diagram of a human 
hippocampus cut in the coronal plane with major substructure labelled. 
 
The main external neuronal inputs into the hippocampus come from the entorhinal 
cortex (EC) which communicates signals from cortical regions, the amygdala and the 
olfactory cortex to the distal dendrites of the granule cells within the Stratum 
Moleculare (Kandel et al. 2000). After the DG, the signal is relayed on to the CA3 
region of the hippocampus proper. From here the signals are sent to the CA1 region. 
Neurons present within the subiculum, CA1 and CA3 regions project axons into the 
fornix which is the main output pathway. This is the main information processing 
pathway within the hippocampus and is known as the trisynaptic circuit (Kandel et 
al. 2000; Nolte & Sundsten 2002).  
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1.1.1: Function of the hippocampus 
Functionally, the hippocampus has a major role in memory formation and recall. 
Primarily, the hippocampus is known to be involved in declarative memory (Squire 
1992) and spatial awareness (Olton 1977; Ekstrom et al. 2003). Two types of 
memory that have been widely studied in relation to the role of the hippocampus and 
memory formation are declarative (explicit) and non-declarative (implicit) memory. 
Declarative memory involves the conscious recall of previous experiences or factual 
knowledge about people, places and things (Kandel et al. 2000). Declarative memory 
can also be subdivided into episodic memories concerning specific events and 
semantic memories concerning knowledge of words etc. (McClelland et al. 1995). 
Non-declarative memory is an unconscious form of memory and is involved in 
performing specific tasks such a riding a bike. Much of the early work in 
understanding the differences between declarative and non-declarative memory came 
from studies involving a human patient referred to as patient H.M (Milner et al. 
1968). In 1952 at the age of 27, patient H.M. underwent an experimental procedure 
to remove parts of the medial temporal lobe including the hippocampus, amygdala 
and parahippocampal gyrus to alleviate severe seizures he suffered as a result of a 
childhood bicycle accident. As a result, patient H.M. suffered from severe but very 
specific memory loss. His non-declarative memory remained largely intact in that he 
could retain his command of language and IQ post surgery. However, he was not 
able to process new memories post surgery. This was one of the first cases linking 
memory and the medial temporal lobe, a large part of which is the hippocampus.  
 
More recent studies have expanded on this showing that declarative memory can be 
impaired by hippocampal damage resulting in retrograde or anterograde amnesia 
Chapter 1 
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(Squire et al. 2004). However, non-declarative memory can remain intact after 
hippocampal impairment (McClelland et al. 1995). Despite the hippocampus 
showing function in memory development and recall, it has also been shown to have 
a role in emotion and anxiety and that functions appear to be specific to sub-regions 
within the hippocampus. This functional segregation of the hippocampus has been 
shown via several lesion studies where the ventral area has been shown to be more 
involved with anxiety and emotional behaviours, with the dorsal hippocampus being 
more involved with spatial learning and memory (Bannerman et al. 2004; McHugh 
et al. 2011; Kjelstrup et al. 2002; Bast et al. 2009). Another indication of the role of 
the hippocampus in the regulation of mood and emotion comes from the fact that it is 
part of the limbic system (Sahay and Hen, 2007). The limbic system of brain 
structures also includes the amygdala and prefrontal cortex (PFC). This system 
relays synaptic inputs which inhibits the paraventricular nucleus (PVN) of the 
hypothalamus. The PVN is part of the hypothalamic-pituitary-adrenal (HPA) axis. 
This axis involves the transduction of neuronal stress responses into endocrine 
responses by releasing corticotrophin-releasing factor (CRH) from the PVN which 
stimulates adrenocorticotropic hormone (ACTH) from the pituitary, ultimately 
leading to glucorticoid release from the adrenal glands (Lopez et al., 1999). 
Heightened activation of this axis is evident after stress and chronic activation has 
been implicated in the etiology of depression and other mood disorders (Kessler, 
1997, Sapolsky, 2000, Sapolsky, 1996, Lupien et al., 2009).  
 
1.1.2: Experimental assessment of hippocampal-associated cognition 
Various behavioural techniques have been developed to assess hippocampal-
associated spatial cognition including contextual fear conditioning and spatial 
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navigation in the Morris water maze, radial arm maze, Barnes maze, Y-maze, or T-
maze and pattern separation (Wills et al., 2014, Sahay et al., 2011a, Clelland et al., 
2009). Most of these behavioural paradigms rely on relational learning, e.g. the 
location of the platform in the Morris water maze in relation to visual cues around 
the arena and/or the innate exploratory behaviour of rodents (Morris et al., 1982, 
Crusio et al., 1989).  
 
The Y-maze, T-maze and radial arm maze can be used to assess spontaneous 
alternation behaviour in rodents (Hughes, 1997, Hughes, 2004, Gerlai, 2001). This 
type of behaviour involves rodents’ tendency to explore a novel environment. In the 
context of a maze, e.g. a Y-maze, continued spontaneous alternation behaviour 
rodents is commonly used as a quick test of spatial working memory and was first 
used for testing drug effects on spatial memory (Kokkinidis and Anisman, 1976b, 
Kokkinidis and Anisman, 1976a, Drew et al., 1973, Swonger and Rech, 1972). In 
this test, rodents are placed in one arm of the maze and allowed to explore freely 
during which time the sequence of arm entries is recorded. These sequences are used 
then to calculate the proportion of arms entered that were different to previous 
entries which is usually reported as percentage alternation in the Y-maze (Hughes, 
2004). Alternation is determined from successive entries of three arms on an 
overlapping triplet set where three different arms are entered (Sarter et al., 1988). 
Therefore, this task requires the rodents to spatially differentiate what arm they last 
entered and subsequently enter a previously unexplored arm. The T-maze can also be 
used to assess continued spontaneous alternation behaviour and it has been 
demonstrated that in normal mice approximately 70% of these triplets will be three 
consecutively different arms. Impairments in hippocampal function by excitotoxic 
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lesions have been shown to impair the percentage alternation in rodents (Gerlai, 
1998) thus indicating that this task is hippocampal-associated.  
 
Contextual fear conditioning is another behavioural paradigm that has been shown to 
be sensitive to hippocampal dysfunction (Kim and Fanselow, 1992, Phillips and 
LeDoux, 1992). This test involves an acquisition phase of placing an animal within a 
specific context and inducing a fear response within said context via a small 
footshock. After a defined delay period, the animal is then returned to the context but 
this time is not exposed to a footshock. The animals freezing behaviour is recorded 
and animals that have normal hippocampal function are able to recall the context and 
associated footshock and thus freeze more. Addition of a tone or cue before the 
shock during the acquisition phase can also be used to differentiate hippocampal-
associated behaviour and non-hippocampal-associated behaviour. Freezing 
behaviour in this cued fear conditioning paradigm has been shown to be maintained 
even after a hippocampal lesion and is suggested to involve the amygdala (Phillips 
and LeDoux, 1992).  Hippocampal lesion studies using contextual fear conditioning 
as a behaviour read-out have highlighted interesting discrepancies in performance 
depending on when the lesions are carried out. For example, rodents who received a 
hippocampal lesion 1 day after the acquisition phase showed a significant 
impairment in context recall (Kim and Fanselow, 1992). However, if lesions to the 
hippocampus are carried out prior to the acquisition phase, up to 28 days prior, 
rodents are still able to acquire a fear response to the context (Kim and Fanselow, 
1992). This indicates that rodents are able to recruit non hippocampal based neuronal 
circuits to aquire a contextual fear response if there is hippocampal dysfunction 
during the memory acquisition phase. However, once the contextual fear memory is 
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acquired, subsequent hippocampal disruption results in impaired retrieval of that 
memory. 
 
The Morris water maze involves assessing the ability of rodents to locate and escape 
from a platform within a large arena filled with opaque water. In this test the 
platform is hidden and the latency for the rodent to locate the platform by relying on 
external visual cues around the arena is recorded (Morris, 1984). This paradigm 
requires that the animal be trained to locate the hidden platform placed just beneath 
the surface of the water. To achieve this, the animal must be given a sufficient 
amount of external visual cues outside the arena, however, the number and type of 
visual cues vary widely across studies. It has been shown that lack of any visual cues 
significantly slows the animal from successfully locating the platform whereas by 
simplifying the external cues (cues closer to arena) rodents showed faster acquisition 
of the platform location during the acquisition/training phase (Morris, 1984, 
D'Hooge and De Deyn, 2001, Lamberty and Gower, 1991). After a defined delay, 
rodents are returned to the maze with the platform removed. In this test phase the 
amount of time the animal spends in the quadrant where the platform was is recorded 
and is used to indicate the spatial memory performance of the animal. This task has 
shown robust reproducibility in mice across laboratories where latency for rodents to 
find the platform are similar across testing sites and when factors such as apparatus 
used, training protocol, animal age and animal housing are accounted for  (Crabbe et 
al., 1999).  
 
Similar to contextual fear conditioning, performance in the Morris water maze is 
strongly associated with hippocampal function as several lesion studies have shown 
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that when the hippocampus is damaged rodents are significantly impaired in learning 
the location of a hidden platform (Morris, 1984, Morris et al., 1982, Pearce et al., 
1998). Additionally, it has been suggested that the dorsal hippocampus is more 
critical in performance in the Morris water maze than the ventral hippocampus 
(Moser et al., 1993, Moser et al., 1995).  
 
The ability to distinguish between similar experiences is important in episodic 
memory and is a function of the hippocampus (Yassa and Stark, 2011). This process 
is widely known as pattern separation. Pattern separation involves taking similar 
sensory inputs and transforming them into dissimilar outputs to ensure the sensory 
inputs can be recalled as different experiences (Sahay et al., 2011a). In its simplest 
form, assessing pattern separation in rodents involves assessing behaviour of rodents 
in two similar contexts. If the rodents successfully distinguish the two contexts their 
behaviour will be different in each context. For example, they may show increased 
exploratory behaviour in the novel context (Clelland et al., 2009, Bekinschtein et al., 
2013a). Pattern separation load can then be adjusted by increasing or decreasing the 
similarity between the two contexts. Hippocampal DG lesion studies have 
demonstrated that when the hippocampus is damaged, rodents fail to distinguish 
between two similar contexts compared to controls (Hunsaker et al., 2008). 
Additionally, it has been demonstrated that enhancing hippocampal neurogenesis 
promotes pattern separation (Sahay et al., 2011a). 
 
1.2: Adult neurogenesis 
Within the adult brain of many mammalian species including rodents and non-
human primates, neurogenesis occurs in two specific regions known as neurogenic 
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niches, namely the subventricular zone (SVZ) of the lateral ventricles and the 
subgranular zone (SGZ) of the DG in the hippocampus (Suh et al., 2009, Eriksson et 
al., 1998, Alvarez-Buylla and Lim, 2004). In these niches it has been shown that 
neural progenitor cells (NPCs) have the ability to replenish themselves via 
symmetrical division, or differentiate into specialized cells of the CNS, such as 
mature neurons or astrocytes via asymmetrical division (Gage et al., 1995, Fisher, 
1997, Zhao et al., 2008). In humans, while there is clear evidence to show ongoing 
neurogenesis in the DG of the hippocampus, there appears to be negligible levels of 
SVZ neurogenesis (Bergmann et al., 2012, Spalding et al., 2013). More recently it 
has also been proposed that neurogenesis occurs within the striatum of humans 
(Ernst et al., 2014). 
 
Evidence of adult neurogenesis first began to appear as early as the 1960s where 
radiolabelling studies using adult rats showed that there was an increase in newborn 
cells within the DG of the hippocampus (Altman and Das, 1965). This study 
demonstrated proliferating cells within the hippocampus of rats by injecting the rats 
with thymidine-H
3
. Thymidine-H
3
 is utilised in the production of chromosomal DNA 
in dividing cells (Hughes et al., 1958, Leblond et al., 1959). Thus the uptake of this 
compound within cells of the hippocampus was proof that dividing cells exist within 
the adult brain. Then in the 1980s, it was first demonstrated that these newborn cells 
can functionally integrate into the surrounding CNS neuronal circuitry in songbirds 
(Paton and Nottebohm, 1984). NPCs were then isolated from the adult mammalian 
brain in the 1990s (Reynolds and Weiss, 1992, Richards et al., 1992). With the 
introduction of BrdU, a thymidine analogue capable of labelling proliferating cells 
and allowing lineage tracing of these newborn cells, neurogenesis was finally 
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demonstrated within humans (Eriksson et al., 1998, Kuhn et al., 1996). It has been 
shown that these proliferating cells are NPCs that are capable of differentiating into 
mature neurons, astrocytes, or oligodendrocytes via asymmetrical division (Gage, 
2000, Zhao et al., 2008).   
 
Hippocampal neurogenesis begins during embryonic development and persists 
throughout life. Multipotent neural progenitor cells (NPCs) undergo a stepwise 
process of proliferation, differentiation into newborn neurons and functional 
integration of those new neurons into the surrounding circuitry (See figure 1.2) 
(Alvarez-Buylla and Lim, 2004). Each of these cellular processes is under strict 
regulation by a wide range of intracellular and extracellular factors. Reductions in 
hippocampal neurogenesis have been associated with neurological and psychiatric 
disorders, such as Alzheimer’s disease and major depression, as well as with aging 
(Verret et al., 2007, Sahay and Hen, 2007, Kuhn et al., 1996, Maruszak and Thuret, 
2014). This then raises the question; can therapies aimed at promoting or protecting 
hippocampal neurogenesis be used to subsequently improve cognitive decline in 
these conditions? With our greater understanding of the promoters and suppressors 
of the various cellular processes of neurogenesis, we will stand well-equipped to 
address this question in future research. 
 
It has been proposed that neurogenesis also occurs within the striatum of humans, 
however this has yet to be widely validated (Ernst et al. 2014). The term niche refers 
to a micro environment within certain tissue types that possess the ability to maintain 
a stable population of proliferating stem or progenitor cells (Morrison and Spradling, 
2008). Thus a niche should be an environment that if its resident stem cells are 
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depleted it should be able to take up and maintain a newly introduced population of 
stem cells.   
  
 
Figure 1.2. Cells and processes involved in hippocampal neurogenesis.  Adapted 
from (O'Leime et al., 2017a). 
 
1.2.1: The neural stem cell (NSC) and neural progenitor cell (NPC) 
Multipotent NSCs reside within the embryonic and adult hippocampus and can give 
rise to NPCs (Gage, 1998, Kriegstein and Alvarez-Buylla, 2009, Eriksson et al., 
1998). Potentiality of cells is a term used to describe the ability of certain cells to 
form other cell types. Totipotent refers to stem cells that can form any cell type, 
pluripotent refers to stem cells that are more lineage restricted and thus cannot form 
placental cells while mulitpotent cell types can only form cells resident in the organ 
that the multipotent cells are situated. In the case of multipotent NPCs, they can form 
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specialised cells of the central nervous system (CNS) (Fisher, 1997, Kennea and 
Mehmet, 2002). The distinctions between NPCs and NSCs are not yet clearly 
defined yet it is thought that NPCs are an intermediary between NSCs and 
differentiated cells and have a more limited capacity for self-renewal compared to 
NSCs (Gage, 1998, Gage, 2000, Sohur et al., 2006, Olynik and Rastegar, 2012). 
However, broadly speaking, NSCs and NPCs can be called NPCs (Sohur et al., 
2006). Therefore, for simplicity in this thesis NPCs will refer to all undifferentiated 
cells that have the ability to self-replicate and differentiate into various cellular 
lineages of the central nervous system (CNS), such as neurons, astrocytes or 
oligodendrocytes.  
 
To date NPCs have been isolated from multiple adult rodent brain regions and can be 
isolated from all embryonic brain regions (Brewer and Torricelli, 2007, Shanley and 
Sullivan, 2006, Reynolds and Weiss, 1992). NPCs were first isolated from adult 
mice in 1992 (Reynolds and Weiss, 1992). Reynolds and Weiss demonstrated the 
isolated NPCs could be induced to differentiate into neurons and astrocytes in vitro 
thus demonstrating the multipotentiality of these cells. The NPCs within the 
neurogenic niches of the mammalian brain is maintain by a careful balance of 
symmetrical and asymmetrical division (Zhao et al., 2008). NPCs divide 
symmetrically to produce two identical daughter cells from a single parent cell and 
maintain the NPC pool. NPCs can also asymmetrically divide as they begin to 
differentiate with a signal parent cell producing one NPC and another lineage fate 
determined cell. This lineage fate determined cell can either become a neuron, 
astrocyte or oligodendrocyte as it differentiates further (Breunig et al., 2007).  
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1.2.2: Cells and processes of adult hippocampal neurogenesis 
The progression of NPCs in the adult hippocampus towards functionally integrated 
mature neurons is a multi step process. As such, a model has been developed to 
outline the main features of the NPCs and the development processes they undergo 
in all mammalian species (See figure 1.3) (Kempermann et al., 2004a). This model 
proposes 6 developmental milestones. The first is the proliferation of ‘type 1’ NPCs, 
or early progenitor cells. These cells are radial glial-like cells with a distinct 
morphology of a triangular soma with apical processes along the vertical axis (Seri et 
al., 2001, Filippov et al., 2003). These cells display the astrocytic marker glial 
fibrillary acidic protein (GFAP) and the marker for NPCs nestin. They make up 
approximately two thirds of the nestin expressing cells within the murine SGZ 
(Filippov et al., 2003, Kronenberg et al., 2003). However, these cells divide very 
slowly as they only account for approximate 5% of dividing cells in the SGZ at any 
given time (Kronenberg et al., 2003). Since this discovery, another type 1 cell has 
been identified with a horizontal morphology and more rapid rate of proliferation 
(Lugert et al., 2010).  
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Figure 1.3: Propose model outlining the various steps NPCs take as they undergo 
the neurogenic process (Kempermann et al., 2004a). 
 
In stages 2 to 4, these type 1 cells divide asymmetrically to produce type 2 cells. 
Type 2 cells are morphologically different to type 1 cells in that they have a more 
flattened longitudinal shape. However they are still classed as NPCs (Kronenberg et 
al., 2003, Filippov et al., 2003). They are GFAP negative and are highly proliferative 
(Kronenberg et al., 2003). Type 2 cells are subdivided into two categories both of 
which express nestin, name type 2a and type 2b (Kempermann et al., 2004a, 
Kronenberg et al., 2003). The difference between these two types is that type 2a cells 
exlusively express nestin whereas type 2b express both nestin and the marker for 
immature neurons, doublecortin (DCX) (Filippov et al., 2003, Kronenberg et al., 
2003, Brown et al., 2003b, Brandt et al., 2003). The expression of DCX indicated 
that type 2b cells are lineage determined. Type 3 cells proliferating neuroblasts and 
are a continuation of the type 2b cells. They exclusively express DCX and the 
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appearance of these cells represents a major morphological change from what was 
NPC into what will become a neuron (Brandt et al., 2003). These cells are restricted 
to a neuronal lineage and express the polysialated form of neural cell adhesion 
molecule (PSA-NCAM) (Kempermann et al., 2004a).  
 
During stage 5, type 3 cells then leave the cell cycle and become postmitotic. 
Approximately 3 days after the first cell division, they transiently express the 
calcium binding protein calretinin and the neuronal marker NeuN (Kempermann et 
al., 2004a). During this stage, newborn neurons begin their migration from the SGZ 
towards the granule cell layer (GCL). These new neurons then begin to extend their 
axons to the CA3 region of the DG and become tonically activated by GABA 
approximately 1 week after their birth (Brandt et al., 2003, Espósito et al., 2005) 
 
Finally, stage 6 involves the integration and final maturation of these post-mitotic 
type 3 cells into the granular cell layer (GCL) of the DG. After 2-3 weeks they 
switch from expressing calretinin to calbindin while maintaining NeuN expression. 
At the same time they begin to develop dendritic GABAergic synaptic inputs 
(Espósito et al., 2005). However, functionally it takes approximately 5 weeks for 
these new neurons to become indistinguishable from the surrounding neurons. This 
was demonstrated by quantifying the expression of neuronal activation markers such 
as c-fos in newborn neurons versus mature neurons after simulation by a learning 
based cognitive task, in this case the Morris water maze (Jessberger and 
Kempermann, 2003). This study demonstrated that as newborn neurons mature, they 
gradually increased their expression of markers of neuronal activation until by 5 
weeks they had similar levels of expression to older neurons. Despite a clear model 
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available for the processes of adult neurogenesis, no clear model is available to date 
for embryonic neurogenesis (Kempermann et al., 2004a). 
 
1.2.3: Embryonic vs. adult hippocampal neurogenesis 
Within the hippocampus, pyramidal neurons are formed within the CA1 and CA3 
regions during embryonic development and reside there throughout adulthood 
(Altman and Bayer, 1990). Granule cells in the DG begin their development during 
the embryonic period and continue to be produced post-natally (Altman and Bayer, 
1990). Development of the DG begins at embryonic day (E) 14 in the rat. At this 
timepoint, precursor cells from the dentate neuro epithelium on the medial wall of 
the lateral ventricle become postmitotic (Schlessinger et al., 1978, Laplagne et al., 
2007). Once these cells become post mitotic they migrate to the external shell of the 
outer blade of the DG. By E18 a secondary dentate shell is evident as a result of 
proliferating neuroblasts migrating to form the granular cell layer (GCL). Mature 
granule neurons are evident 2-3 days before birth with a tertiary dentate shell around 
the hilus region evident at birth. These granule neurons continue to be produced 
post-natally as the DG continues to form until it is fully developed by postnatal day 
(P) 30. By this time NPCs are established in the SGZ where neurogenesis occurs 
throughout adulthood (Gage, 2000, Altman and Bayer, 1990). When comparing 
rodent hippocampus and DG development to human development, it is noteworthy 
to consider that humans have a much longer gestational period as well as having a 
larger hippocampal formation. The DG granule neurons in humans can be 
identifiable at the 11.5
th
 gestational week (Humphrey, 1967). Using the proliferation 
marker Ki67, it was found that proliferating cells are widespread in various 
hippocampal regions in developing humans at the 14
th
 week and as gestation 
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progresses these proliferating cells become more restricted to the hilus region of the 
DG (Seress, 2007). Thus, taking rodent gestation to be approximately 3 weeks and 
human gestation to be on average 40 weeks, it can be seen that appearance of granule 
neurons appear much earlier in humans than rodents. However, this may be due to 
the evolutionary differences between rodents and humans as well as the larger 
hippocampal formation in humans. 
 
The continuation of neurogenesis throughout adulthood was largely discovered by 
employing thymidine-H
3 
or bromodeoxyuridine (BrdU) labelling of mitotic cells 
within the hippocampus. To date, it has been demonstrated in most mammalian 
species (Gould et al., 1997, Kukekov et al., 1999, Ming and Song, 2005, Kornack 
and Rakic, 1999, Eriksson et al., 1998). Within the adult brain, neurogenesis appears 
to be largely confined to two main areas known as neurogenic niches. These niches 
are known as the SGZ of the DG in the hippocampus and the SVZ of the lateral 
ventricle. Within these niches, adult neurogenesis involves slow proliferation of a 
pool of early progenitors cells, more rapid proliferation of progenitors that are more 
restricted in their lineage fate and finally integration of newborn neurons into the 
surrounding circuitry (Ehninger and Kempermann, 2008). It is estimated that in the 
adult human hippocampus there are around 700 new neurons produced each day 
(Spalding et al., 2013). Interestingly, it is suggested that humans replace 
approximately 35% of their DG through neurogenesis whereas rodents are estimated 
to replace only around 10% (Ninkovic and Gotz, 2007, Imayoshi et al., 2008). 
Furthermore, it is well established that there is an age-related decline in neurogenesis 
in rodent models and now this phenomenon has been demonstrated in humans. 
(Spalding et al., 2013, Knoth et al., 2010). Pathology-associated deficits in 
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neurogenesis observed in various experimental models of Alzheimer’s disease (AD) 
and Parkinson’s disease (PD) have also been mirrored in adult human neurogenesis 
(Crews et al., 2010, Höglinger et al., 2004, Zeng et al., 2016, Klein et al., 2016). 
Thus, traits in rodent models of adult neurogenesis appear to be shared in human 
hippocampal neurogenesis and so this provides validation for these models. 
 
The cellular processes involved in embryonic and adult neurogenesis are very similar 
with the two main differences between each primarily arising from differences in the 
tissues that the NPCs are situated in (Kempermann et al., 2004a). Firstly, adult NPCs 
require a microenvironment conducive to neurogenesis (the neurogenic niche) within 
a larger non-neurogenic environment. In effect, adult NPCs need to be protected 
from the wide range of potential anti-neurogenic influences, which may reside within 
the surrounding brain tissue. In this regard, it has been shown that adult rat NPCs 
derived from the non-neurogenic spinal cord region show self-renewal and 
multipotentiality properties once transplanted into the DG (Shihabuddin et al., 2000). 
This indicates that the microenvironment in the DG is crucial for providing support 
for neurogenesis to occur. Secondly, adult neurogenesis is an individualistic process 
with cells at all stages of development present in the same microenvironment at the 
same time whereas embryonic neurogenesis is a highly coordinated process with 
large groups of cells undergoing the same developmental process at the same time 
(Kempermann et al., 2004a). Despite these differences, individual adult NPCs have 
been shown to reiterate all the cellular processes of embryonic NPCs during 
developmental neurogenesis i.e. proliferation, differentiation and functional 
integration of newborn neurons (Kempermann et al., 2004a, Zhao et al., 2008). 
Additionally, the intracellular mechanistic features that regulate each stage of 
Chapter 1 
26 
 
neurogenesis are suggested to be the same in the DG throughout all stages of 
development (Pleasure et al., 2000). Therefore, promoters and inhibitors of 
neurogenesis are likely to have mechanistically similar effects on embryonic NPCs 
and adult derived NPCs.  
 
1.3: Functional role of adult hippocampal neurogenesis 
Functionally, neurogenesis has been linked to certain hippocampal cognitive tasks 
such as spatial learning, memory and regulation of emotion (Ming and Song, 2011, 
Cameron and Glover, 2015, van Praag et al., 2005, Shors et al., 2002). However, its 
exact role remains unclear with a large body of conflicting reports within the 
literature assessing its involvement in various hippocampal-associated cognitive 
tasks (Deng et al., 2010). Hippocampal neurogenesis has been suggested to play a 
role in the stress response and adaptation of the hippocampus in terms of learning 
and memory to certain stressors (Cameron and Glover, 2015, Levone et al., 2015, 
Snyder et al., 2011). Additionally, hippocampal neurogenesis has been proposed to 
be involved in the regulation of anxiety as well as facilitating antidepressant action 
(Revest et al., 2009, Santarelli et al., 2003). 
 
1.3.1: Neurogenesis in learning and memory 
A growing body of evidence over the past two decades suggests that newly born 
neurons in the adult hippocampus contribute to hippocampal dependent learning and 
memory (Deng et al., 2010).  Techniques to manipulate neurogenesis in rodents have 
provided direct evidence of the role of hippocampal neurogenesis in behaviour. 
These include irradiation of the hippocampus (Huo et al., 2012, Madsen et al., 2003, 
Saxe et al., 2006), as well as transgenic animal models (Snyder et al., 2016, 
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Cummings et al., 2014, Saxe et al., 2006) and viral mediated techniques targeting 
neurogenic promoters specifically within NPCs (Murai et al., 2014, Jessberger et al., 
2009b, Taliaz et al., 2010) to ablate or enhance neurogenesis. The majority of these 
techniques used to ablate hippocampal neurogenesis have demonstrated impairments 
in hippocampal associated cognition, such as novel object and novel location 
recognition, fear conditioning, long-term spatial memory in a Morris water maze test 
and pattern separation, an ability to distinguish two similar contexts (Jessberger et 
al., 2009b, Saxe et al., 2006, Snyder et al., 2005, Dupret et al., 2008, Deng et al., 
2009, Sahay et al., 2011a, Winocur et al., 2006, Tronel et al., 2012, Clelland et al., 
2009). It has been shown that neurogenesis and its functional consequences on 
cognition can be selectively enhanced by enhancing NPC survival. Specifically, a 
subsequent improvement in pattern separation has been reported in transgenic mice 
where NPC survival was enhanced by selectively ablating the pro-apoptotic gene 
Bax in NPCs (Sahay et al., 2011a). It has also been established that increasing 
hippocampal neurogenesis via physical exercise induces an improvement in 
cognitive performance (Voss et al., 2013, van Praag et al., 2005, Ryan and Kelly, 
2016). However, enhancing neurogenesis is complex due to its multifactorial process 
of proliferation, differentiation and survival of the newborn neurons, and thus it may 
be difficult to definitively uncover the role of enhanced neurogenesis by 
manipulating one aspect of the process.  
 
It should be noted that it has also been reported that ablation of hippocampal 
neurogenesis had no effect on some of these hippocampal-dependent tasks 
(Hernandez-Rabaza et al., 2009, Wojtowicz et al., 2008, Groves et al., 2013). 
Furthermore, a meta-analysis of the relevant literature revealed no significant effects 
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of ablation of adult neurogenesis on spatial memory or cued fear conditioning 
(Groves et al., 2013), although the meta-analysis showed high levels of heterogeneity 
among the studies. Thus, while there is general consensus that adult hippocampal 
neurogenesis is required for pattern separation, the functional role of hippocampal 
neurogenesis has not yet been clearly demonstrated. It has been suggested that the 
heterogeneity in the findings to date may be due to differences in species, method of 
ablation, behavioural test used or in the variation in stress levels (Groves et al., 2013, 
Dranovsky and Leonardo, 2012, Glasper et al., 2012).  
 
One proposed cellular mechanism for learning and memory is via changes in 
hippocampal synaptic plasticity. Long term potentiation (LTP) is an 
electrophysiological correlate of changes in synaptic plasticity and it has been shown 
that adult born neurons contribute to LTP formation within the DG of rats (Snyder et 
al., 2001). Ablating neurogenesis by using either pharmacological suppression of 
proliferation, or hippocampal irradiation inhibited LTP formation in the DG (Wang 
et al., 2008, Garthe et al., 2009). Conversely, LTP can itself increase the proliferation 
of NPCs in the DG if it is induced in the medial perforant pathway, which relays 
synaptic input to the DG (Bruel-Jungerman et al., 2006). This reciprocal relationship 
between neurogenesis and LTP is suggested to underlie the beneficial effects of 
learning a new task on neurogenesis and vice versa (Snyder et al., 2001, Deng et al., 
2009, Deng et al., 2010). 
 
It is generally believed that neurogenesis can promote the formation of new 
memories however it has also been suggested that hippocampal neurogenesis can 
promote forgetting of old memories (Frankland et al., 2013, Welberg, 2014, Akers et 
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al., 2014, Epp et al., 2016). As hippocampal neurogenesis ultimately involves the 
generation of new synaptic inputs from new neurons into the existing hippocampal 
circuitry, it is believed that these new inputs can interfere with existing neuronal 
circuitry (Akers et al., 2014). It has been demonstrated that increasing neurogenesis 
in adult rats after contextual fear conditioning by either voluntary running, 
administration of memantine or fluoxetine or conditional deletion of p53 impairs 
contextual recall (Akers et al., 2014). Thus, it appears that increased levels of 
hippocampal neurogenesis can impair the stability of existing memories and indeed 
it has been shown that reducing hippocampal neurogenesis can promote the stability 
of these memories (Epp et al., 2016). Additionally, this neurogenesis-associated 
forgetting has been suggested to be involved in the absence of memories from the 
first few years of life however conclusive evidence of this yet still needed (Welberg, 
2014)        
 
1.3.2: Neurogenesis in mood and antidepressant function 
It is well established that prolonged periods of heightened stress exposure can be 
detrimental to brain function and emotion. These effects have been clearly 
demonstrated within the hippocampus where chronic stress has been demonstrated to 
induce hippocampal atrophy, neuronal death, impairments in neurogenesis and in 
hippocampal-associated behaviours (Hueston et al., 2017, Sapolsky, 1996, Malberg 
and Duman, 2003, Hanson et al., 2011). The fact that the hippocampus appears to be 
involved in some aspects of regulating the stress response and the clear deleterious 
effects of stress on the hippocampus has naturally led researchers to question the role 
hippocampal neurogenesis has on the development of depression (Mirescu and 
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Gould, 2006, Dranovsky and Leonardo, 2012, Dranovsky and Hen, 2006, Sahay and 
Hen, 2007, Snyder et al., 2011). 
 
The functional link between hippocampal neurogenesis and depression began to 
emerge when it was noticed that most clinically used antidepressants, 
electroconvulsive therapy and environmental interventions such as exercise all 
enhanced hippocampal neurogenesis (Malberg et al., 2000, Madsen et al., 2000, 
Perera et al., 2007, Duman, 2004, van Praag et al., 1999c). It is evident from the 
literature that rodent and non-human primate models of depression have impairments 
in hippocampal neurogenesis (Czeh et al., 2001, Kronenberg et al., 2009, Tanti and 
Belzung, 2013) and patients with major depression show reduced hippocampal 
volume which could be linked to reduced neurogenesis (Eisch and Petrik, 2012, 
Small et al., 2011, Fotuhi et al., 2012). It has also been demonstrated that ablation of 
neurogenesis by irradiation blocked the behavioural effects of antidepressants in 
mice exposed to chronic unpredictable stress (Santarelli et al., 2003). This study used 
focal irradiation of the hippocampus to ablate neurogenesis and showed that 
treatment with antidepressants did not reverse the increase in latency for these mice 
to feed in a novel environment, a task usually sensitive to antidepressant treatment. 
This has led to the theory that some antidepressants work by altering neurogenesis 
and that neurogenesis itself is an important process in mood regulation (O'Leary and 
Cryan, 2014, Tanti and Belzung, 2013, Eisch and Petrik, 2012).  Structurally, the 
link between neurogenesis and mood regulation has been associated with the ventral 
hippocampus. Evidence for this comes from the fact that connections from the 
ventral hippocampus are made with structures associated with the HPA axis. It has 
also been demonstrated that the mood stabilising drug lithium preferentially 
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promotes neurogenesis in the ventral hippocampus (O'Leary et al., 2012). However, 
it must be noted that in this study this effect was only apparent in stressed animals 
and not in non-stressed animals thus highlighting the potential role of neutral 
hippocampal neurogenesis in stress responses.  
 
However, it is unlikely that impaired neurogenesis is an etiological factor in 
depression or other mood disorders. Support from this comes from the fact that 
ablation of neurogenesis does not induce depression-like or anxiety-like behaviours 
in rodents at baseline (Santarelli et al., 2003). Additionally, blocking neurogenesis 
does not induce anxiety-like behaviour in tests such as the open field, light-dark box, 
or elevated plus maze nor do mice lacking neurogenesis (via irradiation of the 
hippocampus or genetic ablation of glial fibrillary acidic protein-positive neural 
progenitor cells) display depression-like behaviour in the forced-swim test (Holick et 
al., 2008, Airan et al., 2007, Saxe et al., 2006). Thus, this theory has seen some 
modifications in recent years and it is now believed that neurogenesis can be 
regulated by stress and antidepressants ‘under certain as-yet-undefined conditions’ 
rather than neurogenesis being the underlying mediator of stress, depression and 
antidepressant treatment (Hanson et al., 2011). Thus, the exact role of hippocampal 
neurogenesis in mood regulation remains a complex field of research. 
 
It has been suggested that the environment that the new neurons are born into will 
determine their functional significance with regard to both learning and memory and 
mood regulation (Dranovsky and Leonardo, 2012, Glasper et al., 2012). For 
example, it has been proposed that neurons born in conditions of low stress 
contribute to learning and memory while neurons born in conditions of high stress 
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contribute to anxiety-like and escape behaviours (Glasper et al., 2012). Indeed, 
evidence now suggests that there is a critical role for hippocampal neurogenesis in 
the stress response and in the regulation of emotion (Cameron and Glover, 2015, 
Levone et al., 2015, Snyder et al., 2011). Moreover, recent evidence indicates that 
there is overlap between the role of neurogenesis in learning and emotion by 
demonstrating that inhibition of adult neurogenesis in the mouse DG reduces 
defensive behaviour to ambiguous threat cues but does not if the same negative 
experience is reliably predicted (Glover et al., 2017). This indicates that 
neurogenesis is required for adapting to a high stress situation of uncertainty whereas 
adaptation to a predictable stressor may be neurogenesis-independent. This then 
suggests that neurogenesis is a means of fine-tuning behavioural responses to 
environmental cues. 
 
1.3.3: Hippocampal neurogenesis in disease  
As there is strong evidence currently available to support the role of hippocampal 
neurogenesis in promoting hippocampal function (learning and memory, and 
emotional regulation), there is unsurprisingly a wealth of evidence linking 
neurogenesis to a myriad of neurological diseases affecting the hippocampus. 
Altered hippocampal neurogenesis has been associated with various preclinical 
models of neurological and psychiatric disorders such as epilepsy, schizophrenia and 
neurodegenerative diseases. Many of these diseases are associated with impaired 
hippocampal-associated cognition. However, whether abnormal neurogenesis 
contributes to the development of these diseases or results as a consequence remains 
to be determined (Danzer, 2008, Hsieh and Eisch, 2010).  
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Whether neurogenesis is increased or decreased depends on the disease state, and 
increases in neurogenesis do not always represent a positive response. In various 
rodent models of epileptogenesis including pilocarpine models of temporal lobe 
epilepsy (TLE) and direct limbic system electrode stimulation where prolonged 
seizure activity is produced, there is also a robust increase in NPC proliferation 
(Bengzon et al., 1997, Parent et al., 1997, Scott et al., 1998).  This enhancement of 
proliferation also translates to increased neuronal differentiation thus indicating 
successful neurogenesis (Parent et al., 2006). However, the timing of seizure 
induction is an important factor in determining the effects on neurogenesis. Shortly 
after kainic acid induced TLE (5 days), there is an increase in NPC proliferation 
however after 5 months there is a decrease in neurogenesis compared to control 
animals (Hattiangady et al., 2004). Indeed, in human hippocampal tissue there is 
evidence of decreased neurogenesis in epilepsy patients (Mathern et al., 2002, 
Fahrner et al., 2007). Epilepsy is also associated with aberrant displacement of NPCs 
and axonal reorganisation such that these newborn neurons integrate abnormally into 
the surrounding circuitry and promote network hyperexcitabiliy that is associated 
with epilepsy (Parent, 2007). This aberrant displacement of NPCs and axonal 
reorganisation is thus suggested to contribute to epileptogenesis and impairments in 
cognition (Balu and Lucki, 2009).  
 
Schizophrenia, like depression, has been strongly associated with reduced 
hippocampal volume (MacDonald and Schulz, 2009). This may be as a result of 
impaired neurogenesis, however, the most robust evidence linking schizophrenia to 
impaired neurogenesis comes from assessing the role of Disrupted-in-Schizophrenia-
1 (DISC1) gene in schizophrenia. The mutated form of DISC1 is an indicator of 
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schizophrenia susceptibility while its normal form appears to be critical for 
neurogenesis (Enomoto et al., 2009, Ming and Song, 2009, Mao et al., 2009, Kim et 
al., 2009). In preclinical studies using various models of schizophrenia including 
mice expressing mutated DISC1 and repeated phencyclidine (PCP) administration, 
there is a decrease in NPC proliferation and impaired survival and integration of 
newborn neurons (Duan et al., 2007, Liu et al., 2006, Maeda et al., 2007, Reif et al., 
2007). Additionally, mutated DISC1 has been shown to be highly expressed 
specifically in the hippocampi of patients diagnosed with schizophrenia (Nakata et 
al., 2009).  It has also been demonstrated that NPC proliferation is reduced in the 
hippocampi of schizophrenia patients and it is suggested that this might contribute to 
some of the cognitive deficits observed in these patients (Reif et al., 2006). 
Interestingly, drugs used to counteract symptoms of schizophrenia such as 
antipsychotics (clozapine), NMDA antagonists (memantine), and 
acetylcholinesterase inhibitors (donepezil) generally enhance various specific stages 
of neurogenesis and so these may produce their therapeutic effects in part by 
reversing the impairments in neurogenesis (Maeda et al., 2007, Kotani et al., 2008, 
Namba et al., 2009, Balu and Lucki, 2009). 
 
Alzheimer’s disease (AD) is characterised by neuronal loss and the build-up of 
hyperphosphorylated tau and amyloid beta (Aβ) protein into plaques within the basal 
forebrain, cortex, hippocampus and amygdala (Hardy and Selkoe, 2002). The 
hippocampus is one of the first structures to be affected in this disease (Fox et al., 
1996). There are conflicting reports demonstrating both increased and decreased 
hippocampal neurogenesis in various AD animal models as well as in clinical 
samples of hippocampal tissue (Haughey et al., 2002, Jin et al., 2004a, Jin et al., 
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2004b). Additionally, Aβ has been demonstrated to stimulate hippocampal NPC 
proliferation in vitro (Lopez-Toledano and Shelanski, 2004).  In an AD mouse model 
expressing a double or triple mutation in the amyloid precursor protein (APP) there 
is enhanced hippocampal NPC proliferation coupled with increased spine density 
and longer dendrites in newborn neurons (Jin et al., 2004a, Sun et al., 2009). Indeed, 
in humans it has been demonstrated that there is an increase in newborn neurons in 
the SGZ and CA1 region of the hippocampus in post-mortem tissue from AD 
patients (Jin et al., 2004b). However, it has been suggested that this may be a 
compensatory mechanism to replace neuronal loss (Winner et al., 2011). There is 
also evidence demonstrating that neurogenesis is decreased in human post-mortem 
tissue and that this may be mediated by increased bone morphogenic protein 6 
(BMP6) expression which is known to suppress embryonic neurogenesis (Crews et 
al., 2010, Nakashima and Taga, 2002). Thus, as AD is a complex and multifaceted 
disease, adult hippocampal neurogenesis may be differentially affected depending on 
the stage of the disease, the degree of plaque build-up, or even the age at which the 
disease begins (Winner et al., 2011).  
 
Hunttington’s disease (HD) and Parkinson’s disease (PD) are neurodegenerative 
disorders with similar disease etiology to that of AD. Both HD and PD are associated 
with protein aggregates, neuronal loss and lead to devastating impairments in 
cognition, particularly in HD, with PD characterised by initial motor dysfunction and 
late stage cognitive impairments (Winner et al., 2011, Collins et al., 2012). HD and 
PD have been shown to be associated with impaired hippocampal neurogenesis in 
vivo in mice models of these diseases (Lazic et al., 2004, Kohl et al., 2007, Crews et 
al., 2008). However, as with AD, HD and PD are multifaceted neurodegenerative 
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diseases and so the exact impact on hippocampal neurogenesis may differ depending 
on the disease state (Winner et al., 2011).  
 
1.4: Regulators of hippocampal neurogenesis 
Hippocampal neurogenesis is regulated by a wide range of intrinsic signalling 
molecules as well as by external factors influenced by the surrounding environment 
(Aimone et al., 2014). Intrinsic regulators of hippocampal neurogenesis include 
intracellular signalling pathways within NPCs, such as Wnt, Notch, NF-κB and 
mitogen-activated protein kinase (MAPK) pathway (Johnson et al., 2009, Aimone et 
al., 2014, Mu et al., 2010, Lie et al., 2005, Breunig et al., 2007, Faigle and Song, 
2013). These intrinsic factors regulate gene expression within NPCs in order to 
control their proliferation, differentiation and maturation into neurons or glia (Mu et 
al., 2010). Expression and function of these intrinsic regulators can be altered by 
external environmental factors, which subsequently lead to altered hippocampal 
neurogenesis. The main external environmental factors that influence hippocampal 
neurogenesis include stress, exercise, diet, learning, environmental enrichment and 
environmental toxins (Besnard and Sahay, 2016, Stangl and Thuret, 2009, Deng et 
al., 2010, Brown et al., 2003a, van Praag et al., 1999c). Voluntary exercise, learning, 
environmental enrichment and a healthy diet have all been shown to promote 
neurogenesis (Gould et al., 1999, An et al., 2008, van Praag et al., 1999c, van Praag 
et al., 1999a). However, the mechanism underlying their positive effects on 
neurogenesis is the subject of much research. For example, enhanced serum 
concentration of brain derived neurotrophic factor (BDNF) and increased levels of 
dietary nutrients, such as flavonoids (enriched in foods such as cocoa and 
blueberries) have been proposed as mediators of the pro-neurogenic effects of diet 
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and exercise, respectively (Erickson et al., 2011, An et al., 2008). Environmental 
factors that negatively regulate neurogenesis include stress, an unhealthy diet and 
environmental toxin exposure (Gould et al., 1998, Lindqvist et al., 2006, Sava et al., 
2007, Desplats et al., 2012). Interestingly, these negative regulators are all associated 
with neuroinflammation as evidenced by increased microglial activation and 
increased pro-inflammatory cytokine release (Tynan et al., 2010, Goshen et al., 
2008, Goshen and Yirmiya, 2009, Boitard et al., 2014, Purisai et al., 2007). Pro-
inflammatory cytokines released from activated microglia can affect many aspects of 
hippocampal neurogenesis including the proliferation, differentiation and maturation 
of NPCs. Therefore, they are robust manipulators of hippocampal neurogenesis 
(Green et al., 2012, Green and Nolan, 2012b, Ryan et al., 2013, Keohane et al., 2010, 
Yirmiya and Goshen, 2011, Borsini et al., 2015). While microglia are the 
predominant source of pro-inflammatory cytokines within the brain (Hanisch and 
Kettenmann, 2007), it should be noted that astrocytes are also susceptible to 
stimulation to release cytokines. However, they produce relatively low levels of 
cytokines but have been shown to potentiate the release of cytokines from microglia 
in response to an inflammatory insult (Barbierato et al., 2013, Chen et al., 2015).    
 
Successful hippocampal neurogenesis requires and is regulated by a wide range of 
intrinsic and extrinsic signals provided by the microenvironment in which the neural 
progenitor cells reside known as the neurogenic niche. Environmental factors 
influencing NPCs within these neurogenic niches include other NPCs, surrounding 
mature cells, cilia, secreted factors and neurotransmitters (Alvarez-Buylla & Lim 
2004; Ma et al. 2005; Faigle & Song 2013). The neurogenic niche is the main source 
of factors that determine whether NPCs undergo symmetrical or asymmetrical 
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division. Indeed, it has been demonstrated that cells derived from the spinal cord, 
traditionally not a neurogenic niche, display multipotentiality traits when 
transplanted into the DG (Shihabuddin et al., 2000). Additionally, local interneurons 
within the SGZ of the DG can release GABA which is known to enhance dentritic 
development and synaptic integration of newborn neurons (Ge et al., 2006, Ge et al., 
2007). Thus, the neurogenic niche within which the NPCs reside is the main 
determinant of fate of the cells rather than intrinsic factors within the cells 
themselves (Olsson et al., 1998, Brustle et al., 1997).  
 
It is thought that, within the SVZ and SGZ in particular, there are specific factors 
present that promote the differentiation and integration of new neurons. Within the 
SGZ, NPCs reside within close proximity to a dense layer of granular neurons 
including both mature neuronal and immature neuronal phenotypes. There are also 
glial cells present including astrocytes and oligodentrocytes which are believed to 
play a role in maintaining NPCs within the niche. For example, it has been 
demonstrated in vitro that hippocampal astrocytes and not astrocytes from non-
neurogenic spinal cord tissue, promote the neuronal differentiation and survival of 
newborn neurons derived from adult hippocampal NPCs (Lim and Alvarez-Buylla, 
1999, Song et al., 2002). Astrocytes are known to express a number of secreted and 
membrane attached factors such as cytokine (IL-1β and IL-6) and also growth factor 
related proteins (insulin-like growth factor binding protein 6) that are known to 
regulate proliferation and differentiation of NPCs (Barkho et al., 2006). It has also 
been demonstrated that the Wnt signalling pathway is involved in astrocyte-mediated 
promotion of neurogenesis, as inhibition of this pathway impairs the neurogenesis 
supportive role of astrocytes (Lie et al., 2005). Within the SVZ, NPCs are situated in 
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close proximity to ependymal cells of the lateral ventricles and these ependymal cells 
express various factors such as noggin (bone morphogenic protein antagoinist) and 
pigment epithelium-derived factor which can act to regulate NPC self-renewal 
(Ramirez-Castillejo et al., 2006, Lim et al., 2000).  
 
Microglia can also regulate NPCs activity. Not only do microglia remove the 
remains of apoptotic neurons, it has also been suggested that activation of microglia 
is required for the beneficial effects of environmental enrichment on neurogenesis 
(Ziv et al., 2006). Additionally, under inflammatory conditions or after tissue 
damage, the release of either pro- or anti-inflammatory cytokines by activated 
microglia can also regulate NPCs activity either positively or negatively depending 
on the balance of these cytokines (Ekdahl et al., 2009). 
 
NPCs in the SVZ and SGZ are also situated near the vasculature. Indeed within the 
SGZ, dense clusters of proliferating NPCs are found anatomically close to capillaries 
(Palmer et al., 2000). This then makes NPCs susceptible, not just to factors produced 
locally within the neurogenic niche, but also peripheral factors that can circulate in 
the blood stream and have direct effects on NPCs (Alvarez-Buylla and Lim, 2004). It 
has been shown that infusion of vascular endothelial growth factor (VEGF) can 
promote NPC proliferation in the SGZ and SVZ (Cao et al., 2004). Additionally, this 
effect was shown to be blocked by expression of a dominant negative VEGF 
receptor type 2, and that VEGF is required for the neurogenic effects of exercise and 
environmental enrichment. The close proximity of NPCs to the vasculature can also 
partly explain the beneficial effects of certain dietary factors on neurogenesis 
(Hueston et al., 2017). For example, flavonoids (a plant metabolite found in foods 
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such as blueberries, tea, and cocoa) and blueberries have been shown to enhance 
proliferation in chronically stressed and aged rats, respectively (An et al., 2008, 
Casadesus et al., 2004). It is suggested that these beneficial effects may be mediated 
in part by increasing circulating levels of brain derived neurotrophic factor (BDNF) 
(An et al., 2008). As well as receiving beneficial effects of peripheral stimuli, NPCs 
can also receive negative effects via the vasculature. For example stress and 
hippocampal pituitary adrenal (HPA) axis activation can increase circulating levels 
corticosterone (CORT) (cortisol in humans), which in turn can suppress NPCs 
activity (Wurmser et al., 2004).  
 
The importance of the vasculature in delivering factors to the neurogenic niche that 
can regulate hippocampal neurogenesis has been clearly demonstrated using 
heterochronic parabiosis (Villeda and Wyss-Coray, 2013). In this study, young mice 
were exposed to the systemic environment of older mice by suturing young and old 
mice together such that a shared circulatory system was generated (Conboy et al., 
2005). In these paired mice, there is a significant impairment in neuronal 
differentiation and survival as well as synaptic plasticity in the young mice however 
the opposite occurs in the older mice (Villeda and Wyss-Coray, 2013). This study 
shows that the neurogenic niche and residing NPCs are susceptible to circulating 
factors that can enter the niche via the vasculature.  Thus, the neurogenic niche under 
baseline conditions maintains expression of factors conducive to neurogenesis. 
However, it is susceptible to detrimental changes in these factors which in turn can 
inhibit NPC activity and neurogenesis. 
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1.4.1: Extrinsic regulators of hippocampal neurogenesis 
Hippocampal neurogenesis is a highly dynamic physiological process and as such is 
sensitive to a wide range of extrinsic factors. Extrinsic factors are known to both 
enhance and suppress neurogenesis depending on the specific factor (Aimone et al., 
2014). Commonly studied extrinsic regulators of neurogenesis include 
environmental enrichment, exercise, learning, diet and stress (van Praag et al., 
1999c, van Praag et al., 1999a, Kempermann et al., 1997a, Gould et al., 1999, Stangl 
and Thuret, 2009, Dranovsky and Hen, 2006).   
 
1.4.1.1: Environmental enrichment 
An enriched environment is generally defined as an environment that provides 
sensory, social and motor stimulation (Aimone et al., 2014). This paradigm involves 
placing animals in enlarged enclosures with added tunnels, toys, running wheels and 
other animals for social interaction and was originally demonstrated to induce 
enhanced neuroplasticity in rodents (Rosenzweig, 1966, Rosenzweig et al., 1978, 
Walsh et al., 1969). Environmental enrichment (EE) was first demonstrated to 
increase the number of newborn cells as labelled by BrdU and measured 40 days 
after mice were exposed to EE (Kempermann et al., 1997a).  This study did not 
demonstrate an increase in proliferation of NPCs and it largely believed that EE 
promotes the survival of newborn neurons rather than enhancing their proliferation  
(Kempermann et al., 2010). However, more recently an increase in proliferation by 
Ki67 labelling of proliferating cells after 40 days of EE was demonstrated (Karelina 
et al., 2012).  
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EE-induced newborn neurons are suggested to correlate with improved performance 
in hippocampal neurogenesis-associated behaviours such as spatial navigation in the 
Morris water maze (Kempermann et al., 1998, Kempermann et al., 1997a). The 
mechanism by which EE enhances neurogenesis is complex but it is suggested to be 
mediated in part through the increased production of neurotrophins and growth 
factors such as VEGF and BDNF within the hippocampus. In rats, shRNA-mediated 
knockdown of VEGF prevents the pro-neurogenic effects of EE (Cao et al., 2004). In 
mice lacking mitogen/stress-activated kinase 1 (MSK1), a downstream target of 
BDNF, there is no effect of EE on NPC proliferation suggesting that BDNF/MSK1 
signalling is a critical component of the effects of EE (Karelina et al., 2012). It 
should be noted though that increases in VEGF after EE have been reported in rats 
but not in mice and so there may be species specific differences in the mechanisms 
of EE-induced neurogenesis (Kuzumaki et al., 2011).  
 
1.4.1.2: Exercise 
In many EE paradigms, running wheels were added to the environment and it was 
since discovered that voluntary exercise alone is one of the strongest environmental 
enhancers of neurogenesis (van Praag et al., 1999c, van Praag et al., 1999a). Rodents 
who are allowed access to a running wheel in their homecage show increases in 
synaptic strength and plasticity, hippocampal-associated cognition, expression of 
growth factors and proliferation of NPCs (Wang and van Praag, 2012, van Praag et 
al., 1999a, van Praag et al., 1999c). Indeed, it has been suggested that the positive 
effects of EE are predominantly a result of increased exercise activity (Kobilo et al., 
2011). One study where mice were divided into four groups (control, running, EE 
and EE plus running), only the groups with access to running wheels demonstrated 
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increases in NPC proliferation, newborn neurons and neuronal survival (Kobilo et 
al., 2011). Notwithstanding this, it is believed that EE and exercise have additive 
effects on neurogenesis, with EE enhancing the survival of newborn neurons and 
exercise promoting NPC proliferation (Kempermann et al., 2010, Fabel et al., 2009). 
 
Aerobic exercise has been demonstrated to promote hippocampal neurogenesis-
associated spatial navigation behaviour in the MWM. Mice who were allowed access 
to a running wheel displayed reduced latencies to find the hidden platform (van 
Praag et al., 1999a).  Additionally, exercise has been shown to reverse the 
detrimental effects of aging on neurogenesis and related cognition (van Praag et al., 
2005). Like with EE, BDNF has been suggested to be a major component in 
mediating the effects of exercise on neurogenesis (Bekinschtein et al., 2011). BDNF 
mRNA expression was found to be increased in rats after exercise and was strongly 
correlated with the distance the rats ran on the running wheels (Neeper et al., 1995). 
Moreover, blockade of BDNF signalling in rats was shown to prevent exercise-
induced improvements in MWM performance, and intracerebroventricular injection 
of BDNF can mimic exercise induced improvements in object recognition (Gomez-
Pinilla et al., 2008, Griffin et al., 2009).  
 
1.4.1.3: Learning 
It is widely accepted that hippocampal neurogenesis has been linked with improved 
learning and memory in certain hippocampal-associated tasks (Leuner et al., 2006). 
Interestingly, the process of learning has been linked in turn with enhancing 
neurogenesis (Gould et al., 1999, van Praag et al., 1999a). Evidence for a positive 
relationship between learning and neurogenesis first appeared in studies assessing 
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neurogenesis in songbirds during seasonal fluctuations in song learning behaviour 
(Alvarez-Buylla et al., 1990, Goldman and Nottebohm, 1983). Evidence then came 
from rodent studies where rats trained in trace eyeblink conditioning and spatial 
learning in the MWM displayed an increase in the number of newborn neurons after 
training (i.e learning) (Gould et al., 1999).  Moreover, the effects of learning 
appeared to require learning hippocampal-dependent tasks, as hippocampal 
independent tasks (i.e. delay eyeblink conditioning and cued navigation in the 
MWM) did not increase the number of newborn neurons (Gould et al., 1999). Since 
then, studies have been carried out to try and elucidate the complex and seemingly 
reciprocal relationship between learning and neurogenesis. 
 
The process of learning is suggested to comprise of two main phases (Dobrossy et 
al., 2003). The first phase which involves rapid improvement in performance was 
found to have no effect on the number of newborn neurons in rats, whereas the 
second phase which involves slow increases in performance increased the number of 
newborn neurons and their survival after MWM training (Dobrossy et al., 2003). 
This effect was also demonstrated in trace eyeblink conditioning in rats (Leuner et 
al., 2004). The number of learning or training sessions has been shown to determine 
the impact on neurogenesis with few trials increasing cell survival and more trials 
having no effect or even decreasing cell survival (Gould et al., 1999, Dobrossy et al., 
2003, Olariu et al., 2005, Ambrogini et al., 2004, Snyder et al., 2005). However, this 
may be task dependent as 200 trace eyeblink training trials did not enhance cell 
survival whereas 800 trials did (Leuner et al., 2004). Moreover, it has more recently 
been suggested that for neurogenesis to be enhanced by learning, the learning 
paradigm must be sufficiently difficult, yet must be successfully learned (Curlik and 
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Shors, 2011). There is a clear linkage between successful neurogenesis and learning 
and vice versa. However, the ability of one to regulate the other is complex and may 
be task difficulty and duration dependent.  
 
1.4.1.4: Diet 
Diet is a readily modifiable factor that can influence cognition, mood, and 
hippocampal neurogenesis (Stangl and Thuret, 2009, Zainuddin and Thuret, 2012, 
Murphy et al., 2014). In humans it is suggested that the increase in ‘Western’ diets 
high in processed foods, fats and sugars is contributing to increased cognitive and 
emotional disorders (Jacka et al., 2010, Kanoski and Davidson, 2011). Conversely, 
healthy diets such as the Mediterranean diet that are high in vegetables, fruits, fish, 
and nuts and are rich in macronutrients such as omega-4, flavonoids promote healthy 
cognition (Willett et al., 1995, Feart et al., 2010, Panza et al., 2004). 
 
There are several ways in which diet can be modulated to potentially alter 
hippocampal neurogenesis, including altering calorie intake, meal texture and/or 
meal composition (Stangl and Thuret, 2009). Low calorie diets have been shown to 
increase memory performance in aged humans (Witte et al., 2009). Likewise in 
rodents, calorie restriction has been shown to enhance survival of new neurons and 
improve spatial learning in the radial arm maze and MWM (Lee et al., 2002a, Lee et 
al., 2002b, Lee et al., 2000, Stewart et al., 1989). Interestingly, intake of soft textured 
diet in rats has been associated with decreased proliferation in the hippocampus, 
however the mechanism for this is not fully understood (Aoki et al., 2005). It has 
since been demonstrated that liquid diet intake does impair proliferation in the 
hippocampus but does not alter the rate of new neuron production thus ultimately not 
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affecting neurogenesis (Patten et al., 2013). Diets rich in flavonoids, a compound 
found in berries, green tea, parsley and cocao, can increase NPC proliferation and 
performance in hippocampal-related memory tasks (Wang et al., 2011, Yoo et al., 
2010, Lee et al., 2010). Additionally, in rats exposed to chronic unpredictable stress, 
a flavonoid rich diet reversed the stress-induced decrease in proliferating NPCs 
within the DG (An et al., 2008). Similar pro-neurogenic and improved neurogenesis-
associated cognitive effects have been demonstrated with omega-3 fatty acids, 
polyphenols, magnesium, and zinc (Kawakita et al., 2006, Valente et al., 2009, 
Abumaria et al., 2013, Levenson and Morris, 2011). 
 
Conversely, diets high in fat and/or sugar have been demonstrated to impair 
hippocampal neurogenesis and associated cognition. For example, access to sucrose 
in drinking water for just two hours daily impaired hippocampal-associated spatial 
pattern separation and this coincided with a reduction in newborn neurons in the 
hippocampus of rats (Reichelt et al., 2016). Likewise, high fat diet intake has been 
shown to impair NPC proliferation and is also linked with impairments in spatial 
memory in the MWM in rats (Lindqvist et al., 2006, Molteni et al., 2002). The 
combination of both high fat and high sugar diet into a single ‘cafeteria diet’ has also 
been shown to impair hippocampal-associate spatial memory after just 5 days of 
consuming the diet in rats (Beilharz et al., 2014). Interestingly, it has been shown 
that young mice (P21) fed a high fat diet for 11 weeks exhibit impaired cognitive 
performance in the radial arm maze and a reduced number of newborn neurons 
whereas adult mice fed the same diet do not (Boitard et al., 2012). Similarly, rats 
displaying cognitive deficits in MWM performance after juvenile high fat diet intake 
displayed no deficits after adult high fat diet intake (Boitard et al., 2014). However, 
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in rats fed a high fat diet for 3 months and then switched to standard chow for 3 
months, impairments in MWM performance are reversed (Boitard et al., 2016). 
Taken together, these studies indicate that the adolescent period is a particularly 
plastic period yet also vulnerable to diet induced impairments in hippocampal 
neurogenesis-associated cognition (Hueston et al., 2017). 
 
The mechanisms by which diet influences neurogenesis are complex. For many 
dietary modulations, whether there is a direct interaction between nutrients in the 
various diets and NPCs or if the diets regulate neurogenesis indirectly, remain to be 
elucidated. In many cases it may be a combination of both. For example, omega-3 
fatty acids have been shown to directly stimulate the birth of new neurons in vitro 
while also enhancing pro-neurogenic BDNF expression which could indirectly 
stimulate neurogenesis (Kawakita et al., 2006, Wu et al., 2004). Interestingly, the 
pro-neurogenic effect of calorie restriction was not evident in BDNF
-/+ 
mice where 
there is reduced BDNF signalling (Lee et al., 2002a). This suggests that BDNF may 
mediate some of the effects of certain diets on neurogenesis. Alternatively, the 
effects of diet on neurogenesis may, in part, be mediated by its effects on the gut 
microbiota composition. As diet is the leading factor in microbiota alterations, and 
microbiota composition has been demonstrated to affect hippocampal neurogenesis, 
this represents another possible indirect mechanism through which diet can 
manipulate neurogenesis (Ogbonnaya et al., 2015, Heberden, 2016, De Filippo et al., 
2010, McAllan et al., 2014). 
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1.4.1.5: Stress 
Stress has widely been demonstrated as a potent manipulator of neurogenesis 
(Aimone et al., 2014, Levone et al., 2015, Schoenfeld and Gould, 2012). Stressors 
known to affect neurogenesis can either be physical (e.g. restraint stress, footshock), 
social (e.g. social defeat or subordination stress), or odour (e.g. predator odour) 
based. Additionally, these stressors can either be chronic or acute (Schoenfeld and 
Gould, 2012, Gould et al., 1997, Tanapat et al., 2001, Malberg and Duman, 2003). 
Chronic social defeat stress, where an aggressor rodent is placed in the cage with the 
test subject, has been demonstrated to decrease NPC proliferation in several animal 
models (Czeh et al., 2001, Czeh et al., 2007, Ferragud et al., 2010). Similar anti-
neurogenic effects have been demonstrated after chronic stress paradigms using 
restraint stress and footshock, which impair NPC proliferation and neuronal 
differentiation in rodents however, the effects on differentiation may result from 
impaired proliferation (Dagyte et al., 2009, Bain et al., 2004).  
 
Acute stressors are generally a single stressful event and results are more variable 
than chronic stress. Acute exposures to predator odour or acute social defeat have 
been shown to robustly reduce NPC proliferation and neuronal differentiation in 
rodents (Tanapat et al., 2001, Lagace et al., 2010). Acute restraint stress have shown 
conflicting results with some studies showing no effect on NPC proliferation in adult 
rats (Pham et al., 2003), and others showing decreased proliferation in rats and an 
increase in mice (Bain et al., 2004). Chronic restraint stress has also yielded species 
dependent results, with rats exhibiting reduced newborn neuron survival but 
enhanced survival in mice (Snyder et al., 2009). The conflicting results have been 
suggested to be a result of variations in species and strain differences in stress 
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susceptibility (Buynitsky and Mostofsky, 2009). Indeed, it has also been suggested 
that variation in neurogenesis across species and strains may determine their 
responses to stressors, and increased neurogenesis may even promote stress 
resilience (Levone et al., 2015). 
 
Stress is associated with HPA activation and release of glucocorticoids from the 
adrenal glands into the bloodstream (Schoenfeld and Gould, 2012). Corticosterone 
itself can cross the blood brain barrier and has been demonstrated to suppress NPC 
proliferation (Cameron and Gould, 1994b, Wong and Herbert, 2006). Conversely, 
adrenalectomy has been shown to result in enhanced NPC proliferation (Gould et al., 
1992, Cameron and Gould, 1994a). This suggests that stress effects on circulating 
glucocorticoids mediate its effects on neurogenesis. However, it has been 
demonstrated that the pro-inflammatory cytokine interleukin-1 beta (IL-1β) mediates 
the effects of stress, specifically on neurogenesis (Koo and Duman, 2008).Thus, the 
mechanism of stress-induced impairments in neurogenesis may rely on multiple 
factors including glucocorticoid and cytokine expression. 
 
1.4.2: Intrinsic regulators of hippocampal neurogenesis 
As well as extrinsic regulators of neurogenesis, there are a host of intracellular 
intrinsic regulators of neurogenesis. These include members of several signalling 
pathways and associated transcription factors that act to regulate gene expression 
within NPCs, which in turn maintains the various stages of neurogenesis under strict 
control (Horgusluoglu et al., 2017, Aimone et al., 2014, Zhao et al., 2008). As 
neurogenesis is a complex and dynamic process, so too are the intrinsic factors that 
regulate it, with many overlapping signalling pathways which are differentially 
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activated depending on the stage of neurogenesis they regulate (Aimone et al., 2014, 
Urbán and Guillemot, 2014). 
 
1.4.2.1: Signalling pathways in neurogenesis 
Several critical signalling pathways are involved in regulating various stages of 
hippocampal neurogenesis including NPC proliferation. Arguably some of the most 
important of these pathways include Wnt, Notch, and Sonic hedgehog (Shh) 
signalling pathways (Aimone et al., 2014, Balu and Lucki, 2009). Wnt proteins and 
their cognate receptors are expressed in hippocampal NPCs (Lie et al., 2005). Wnt 
proteins are cystein rich secreted glycoproteins and can signal via two distinct 
pathways, the canonical β-catenin pathway and non-canonical β-catenin-independent 
pathway (Nusse and Varmus, 1982, Willert et al., 2003). Typically, it is signalling 
via the canonical β-catenin pathway that regulates Wnt effects on hippocampal 
neurogenesis (Willert et al., 2003). Wnt proteins can be released by astrocytes near 
the NPCs within the DG which in turn promotes NPC proliferation and neuronal 
differentiation via activation of Wnt signalling-dependent activation of NeuroD1 
(Kuwabara et al., 2009, Song et al., 2002). Additionally, it has been demonstrated 
that overexpression of Wnt3 increased NPC proliferation and neuronal 
differentiation within the hippocampus while blockade of Wnt signalling reduced 
proliferation and differentiation (Lie et al., 2005). Glycogen synthase kinase 3 beta 
(GSK3β) is a negative regulator of Wnt signalling via inhibiting the Wnt co-
signalling molecule β-catenin, and plays an important role in maintaining control of 
Wnt signalling to regulate normal neurogenesis, particularly during embryonic 
development (Ikeya et al., 1997, Reya et al., 2003, Zeng et al., 1997, Salinas and 
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Zou, 2008). Conversely, GSK-3β may mediate some of the anti-proliferative effects 
of IL-1β associated inflammation on NPCs (Green and Nolan, 2012b). 
 
Notch signalling regulates a wide range of aspects involved in neurogenesis 
including NPC proliferation, differentiation, and survival (Louvi and Artavanis-
Tsakonas, 2006, Faigle and Song, 2013). Notch receptors are single-pass 
transmembrane receptors that, when activated by surface ligands on neighbouring 
cells, are cleaved to release an intracellular fraction that translocates to the nucleus 
(Schroeter et al., 1998). Overexpression of activated Notch in adult mice has been 
demonstrated to induce an increase in NPC proliferation thus, maintaining the NPC 
pool (Breunig et al., 2007). Likewise, inhibition of Notch signalling led to a decrease 
in NPC proliferation and premature neuronal differentiation (Breunig et al., 2007). In 
addition to this, Notch deletion led to dendritic arborisation whereas Notch1 
overexpression led to increased dendritic complexity (Breunig et al., 2007). Thus, 
Notch signalling acts to maintain NPC in a proliferative state and also regulates the 
dendritic complexity of newborn neurons. 
 
Sonic hedgehog (Shh) is an extracellular soluble signalling protein that has been 
demonstrated to be vitally important in regulating nervous system development 
(Ruiz i Altaba et al., 2002). Post-natally, Shh has been shown to be involved in the 
formation and maintenance of a hippocampal NPC pool (Han et al., 2008). Shh 
signals via two different receptors, patched (Ptc) and smoothened (Smo), both of 
which are expressed on hippocampal NPCs (Lai et al., 2003, Traiffort et al., 1998). 
In the absence of a Shh ligand, Ptc represses signal transduction from the Smo 
receptor thus repressing downstream signalling. After binding of Shh to Ptc, 
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disinhibition of Smo leads to activation of an intracellular signalling cascade 
resulting in the differential regulation of Shh target genes (Philipp and Caron, 2009). 
Overexpression of active Shh with the DG of rats has been demonstrated to increase 
cell proliferation and survival without affecting neuronal differentiation (Lai et al., 
2003). Interestingly, recruitment of Shh signalling is suggested to be a mechanism 
through which electroconvulsive shock therapy promotes hippocampal NPC 
proliferation (Banerjee et al., 2005). Conversely, administration of cyclopamine, a 
Shh inhibitor, reduced cell proliferation (Lai et al., 2003, Banerjee et al., 2005). 
Additionally, Smo knockout mice show significant impairments in NPC proliferation 
within the SGZ (Machold et al., 2003, Han et al., 2008). 
 
1.4.2.2: Nuclear receptors in neurogenesis 
Nuclear receptors (NRs) are a superfamily of intracellular ligand regulated 
transcription factors and are common drug targets: approximately 13% of all Food 
and Drug Administration (FDA) approved drugs target NRs (Rask-Andersen et al., 
2011). The NR superfamily shares a similar three domain structure. These domains 
include a highly conserved DNA binding domain, a ligand binding domain, and a 
variable N-terminal transactivation domain, which binds various co-activators and 
co-repressors. As NRs are transcriptional regulators, they govern many aspects of 
development, reproduction and metabolism via suppression or promotion of gene 
expression (Sun and Shi, 2010). Many nuclear receptors have been demonstrated to 
regulate neurogenesis including glucocorticoid receptors (GRs), estrogen receptors 
(ERs), peroxisome proliferator activated receptors (PPARs) and the orphan nuclear 
receptor tailless homolog (TLX or NR2E1) (See figure 1.4 and 1.5) (O'Leime et al., 
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2017a). As TLX is a major topic in this thesis, it will be discussed in greater detail in 
section 1.5.3. 
 
Glucocorticoid receptors (GRs) have a pivotal role to play in the stress response and 
immune function (Garcia et al., 2004, Busillo and Cidlowski, 2013). The main 
activators of GRs are adrenal glucocorticoid hormones or stress hormones. 
Corticosterone (CORT), or cortisol in humans, is a lipophilic glucocorticoid 
hormone produced from cholesterol that readily passes the blood brain barrier and 
can enter neuronal cells through the cell membrane. CORT is produced mainly by 
the adrenal glands, however there is evidence to suggest that it is also produced 
within the hippocampus where there is an abundance of enzymes required for its 
production (Beyenburg et al., 2001, Gomez-Sanchez et al., 1996, Stromstedt and 
Waterman, 1995). Two types of GR exist, the glucocorticoid receptor (GR) and the 
mineralocorticoid receptor (MR). GRs are expressed in about 50% of all 
proliferating NPCs with MRs below detectable levels, and as NPCs begin to express 
the immature neuronal marker doublecortin (DCX), the expression of GR within 
these cells is significantly reduced but is restored again once the NPCs mature into 
neurons (Garcia et al., 2004, Cameron et al., 1993, Boku et al., 2009). This suggests 
that GRs initially mediate the effects of CORT on NPCs proliferation and are then 
subsequently involved in the regulation of neuronal activity. Mice lacking GR 
display impairments in hippocampal neurogenesis-associated behaviours. For 
example, deficits in contextual fear conditioning in GR knockdown mice is coupled 
with reduced NPC proliferation and accelerated neuronal differentiation (Fitzsimons 
et al., 2013). 
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Peroxisome Proliferator Activated Receptors (PPARs) consist of three main 
subtypes; PPARα, PPARβ/δ, and PPARγ. They can be activated by endogenous lipid 
compounds, such as prostaglandins and other fatty acids, as well as synthetic 
compounds from the diabetic drug class thiazoladinediones (Ahmadian et al., 2013). 
Much of the focus on the role of PPARs in hippocampal neurogenesis to date has 
focused on PPARγ, although all PPAR subtypes have been shown to be expressed in 
the DG of the hippocampus in adult rats and in mouse NPCs from the SVZ (Bordet 
et al., 2006, Sun and Shi, 2010, Moreno et al., 2004, Cimini et al., 2007). PPAR 
deficient NPCs failed to proliferate whereas treatment with the PPARγ agonist 
rosiglitazone induced cell growth and inhibited differentiation of NPCs into neuronal 
cells (Wada et al., 2006). Both PPARγ and PPARβ/δ activation in NPCs in the SVZ 
of adult mice leads to increased proliferation in these cells (Bernal et al., 2015). 
These authors also demonstrated that PPARγ activation increased the expression of 
PPARβ/δ, suggesting that these receptor isotypes work in tandem to promote 
proliferation of NPCs. It should be noted however, that the variation of PPAR effects 
on neurogenesis may be due to the wide variety of compounds used to modulate their 
activity with each one having differing dosage and time dependent effects 
(Ghoochani et al., 2012, Wada et al., 2006). Indeed, it has been shown that with 
doses of the PPARγ agonists rosiglitazone or pioglitazone in excess of 30μM, cell 
proliferation of embryonic NPCs is significantly reduced (Wada et al., 2006). 
 
Two types of estrogen receptors (ERs) exist; ERα and ERβ. Both are expressed 
within the hippocampus of rodents and humans, with ERα displaying a slightly 
higher expression profile in rodents and ERβ slightly higher in humans (Mitterling et 
al., 2010, Pérez et al., 2003, Towart et al., 2003, Osterlund et al., 2000, González et 
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al., 2007). The sex or estrogen hormones estradiol, estrone, and estriol bind to ERs. 
Estradiol is the most potent and has been the focus of most research to date on the 
role of the ERs in hippocampal function (McEwen et al., 2012, McEwen and Milner, 
2007, Vasudevan and Pfaff, 2008). Estradiol is synthesised from cholesterol, mainly 
in the ovaries in females and estrogen has also been shown to be locally produced by 
hippocampal neurons in male rats (Hojo et al., 2004). It has been shown in rats, that 
ERs are expressed within adult and postnatal hippocampal NPCs (Mazzucco et al., 
2006, Pérez et al., 2003). Administration of estradiol to female rats or meadow voles 
has been shown to increase NPC proliferation, however this effect was only 
observed after 4 hours of treatment whereas with 48 hours of treatment there was a 
suppression of cell proliferation within the DG (Ormerod and Galea, 2001, Ormerod 
et al., 2003). Estradiol induces a rapid increase in serotonin levels that has been 
suggested to mediate estradiol effects on NPC proliferation in the DG of rats (Banasr 
et al., 2001). With prolonged estradiol exposure, adrenal activity is increased and so 
suppression of the proliferation of NPCs within the DG ensues (Ormerod et al., 
2003). Thus, normal nuclear receptor mediated signalling play a critical role in 
regulating neurogenesis, however excessive or impaired signalling through these 
receptors can result in dysregulation. 
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Figure 1.4: Nuclear Receptor signalling. A) Glucocorticoid receptor (GR) 
signalling. B) PPAR receptor signalling. C) Estrogen receptor (ER) signalling. D) 
NR2E1 (TLX) receptor signalling. GRs can be activated by ligands, such as 
corticosterone in rodents, once activated they form homodimers and regulate gene 
transcription. PPARs are activated by a wide variety of synthetic and endogenous 
ligands and can form heterodimers with the retinoid x receptor (RXR) to regulate 
gene transcription. ERs form either homo or heterodimers with other ER subtypes 
once activated by ligands, such as estradiol. NR2E1 is an orphan nuclear receptor 
and as such has no known ligand yet it recruits various co-signalling molecules, such 
as HDAC3/5 and LSD1 to repress gene expression. (O'Leime et al., 2017a). 
 
1.4.3: TLX (NR2E1) 
Homolog of the drosophila tailless gene (TLX) is an orphan nuclear receptor, which 
is also known as nuclear receptor subfamily 2 group E member 1 (NR2E1), is 
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predominantly expressed in the eye and forebrain (Monaghan et al., 1995). Indeed, 
the expression of TLX is mainly restricted to the mammalian CNS (Li et al., 2012). 
In the adult, TLX is mainly expressed in the DG in the hippocampus and the SVZ 
zone of the lateral ventricles. Like most nuclear receptors, TLX has at least three 
structural domains, a DNA binding domain, an N-terminal transactivation domain 
and a moderately conserved ligand-binding domain (LBD) (Yu et al., 1994, Bain et 
al., 2007, Benod et al., 2014a). TLX functions primarily as a transcriptional repressor 
of downstream target genes. To do so, TLX recruits transcriptional co-repressors, 
such as the epigenetic modulators lysine-specific histone demethylase 1 (LSD1), and 
HDACs 3 and 5, which repress gene expression and in turn suppress the expression 
of anti-proliferative genes to regulate NPC proliferation (Sun et al., 2007, Sun et al., 
2010, Sun et al., 2011). Genes regulated by TLX include Ascl1, Pou5f1, Pax2, Mir9, 
Mir137, Pten, p21, Cdkn1a, Sirt1, and Wnt7a (Islam and Zhang, 2014). Importantly, 
repression of cyclin dependent kinase inhibitor p21 and the tumour suppressor gene 
Pten by TLX activation, promote the proliferation of NPCs (Sun et al., 2007). At a 
cellular level, TLX has been demonstrated to be critical for maintaining neural stem 
cell proliferation in both the developing embryonic forebrain and dorsal midbrain, 
and within the neurogenic niches of the adult brain (Monaghan et al., 1995, Shi et al., 
2004, Sun et al., 2007).  
 
TLX expressing NPCs from the SGZ, SVZ, and olfactory bulb proliferate and are 
capable of differentiating into all neural cell types whereas NPCs lacking TLX fail to 
proliferate (Shi et al., 2004). The importance of TLX was further demonstrated by 
the fact that reintroduction of TLX into NPCs restored all of the deficits in 
proliferation observed in the cells lacking TLX (Shi et al., 2004). Moreover, 
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overexpression of TLX within hippocampal NPCs has been shown to enhance the 
proliferation phase of neurogenesis and subsequently improve learning and memory 
processes in mice (Murai et al., 2014). TLX knockout mice show deficits in 
hippocampal neurogenesis and impaired learning and memory as well as a 
heightened stress response (Monaghan et al., 1997, Young et al., 2002, O'Leary et 
al., 2016a). More recently, it has been demonstrated that mice with a spontaneous 
deletion of TLX (not genetically engineered to delete TLX) display impairments in 
hippocampal neurogenesis-associated cognitive tasks (O’Leary et al., 2016). 
Specifically, this study demonstrated that TLX
-/- 
mice displayed impaired spatial 
memory as tested by spontaneous alternations in the Y-maze. Additionally, it was 
reported that male adolescent mice displayed impaired contextual fear conditioning 
performance indicating a role for TLX in sex and age dependent effects on certain 
hippocampal neurogenesis-associated tasks (O'Leary et al., 2016a).  
 
Most work to date assessing the relevance of TLX in hippocampal neurogenesis-
associated cognition has focused on genetic reductions (germline knockouts or 
inducible knockouts) in TLX expression (O'Leary et al., 2016b). For example,  TLX 
knockout in mice (cre-lox deletion) resulted in impaired performance in the Morris 
water maze spatial memory task (Zhang et al., 2008). This impairment in cognition 
was also associated with impaired hippocampal neurogenesis. However, it has been 
demonstrated that enhancing TLX expression specifically in NPCs can promote 
hippocampal neurogenesis and enhance performance in the Morris water maze task 
(Murai et al., 2014). This study demonstrated the potential for TLX as a therapeutic 
target to selectively enhance hippocampal neurogenesis and associated cognition. 
Thus, it would appear the TLX is intrinsically linked with both the cellular 
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mechanisms and functional outcomes of hippocampal neurogenesis and as such its 
role in mitigating neuropathology-induced deficits in neurogenesis will be of interest 
for future research. 
 
 
Figure 1.5. Nuclear receptors regulate various aspects of hippocampal neurogenesis 
(O'Leime et al., 2017a).  
 
1.5: Experimental manipulation of neurogenesis 
To determine the role of hippocampal neurogenesis in various behaviours, 
researchers use different methods to either ablate or enhance hippocampal 
neurogenesis and thus determine the consequent effects on behaviour. As 
neurogenesis involves multiple processes (i.e. proliferation of NPCs, differentiation, 
integration, and survival of newborn neurons), various methods have been developed 
to target specific or several of these processes, and these methods have greatly 
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enhanced our understanding of the functional role of hippocampal neurogenesis 
(Imayoshi et al., 2011). 
 
1.5.1: Irradiation 
Exposure of the brain to radiation occurs during many clinical situations particularly 
as a form of cancer therapy (Burger et al., 1979, Sheline et al., 1980). It has been 
demonstrated with aggressive radiation therapy treatments, that there is significant 
tissue destruction and subsequent morphological and cognitive impairments in both 
humans and animal models (Caveness, 1977, Schultheiss et al., 1995, Hopewell, 
1979, Fike and Gobbel, 1991, Van der Kogel, 1991). However, even after lower 
doses of ionizing radiation, cognitive impairments are evident despite little effect on 
morphology (Abayomi, 1996, Butler et al., 1994, Kramer et al., 1992). Cognitive 
impairments that have been typically reported include impaired attention and 
memory performances which are indicative of impairments in hippocampal function 
(Crossen et al., 1994, Imperato et al., 1990, Roman and Sperduto, 1995). It has since 
been demonstrated that radiation directed at the hippocampus of adult rats induces a 
long-lasting suppression of proliferating cells (Tada et al., 2000).  
 
Radiation-induced suppression of neurogenesis has been used to assess the role of 
hippocampal neurogenesis in rodents subjected to various behavioural paradigms 
such as MWM, Barnes maze, contextual fear conditioning and novel object 
recognition (Wong-Goodrich et al., 2010, Winocur et al., 2006, Rola et al., 2004, Ji 
et al., 2014, Rao et al., 2011, Conner et al., 2010). Additionally, radiation-mediated 
ablation of neurogenesis was used to demonstrate that some antidepressants function 
by enhancing neurogenesis (Santarelli et al., 2003). All of these behaviours have 
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been demonstrated to be impaired weeks to months after hippocampal irradiation. 
However, these results may not be a consequence of impaired neurogenesis alone. 
Radiation treatment has been demonstrated to induce a significant inflammatory 
response with increased oxidative stress and cytokine expression (Hong et al., 1995, 
Kataoka, 2013, Nakatsukasa et al., 2008). Interestingly, treatment of rats with the 
anti-inflammatory drug indomethacin is sufficient to prevent the detrimental effects 
of radiation on neurogenesis (Monje et al., 2003). This then suggests, that radiation 
is not an entirely effective method of assessing the functions of neurogenesis as 
multiple non-neurogenesis effects may result due to increased inflammation. 
 
1.5.2: Transgenic animals 
Neurogenesis can be selectively ablated or enhanced using transgenic animals. Site 
specific recombinases (SSRs) are enzymes used as part of genome editing 
technology to delete or insert specific DNA sequences into specific regions of the 
genome (Nagy, 2000, Wu et al., 2007). A commonly used recombinase is Cre 
receombinase (Nagy, 2000). Cre recognises loxP recognition sites within DNA and 
effectively excises any DNA sequence found between two loxP recognition sites 
(Imayoshi et al., 2011). Control of Cre-mediated recombination of specific genes is 
commonly achieved by fusing the Cre protein to the mutated ligand-binding domain 
(LBD) of the estrogen receptor to produce a ligand-dependent chimeric CreER 
recombinase (Metzger et al., 1995, Feil et al., 1997). In these transgenic mice, CreER 
is activated by administration of the synthetic ER antagonist tamoxifen which results 
in genetic recombination by Cre recombinase (Indra et al., 2000, Li et al., 2000). 
Moreover, this genetic recombination cannot be induced by natural ER ligands such 
as estradiol, thus providing robust control over gene expression. 
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Using this CreER recombinase genome editing technology, researchers can generate 
transgenic mice in which the CreER recombinase gene is driven by NPC specific 
promoters such as the Nestin promoter or glial fibrillary acidic protein (GFAP) 
promoter (Imayoshi et al., 2006, Lagace et al., 2007, Favaro et al., 2009). This 
results in only NPCs expressing CreER. These transgenic mice can then be used to 
cross breed with reporter mice which have ubiquitous expression of a reporter gene 
such as (green fluorescent protein) GFP. The expression of this reporter gene is 
prevented by transcriptional STOP cassette which is flanked by two loxP sites. Thus, 
when CreER is activated by tamoxifen, the STOP sequence is removed allowing for 
transcription of the reporter specifically in CreER expressing cells, i.e. NPCs. These 
CreER-reporter transgenic mice are used widely for visualising and tracing the 
lineage of NPCs in response to various stimuli.     
 
Neurogenesis can be successfully manipulated using transgenic animals also. In 
nestin-CreER transgenic mice where loxP flanked Bax (a pro-apoptotic gene) is 
expressed specifically in nestin expressing NPCs, administration of tamoxifen to 
these mice removed Bax expression within NPCs of these mice (Sahay et al., 2011a, 
Hill et al., 2015). This enhances survival of NPCs which in turn results in increased 
new neuron survival as they differentiate, as well as improved pattern separation 
performance and reduced anxiety and depression-like behaviours in CORT treated 
mice (Sahay et al., 2011a, Hill et al., 2015). There are other forms of transgenic mice 
commonly used to study neurogenesis apart from CreER mice. These include GFAP-
TK or nestin-TK mice in which the expression of herpes simplex virus thymidine 
kinase (HSV-TK) is driven by either GFAP or nestin promoters thus localising HSV-
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TK expression largely to NPCs.  Expression of thymidine kinase renders the cells 
susceptible to the anti-viral drug valganciclovir and when these animals are 
administered this drug, GFAP or nestin expressing cells are ablated. This method has 
been used to ablate neurogenesis and demonstrate impairments in specific fear 
learning paradigms with ambiguous rather than reliably predicted cues (Glover et al., 
2017, Snyder et al., 2011). Additionally, transgenic models in which the nuclear 
receptor TLX is overexpressed specifically in NPCs have been used to demonstrate 
that increase TLX-induced NPC proliferation promotes hippocampal neurogenesis-
associated spatial navigation in the MWM (Zhang et al., 2008, Murai et al., 2014). 
These extremely targeted manipulations of neurogenesis are valuable in unravelling 
the exact role neurogenesis plays in behaviour.  
 
1.5.3: Spontaneous deletion animal models 
Spontaneous deletion animal models are models in which there is a deletion of s 
specific gene which has not been experimentally induced (i.e. targeted knockouts). 
Of particular interest to the study of neurogenesis is the TLX spontaneous deletion 
mouse model. In this model, a spontaneous germline genetic disruption occurs, 
which results in the complete deletion of the TLX gene without affecting the 
transcription of neighbouring genes (Kumar et al., 2008, Young et al., 2002). The 
occurrence of this specific spontaneous deletion has been investigated in a variety of 
mouse strains including C57BL/6J, 129P3/JEms and Bl6129F1 (Young et al., 2002). 
The majority of work has been carried out on the 129P3/JEms and crossbred 
Bl6129F1 strains as these strains do not display the hydrocephalus evident in the 
C57BL/6J strain (Young et al., 2002, Kozareva et al., 2017a, O’Leary et al., 2016). 
As TLX is a critical regulator of hippocampal neurogenesis, spontaneous deletion 
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TLX mice have severely impaired hippocampal neurogenesis as well as significant 
impairments in associated cognitive processes such as contextual fear conditioning 
and spontaneous alternation in the Y-maze (O’Leary et al., 2016, Shi et al., 2004). 
Additionally, these mice display a broad range of behavioural abnormalities 
including increased aggressiveness and anxiety-like behaviour as well as 
hyperactivity (Roy et al., 2002, O'Leary et al., 2016a). As these mice lack TLX from 
development, it could be that the behavioural effects observed are due to 
developmental deficits in TLX rather than deficits in adulthood. Nonetheless, the 
fact these mice relatively easy to produce means they represent a valuable alternative 
to developing transgenic models. 
 
1.5.4: Viral vectors 
Viral vectors are a common method of gene delivery which hijacks the ability of 
viruses to transfer their genes into a host cell (Deglon and Hantraye, 2005). Various 
types of viral vectors exist, each with their own advantages and disadvantages. 
Important aspects to consider when utilising viruses to manipulate hippocampal 
neurogenesis include whether the virus can transfect mitotic cells, post-mitotic cells 
or both, the size of the gene that is being transferred, and whether the transferred 
gene is to be inserted into the host genome for prolonged expression or remain 
extranuclear for short term expression (Walther and Stein, 2000). Additionally, viral 
vectors can be used to transfer short hairpin RNA (shRNA) molecules which can be 
used to block endogenous gene expression (Bahi and Dreyer, 2012). The most 
commonly used viral vectors for CNS gene transfer include viruses derived from 
adeno-associated virus (AAV), herpes simplex virus and lentiviruses (LV) (Senut et 
al., 2000, Natsume et al., 2001, Osinde et al., 2008). Many of these have been used 
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to manipulate aspects of neurogenesis or assess the effects of prolonged expression 
of various protein factors on neurogenesis (Jessberger et al., 2009b, Ryan et al., 
2013, Lagace et al., 2008, Xu et al., 2015, Aelvoet et al., 2015, Pechnick et al., 2011, 
Wu et al., 2013, Yoshimura et al., 2003). 
 
AAV was originally discovered as a contaminant in laboratory stocks of adeno virus 
(Monahan and Samulski, 2000). AAV are small, non-pathogenic viruses that are 
capable of transferring small amounts of DNA into the host cells. AAVs transfer 
DNA sequences which can site specifically intergrate into the host genome. In 
human cells, it was initially suggested that approximated 70% of transductions result 
in successful integration of viral transferred genes into the host genome (Kotin et al., 
1990, Weitzman et al., 1994). However, AAV transferred genetic material does not 
generally integrate, and indeed integration after AAV transfection has been 
associated with tumorigenesis in mice (Deyle and Russell, 2009). However, AAVs 
do provide long-term stable gene expression and can transfect dividing and non-
dividing cells (Bouard et al., 2009). The AAV genome itself is small (4.7kb) but 
very little of the viral genome is required for successful transduction of host cells and 
transfer of desired genetic material (Lim et al., 2010).  
 
Due to their ability to induce stable expression of the transferred genetic material and 
low immune response to the virus itself, AAV-derived viral vectors have been used 
in clinical trials for various CNS related pathologies including transfer of 
neurotrophic factors in neurodegenerative disease such as AD (Lim et al., 2010). 
AAV has also been used to induce sustained IL-1β expression within the 
hippocampus, which in turn was shown to suppress neurogenesis (Wu et al., 2013). 
Chapter 1 
66 
 
However, one of the main drawbacks with AAVs is their inability to transfer larger 
genetic sequences and so it is difficult to transfer a gene encoding a protein of 
interest and a tag to identify successfully transduced cells. The ability to mark and 
track transduced cells is important in tracking NPCs as they progress through the 
neurogenesis process.  
 
HSV vectors are similar to AAV in that they transfer DNA, however they are much 
larger vectors and can transfer much larger amounts of genomic material (Hibbitt 
and Wade-Martins, 2006). However, they do not possess the ability to target dividing 
cells therefore they cannot target NPCs (Bouard et al., 2009). They can modulate 
neurogenesis indirectly by transducng surrounding neurons to induce the expression 
of factors like fibroblast growth factor 2 (FGF2) which is known to stimulate NPC 
prolfieration (Yoshimura et al., 2003, Reynolds and Weiss, 1992). 
 
LVs are members of the retrovirus family of viruses which includes human 
immunodeficiency virus (HIV), as well as simian (SIV), equine (EIAV) and feline 
(FIV) immunodeficiency viruses (Escors and Breckpot, 2010). As such, the LV 
genome is a single stranded RNA (ssRNA) sequence of about 9.7kb in length (Lim 
et al., 2010). This RNA based genomic material includes transcripts for virus 
packaging, reverse transcription, nuclear localisation and nuclear integration of 
reverse transcribed genes into the host genome (Lim et al., 2010).  LVs have been 
the focus of some research to ascertain their application as clinical gene delivery 
vectors (Sakuma et al., 2012). This is due to their ability to transfect a broad range of 
cell types including post-mitotic cells or slowly dividing cells which in many cases 
NPCs are (Kempermann et al., 2004a). Classical retrovirus cannot transduce post-
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mitotic cells as they require shedding of the nuclear membrane of the host cell 
(which occurs during mitosis) to successfully transduce cells (Naldini, 1998). 
However, following reverse transcription of ssRNA from modern LV vectors into 
doublestranded DNA (dsDNA) within the host cell cytoplasm, dsDNA can gain 
entry to the nucleus of the host cell via active transport mechanisms (Escors and 
Breckpot, 2010). The dsDNA is then integrated into the host DNA which results in 
long-term expression of the viral genomic material. 
 
As the LV vector genome is based on HIV, it is very important that the aspects of the 
LV genome that are HIV based (i.e. not the gene being transduced) are not capable 
of replication. In this regard, steps have been taken to maximise the biosafety of LV 
vectors such as removal of the majority of viral genes that could contribute to viral 
self replication (Manfredsson and Mandel, 2011). Additionally, preclinical studies 
using LV vectors use LVs with a FIV, SIV or EIAV genomic background to 
minimise the ability of the virus to replicate in humans (Manfredsson and Mandel, 
2011). LVs have a wide range of beneficial aspects in their use in preclinical and 
clinical research into gene delivery. This includes their ability to transduce post-
mitotic or slowing proliferating cells, their low potential of producing self replicating 
viruses, their lack of viral gene expression and their relatively high capacity for 
transferring genetic material (Naldini et al., 1996a, Naldini et al., 1996b, Zufferey et 
al., 1997, Dull et al., 1998, Blomer et al., 1997, Zufferey et al., 1998). 
 
LVs have been used to transfer interfering RNA (iRNA) into the hippocampus of 
rats to suppress hippocampal neurogenesis (Jessberger et al., 2009b). This study used 
LVs to transfer iRNA designed to inhibit Wnt signalling which resulted in impaired 
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proliferation of NPCs and subsequent impairments in spatial and object recognition. 
Additionally, it has been demonstrated that NPCs can be induced to overexpress IL-
1β which in turn reduces their proliferation in vitro (Ryan et al., 2013). Conversely, 
overexpression of PPARδ in the hippocampus of rats enhances NPC proliferation 
and rescues depressive-like behaviours after chronic mild stress (Ji et al., 2015). 
However, LV vectors themselves can cause a local immune response when injected 
intrahippocampally (Kunitsyna et al., 2016). This study did not observe any 
impairment in hippocampal-associated learning and memory as assessed by 
contextual fear conditioning. Therefore, although extremely useful in transferring 
large amounts of genetic material and being able to target hippocampal NPCs, LV 
vectors, future generation of LVs should aim to minimize viral effects on immune 
activation. 
 
1.6: Neuroinflammation in the CNS 
Neuroinflammation was initially characterised by the infiltration of peripheral 
immune cells in response to central viral or bacterial infection, ischemic stroke, or 
multiple sclerosis (Crotti and Glass, 2015, Hensley, 2010, Aguzzi et al., 2013). 
However, the local production of inflammatory mediators such as cytokines within 
the CNS is another major component of neuroinflammation. Under pathological 
conditions as well as neurodegenerative disorders where neuroinflammation is 
evident, the mechanisms of hippocampal neurogenesis deregulation at an 
intracellular level are the focus of much ongoing research. It has been shown that 
inflammation negatively affects hippocampal neurogenesis (Ekdahl et al., 2009, 
Monje et al., 2003, Heine et al., 2004).  
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Neuroinflammation has been associated with many psychiatric and 
neurodegenerative disorders where cognitive dysfunction is evident (Raison et al. 
2006; Leonard 2007). Moreover, cognitive dysfunction in pathological conditions 
and through aging has been strongly linked with decreased hippocampal 
neurogenesis (Kuzumaki et al. 2010; Kohman & Rhodes 2013). From the evidence 
to date, it appears that interplay exists between hippocampal neurogenesis, 
inflammation and cognitive function in aging and pathological conditions.  
 
1.6.1: Neuroinflammation in neurodegenerative and psychiatric disorders 
Neurodegenerative diseases such as AD, PD and HD have been linked with central 
neuroinflammatory processes such as sustained microglial activation and cytokine 
release (Schellenberg and Montine, 2012, Samii et al., 2004, Silvestroni et al., 2009). 
However, these neurodegenerative pathologies do not display the characteristics 
initially associated with neuroinflammation such as peripheral immune cell 
infiltration from the blood stream (Crotti and Glass, 2015). Psychiatric disorders 
associated with neuroinflammation include depression, bipolar disorder and 
schizophrenia (Rao et al., 2010, Raison et al., 2006, Hope et al., 2009, Schiepers et 
al., 2005, O'Brien et al., 2006, Dowlati et al., 2010). The close association between 
evidence of neuroinflammation and neurodegenerative and psychiatric disorders has 
led to the suggestion that neuroinflammation itself may be an important component 
to the aetiology and/or progression of these pathologies (Ransohoff, 2016, Raison et 
al., 2006). 
 
The first indication for the involvement of neuroinflammation in neurodegenerative 
disorders came from the observation of active microglia in brain autopsy tissue of 
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patients with AD and PD (McGeer et al., 1988b, McGeer et al., 1988a, Rogers et al., 
1996). Since then, it has been demonstrated that there is a significant increase in the 
expression pro-inflammatory cytokines such as TNFα, IL-1β, and IL-6 within brain 
tissue and plasma of AD patients (Fillit et al., 1991, Swardfager et al., 2010, 
Forlenza et al., 2009). Similar increases in cytokine expression within the striatum, 
substantia nigra and plasma of PD patients have also been observed (Mogi et al., 
1994a, Mogi et al., 1994b, Hunot et al., 1999, Dobbs et al., 1999). Interestingly, 
increased occurrences of single nucleotide polymorphisms (SNPs) in the Il1b gene 
are associated with the development of AD (Griffin et al., 2000, Nicoll et al., 2000, 
Di Bona et al., 2008). A SNP in the Il1b gene, that introduces a Taq1 restriction site 
into the gene, results in a fourfold increase in IL-1β production and also a 1.6 fold 
increased chance of developing AD (Di Bona et al., 2008). Additionally, reactive 
microglia have been shown to localise around amyloid-β (Aβ) plaques in the 
hippocampus of AD patients, and Aβ plaques themselves can induce the release of 
cytokines from microglia which potentially exacerbates cell death and 
neurodegeneration (McGeer et al., 1993, Sheng et al., 1995a, Block and Hong, 
2005). 
 
Increased expression of pro-inflammatory cytokine related enzymes have been 
observed in PD patients (Collins et al., 2012). Several pre-clinical models of PD are 
also associated with an increased inflammatory profile within the brain. For 
example, in rodent models using 6-hydroxydopamine or 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) to induce parkinsonian symptoms, there is an increase in 
the expression of TNFα in the mid-brain and substantia nigra (Ferger et al., 2004, 
Nagatsu and Sawada, 2006). Additionally, inhibition of TNF synthesis or signalling 
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in the MPTP mouse model of PD prevents striatal neuronal toxicity, and blockade of 
TNF signalling in the 6-hydroxydopamine model attenuates motor impairments in 
rats (Ferger et al., 2004, McCoy et al., 2006).  It has been demonstrated that α-
synuclein, the protein that aggregates to form Lewy bodies in PD, can induce the 
activation and release of cytokines from microglia (Hoenen et al., 2016). Indeed, it 
has previously been demonstrated that microlia aggregate around Lewy bodies and 
this may promote disease progression (Zhang et al., 2005).  
 
Unlike AD and PD which are multifactorial pathologies associated with several 
genetic mutations and environmental factors, HD is caused by a single mutation in 
the Huntington gene (Htt) which results in progressive neuronal loss and severe 
cognitive impairments (MacDonald et al., 1993). Although HTT protein is expressed 
ubiquitously throughout the body, Htt mRNA is expressed threefold higher within 
immune cells suggesting the dysregulation of this gene can also have a direct impact 
on inflammatory responses (Soulet and Cicchetti, 2011). Activated microglia are 
evident in pre-symptomatic mutated Htt gene carriers, even up to 15 years before the 
predicted disease onset (Tai et al., 2007). Increases in plasma IL-6 are also evident 
during the same timeframe microglia activation occurs (Bjorkqvist et al., 2008). 
Additionally, in cerebrospinal fluid of HD patients there are increased concentrations 
of TNFα, IL-6 and IL-8 (Bjorkqvist et al., 2008). Thus, from the evidence within the 
literature there is a clear link between neuroinflammation and neurodegeneration. 
However, whether neuroinflammation plays a causal role or is a consequence of 
neuronal loss in specific neurodegenerative disorders remains the focus of much 
research. 
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There is mounting evidence linking psychiatric disorders, particularly depression, 
and neuroinflammation (Raison et al., 2006, Miller et al., 2009, Pariante, 2017, 
Khansari and Sperlagh, 2012, Na et al., 2014). For example, there is an increase in 
pro-inflammatory cytokine expression in depressed patients (Maes et al., 1991, 
Raison et al., 2006), pro-inflammatory cytokines themselves induce depressive 
behaviours in rodents (Smith, 1991, Goshen et al., 2008), pro-inflammatory cytokine 
production is suppressed by antidepressant drugs (Xia et al., 1996, Shen et al., 1999, 
Reynolds et al., 2005) and pro-inflammatory cytokines can disrupt HPA axis 
regulation (Maes et al., 1993a, Maes et al., 1993b). These studies and others have 
given support to the ‘cytokine hypothesis’ of depression which was first put forward 
in 1991 (Smith, 1991). This hypothesis proposes that excessive release of cytokines 
is the cause of depression. However, not all depressed patients exhibit 
neuroinflammation. It has been suggested that pre-exposure during early life to a 
stressful event or trauma is a leading cause of inflammation related depression 
(Danese et al., 2011, Danese et al., 2007, Danese et al., 2008). However, it has been 
demonstrated that treatment of rodents with antidepressants reduces cytokine-
induced depressive behaviours as well as cytokine production (Castanon et al., 2002, 
Obuchowicz et al., 2006a). This suggests that cytokines, when increased in 
depressed patients, can potentially contribute to depressive symptoms. 
 
Increased expression of pro-inflammatory cytokines have also been detected in post-
mortem brain tissue of bi-polar and schizophrenia patients (O'Brien et al., 2006, 
Hope et al., 2009, Rao et al., 2010). The mood stabiliser lithium, which is commonly 
used to treat bi-polar disorder, has also been demonstrated to reduce pro-
inflammatory TNFα expression and increase anti-inflammatory IL-10 expression in 
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rat microglia in vitro (Wang et al., 2010, Martin et al., 2005). Similar to lithium, 
antipsychotic drugs such as perazine used to treat schizophrenia can also reduce 
cytokine expression (Obuchowicz et al., 2006b). Thus, neuroinflammation appears to 
be involved in both neurodegenerative diseases and psychiatric disorders, however 
the molecular mechanisms of these interactions remain to be fully elucidated.  
 
1.6.2: Activation and regulation of microglia 
Within the brain, microglia are the main immune cell type and provide support for 
the surrounding neuronal circuits. Microglia have a distinct lineage compared to 
other glial cells in the CNS such as astrocytes and oligodendrocytes and they make 
up approximately 12% of all neuroglial cells within the CNS (Lawson et al., 1990, 
Aguzzi et al., 2013). They colonise the brain during embryonic development before 
the formation of the blood brain barrier (BBB), after which they remain confined to 
the brain throughout life (Ajami et al. 2007). Microglia are derived from mesodermal 
precursor cells that infiltrate the CNS during development and they express cell 
surface markers such as Fc, CD11b and Iba1 which are also expressed on 
macrophages (de Haas et al., 2008, Ohsawa et al., 2004). The overlap in marker 
expression between microglia and macrophages alludes to the phagocytic functions 
of microglia. 
 
Microglia can either be inactive or active depending on their response to their 
environment. In normal conditions, microglia adopt a ‘resting’ phenotype. While in 
this phenotype, microglia have a small soma and many branching, long, thin 
processes. These processes act as detectors for any detrimental insult to the brain. It 
has been shown that microglia are highly motile in this phenotype as they survey 
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their environment (Nimmerjahn et al. 2005). When microglia become activated by 
an insult such as an infection, they retract their processes, increase the expression of 
activation markers and release certain cytokines to combat the insult (Kettenmann et 
al. 2013). Active microglia can be identified by their morphological features as well 
by the fact that they have increased expression of cell surface antigen expression 
such as major histocompatibility complex class II and membrane receptors such as 
CD45 (de Haas et al., 2008, Ford et al., 1995). Activation of microglia is a normal 
and necessary process to protect the brain from prolonged injury. Indeed, as it has 
been suggested that half of all newborn neurons die via  apoptosis within a few days, 
microglia play an important role in clearing up cell remnants (Sierra et al., 2010, 
Kempermann et al., 2003, Dayer et al., 2003, Biebl et al., 2000). However, if 
microglia remain in this activated state chronically they become maladaptive and can 
damage the brain. In response to stress, infections or age, sustained microglia 
activation is a common occurrance (Ekdahl et al. 2009).  
 
Activation of microglia is a complex process as microglia can be classically 
activated which leads to increased inflammatory responses or they can be 
alternatively activated which can lead to a neuroprotective phenotype (Kohman and 
Rhodes, 2013). Classical activation of microglia results in the release of a host of 
cytokines and this activation state is the main source of inflammatory cytokines 
within the brain (Hanisch 2002; Rothwell et al. 1996). Activation of microglia 
occurs rapidly within minutes after detection of a host of factors such as viral 
infections, lipopolysaccharide (LPS) exposure, neuronal death and cytokines 
(Davalos et al., 2005, Hanisch and Kettenmann, 2007, Colton and Wilcock, 2010). 
LPS is a bacterial endotoxin commonly used to induce microglial activation in vitro 
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and in vivo. To this end, LPS-induced activation of microglia is mediated via toll-
like receptor-4 (TLR4) binding on microglia and has been shown to significantly 
increase their production of inflammatory cytokines such as TNFα, IL-1β and IL-6 
(Kohman and Rhodes, 2013).  
 
Microglia can also shift to an alternatively activated state, in which release of pro-
inflammatory cytokines is reduced and cell death is attenuated. The main initiators of 
this shift come from cytoactive agents released by cells around the site of injury or 
infection such as regulator TH2 immune cells (Colton, 2009). These cytoacive agents 
are predominantly anti-inflammatory cytokines such as IL-4 and IL-13 (Butovsky et 
al., 2006, Colton, 2009). Microglia themselves once in this alternative activated state 
can release other anti-inflammatory cytokines such as IL-10 and TGFβ, as well as 
growth factors such as insulin-like growth factor (IGF), neural growth factor (NGF) 
and brain derived neural growth factor (BDNF) (Kohman and Rhodes, 2013). The 
expression of alternatively activated microglia typically occurs after their pro-
inflammatory classically activated phase (Cacci et al., 2008, Thored et al., 2009). It 
is thought that this transition occurs to limit neuronal damage during the pro-
inflammatory phenotype while also promoting neuronal repair. Indeed, this transition 
is also vitally important in maintaining hippocampal neurogenesis during periods of 
neuroinflammation (Kohman and Rhodes, 2013). 
 
1.6.3: Neuroinflammation and hippocampal neurogenesis 
It was initially demonstrated that hippocampal neurogenesis is impaired by LPS 
induced classical activation of microglia (Monje et al., 2003, Ekdahl et al., 2003). 
Monje et al. demonstrated that after intraperitoneal (i.p) injection of LPS to rats, 
Chapter 1 
76 
 
there was a significant reduction in proliferation and neuronal differentiation as well 
as reduced newborn cell survival (Monje et al., 2003). These impairments were 
correlated with a 240% increase in the density of activated microglia within the DG 
and were prevented by co-administration of the non-steroidal anti-inflammatory 
indomethacin. Additionally, they demonstrated using co-cultures of microglia and 
NPCs in vitro that the impairments of neuronal differentiation were mediated by 
cytokine release rather than microglia-NPC direct interactions (Monje et al., 2003). 
These data were also supported by another study that demonstrated that 4 weeks of 
cortical LPS infusion in rats induced significant microglia activation as well as 
impairments in neuronal differentiation (Ekdahl et al., 2003). This study also 
demonstrated that inhibition of microglial activation using minocycline attenuated 
the effects of LPS on neurogenesis indicating that microglial activation is critical for 
the effects of inflammation on neurogenesis. 
 
Inflammation has generally been shown to be a robust suppressor of neurogenesis as 
it is capable of impacting on all aspects of neurogenesis. For example, in addition to 
the data described above, it has been shown that 5 hours after i.p injections of LPS 
there was a significant reduction in proliferation of NPCs in the DG of rats (Fujioka 
and Akema, 2010). As well as impacting the proliferation, differentiation and 
survival of newborn neurons (Monje et al., 2003, Ekdahl et al., 2003, Fujioka and 
Akema, 2010), inflammation can also impact upon the integration into the 
surrounding circuitry of those new neurons that do manage to survive chronic 
inflammatory conditions. For example, it has been demonstrated that chronic LPS-
induced inflammation in rats resulted in increased inhibitory neuronal signalling 
specifically to new neurons within the hippocampus (Jakubs et al., 2008). This study 
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demonstrated that although all neurons assessed within the hippocampus displayed 
enhanced frequency of spontaneous excitatory postsynaptic currents, only the 
newborn neurons (relative to pre-existing neurons) displayed enhanced inhibitory 
characteristics. Specifically, these new neurons born during chronic inflammation 
displayed increased frequency of spontaneous inhibitory postsynaptic currents as 
well as increased density of inhibitory synapses in their distal dendrites (Jakubs et 
al., 2008). It has also been demonstrated that new neurons born during periods of 
chronic inflammation have reduced participation in hippocampal contextual 
processing (Belarbi et al., 2012). These studies demonstrate that not only can 
inflammation impact all processes of neurogenesis, but that these effects may be 
long-lasting and even result in impairments in the functional role of neurogenesis. 
 
Another aspect in which inflammation can regulate neurogenesis is by microglial-
mediate synaptic pruning of newborn neurons (Hong and Stevens, 2016, Schafer et 
al., 2012, Paolicelli and Gross, 2011, Tremblay et al., 2010). Using their highly 
motile processes, microglia can engulf synapses and regulate their connectivity 
(Paolicelli and Gross, 2011, Hong and Stevens, 2016). Under physiological 
conditions, the extent interaction between microglia and specific neuronal synapses 
is highly regulated by the activity of these synapses with microglia pruning less 
active neuronal inputs (Tremblay et al., 2010, Schafer et al., 2012). Thus microglial 
synaptic pruning can be seen as a way of optimising neuronal connectivity. 
Furthermore, the mechanism behind this microglial-mediated synaptic pruning 
appears to involved the complement system of proteins as mice lacking C1q, C3, or 
CR3 display impaired synaptic connectivity (Schafer et al., 2012). Conversely, in 
pathological conditions were increased inflammation and microglial activation such 
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as in AD, there is also an increase in compliment driven microglial pruning which 
results in excessive synapse loss (Hong and Stevens, 2016, Hong et al., 2016). 
 
Despite the wealth of evidence demonstrating that inflammation is detrimental to 
neurogenesis, it must be stated that general immune function is of critical importance 
in maintaining neurogenesis. For example, it is has been shown that immune 
deficient severe combined immunodeficiency (SCID) mice have impaired 
proliferation of NPCs both at baseline and after pro-neurogenic environmental 
enrichment as well as impaired spatial cognition (Ziv et al., 2006). Additionally, it 
was found that these effects could be attenuated by reintroduction of T-cells with 
CNS-specific antigens. Another study demonstrated that expression of the antigen 
recognition receptor, Toll-like receptor-2 (TLR2), on NPCs is important in 
maintaining neuronal differentiation (Rolls et al., 2007). Thus, under baseline 
conditions, normal immune function is required to maintain hippocampal 
neurogenesis. 
 
1.6.4: Cytokines that impact upon hippocampal neurogenesis 
As well as studies demonstrating the effects of LPS-induced inflammation on 
neurogenesis, there are several studies that have assessed the impact of specific 
cytokines such as TNFα, IL-6, IL-10 and IL-1β on neurogenesis. Cytokines are 
generally small proteins of about 8-30kDA in size. They are usually released in 
precursor form from immune cells such as monocytes, macrophages and 
lymphocytes in the periphery as well as from microglia and astrocytes within the 
CNS (Kim et al., 2016). Within the CNS they are released mainly by microglia but 
also by astrocytes in response to infection, injury or even chronic stress (Barbierato 
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et al., 2013, Sorrells et al., 2009, Nathan, 2002, Woodroofe, 1995). However, active 
cytokines released in the periphery can cross the BBB to exert their effects in the 
CNS. This generally occurs during periods of inflammation where the inflammatory 
response can result in increased BBB permeability (Stolp et al., 2005). Indeed the 
pro-inflammatory cytokines TNFα and IL-1β have themselves been shown to break 
down the BBB (Quagliarello et al., 1991, Blamire et al., 2000, de Vries et al., 1996). 
 
Cytokines may act as autocrine or paracrine mediators of cell activity within the 
CNS (Rothwell et al., 1996). Generally, cytokines act as signal communicators 
between immune cells and neurons or NPCs and these signals are roughly divided 
into either pro- or anti-inflammatory, either promoting or inhibiting inflammation, 
respectively (Kim et al., 2016). IL-1β, TNFα and IL-6 are three of the most widely 
studied pro-inflammatory cytokines with regard to hippocampal neurogenesis. 
Alternatively, IL-10 and IL-4 are widely known anti-inflammatory cytokines. 
However, it is not entirely accurate to divide cytokines into either pro- or anti-
inflammatory, as it has been suggested that the inflammatory outcome of certain 
cytokines may depend on their concentration, the cells they target, the timing of 
activation or the type of activation signal (Cavaillon, 2001). Under normal 
conditions, cytokines maintain a relatively low concentration and it has even been 
shown that certain cytokines such as IL-1β are required to maintain normal 
hippocampal neurogenesis-associated cognition (Goshen et al., 2007, Pitossi et al., 
1997). However, during pathological conditions the expression of cytokines can 
increase up to 100-fold more than under normal conditions (Lee et al., 2002c). 
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1.6.4.1: TNFα 
TNFα is a pro-inflammatory cytokine released in its inactive form as a 25kDa 
protein from microglia. This pro-TNFα is then proteolytically cleaved by TNFα 
converting enzyme (TACE) into its active, soluble, 17kDa form (Kriegler et al., 
1988, Gearing et al., 1994, McGeehan et al., 1994). However, both pro-TNFα and 
cleaved TNFα have been shown to have varying degrees of biological activity 
(Decker et al., 1987). TNFα can bind to two receptors, namely tumour necrosis 
factor-receptor 1 (TNF-R1) and tumour necrosis factor-receptor 2 (TNF-R2) both of 
which are expressed on neurons, NPCs and glia (Kinouchi et al., 1991, Dopp et al., 
1997, Widera et al., 2006). TNF-R1 is thought to be the main mediator of the 
biological activity of TNFα with cell death being the main outcome (Goetz et al., 
2004, Tartaglia et al., 1993).  
 
The effects of TNFα on neurogenesis are found to be variable depending on what 
stage of the neurogenic process NPCs are in when they encounter TNFα (Yirmiya 
and Goshen, 2011).  Initial in vitro studies demonstrated that when TNFα expression 
was increased, NPC proliferation was reduced (Ben-Hur et al., 2003, Monje et al., 
2003). However, another study demonstrated that, when NPCs under proliferative 
conditions were exposed to TNFα, there was no effect on proliferation, yet when 
NPCs undergoing differentiation were exposed to TNFα, there was a reduction in 
neuronal differentiation and an increase in astrocyte differentiation (Keohane et al., 
2010). The effects of TNFα on NPC proliferation had previously been found to be 
dose dependent, where high concentrations induced cell death but lower 
concentrations may even act to promote NPC proliferation (Bernardino et al., 2008). 
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Thus, the varying effects of TNFα on neurogenesis may be a result of varying 
dosages. 
 
It has been demonstrated that inhibition of TNF signalling using the TNF inhibitor 
pentoxifylline, prevented impairments in neuronal differentiation induced by LPS 
activated microglia in vitro (Liu et al., 2005). This suggests that TNFα may be the 
predominant mediator of activated microglia-induced suppression of neuronal 
differentiation. Additionally, it has been demonstrated that in TNF-R1 knockout 
mice as well as mice with both TNF-R1 and TNF-R2 knocked out there is a 
reduction in the number of new born neurons (Iosif et al., 2006). This reduction was 
not evident in TNF-R2 knockout mice which suggests that TNF-R1 is also the 
primary receptor mediating the effects of TNF on neurogenesis.  
 
Assessment of TNFα-induced changes in cognitive function associated with 
neurogenesis has yielded conflicting reports, with one study demonstrating an 
enhancement in spatial memory in the MWM in TNF knockout (KO) mice compared 
to WT mice (Golan et al., 2004), while other studies demonstrated no differences 
(Gerber et al., 2004, Scherbel et al., 1999). However, TNFα KO mice were more 
susceptible to memory impairments after brain injury compared to WT (Gerber et al., 
2004). Furthermore, aged mice with TNFα overexpression (OEX) displayed spatial 
memory impairments whereas young mice with TNFα OEX did not (Golan et al., 
2004). These studies indicate that TNFα may mediate impairments in neurogenesis-
associated behaviour during injury or with aging. 
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1.6.4.2: IL-6 
IL-6 is a single chain 21kDA glycoprotein and is another commonly studied pro-
inflammatory cytokine (Simpson et al., 1997, Yirmiya and Goshen, 2011). IL-6 
signals via its cognate receptor, the IL-6 receptor (IL-6R), which is a type 1 cytokine 
receptor and tranduces IL-6 signals via its association with the transmembrane 
protein gp130 (Simpson et al., 1997). Gp130 is expressed in nearly all tissue types 
and within the CNS, IL-6R is expressed highest within the hippocampus of rats 
(Gadient and Otten, 1994). Initially, IL-6 was demonstrated to impair hippocampal 
plasticity as it was shown to impair LTP formation in the DG of rodents (Li et al., 
1997, Bellinger et al., 1995, Tancredi et al., 2000). These effects on hippocampal 
plasticity were mediated via the IL-6 receptor because when this receptor was 
blocked by antibodies, IL-6 administration to hippocampal slices did not impair LTP 
formation (Li et al., 1997).  
 
As well as its detrimental effects on hippocampal LTP, IL-6 has been shown to 
negatively impact upon hippocampal neurogenesis. For example, astrocyte mediated 
overexpression of IL-6 has been shown to reduce hippocampal neurogenesis by up to 
63% in mice (Vallieres et al., 2002). This astrocyte-mediated IL-6 overexpression 
robustly impaired neurogenesis by suppressing proliferation, differentiation and 
survival of NPCs. However, these effects were not mediated by an increase in cell 
death or any increase in glial cell activation or expression (Vallieres et al., 2002). 
Using conditioned media from activated microglia, NPCs where shown to have 
reduced neuronal differentiation in vitro (Monje et al., 2003). This study also 
demonstrated similar effects with the addition of just IL-6 to NPCs and both the 
conditioned media and IL-6 effects were reversed by addition of an IL-6 neutralizing 
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antibody. This approach of treating NPCs with conditioned media from activated 
microglia was also used to demonstrated that IL-6 released from microglia promote 
astrocyte differentiation, an effect which was blocked by administration of a 
neutralizing IL-6 antibody (Nakanishi et al., 2007). Thus, the evidence suggests that 
IL-6 acts to suppress neurogenesis and promote NPC differentiation into astrocytes.  
 
IL-6 has not been demonstrated to robustly affect hippocampal neurogenesis-
associated spatial memory (Yirmiya and Goshen, 2011). One study demonstrated 
that intracerebroventricular (i.c.v.) administration of IL-6 in rats prior to training in 
the MWM did not affect spatial memory in this task, whereas i.c.v. administration of 
IL-1β over the same time period did impair spatial memory performance (Oitzl et al., 
1993). Alternatively, IL-6 KO mice have been shown to have improved spatial 
memory performance in the radial arm maze compared to WT mice (Braida et al., 
2004), and acute blockade of IL-6 improved acquisition in a forced alternation task 
(another method of assessing spatial memory) (Balschun et al., 2004). This has led to 
the suggestion that IL-6 may act to negatively regulate memory formation. However, 
IL-6 has been shown to have both pro- and anti-inflammatory properties depending 
on the magnitude and duration of its expression, and elevations in its expression in 
humans has been shown to correlate with improved memory retention scores in 
certain conditions (Jones et al., 2005, Kozora et al., 2001, Shapira-Lichter et al., 
2008). This dual inflammatory role of IL-6 may then account for some of the 
discrepancies between the effects of IL-6 on neurogenesis and neurogenesis-
associated behaviours. 
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1.6.4.3: IL-10 
IL-10 was first discovered as a factor secreted by T-helper 2 immune cells that was 
able to suppress further cytokine production (Fiorentino et al., 1989). As its function 
as an anti-inflammatory cytokine, IL-10 acts to prevent the development of 
inflammatory or autoimmune reactions by limiting the immune response to 
pathogens (O'Garra and Vieira, 2007). IL-10 has been shown to be produced and 
secreted by microglia and astrocytes within various brain regions including the 
hippocampus and it is thought that the secretion of IL-10 after an inflammatory 
stimulus such as LPS is a form of negative feedback mechanism (Lobo-Silva et al., 
2016, Martin et al., 2005, Lieberman et al., 1989, Huang et al., 2009). Specifically, 
IL-10 has been demonstrated to inhibit LPS-induced increases in TNFα and IL-6 in 
the CNS (Sheng et al., 1995b, Agnello et al., 2000), and IL-1β within the 
hippocampus of rats  (Lynch et al., 2004). 
 
IL-10 signals via the IL-10 receptor family which, when activated, initiates the Jak-
stat signalling cascade (Moore et al., 2001). Activation of IL-10 receptors have also 
been shown to inhibit the NF-κB pathway, a commonly recruited pathway by pro-
inflammatory cytokines, by inhibiting IκB kinase and preventing NF-κB DNA 
binding in monocytic cell lines (Schottelius et al., 1999). Within neurons, IL-10 
signalling has been shown to enhance neuronal survival, potentially in part by its 
ability to enhance the expression of anti-apoptotic genes such as Bcl-2 and Bcl-xl 
and suppressing pro-apoptotic caspase-3 expression (Moore et al., 2001, Zhou et al., 
2009a, Zhou et al., 2009b). 
 
Chapter 1 
85 
 
IL-10 largely impacts upon hippocampal neurogenesis by indirectly suppressing pro-
inflammatory cytokine expression and blocking their effects on NPCs. For example, 
IL-10 overexpression in the APPPS1 mouse model of AD, enhanced hippocampal 
neuronal differentiation and survival (Kiyota et al., 2012). Additionally, this study 
suggested that the effects of IL-10 were largely mediated by their anti-inflammatory 
effects on microglia rather than their direct action on NPCs. Although there is no 
definitive evidence to suggest that the IL-10 receptor is expressed on hippocampal 
NPCs, there are reports that this receptor is expressed on NPCs from the SVZ 
(Perez-Asensio et al., 2013). Additionally, it was demonstrated in SVZ NPCs, that 
IL-10 maintains NPCs in an undifferentiated proliferative state and that this effect 
may be mediated by IL-10 receptor-mediated activation of ERK/Stat3 pathway 
(Perez-Asensio et al., 2013, Pereira et al., 2015). Therefore, it is possible that 
hippocampal NPCs may also express IL-10 receptors allowing IL-10 itself to directly 
regulate NPC function. In combination with its anti-inflammatory mechanisms, IL-
10 positions itself as a strong pro-neurogenic cytokine. 
 
1.6.4.4: IL-1β 
IL-1β is a pro-inflammatory cytokine that plays a role in hippocampal 
neuroinflammation due to its heightened receptor expression profile in the 
hippocampus (Farrar et al., 1987). It is part of the IL-1 family of proteins which also 
includes IL-1α and the interleukin-1 receptor anatgonist (IL-1RA) (Rothwell and 
Luheshi, 2000). IL-1α and IL-1β were first sequenced and cloned in 1984 followed 
by IL-1RA in 1985 (Arend et al., 1985, Lomedico et al., 1984, Auron et al., 1984). 
IL-1β is produced predominantly by microglia but also by pyramidal neurons and 
astrocytes in the hippocampus (Bandtlow et al., 1990, Lechan et al., 1990, Eriksson 
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et al., 1999, Barbierato et al., 2013). IL-1β is initially synthesised as a 31kDA 
inactive precursor protein which is then cleaved into its 17kDa active form by 
caspase-1 (Dinarello, 1997). This active form is then released into the extracellular 
matrix, where it binds to its cognate transmembrane receptor interleukin receptor 
type 1 (IL-1R1) (Hanisch and Kettenmann, 2007, Rothwell et al., 1996, Green and 
Nolan, 2012b). Alternatively, IL-1β can bind to IL-1R2, which is a decoy receptor 
and does not produce a physiological response (McMahan et al., 1991). IL-1RA is 
the endogenous antagonist of IL-1β which binds with almost equal affinity as IL-1β 
to IL-1R1 (Seckinger et al., 1987, Hannum et al., 1990). IL-1RA is expressed and 
produced by both pyramidal neurons and microglia within the hippocampus 
(Eriksson et al., 1999).  
 
As well as influencing the function of mature neurons, IL-1β can directly influence 
NPCs via interaction with IL-1R1 on both embryonic and adult NPCs (Green and 
Nolan, 2012b, Ryan et al., 2013). The expression of IL-1R2 has not been 
demonstrated on NPCs. However, it has been shown to be mainly expressed on 
microglia, which suggests it plays a role in dampening cytokine-induced activation 
of microglia (Pinteaux et al., 2002). Upon binding to IL-1R1, IL-1β induces an 
intracellular signalling cascade, which ultimately leads to altered gene expression of 
IL-1β target genes and a heightened pro-inflammatory response (Sims et al., 1993). 
Classical IL-1β signalling in NPCs involves activation of the NF-κB pathway. NF-
κB is composed of homo- or heterodimeric combinations of the Rel family of 
proteins consisting of p52, p65 (Rel A), c-Rel, RelB, and p50. These proteins work 
in combination or with other co-factors, such as creb binding protein (CBP) to 
regulate the transcription of NF-κB target genes (Sheppard et al., 1999). However, in 
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mature neurons, IL-1β can also activate the MAPK pathway which suggests that IL-
1β may recruit different pathways within NPCs as they proceed through the stages of 
neurogenesis (Koo and Duman, 2008, Srinivasan et al., 2004, O'Leime et al., 2017a). 
The MAPK pathway is a signal transduction pathway that can be activated by 
various cytokines and growth factors that act on cell surface kinase-linked receptors 
(Johnson and Lapadat, 2002). Once this pathway is activated there is a cascade of 
protein phosphorylation, which ultimately leads to altered gene expression and 
regulation of cell division, apoptosis, and tissue regeneration (Rang et al., 2012). See 
figure 1.6 for schematic of both pathways. 
 
 
Figure 1.6 Schematic of IL-1β signalling cascades. Within neurogenic cells, IL-1β 
signals via either NF-κB or MAPK pathways. Interleukin-1 beta (IL-1β), interleukin 
receptor type 1 (IL-1R1), interleukin receptor type 2 (IL-1R2), creb binding protein 
(CBP), long term potentiation (LTP). (O'Leime et al., 2017a). 
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IL-1β has been shown to negatively impact upon the proliferation, differentiation 
and survival of hippocampal NPCs in cultures of rat hippocampal NPCs (Green et 
al., 2012, Ryan et al., 2013). There is further in vitro evidence to suggest that IL-
1RA can reverse IL-1β-induced suppression of NPC proliferation as well as its 
promotion of astrogenesis in cultures of rat hippocampal neurospheres (Green and 
Nolan, 2012b, Ryan et al., 2013, Koo and Duman, 2008). It should also be noted that 
IL-1β may differentially influence NPCs or respond to changes in neurogenesis 
depending on the time during the lifespan at which changes in either inflammatory 
insult or neurogenesis occur. For example, an increase in hippocampal IL-1β was 
demonstrated in juvenile rats but not in adult rats subjected to whole brain irradiation 
(which ablates neurogenesis) (Blomstrand et al., 2014) and thus suggests that 
different inflammatory mechanisms may be involved in regulating hippocampal 
neurogenesis at different ages. Likewise, inflammatory-induced changes in 
neurogenesis during embryonic or postnatal development may result in overall 
changes in the number of proliferating cells in the adult DG, which may 
consequently cause structural changes in the hippocampus and ultimately lead to 
changes in behaviour (Green and Nolan, 2014). Development of anti-inflammatory 
interventions to circumvent inflammatory-induced impairments in neurogenesis and 
associated hippocampal functions should also take into consideration the timing 
during the lifespan of the intervention. Taken together, the evidence to date suggests 
that the signalling mechanism of IL-1β in NPCs during both development and in the 
adult hippocampus represents an important avenue for future research. 
 
It has also been shown that IL-1β can suppress neuronal differentiation in a human 
hippocampal progenitor cell line (Zunszain et al., 2012b). While this study also 
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reported an increase in cell proliferation in response to IL-1β, which is contrary to 
what has been shown in rodent cell models, the increase in cell proliferation does not 
necessarily indicate enhanced neurogenesis. It is possible that an increase in cell 
proliferation in response to IL-1β leads to a phenotypic shift towards astrocyte rather 
than neuronal production, as has been previously demonstrated in response to IL-1β 
in primary cultures of rat NPCs (Green et al., 2012). It is also possible that the 
signalling mechanisms underlying IL-1β-induced changes in cell proliferation in 
human and rodent NPCs are not comparable, but this has yet to be explored in more 
detail. In addition, it is likely that immortalised cells, as is the case for the human 
hippocampal progenitor cell line, may respond differently to cytokine stimulation 
compared to cultured primary cells or indeed NCPs in vivo. This may be due to 
genotypic and phenotypic variation which can come about due to serial passaging of 
cell lines over time (Pan et al., 2009). Notwithstanding this, these discrepancies 
highlight the importance of assessing not only the proliferation status of NPCs but 
also their differentiation phenotype, as only the complete progression from 
proliferating NPCs to integrated mature neurons represents successful neurogenesis.  
 
While there is evidence to suggest that low expression levels of IL-1β are required 
for hippocampal-related learning and memory it is well established that chronically 
elevated IL-1β has detrimental effects on memory and cognition (Yirmiya and 
Goshen, 2011, Lynch, 2015). For example, it has been demonstrated that transgenic 
overexpression or pharmacological administration of IL-1RA impairs contextual fear 
conditioning and spatial navigation in the MWM in rodents, indicating that baseline 
IL-1β is indeed required to facilitate certain forms of memory (Goshen et al., 2007). 
Indeed, this study demonstrated a slight increase in IL-1β expression 24 hours after 
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fear conditioning, indicating its role in fear learning (Goshen et al., 2007). Other in 
vivo studies have provided evidence that neurogenesis is a mediator of IL-1β-
induced changes in cognitive behaviours. For example, impairments in performance 
in the MWM and reduced neurogenesis due to elevated levels of hippocampal IL-1β 
in rodents can be rescued by administration of IL-1RA (Ben Menachem-Zidon et al., 
2014). These studies demonstrate that IL-1RA is an important tool to examine the 
effects of IL-1β signalling on hippocampal neurogenesis and associated behavioural 
tasks. They also highlight the complexity of assessing the contribution of IL-1β to 
hippocampal function. Generally it is thought that slight elevations in IL-1β could 
potentially facilitate hippocampal-associated cognition whereas a substantially or 
chronically elevated IL-1β is detrimental (Goshen et al., 2007). See table 1 for a 
summary of evidence showing the effects of IL-1β on hippocampal neurogenesis and 
associated cognition.  
 
The link between IL-1β signalling and TLX is only beginning to be studied. So far, it 
has been shown that IL-1β decreases TLX expression in both adult and embryonic 
hippocampal NPCs (Green and Nolan, 2012b, Ryan et al., 2013). Furthermore, co-
treatment of hippocampal NPCs with IL-1β and IL-1RA or siRNA to inhibit IL-1R1 
expression restored TLX expression in hippocampal NPCs (Ryan et al., 2013). Little 
is currently known about the molecular interactions between IL-1β and TLX 
signalling, however, based on evidence from the literature, the NF-κB pathway may 
be a potential mediator between IL-1β and TLX. The expression of p52, p65, p50, 
and CBP has been reported in NPCs from embryonic and rat forebrain where they 
have been shown to be involved in a range of processes, such as proliferation of 
NPCs and regulation of the effects of environmental enrichment on neurogenesis 
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(Shingo et al., 2001, Lopez-Atalaya et al., 2011, Kaltschmidt and Kaltschmidt, 
2009). RelB and c-Rel are expressed on migratory NPCs involved in SVZ 
neurogenesis and thus may play a role in the regulation of NPC migration (Denis-
Donini et al., 2005). Many of the target genes of TLX, such as Cdkn1a and Pten are 
also regulated by NF-κB signalling in embryonic mouse fibroblasts. NF-κB targets 
these genes to enhance their expression while TLX represses their expression (Xia et 
al., 2007). None of these signalling interactions have been demonstrated in 
hippocampal NPCs however and this represents an important area for future research 
as NF-κB has been shown to be a involved in IL-1β-mediated suppression of 
neurogenesis (Koo and Duman, 2008, Koo et al., 2010).  
 
1.6.4.5: Cytokine network 
Despite the insights gained into how IL-1β signals intracellularly, it is important to 
acknowledge that the presence of other cytokines in the microenvironment can alter 
the effects of IL-1β and vice versa. This interaction may also explain some of the 
contradictory effects of IL-1β. There is clear evidence to show that IL-1β can 
negatively modulate cognitive processes associated with hippocampal neurogenesis 
however, there is also evidence to show positive effects. Indeed, it has been 
suggested that IL-1β is a requirement for certain forms of cognition and memory 
formation. An example of this is the fact that IL-1β has been shown to both improve 
and impair contextual fear conditioning (Goshen et al.; Gonzalez et al. 2009; 
Gonzalez et al. 2013). Instead of these effects being a direct result of IL-1β 
signalling, it is possible that the inflammatory network that IL-1β induces may differ 
depending on the intensity of IL-1β and/or the presence of other cytokines. For 
example, it has been reported that IL-1β can lead to increases in TNFα and IL-6, 
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other members of the IL-1 family, as well as cytokine receptors (Anisman et al. 
2008; Moore et al. 2009; Shaftel et al. 2007; Skelly et al. 2013). In a similar fashion, 
TNFα and IL-6 have been shown to alter the expression of other cytokines (Balschun 
et al. 2004; del Rey et al. 2013; Skelly et al. 2013). Thus the expression status of 
cytokines other than IL-1β could be determined by the expression level of IL-1β 
itself. Decreased IL-4 expression has been shown to correlate with upregulation of 
IL-1β and subsequent impairments in memory while increases in IL-4 can prevent 
the inflammatory induced deficits in memory in models of AD (Maher et al. 2004; 
Maher et al. 2005; Kiyota et al. 2010; Kiyota et al. 2012). In addition, IL-10 has been 
shown to reduce the effects of IL-1β or LPS on hippocampal plasticity (Kelly et al. 
2001; Lynch et al. 2004). This network of cytokine activity adds a level of 
complexity to the signalling of any one cytokine and may account for the complexity 
and variability reported regarding the effects of cytokines on cognitive processes. 
  
 93 
 
Species IL-1B Manipulation IL-1B Signalling 
Mechanism 
In vitro hippocampal 
effects 
In vivo hippocampal 
effects 
Overall effect on 
neurogenesis 
Reference 
E18 rat 10ng/ml in culture media Upregulation of GSK-3β ↓ NPC proliferation 
↑ Astrocytic differentiation 
↓ Neuronal differentiation 
- ↓ Green & Nolan 2012 
Green et al. 2012 
Adult rat 10ng/ml in culture media IL-1R1 binding ↓ NPC proliferation 
↓ Neuronal differentiation 
- ↓ Ryan et al. 2013 
Adult rat Interferon alpha mediated 
increase in IL-1β 
IL-1R1 binding ↓ NPC proliferation - ↓ Kaneko et al. 2006 
Postnatal day 1 rats 5, 10, and 10ng/ml in 
culture media 
IL-1R1 binding ↓ Neuronal differentiation 
(Serotonergic neurons) 
- ↓ Zhang et al. 2013 
Human hippocampal 
progenitor cells 
10mg/ml in culture media - ↑ NPC proliferation 
↓ Neuronal differentiation 
- ↓ Zunszain et a. 2012 
E16 rat 0.8 – 500ng/ml in culture 
media 
↑ SAPK/JNK ↓ NPC proliferation 
↓ Neuronal differentiation 
- ↓ Wang et al. 2007 
Aged adult mice Inhibition of IL-1β 
activation by caspase-1 
cleavage 
- - ↑ proliferation ↑ Gemma et al. 2007 
Adult mice MyD88 knockout 
(Disruption of IL-1R1 
dependent signalling) 
IL-1R1 independent - ↓ NPC proliferation ↓ Wu et al. 2013 
Adult rat 20ng/ml or 200ng/ml 
ICV 
↑NF-κB - ↓ Cell proliferation ↓ Koo & Duman 2008 
Mice OEX of IL-1RA - - Impaired MWM 
performance 
↓ Goshen et al. 2007 
Mice Transplantation of NPC 
OEX IL-1RA 
- - Prevention of stress 
induced impairments in 
fear conditioning 
↑ Ben Menachem-Zidon et 
al. 2008 
Mice Transplantation of NPC 
OEX IL-1RA 
- - Improved MWM 
performance in model of 
AD 
 Ben Menachem-Zidon et 
al. 2014 
Rats Intrahippocampal IL-1β 
infusion (5ng/0.25μl) 
↑ MAPK (p-ERK) - Impaired fear conditioning 
Prevented by MAPK 
inhibition 
 Gonzalez et al. 2013 
Table 1: Summary of literature assessing the effects of IL-1β on hippocampal neurogenesis.  
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1.7: Aims 
The overall aim of this thesis is to investigate the function of TLX in hippocampal 
neurogenesis and hippocampal-associated cognition in the presence and absence of 
the pro-inflammatory cytokine IL-1β. Inflammation is known to be a potent 
suppressor of hippocampal neurogenesis and IL-1β is a key player in hippocampal 
inflammation. IL-1β can suppress the expression of TLX in proliferating NPCs and 
so we aim to further elucidate the functional interactions between IL-1β and TLX in 
the hippocampus and hippocampal NPCs. We also focus on how these two 
regulators of neurogenesis can impact individually upon hippocampal-associated 
cognition. We hypothesize that TLX can be manipulated to firstly mitigate the 
effects of IL-1β on NPC proliferation in vitro, secondly regulate transcriptome 
responses to IL-1β in vivo and thirdly alter cognitive performance in hippocampal 
associated tasks. Additionally, we hypothesize that sustained IL-1β expression in 
conjunction with adolescent consumption of a diet high in fat and sugar can impact 
upon hippocampal cognitive processes. To test these hypotheses, our aims were: 
 
Aim 1: To determine the effect on NF-κB inhibition on IL-1β-induced suppression 
of TLX expression in primary cultures of rat hippocampal NPCs (Chapter 2) 
 
Aim 2: To examine whether TLX overexpression can prevent the effects of IL-1β on 
neurogenesis in vitro (Chapter 2). 
 
Aim 3: To determine the transcriptome changes in the hippocampus of TLX 
knockout mice (Chapter 3) 
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Aim 4: To determine transcriptome changes in the hippocampus of TLX knockout 
mice induced by hippocampal IL-1β administration. (Chapter 3). 
 
Aim 5: To determine if TLX overexpression in vivo can promote hippocampal 
neurogenesis-associated behaviours in rats (Chapter 4). 
 
Aim 6: To determine whether cafeteria diet during adolescence can impair 
hippocampal neurogenesis-associated cognition in rats (Chapter 5). 
 
Aim 7: To assess whether hippocampal IL-1β overexpression during adulthood can 
exacerbate adolescent cafeteria diet-induced effects on hippocampal neurogenesis-
associated cognition in rats (Chapter 5).  
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Abstract 
Hippocampal neurogenesis is a lifelong process whereby new neurons are produced 
and integrate into the host circuitry within the hippocampus. It is regulated by a 
multitude of extrinsic and intrinsic regulators and is believed to contribute to certain 
hippocampal-dependent cognitive tasks. Hippocampal neurogenesis and associated 
cognition have been demonstrated to be impaired following increases in levels of the 
pro-inflammatory cytokine IL-1β in the hippocampus; such as occurs in various 
neurodegenerative and psychiatric disorders. IL-1β also suppresses the expression of 
TLX. TLX is an orphan nuclear receptor which functions to promote NPC 
proliferation while suppressing neuronal differentiation. Therefore, manipulation of 
TLX represents a potential strategy to prevent the anti-proliferative effects of IL-1β. 
In this study, we assessed the mechanism underlying IL-1β-induced changes in TLX 
expression and determined the protective capacity of TLX in mitigating the effects of 
IL-1β on embryonic rat hippocampal neurosphere expansion. We demonstrated that 
IL-1β activated the NF-κB pathway in proliferating NPCs and that this pathway 
activation was responsible for IL-1β-induced changes in TLX expression. 
Additionally, we report that enhancing TLX expression prevents IL-1β-induced 
suppression of neurosphere expansion. Thus, we highlight TLX as a potential 
protective regulator of the anti-proliferative effects of IL-1β on hippocampal 
neurogenesis. 
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1: Introduction 
Hippocampal neurogenesis is a process by which new neurons are born from neural 
progenitor cells (NPCs) in the hippocampus. The process begins during embryonic 
development and persists into adulthood, where it is thought to contribute to 
hippocampal-dependent cognitive function (Kohman and Rhodes, 2013, Zhao et al., 
2008). Evidence of this functional role of hippocampal neurogenesis in the adult has 
been shown in vivo due to its involvement in various cognitive tasks such as Morris 
water maze (Drapeau et al., 2007, van Praag et al., 1999c, van Praag et al., 1999a, 
van Praag et al., 2005), novel object and novel location recognition (Jessberger et al., 
2009a, Rola et al., 2004, Madsen et al., 2003), and pattern separation in rodents 
(Sahay et al., 2011b, Clelland et al., 2009, Creer et al., 2010, Bekinschtein et al., 
2011). Additionally, adult hippocampal neurogenesis has been demonstrated to be 
impaired in conditions where there is a subsequent impairment in hippocampal 
cognition, such as stress, depression, aging, and neurodegeneration (Lazarov et al., 
2010, Na et al., 2014, Santarelli et al., 2003, Tanti and Belzung, 2013, Yirmiya and 
Goshen, 2011). Many of these conditions have been associated with increased 
inflammation and expression of the pro-inflammatory cytokine interleukin-1β (IL-
1β) in the brain (Maes et al., 2012, Godbout and Johnson, 2009, Leonard, 2007, 
Nolan et al., 2013).  
 
Inflammation is well established as having negative consequences on central nervous 
system function and on hippocampal neurogenesis. Release of IL-1β occurs from 
activated microglia as a result of stress, infection, neurodegeneration, or indeed with 
aging (Raison et al., 2006, Leonard, 2007, Kettenmann et al., 2013, Yirmiya and 
Goshen, 2011). The cognate receptor for IL-1β is the IL-1 receptor type 1 (IL-1R1) 
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and this receptor is highly expressed on glia, neurons, and NPCs in the hippocampus 
of the rodent brain (Farrar et al., 1987, Parnet et al., 1994, Green et al., 2012, Ryan et 
al., 2013). After binding to IL-R1, IL-1β induces an intracellular signalling cascade 
leading to altered gene transcription and a heightened pro-inflammatory response 
(Rothwell et al., 1996, Green and Nolan, 2012b, Sims et al., 1993). In most cell 
types, ligation of IL-1β to IL-1R1 activates the nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) signalling pathway (DiDonato et al., 1997). 
NF-κB is composed of homo- or heterodimeric combinations of the Rel family of 
proteins, consisting of p52, p65 (Rel A), c-Rel, RelB, and p50. These proteins work 
in combination or with other co-factors, such as creb binding protein (CBP), to 
regulate the transcription of NF-κB target genes (Sheppard et al., 1999). 
Consequences of sustained elevation of IL-1β in the hippocampus include impaired 
synaptic plasticity and hippocampal dependent learning and memory (Vereker et al., 
2000, Goshen et al., 2008, Pugh et al., 1999, Green and Nolan, 2012b, Ryan et al., 
2013). Indeed the NF-κB pathway has been suggested to mediate the effects of IL-1β 
on long term potentiation (LTP) (Tong et al., 2012, Vereker et al., 2000, Lynch, 
2004). It has also been demonstrated that IL-1β can recruit the NF-κB pathway to 
suppress hippocampal neurogenesis. For example, it has been demonstrated that 
inhibition of the NF-κB pathway prior to extrinsic administration of IL-1β to 
hippocampal NPCs in vitro prevented an IL-1β-induced suppression of proliferation 
in these cells (Koo and Duman, 2008). However it is uncertain how the activation of 
this pathway can affect intrinsic regulators of hippocampal neurogenesis. 
 
The study of signalling mechanism within embryonic NPCs provides valuable 
insights into signalling mechanisms which may occur within adult NPCs (Hodge and 
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Hevner, 2011, Kriegstein and Alvarez-Buylla, 2009, Liu and Zhao, 2009, Qu and 
Shi, 2009). IL-1R1 is expressed on both embryonic and adult NPCs (Green et al., 
2012, Ryan et al., 2013) and IL-1β has been shown to negatively impact upon 
various aspects of hippocampal neurogenesis such as proliferation, differentiation, 
and survival (Green et al., 2012, Ryan et al., 2013, Koo and Duman, 2008). TLX 
(Orphan nuclear receptor tailless homolog), or Nr2e1 (nuclear receptor subfamily 2 
group E member 1), is an orphan nuclear receptor and an intrinsic regulator of 
neurogenesis that is required to maintain the pool of NPCs within the hippocampus 
by promoting NPC proliferation and suppressing differentiation (Shi et al., 2004, 
Zhao et al., 2010). Studies using transgenic models show that TLX can contribute to 
hippocampal dependent learning and memory (Shi et al., 2004, Murai et al., 2014, 
O'Leary et al., 2016b). For example in TLX
-/-
 mice, impairments in hippocampal-
associated cognitive function and hippocampal neurogenesis have been reported 
(Monaghan et al., 1995, Roy et al., 2002). It has also been demonstrated that IL-1β 
negatively regulates the expression of TLX within both adult and embryonic NPCs, 
with subsequent impairments in NPC proliferation (Green and Nolan, 2012b, Ryan 
et al., 2013, O'Leary et al., 2016a). However, the associated signalling remains 
largely unknown. Likewise, whether TLX manipulation can prevent the effects of 
IL-1β on NPC expansion has not been investigated. Here we identify the NF-κB 
signalling pathway as a key mediator of the effects of IL-1β on TLX expression and 
show that restoration of TLX expression is sufficient to prevent the negative effects 
of IL-1β on NPC expansion in vitro. These data along with previous data from ours 
and others groups highlight TLX as a potential regulator of IL-1β-induced 
impairments in hippocampal neurogenesis.  
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2: Experimental Methods 
2.1: Preparation and treatments of rat hippocampal NPCs 
Embryonic day (E) 18 rat hippocampi (Biological Services Unit, UCC, Cork, 
Ireland) were cultured for 6 days in vitro (DIV) as previously described (Green et al. 
2012; Keohane et al. 2010). Neurospheres were kept under proliferative conditions 
in T25 flasks at a density of 2x10
6 
cells/10ml of proliferation media (DMEM:F12 
(Sigma-Aldrich), 2% B27 supplement (Invitrogen), 1% penicillin/streptomycin 
(Sigma-Aldrich), 10ng/ml EGF (Sigma-Aldrich), 10ng/ml FGF (Millipore), 200mM 
L-glutamine (Sigma-Aldrich), 33mM D-glucose (Sigma-Aldrich)). At 6DIV the 
neurospheres were dissociated using 0.1% trypsin-EDTA enzyme (Sigma-Aldrich) 
and treated as a single cell suspension. 5x10
4 
cells were plated in proliferation media 
onto poly-D-lysine (Sigma-Aldrich) coated coverslips for immunocytochemical 
analysis and 5x10
5
 cells were seeded per well in proliferation media in six well 
plates for PCR analysis. In the first set of experiments, recombinant rat IL-1β 
(10ng/ml) (R&D Systems) was added to the media for 10min, 30min, 1h, 2h, 4h or 
6DIV to measure mRNA expression levels of TLX, p21 and IκBα, and p65 and TLX 
protein levels. A second series of NPC cultures were treated  with IL-1β (10ng/ml) 
for 8hr, 16hr, and 24hr to assess the effects of longer term treatment of IL-1β on 
TLX and p21 mRNA expression. In a subsequent series of experiments, IL-1β 
(10ng/ml) was added to the proliferation media with or without the NF-κB inhibitor, 
JSH-23 (25μM) (Sigma-Aldrich) for 3h in vitro and mRNA expression levels of 
TLX, p21 and IκBα, as well as protein levels of TLX were assessed. We chose to use 
JSH-23 at a concentration of 25μM throughout this study as this concentration had 
previously been shown to suppress NF-κB signalling in cultured adult rat derived 
hippocampal NPCs without affecting viability (Koo et al., 2010). 
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2.2: Lentiviral production and transduction of NPCs with TLX lentivirus 
Mouse TLX (Nr2e1) was cloned into a pCDF-CMV-IRES-GFP lentiviral FIV 
backbone using standard cloning methods. Transgene expression of TLX was driven 
by a cytomegalovirus (CMV) promoter which was connected via an internal 
ribosomal entry sequence (IRES) to a GFP reporter. Lentiviral particles were 
produced by transfecting a HEK 293T producer cell line with the lentiviral Nr2e1 
plasmid or lentiviral GFP control plasmid and pPACKF1
TM
 Lentivector Packaging 
Kit (System Biosciences, 2438 Embarcadero Way, Palo Alto, CA, 94303, USA). 
Harvested viral supernatant was aliquoted and stored at -80°C until use. Packaged 
viruses had titres of approximately 1x10
6
 TU/ml. On the day of seeding, 5x10
5 
dissociated NPCs were plated in each well of a 6 well plate along with 7x10
4 
TU/ml 
of lentivirus overexpressing either TLX or GFP. After 24 hours, recombinant rat IL-
1β (10ng/ml) or phosphate buffered saline (PBS) was added. Cells were allowed to 
proliferate as neurospheres and were kept under proliferative conditions for a further 
6DIV. 
 
2.3: PCR 
Total cellular RNA was extracted from the dissociated NPCs derived from the 
neurospheres using a Total Mammalian RNA extraction kit (Sigma-Aldrich) 
following the manufacturer’s instructions. Extracted RNA was treated with DNase 
(Sigma-Aldrich) to remove any DNA contamination. Complimentary DNA (cDNA) 
was prepared using the High capacity cDNA reverse transcription kit (Applied 
Biosystems). PCR was carried out on a 96 well plate using a StepOnePlus Real-Time 
PCR machine (Applied Biosystems) using the following primers: TLX F: 
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GCTTTCTTCACAGCGGTCAC, R: GCAGACACAGCGGTCAACT; IκBα F: 
TGAAGTGTGGGGCTGATGTC, R: AGGGCAACTCATCTTCCGTG; p21 F: 
GTATGCCGTCGTCTGTTCGG,  R: GCAGAAGACCAATCGGCGCT; and 
SHDA F: CCCACTAACTACAAGGGACAGG, R: TTGGCACCATGCACTGAG. 
The PCR consisted of the following steps: 95°C for 3 minutes to denature the cDNA 
followed by 45 cycles of 95°C for 10 seconds and 60°C for 30 seconds. Each 
reaction consisted of 1μl of sample (5ng/ul), 10μl of Sybr MasterMix (KiCqStart® 
SYBR® Green qPCR ReadyMix™ with ROX™ for ABI instruments, Sigma-
Aldrich), 0.1μl of both forward and reverse primers, and 8.8μl of RNase free H2O. 
RNA elution solution was used instead of samples to ensure no amplification 
occurred as a result of self complimentary primers. Results were normalised to 
succinate dehydrogenase (SDHA) and analysed using the ΔΔCT method (Livak and 
Schmittgen, 2001). 
 
2.4: Immunocytochemistry 
Cells were incubated in 5% donkey serum overnight at 4°C to block non-specific 
antibody binding. Cells were then incubated with antibodies against TLX (Santa 
Cruz, sc292096, 1:100, donkey anti-rabbit) or p65 (Abcam, ab7970, 1:100, donkey 
anti-rabbit) at 4°C overnight and subsequently incubated with the appropriate 
fluorescently tagged secondary antibody (Alexafluor, Invitrogen) for 2h at room 
temperature in the dark. The cells were counterstained with 4’6-diamidino-2-
phenylindole (DAPI) (1:2500) to identify the nuclei. For each protein a sample of 
cells was incubated with blocking solution and secondary antibody, but without prior 
incubation with primary antibody, as a negative control. 
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2.5: MTT viability analysis of treated NPCs 
After 6DIV of IL-1β treatment or 3 hours of JSH-23 with and without IL-1β 
treatment, NPCs were seeded at a density of 2 x 10
4
 cells in a 96-multiwell plate, in 
proliferation media. Cells were incubated with 0.5mg/mL Thiazolyl Blue 
Tetrazolium Bromide (Sigma) in proliferation media (without IL-1β or JSH-23) 
under conditions of 5% CO2 at 37 °C for 3 hours. The solution was removed and 
cells were lysed using DMSO. Lysates were transferred to a fresh 96-multiwell plate 
and the absorbance 129 was read on a Multiskan spectrophotometer (Thermo Fisher) 
at an absorbance wavelength of 540nm and a reference wavelength of 690nm. Each 
experiment was carried out three times and in technical triplicate. 
 
2.6: Neurosphere diameter analysis, cell counts, and densitometry 
Neurospheres were imaged using an inverted microscope (IX70, Olympus) at 10x 
magnification each day for 5DIV. At 6DIV neurospheres were dissociated to assess 
changes in TLX and p21 expression as previously described. For diameter analysis, 
images of five individual neurospheres were captured per field of view from four 
fields of view per flask per time point. Neurosphere diameter was measured using 
ImageJ (version 1.47, NIH, Bethesda, MD, USA). At least 20 spheres were analysed 
per condition. Each experiment was repeated at least 3 times. Immuno-labelled cells 
were imaged using an upright microscope (BX53, Olympus). Positively-stained cells 
were counted from five random fields of view per coverslip. For each condition, 
cells from four coverslips were counted and each experiment was repeated three 
times. Merged images of DAPI with TLX or p65 immunolabelled cells were used to 
analyse densitometry of nuclear staining from ten randomly selected TLX or p65-
positive cells per field of view using ImageJ software. Twenty micrographs per 
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condition were analysed from three independent experiments. Background 
fluorescence intensity was controlled for by thresholding. Data were expressed as 
arbitrary units of the intensity ratio of nuclear: nuclear + cytoplasmic TLX and each 
dataset resulting from IL-1β treatment was normalised to its respective control.  
 
2.7: Statistical Analysis 
Unpaired Student’s t-test and one-way or two-way ANOVA followed by a 
Bonferroni post hoc test were performed where appropriate to determine which 
conditions were significantly different from each other. Results are displayed as 
mean with SEM and deemed significant when p<0.05. 
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3: Results 
3.1: IL-1β suppresses neurosphere expansion 
Two-way ANOVA revealed a main effect of IL-1β (10ng/ml) treatment (p<0.001) 
and treatment duration (p<0.001). Post hoc analysis showed that IL-1β suppressed 
neurosphere expansion under proliferative conditions after 4 and 5DIV (*p<0.05 vs. 
Ctrl) (Fig. 2.1A, B). Under the same conditions at 6DIV, IL-1β induced a significant 
increase in the mRNA expression of the tumour suppressor gene p21 in dissociated 
NPCs (**p<0.01 vs. Ctrl) (Fig. 2.1C). IL-1β also induced a significant decrease in 
the mRNA expression of TLX, a known promoter of cell proliferation in NPCs, at 
this timepoint (**p<0.01) (Fig. 2.1D). This is consistent with a previous report 
demonstrating that IL-1β reduced the protein expression levels of TLX in 
hippocampal NPCs after 7 DIV (Green and Nolan, 2012b). IL-1β did not induce a 
reduction in cell viability at this dose and over this timeframe (Fig. 2.1E) which 
supports previous data (Green et al., 2012).  
 
3.2: IL-1β induces rapid activation of NF-κB  
To assess whether IL-1β administration induced translocation of the NF-κB subunit 
p65 to the nucleus in hippocampal NPCs, an indicator of NF-κB activation, we 
assessed the ratio of nuclear to cytoplasmic expression of p65 (RelA), a key 
signalling component of the NF-κB pathway. As NF-κB signalling has been shown 
to be rapidly activated in human glial cells after IL-1β exposure (Griffin and 
Moynagh, 2006), we assessed p65 translocation to the nucleus from 10 minutes to 4 
hours after IL-1β administration. IL-1β administration induced a significant increase 
in nuclear translocation of p65 protein at 10 minutes after IL-1β indicating increased 
NF-κB activation (F (5, 114) = 19.21, *** = p<0.001 vs. Ctrl) (Fig. 2.2A, C). A 
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negative feedback mechanism was evident due to the fact that mRNA expression of 
IκBα, a negative regulator and target gene of p65, was significantly increased 10 
minutes after IL-1β (F (5, 18) = 6.56, *** = p<0.001 and * = p<0.05 vs. Ctrl) (Fig. 
2.2B). The increase in IκBα expression was maintained for up to 4 hours which 
coincided with a decrease in nuclear p65 protein expression at 4 hours after IL-1β 
(** = p<0.01 vs. Ctrl) (Fig. 2.2A).  
 
3.3: IL-1β induces suppression of TLX expression 
As we observed NF-κB activation induced by IL-1β in hippocampal NPCs, we next 
assessed the effects of IL-1β on TLX expression in hippocampal NPCs over the 
same time frame. After 30 minutes of IL-1β exposure there was a decreased mRNA 
expression of TLX in proliferating NPCs (F (5, 12) = 3.17, *p<0.05) (Fig. 2.3A). 
This resulted in a significant decrease in TLX protein after 1 hour of IL-1β exposure 
(F (5, 114) = 20.75, ***p<0.001) (Fig. 2.3B, C). We assessed TLX mRNA 
expression after an extended treatment with IL-1β and show that it remained reduced 
after 8 hours of IL-1β exposure, normalised at 16 hours, and was significantly lower 
that control again at 24 hours after IL-1β treatment. F (3, 3) = 18.88, ***p<0.001, 
**p<0.01) (Fig. 2.3D) This corroborates previous data showing a reduction in TLX 
protein expression at 24h in response to IL-1β (Ryan et al., 2013). As TLX functions 
as a transcriptional suppressor, we assessed the effect of IL-1β on the expression of 
the TLX target gene and suppressor of proliferation, p21. IL-1β induced a significant 
increase in p21 mRNA expression after 2 hours (F (5, 18) = 3.25, ** = p<0.01 vs. 
Ctrl), however this effect was not significant after 4 hours (Fig. 2.3E). Therefore, we 
extended our treatment times and observed that after 8 hours of IL-1β exposure there 
was no change in p21 expression compared to control. However, after 16 and 24 
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hours p21 mRNA expression was significantly higher than controls (F (3, 8) = 12.16, 
** = p<0.01) (Fig. 2.3F). 
 
3.4: IL-1β mediates its effects on TLX expression via NF-κB pathway activation 
To assess whether the IL-1β-induced activation of NF-κB pathway is responsible for 
the IL-1β-induced decrease in TLX expression, we pre-treated hippocampal NPCs 
with JSH-23, an inhibitor of NF-κB activation (Koo et al., 2010). We demonstrate 
that when this pathway is inhibited, the IL-1β-induced reduction in TLX mRNA 
expression is attenuated (F (3, 8) = 12.14,*** = p<0.001 vs. Ctrl; + = p<0.05 vs. IL-
1β) (Fig. 2.4A). The changes in TLX mRNA expression were mirrored by the 
changes in TLX protein expression (F (3, 796) = 75.57, *** = p<0.001 vs. Ctrl; +++ 
= p<0.001 vs. IL-1β) (Fig. 2.4B, C). Treatment of NPCs with JSH-23 had no effect 
on the IL-1β -induced increase in in the mRNA expression of the TLX target gene 
p21 (Fig. 2.4D) but attenuated the IL-1β -induced activation of NF-κB target gene 
IκBα (Fig. 2.4E). The attenuation of IL-1β-induced decrease in TLX by JSH-23 was 
not due to a reduction in total cell viability, as neither IL-1β nor JSH-23 reduced cell 
viability compared to control during this acute incubation period (Fig. 2.4F). 
 
3.5: Increased TLX expression prevents IL-1β-induced suppression of neurosphere 
expansion 
To assess whether TLX could prevent the IL-1β-induced decrease in neurosphere 
expansion we transduced neurospheres with lentiviruses expressing either GFP or 
TLX and showed that they did not significantly impair neurosphere expansion 
compared to control non lentiviral transduced neurospheres across all timepoints 
(Fig. 2.5A, B). Two-way ANOVA revealed a main effect of treatment with lentivirus 
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with or without IL-1β (F (5, 216) = 29.575, p<0.001) and treatment duration (F (5, 
216) = 120.422, p<0.001) and an interaction effect of treatment x treatment duration 
(F (25, 216) = 1.780, p<0.05). Post hoc analysis showed that IL-1β treatment of 
GFP-transduced neurospheres impaired neurosphere expansion to a similar extent as 
non-lentiviral transduced neurospheres treated with IL-1β at 4DIV, 5DIV, and 6DIV 
(p<0.05) (Fig. 2.5A) while IL-1β treatment of TLX-transduced neurospheres did not 
(Fig. 5.5B). Moreover, neurospheres transduced with lentivirus overexpressing TLX 
significantly attenuated IL-1β-induced impairment in neurosphere expansion at 
4DIV, 5DIV, and 6DIV (p<0.01) (Fig. 2.5B, C). IL-1β-treated GFP-transduced 
neurospheres showed impaired expansion compared to GFP-transduced controls at 
6DIV (p<0.001) (Fig. 2.5D) and this effect was not apparent in IL-1β-treated TLX-
transduced neurospheres compared to TLX-transduced controls (Fig. 2.5D, E). To 
confirm the efficacy of the lentiviral transduction, we assessed TLX mRNA 
expression in GFP and TLX transduced neurospheres at 6DIV. In the absence of IL-
1β, there was no significant difference in TLX mRNA expression between TLX and 
GFP transduced neurospheres (Fig. 2.5F). However, after treatment with IL-1β for 
6DIV, TLX transduced neurospheres maintained a significantly higher expression of 
TLX mRNA compared to GFP transduced neurospheres (F (3, 25) = 7.73, # = 
p<0.05 between GFP + IL-1β and TLX + IL-1β, ** = p<0.01 between GFP and GFP 
+ IL-1β, $$$ = p<0.001 between TLX and GFP + IL-1β) (Fig. 2.5F). Both GFP and 
TLX overexpressing cells display an increase in the mRNA expression of IκBα in 
response to IL-1β treatment however the increase in expression only reaches 
significance in the TLX-transduced neurospheres (F (3, 19) = 5.71, +++ = p<0.001 
vs. TLX) (Fig 2.5G). 
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4: Discussion 
The present study demonstrates that TLX may protect against IL-1β-induced 
suppression of hippocampal NPC proliferation, and thus TLX is an important 
regulator of neuroinflammatory-induced changes in hippocampal neurogenesis. 
Specifically, we have shown that IL-1β induces a decrease in hippocampal NPC 
neurosphere expansion, which is consistent with previous reports (Ryan et al., 2013, 
Green and Nolan, 2012b). This decrease is associated with a significant reduction in 
TLX expression, a regulator of NPC proliferation, and an increase in p21 expression, 
a mediator of cell cycle arrest and reduced proliferation (Sun et al., 2007, Sharpless 
and DePinho, 2004, Waga et al., 1994). Additionally, we demonstrate that IL-1β 
recruits the NF-κB pathway in embryonic hippocampal NPC neurospheres and that 
pharmacological inhibition of this pathway is sufficient to reverse the negative 
effects of IL-1β on TLX expression. Finally, we show that restoration of TLX 
expression in the presence of IL-1β protects against IL-1β-induced suppression of 
neurosphere expansion. This suggests that TLX can mitigate the anti-proliferative 
effects of IL-1β on hippocampal NPCs.  
 
We, and others, have previously established that IL-1β induces a decrease in 
hippocampal NPC proliferation in cultures of embryonic and adult neurospheres 
(Green and Nolan, 2012b, Ryan et al., 2013, Koo and Duman, 2008), and 
neurosphere expansion has been correlated with increased proliferation of NPCs 
from both the hippocampus and subventricular zone of the lateral ventricles (Widera 
et al., 2006, Murai et al., 2014). We also observed that IL-1β at the dosage and 
duration of treatment used in the current study does not affect cell viability. We did 
however, demonstrate that IL-1β decreased the mRNA expression of TLX after short 
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treatment duration for up to 24 hours as well as after a longer treatment duration of 6 
days. This supports previously published data reporting an IL-1β- induced decrease 
in the protein expression of TLX at both 24 hours (Ryan et al., 2013) and 7 days 
(Green and Nolan, 2012b). As TLX promotes cell proliferation, the suppression of 
neurosphere expansion in response to IL-1β is potentially mediated via reduced 
expression levels of TLX. Additionally, we observed an increase in the mRNA 
expression of the TLX target gene p21 after IL-1β treatment for up to 5 days. p21 
expression in suppressed by TLX and when its expression is increased it induces cell 
cycle arrest and reduces proliferation (Waga et al., 1994, Pechnick et al., 2011, Sun 
et al., 2007). Therefore, based on the current study and previous reports (Green and 
Nolan, 2012b, Ryan et al., 2013), the ability of IL-1β to reduce neurosphere 
expansion is likely due to a reduction in NPC proliferation rather than an induction 
of cell death.  
 
The NF-κB pathway has been shown to be responsible for inhibiting cell 
proliferation in vitro and in vivo in several cell types including rat hippocampal 
NPCs, mouse embryo fibroblasts, and human epithelial cells (Seitz et al., 2000, Chen 
et al., 2006, Koo and Duman, 2008). IL-1β has previously been shown to recruit the 
NF-κB pathway to suppress hippocampal NPC proliferation in vivo (Koo and 
Duman, 2008). NF-κB is rapidly activated in response to IL-1β in human glial cells 
(Griffin and Moynagh, 2006) and thus we hypothesised that a rapid activation may 
also occur in hippocampal NPCs. Indeed, we observed translocation of the p65 
subunit to the nucleus (an indicator of NF-κB activation (Xie et al., 2016, Zhu et al., 
2015)) of hippocampal NPCs within 10 minutes of IL-1β administration. We also 
demonstrated activation of the NF-κB target gene IκBα within this time frame. 
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Inhibition of NF-κB activation using JSH-23 (Koo and Duman, 2008, Arias-
Salvatierra et al., 2011, de Vries et al., 2014, Kesanakurti et al., 2013) abrogated the 
IL-1β-induced decrease in TLX mRNA and protein expression in hippocampal 
NPCs after 3 hours of exposure to IL-1β and also attenuated the IL-1β -induced 
increase in IκBα mRNA expression. Thus, the NF-κB pathway appears to be a 
potential mediator of IL-1β-induced changes, not only on NPC proliferation as 
previously shown (Koo et al., 2010, Koo and Duman, 2008) but also on TLX 
expression. It is tempting to speculate that suppression of TLX by IL-1β via 
enhanced NF-κB activation is the predominant mechanism which determines the 
outcome of IL-1β-induced changes in proliferation of NPCs. The data herein would 
suggest that IL-1β-induced activation of NF-κB results in the suppression of TLX 
gene expression resulting in a subsequent decline in TLX protein expression and 
NPC proliferation. This mechanistic pathway would be more likely than a direct 
protein interaction between TLX and NF-κB signalling due to the fact that changes 
in TLX and p65 expression occur at largely different timepoints and locations within 
the NPCs.  
 
We did not observe an effect of NF-κB inhibition on expression of the TLX target 
gene p21 in response to IL-1β. JSH-23 has been established as a selective NF-κB 
inhibitor but any non-specific signalling effects that JSH-23 treatment may have in 
hippocampal NPCs that may impact upon target genes cannot be ruled out (Shin et 
al., 2004, Kumar et al., 2011, Arias-Salvatierra et al., 2011). However, we observed 
that JSH-23 treatment attenuated the IL-1β-induced increase in the NF-κB target 
gene IκBα therefore our data are a proof of concept that NF-κB signalling is at least 
partially responsible for the effects of IL-1β on TLX expression. It should be noted 
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though that IL-1β does not exclusively recruit NF-κB signalling pathways 
components to mediate its effects on hippocampal NPC proliferation (Wang et al., 
2007, Zunszain et al., 2012a, O'Leime et al., 2017a). Specifically it has previously 
been demonstrated that IL-1β treatment for 48 hours induced the activation of 
SAPK/JNK signalling in embryonic rat forebrain NPCs in vitro and that SAPK/JNK 
signalling, and not the NF-κB pathway, mediated IL-1β-induced decrease in 
proliferation of these NPCs (Wang et al., 2007). The differences reported in that 
study may be related to brain region, embryonic age of the NPCs, or treatment 
duration of IL-1β. The results also suggest that, at specific stages in development, 
IL-1β may recruit different pathways to exert its effects on NPCs, or indeed, longer 
incubations with IL-1β may result in different signalling pathway activation. We 
have previously shown that IL-1β can increase the activity of GSK-3β, a negative 
regulator of Wnt signalling pathway (Wu and Pan, 2010), in proliferating 
hippocampal embryonic NPCs with subsequent reductions in proliferation (Green 
and Nolan, 2012b). Additionally, that study demonstrated that when GSK-3β was 
inhibited, the IL-1β-induced suppression of NPC proliferation and TLX expression 
were ameliorated. However, that study assessed the effects of chronic IL-1β 
administration and so GSK-3β, and potentially Wnt signalling, may regulate the 
chronic effects of IL-1β on TLX and NPC proliferation. Interestingly, GSK-3β can 
interact with NF-κB signalling to regulate cytokine production, and so the protective 
effects of inhibiting GSK-3β after IL-1β exposure may be indirectly mediated by the 
subsequent effects on NF-κB signalling (Green and Nolan, 2012a, Martin et al., 
2005). Assessment of the differential activation of specific pathways in response to 
individual activators as NPCs proliferate, differentiate, and integrate into the 
surrounding neuronal circuitry provides an interesting avenue for future research. 
Chapter 2 
 
115 
 
 
An interesting insight into the transcriptional effects of IL-1β in NPCs is the increase 
in p21 expression after IL-1β treatment of proliferating NPCs demonstrated in this 
study. p21 is a potent suppressor of the cell cycle, and subsequently is an important 
regulator of cell proliferation (Sharpless and DePinho, 2004). TLX has previously 
been shown to suppress the expression of p21 in neural stem cell (NSC) cultures 
(unknown source) which is correlated with an increase in NPC proliferation (Sun et 
al., 2007). However, the study did not attempt to manipulate the increase in p21 
expression (either knockdown or other method of inhibition) to assess the direct role 
of p21 on NSC proliferation (Sun et al., 2007). The importance of p21 in regulating 
the proliferation of hippocampal NPCs has since been established in p21
-/-
 mice 
where there is a significant increase in NPC proliferation (Pechnick et al., 2011) and 
so it is reasonable to suggest that the mechanism by which TLX regulates 
proliferation involves the regulation of p21 expression. We demonstrate here that 
when TLX expression is suppressed by IL-1β, there is a concurrent increase in p21 
expression which suggests that IL-1β may suppress NPC proliferation by enhancing 
p21 expression. This theory is supported by findings showing an increase in 
hippocampal IL-1β expression, a subsequent increase in hippocampal p21 
expression, and reduced hippocampal NPC proliferation and neuronal differentiation 
in a mouse model of inflammatory bowel disorder (Zonis et al., 2015). 
 
Deficits in neurogenesis in TLX null mice have been reported by several research 
groups (Murai et al., 2014, Sun et al., 2007, Monaghan et al., 1997, Li et al., 2008). 
For example, Shi and colleagues have demonstrated that NPCs of TLX
-/-
 mice have 
prolonged cell cycles and impaired proliferation during embryonic development (Li 
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et al., 2008). This was also demonstrated in adult hippocampal NPCs, where there 
was an impairment in NPC proliferation within the hippocampus of adult mice with 
an induced recombination of the TLX gene (Zhang et al., 2008). Functionally, 
deficits in TLX expression and subsequent suppression of hippocampal neurogenesis 
have been demonstrated to impair spatial memory in mice, which is a hippocampal-
associated cognitive process (Zhang et al., 2008). More recently, it has been shown 
that overexpressing TLX can rescue the proliferative defects in mice lacking TLX, 
and improve hippocampal neurogenesis-associated cognition as evidenced by 
improved performance in the Morris water maze (Murai et al., 2014). Taken 
together, these data show that TLX can be manipulated to positively regulate 
hippocampal neurogenesis and associated cognition. However, little has been done in 
assessing whether TLX can mitigate the negative effects of an external insult such as 
inflammation on hippocampal neurogenesis. In the current study, we show that 
overexpression of TLX rescued the negative effects of IL-1β on hippocampal 
neurosphere expansion. Thus, TLX may act as a regulator of IL-1β-induced deficits 
in NPC expansion but whether this effect translates in vivo remains to be determined. 
As we have demonstrated that NF-κB signalling may mediate the suppressive effects 
of IL-1β on TLX expression, the ability of TLX to counter the effects of IL-1β on 
neurosphere expansion may not be mediated by suppressing NF-κB signalling. This 
is due to the fact that both GFP and TLX overexpressing neurospheres both show a 
similar increase in IκBα expression following IL-1β treatment. As previously 
discussed, IL-1β can recruit multiple pathways to regulate NPC proliferation and so 
TLX may potentially interact with pathways other than NF-κB to mitigate the effects 
of IL-1β on neurosphere expression (Song et al., 2013, O'Leime et al., 2017a, Wang 
et al., 2007). Notwithstanding, our study demonstrates that TLX can prevent the 
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functional effects of IL-1β on neurosphere expansion and so future studies will 
involve identifying the specific signalling interactions between these two regulators 
of NPC proliferation. It should be noted, however, that overexpression of TLX can 
lead to hyperproliferation of NPCs and increased glioma formation in vivo (Liu et 
al., 2010, Park et al., 2010). However this may be overcome with the advent of 
pharmacological ligands for TLX. Indeed efforts have been made to identify ligands 
for this orphan nuclear receptor in order to target and manipulate TLX function 
(Benod et al., 2014b). Moreover, ligands may provide a controllable regulation of 
TLX function and thus avoid the potential side-effects of enhanced TLX expression.  
 
In conclusion, the current study provides evidence that IL-1β-induced 
downregulation of TLX is mediated by the NF-κB pathway, and that enhanced TLX 
expression prevents IL-1β-induced reduction in NPC neurosphere expansion 
potentially via an NF-κB independent mechanism. We propose that the IL-1β-
mediated suppression of TLX results in increased p21 expression which leads to 
reduced cell proliferation. Further research on the role of TLX in modulating 
neuroinflammatory-induced deficits in hippocampal neurogenesis will pave the way 
to the development of new therapeutic strategies for hippocampal-dependent 
cognitive disorders.  
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Figure 2.1: IL-1β-induced suppression of hippocampal neurosphere expansion is 
associated with increased p21 expression and reduced TLX expression.  A) 
Neurosphere diameter from IL-1β-treated and untreated cultures (n=3) (Two-way 
ANOVA with Bonferroni post hoc). B) Representative images of control and IL-1β-
treated neurospheres at 5DIV. Scale bar = 100μm. C) Relative mRNA expression of 
p21 in untreated and IL-1β-treated cultures after 5DIV under proliferative conditions 
(n=8) (Student’s t-test). D) Relative mRNA expression of TLX in untreated and IL-
1β-treated cultures after 5DIV under proliferative conditions (n=8). E) Cell viability 
of NPCs treated with IL-1β. Data are expressed as mean ± SEM *p<0.05, **p<0.01 
(Student’s t-test).  
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Figure 2.2: IL-1β induces rapid activation of NF-κB signalling in proliferating 
hippocampal NPCs. Ratio of nuclear:cytoplasmic p65 staining intensity (AU = 
Arbitrary Units) (n=3) (A) and  relative mRNA expression of IκBα (B) in untreated 
and IL-1β-treated NPCs (n=3). C) Representative images of p65 staining. Scale bar 
= 5μm. Data are expressed as mean ± SEM *=p<0.05, **p<0.01, and ***p<0.0001 
(ANOVA with Bonferroni post-hoc). 
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Figure 2.3: IL-1β suppresses TLX expression. Relative mRNA expression of TLX 
(n=3) (A) and ratio of nuclear:cytoplasmic TLX staining intensity (AU = Arbitrary 
Units) (n=3) (B) in untreated and IL-1β-treated NPCs at 10min, 30min, 1h, 2h and 
4h post IL-1β treatment C) Representative images of TLX staining. Scale bar = 5μm. 
D) Relative mRNA expression of TLX in untreated and IL-1β-treated NPCs at 8h, 
16h, and 24h post IL-1β treatment (n=3). E) Relative mRNA expression of p21 in 
untreated and IL-1β-treated NPCs at 10min, 30min, 1h, 2h and 4h post IL-1β 
treatment(n=3). F) Relative mRNA expression of p21 in untreated and IL-1β-treated 
NPCs at 8h, 16h and 24h post IL-1β treatment (n=3). Data are expressed as mean ± 
SEM where **p<0.01, and ***p<0.0001 compared to ctrl (ANOVA with Bonferroni 
post-hoc).  
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Figure 2.4: Inhibition of NF-κB signalling prevents IL-1β-induced decrease in TLX 
expression. Relative mRNA expression of TLX (A) and nuclear TLX protein 
expression (B) in untreated, IL-1β-treated, JSH-23 treated, and IL-1β+JSH-23 
treated hippocampal NPCs. C) Representative images of TLX staining. Scale bar = 
5μm. Relative mRNA expression of p21 (D) and IκBα (E) in untreated, IL-1β-
treated, JSH-23 treated, and IL-1β+JSH-23 treated hippocampal NPCs. F) Cell 
viability after untreated, IL-1β-treated, JSH-23 treated, and IL-1β + JSH-23 treated 
hippocampal NPCs. Data are expressed as mean ± SEM where ***p<0.001 
compared to vehicle and +++p<0.001 compared to IL-1β (ANOVA with Bonferroni 
post-hoc).  
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Figure 2.5: TLX overexpression (OEX) protects IL-1β-induced suppression of 
neurosphere growth. A) Effect of GFP OEX on IL-1β-induced changes in 
neurosphere growth. *p<0.05, **p<0.01, Ctrl compared to GFP+IL-1β. $$$p<0.001, 
Ctrl compared to IL-1β. ++p<0.01 GFP compared to GFP+IL-1β. ##p<0.01, 
###p<0.001 GFP compared to IL-1β (Two way ANOVA with Bonferroni posthoc, 
n=7). B) Effect of TLX OEX on IL-1β-induced changes in neurosphere growth. 
$$p<0.01, $$$p<0.001, Ctrl compared to IL-1β. +p<0.05 Ctrl compared to TLX. 
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##p<0.01, ###p<0.001 TLX compared to IL-1β. **p<0.01, ***p<0.001 TLX+IL-1β 
compared to IL-1β (Two way ANOVA with Bonferroni posthoc, n=7). C) 
Comparison of GFP OEX and TLX OEX on IL-1β induced changes in neurosphere 
growth. *p<0.05 GFP compared to TLX. $$p<0.01 GFP compared to GFP+IL-1β. 
++p<0.01, +++p<0.001 TLX compared to GFP+IL-1β. ##p<0.01, ###p<0.001 
TLX+IL-1β compared to GFP+IL-1β (Two way ANOVA with Bonferroni posthoc, 
n=7). D) Comparison of GFP OEX and TLX OEX on IL-1β-induced changes in 
neurosphere growth at 6DIV, ***p<0.001 GFP compared to GFP+IL-1β (One way 
ANOVA with Bonferroni post hoc test, n=7). E) Representative images of GFP 
OEX and TLX OEX neurospheres, untreated or IL-1β-treated. Scale bar = 100μm. 
Relative mRNA expression of (F) TLX, **p<0.01 GFP compared to GFP+IL-1β. 
$$$p<0.001 TLX compared to GFP+IL-1β. # p<0.05 GFP+IL-1β compared to 
TLX+IL-1β (Two way ANOVA with Bonferroni posthoc, n=7), and (G) IκBα, 
+++P<0.001 TLX compared to TLX+IL-1β (Two way ANOVA with Bonferroni 
posthoc, n=7), after lentiviral treatment of neurospheres with and without IL-1β 
treatment.. Data are expressed as mean ± SEM. 
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Abstract 
TLX is an orphan nuclear receptor highly expressed within neural progenitor cells 
(NPCs) in the hippocampus where is regulates proliferation. Inflammation has been 
shown to have negative effects on hippocampal function as well as on NPC 
proliferation. Specifically, the pro-inflammatory cytokine IL-1β has been shown to 
suppress NPC proliferation as well as TLX expression in the hippocampus. 
However, it is unknown whether TLX itself is involved in regulating the 
inflammatory response in the hippocampus. To explore the role of TLX in 
inflammation, we assessed changes in the transcriptional landscape of the 
hippocampus of TLX knockout mice (TLX
-/-
) compared to wildtype (WT) littermate 
controls with and without intrahippocampal injection of IL-1β using a whole 
transcriptome RNA sequencing approach. We demonstrated that there is an increase 
in the transcription of genes involved in the promotion of inflammation and 
regulation of cell chemotaxis (Tnf, Il1b, Cxcr1, Cxcr2, Tlr4) and a decrease in the 
expression of genes relating to synaptic signalling (Lypd1, Syt4, Cplx2) in cannulated 
TLX
-/-
 mice compared to WT controls. We demonstrate that mice lacking in TLX 
share a similar increase in 176 genes involved in regulating inflammation (e.g. 
Cxcl1, Tnf, Il1b) as WT mice injected with IL-1β into the hippocampus. Moreover, 
TLX
-/-
 mice injected with IL-1β display a blunted transcriptional profile compared to 
WT mice injected with IL-1β. Thus, TLX-/- mice, which already have an exaggerated 
inflammatory profile after cannulation surgery, are primed to respond differently to 
an inflammatory stimulus such as IL-1β. Together, these results demonstrate that 
TLX regulates hippocampal inflammatory transcriptome response to brain injury (in 
this case cannulation surgery) and cytokine stimulation. 
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1: Introduction 
The hippocampus is one of two regions of the adult brain that neural progenitor cells 
(NPCs) reside throughout the lifespan (Gage, 2000, Zhao et al., 2008). Specifically 
within the dentate gyrus (DG) of the hippocampus, these NPCs are core components 
of neurogenesis (i.e. the birth of new neurons) and this process is thought to 
contribute to hippocampal cognitive functions such as spatial memory (Kempermann 
et al., 2004b, Shors et al., 2002) as well as playing a role in the regulation of emotion 
(O'Leary and Cryan, 2014). For hippocampal neurogenesis to occur, NPCs must 
successfully progress from a proliferative state to fully mature integrated neurons 
(Deng et al., 2010). This progression is under strict regulation by a host of intrinsic 
and extrinsic factors (Suh et al., 2009). One of these regulators is the orphan nuclear 
receptor subfamily 2 group E member 1 (Nr2e1 or TLX) (Niu et al., 2011, Li et al., 
2012, Shi et al., 2004, Zhang et al., 2008). TLX is required to maintain NPCs in a 
proliferative state and to prevent ectopic neural differentiation (Shi et al., 2004, Zhao 
et al., 2010). Its expression in the adult mouse brain is localised to the neurogenic 
niches and specifically within the NPCs of these niches (Monaghan et al., 1995). 
Mice lacking TLX display reduced hippocampal volume as well as impaired 
neurogenesis due to the fact that NPCs fail to proliferate (Shi et al., 2004). TLX 
deficient mice also have impaired long-term potentiation (LTP) in the DG and 
display deficits in hippocampal neurogenesis-associated spatial memory cognition 
(O'Leary et al., 2016b, Christie et al., 2006, Roy et al., 2002, O'Leary et al., 2016a). 
Although there are profound behavioural and cellular defects observed in mice 
lacking the TLX, to date it has not been determined how the whole hippocampal 
transciptome may be affected by the loss of this NPC-specific transcription factor. 
Moreover, whether intrinsic regulators of neurogenesis, such as TLX, can regulate 
 Chapter 3 
128 
 
wider hippocampal transcriptional responses to negative stimuli such as 
inflammation is not fully known.  
 
It has been established that hippocampal inflammation can induce deficits in 
hippocampal neurogenesis and associated cognitive function (O'Leime et al., 2017a, 
Kohman and Rhodes, 2013, Yirmiya and Goshen, 2011). Interestingly, it has been 
demonstrated that NPCs themselves can regulate the inflammatory environment 
when transplanted into a region of tissue damage (Pluchino et al., 2005, Martino and 
Pluchino, 2006). Interleukin-1 (IL-1β) is a pro-inflammatory cytokine whose 
receptor, IL-1 receptor type 1 (IL-1R1) is expressed in proportionately higher levels 
in the hippocampus compared to other brain regions (Parnet et al., 1994, Farrar et al., 
1987).  IL-1R1 is also expressed on NPCs in the hippocampus (Green et al., 2012; 
Ryan et al., 2013). IL-1β is predominantly responsible for the negative effects of 
neuroinflammation on hippocampal neurogenesis and hippocampal-related 
impairments due to its receptor expression profile (Ryan et al., 2013, Green and 
Nolan, 2012b, Kelly et al., 2003, Koo and Duman, 2008, Hein et al., 2010). It is 
noteworthy that IL-1β has been demonstrated to inhibit the expression of TLX in 
both embryonic and adult hippocampal NPCs (Green and Nolan, 2012b, Ryan et al., 
2013). However, it is unknown whether TLX itself can regulate the IL-1-induced 
inflammatory response within the hippocampus. To address this, we compared the 
transcriptome changes in the hippocampus of TLX knockout (TLX
-/-
) mice to wild 
type (WT) mice following an inflammatory stimulus with IL-1β. 
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2: Methods 
2.1: Animals  
Postnatal day (P) 52 male TLX
-/- 
and wildtype (WT) littermate control mice (on a 
cross BL6/129S1 background) were used in this study (n=4-8). Breeding pairs were 
kindly provided by Prof. Elizabeth Simpson, University of British Colombia and 
were generated as previously described (Wong et al., 2010). Briefly, male TLX 
heterozygous mice (TLX
-/+) on a 129S1 background were crossbred with female BL6 
TLX
-/+ mice to generate TLX wildtype controls (TLX+
/+
), TLX
-/+, and TLX knockout 
(TLX
-/-
) pups with offspring genotypes followed Mendelian inheritance (See figure 
3.1 for breeding summary and numbers of mice used per group).  All pups were 
weaned at P21 and tailsnips were taken for genotype analysis which was carried out 
using an Extract N’ Amp kit (Sigma-Aldrich) as per the manufacturer’s instructions. 
After genotyping, the animals were single housed under standard housing conditions 
(temperature 21ᵒC and relative humidity 55%), with food and water available ad 
libitum. All experiments were conducted in accordance with the European Directive 
2010/63/EU, and under an authorization issued by the Health Products Regulatory 
Authority Ireland and approved by the Animal Ethics Committee of University 
College Cork.  
 
2.2: Experimental design 
For RNA sequencing analysis, TLX
-/-
 and WT mice were injected with either IL-1β 
or vehicle (phosphate buffered saline (PBS)) via cannulation, thus there were four 
experimental groups for the RNA sequencing section of this study (Figure 3.1, Table 
3.1). Hippocampal tissue from an additional group of non-cannulated TLX
-/-
 and WT 
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mice was taken for PCR analysis to assess the effect of cannulation on cytokine (IL-
1β and TNFα) expression. 
 
2.3: Stereotaxic surgery for hippocampal cannulation 
At P52 (4 days prior to IL-1β or PBS microinjection), TLX-/- and WT mice were 
anaesthetised using a mixture of ketamine (0.25ml), xylazine (0.2ml) and sterile 
0.9% NaCl (2.05ml) at a dose of 0.1mls/10g (i.p.) and placed in a Kopf stereotaxic 
frame. A guide cannula (Plastics1, Gauge: 22, Pedestal Length: 4mm, Projection: 
1.5mm) was implanted unilaterally into the dorsal hippocampus at the following co-
ordinates: AP -1.7, ML -1.2 and DV -1.5 relative to bregma. Animals were randomly 
implanted on the left or right hemisphere. The cannula was secured in place using 
superglue as a base layer followed by dental cement. After the dental cement had 
hardened sufficiently, animals were administered Carprofen (0.1ml/30g, i.p.) and 
0.5ml of 5% Glucose (5g/100ml; i.p.), and returned to their home cage. 
 
2.4: Intrahippocampal microinjections 
At P56 mice were unilaterally injected into the hippocampus with 1l of either 
recombinant mouse IL-1β (10ng/l; R&D systems) or PBS (filtered using a 0.2μm 
sterile filter) and infused at a rate of 0.5ul/min using an automated ‘Pico Plus’ 
microinjector (Harvard Apparatus, Kent, UK). The injection cannula projected a 
further 0.5mm past the guide cannula to give a total depth of 2.0mm and was left in 
place for an additional 2 min for diffusion before the needle was withdrawn. Mice 
were sacrificed by decapitation one hour after injection. This timepoint was chosen 
as we have previously demonstrated that IL-1β can induce a significant reduction in 
TLX gene expression in hippocampal NPCs at this timepoint (O'Leime et al., 
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2017b). Moreover, we aimed to assess the immediate gene expression changes 
induced by IL-1β rather than secondary gene expression changes induced by the 
release of other regulators of gene expression as a result of IL-1β injection. The 
injection needle was attached to the guide cannula and mice were allowed to move 
freely during the injection. After one hour, left or right hippocampi were removed, 
flash frozen on dry ice and stored at -80°C.  
 
2.5: Hippocampal RNA Extraction  
Total RNA was extracted and DNase treated from hippocampal tissue from both WT 
and TLX
-/-
 animals using the mirVana
TM
 total RNA extraction kit (Ambion/Life 
Technologies, Dublin, Ireland) and Turbo DNA-free kit (Ambion/life technologies) 
as per the manufacturer’s instructions. The total concentration of extracted RNA was 
quantified using a Nanodrop 2000 (Thermo Scientific, UK) and was stored at -80°C 
until sent for sequencing.  
 
2.6: mRNA sequencing  
Equal volumes of total hippocampal RNA from each animal (no pooling of samples 
was conducted) was sent for sequencing by Exiqon (Vedbaek, Denmark) and 
conducted on an Illumina NextSeq500 sequencer with an average of 30 million reads 
with a 50 basepair paired-end read length.  Annotation of the obtained sequences was 
performed using the reference genome annotation: Mus musculus (organism), 
GRCm38 (reference genome), Ensembl_70 (annotation reference). 
 
2.7: Differential gene expression and functional enrichment analysis 
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Data analysis was conducted by Exiqon using XploreRNA automated analysis 
software. The data analysis pipeline used in this software is based on the Tuxedo 
software package which is a combination of open-source software and makes use of 
peer-reviewed statistical methods. Additionally, Exiqon employs specialised 
software developed at Exiqon to interpret and enhance the readability of the finalised 
results. The components of the data analysis pipeline used at Exiqon for RNA 
sequencing include Bowtie2 (v. 2.2.2.), Tophat (v. 2.0.11.), and Cufflinks (v. 2.2.1.). 
Briefly, Bowtie2 is a sequence aligner used by Tophat to align the sequencing reads 
to the reference genome (GRCm38, UCSC Genome brower and Ensembl_70 
(annotation reference)). Cufflinks uses the alignment results from Tophat and 
assembles the aligned sequences into transcripts to construct a map of the 
transcriptome. Cufflinks assembles the aligned reads into transcript isoforms based 
on exon usage and also determines transcriptional start sites. Additionally, Exiqon 
performs fragment bias correction which corrects for sequence bias during library 
preparation. Cuffdiff is used when comparing groups to calculate the number of 
fragments per kilobase of transcript per million mapped fragments (FPKM) and to 
determine differential gene expression and regulation based on the assembled 
transcripts from the submitted samples using the Cufflinks output. An adjusted p-
value of ≤0.05 was considered significantly differentially regulated. Differentially 
regulated genes were analysed for enrichment of Gene Ontology (GO) terms and 
KEGG pathways using the DAVID Bioinformatics Resources (v6.8) (Huang da et 
al., 2009). 
 
2.8 Quantitative real-time PCR (qRT-PCR) 
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Validation of RNA sequencing was performed using specific PrimerTime
®
 qPCT 
assays sourced from IDT (Integrated DNA Technologies) (Table 2). cDNA was 
reversed transcribed using the high capacity cDNA reverse transcription kit (Applied 
Biosystems) using the SureCycler
®
 8800 (Agilent Technologies) and diluted to a 
final concentration of 10ng/l. All qRT-PCR was performed in 3 technical replicates 
for each biological sample on a LightCycler
®
 480 Instrument II (Roche). 
Quantification of gene expression was analysed using the ΔΔ Ct method (Livak and 
Schmittgen, 2001). RNA sequencing data was validated for four genes that 
contributed to the enrichment for TNF signalling in our KEGG pathway analysis 
using the following primers from Integrated DNA Technologies (IDT): SDHA 
(Mm.Pt.56a.12170577), IL-1β (Mm.PT.58.41616450), IL-6 (Mm.Pt.58.10005566), 
TNF (Mm.PT.58.12575861).  
 
2.9 STRING analysis 
The STRING database, which stems from computational predictions was used to 
investigate direct (physical) and indirect (functional) associations between 
differentially regulated genes. An interaction network was created using a list of 
differentially regulated genes between WT and TLX
-/-
 and genes that were 
commonly up-regulated in WT vs. TLX
-/-
 and WT vs. WT + IL1B (172 genes). The 
string network was visualized using the following parameters: excluded any genes 
that there was no evidence of association of connectivity, minimum required 
interaction score was set at high confidence (0.007), and meaning of network edges 
was set to line thickness indicating strength of data support. KEGG pathway analysis 
was also conducted in STRING which indicated among the 172 up-regulated genes 
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that TNF signalling pathway was the most significantly enriched pathway p<0.001 
(red nodes).  
 
2.10 Statistics  
An adjusted p value (q value, Benjamini-Hochberg method) of ≤0.05 for RNA 
sequencing data was considered to indicate significantly differentially regulated gene 
expression. For Gene Ontology (GO) and KEGG analysis a cut off of 0.05 FDR p 
value was used to determine significance. For RT-PCR validations, one-way 
ANOVA followed by Tukey’s post-hoc analysis or student’s t-test was used where 
appropriate to determine statistical significance which was established at p≤0.05. 
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3: Results 
3.1: TLX regulates inflammatory gene expression in the hippocampus of mice.  
By performing pairwise analysis of whole transcriptome RNA sequencing data, we 
compared differentially expressed genes in the hippocampus between vehicle 
injected cannulated WT and TLX
-/-
 mice. We identified a large number of 
differentially expressed genes in the hippocampus of TLX
-/-
 mice compared to WT 
controls (1542 genes) (Figure 3.2A, B). Of these 1542 genes, the majority were up-
regulated (1272 genes) with a smaller subset down-regulated (274 genes) in TLX
-/- 
mice (Figure 3.2A, B, C). Next we assessed the biological functions of these up- and 
down-regulated genes in TLX
-/-
 mice. We observed a significant enrichment in GO 
terms such as regulation of inflammatory response, cytokine production, and cellular 
responses to cytokine stimulus (e.g. Tnf, Il1b, IL6, Tlr2, Nfkbia and Tlr4) (Figure 
3.2D). GO analysis on the list of down-regulated genes observed in TLX
-/- 
mice 
revealed an enrichment in genes involved in synpatic signalling such as Syt4, Syt17, 
and Lypd1 compared to WT control (Figure 2.2E). 
 
3.2: TLX
-/- 
mice 
 
display similar transcriptional profile to that of WT mice injected 
intrahippocampally with IL-1β. 
We found a large number of genes to be similarly up-regulated in TLX
-/- 
and WT + 
IL-1β mice compared to WT mice (Figure 3.3A, B). Of the 1272 genes whose 
expression increased in TLX
-/- 
mice compared to WT mice, 176 or 13.8% these 
genes are also increased in WT + IL-1β. We assessed the biological function of these 
genes and and observed an orcastrated enrichment in GO terms for cellular response 
to cytokines (e.g. Cxcl1, Il1b, Tnf, Ccl2), regulation of inflammatory response (e.g. 
Tlr2, Ccl4, Ccl7, Ier3), and apoptotic processes (e.g. Ier3, Cyr61, LgalsS3, Perp) 
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(Figure 3.3C, E). KEGG pathway analysis revealed a significant enrichment for 
genes involved in inflammatory pathway signalling such as TNF signalling (Tnf, 
Fos, Jun, Il1b), cytokine-receptor interaction (Csf3, Il6, Ccl2, Il1b, Il1a), NF-κB 
signalling (Nfkbia, Lbp, Ptgs2), and TLR signalling (Tlr2, Il1b, Nfkbia, Lbp) (Figure 
3.3D, E).  This indicated that in TLX
-/- 
mice, there is a similar dyresgulation of 
inflammatory gene expression to that induced by IL-1β within the hippocampus of 
WT mice. Additionally, KEGG pathway analysis using two web based algorythims 
(DAVID and STRING) indicated that TNF signalling was the most significant and 
prominent pathway to be enriched in this subset of differentially up-regulated genes 
(172) (Figure 3.4A, B).    
 
3.3: Cannulated TLX
-/- 
mice
 
have a significantly different cytokine response to IL-1β  
WT + IL-1β mice show a down-regulation in 7 genes and an up-regulation in 221 
genes within the hippocampus compared to cannulated WT mice (Figure 3.5A, B). 
TLX
-/- 
+ IL-1β mice display a much reduced transcriptional response as they display 
a differential transcriptional response in 38 genes and only 5 of those were up-
regulated compared to TLX
-/- 
mice (Figure 3.5A, B). GO enrichment analysis only 
showed significant enrichment among down-regulated genes (33 genes) between 
TLX
-/- 
and TLX
-/- 
+ IL-1β groups of mice (Figure 3.5A). Specifically, we observed 
enrichment in GO terms such as cell (including leukocytes and neutrophils) 
chemotaxis, (Cxcl13, Ccr1, Trem1), defence to bacterium (Lyz2, Lyz1), response to 
LPS (Lcn2, Cxcl13), and acute inflammatory response ( S100a8, Saa3) (Figure 
3.5C).    
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3.4: TLX potentially regulates TNF signalling indirectly via two separate gene 
interactions and cannulation induces a significant increase in IL-1β and TNFα 
expression in TLX
-/- 
mice 
As we identified TNF signalling as a possible mechanism through which TLX 
regulates inflammation, we again used STRING analysis to identify the link between 
TLX (Nr2e1) and TNF signalling. We identified Top2a and Bcl6b as two genes from 
all differentially regulated genes (1542 genes) in TLX
-/-
 mice compared to WT mice 
that may interact with TLX and potentially mediate the regulatory effects of TLX on 
TNF signalling (Figure 3.6A). We confirmed our sequencing results using qRT-PCR 
that TNFα and IL-1β, which have been shown from our KEGG analysis to be highly 
involved in regulating TNF signalling, have elevated expression levels in cannulated 
TLX
-/- 
mice (Figure 3.6B, C). We also assessed the expression of these genes in non-
cannnulated mice. Non-cannulated TLX
-/- 
mice have similar hippocampal expression 
of IL-1β and TNFα to that of non-cannulated WT mice (Figure 3.6B, C). However, 
after hippocampal cannulation surgery, there is a significant increase in IL-1β 
(F(3,24)=12.34, ***=P<0.001) and TNFα (F(3,24)=10.12, ***=P<0.001) expression 
in TLX
-/- 
mice only (Figure 3.6B, C). There is a non-significant trend towards an 
increase in these cytokines in WT mice after hippocampal cannulation surgery.  
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Discussion 
In the present study, we demonstrate that TLX acts to regulate the transcription of 
genes involved in maintaining a normal inflammatory profile after cannulation 
surgery and in response to an IL-1β stimulus in the hippocampus of mice. Firstly, we 
demonstrated an orchestrated up-regulation in genes involved in inflammatory 
processes in the hippocampus of TLX
-/- 
mice when compared to WT mice. WT mice 
injected with IL-1β into the hippocampus display a significant up-regulation in genes 
involved in cellular responses to cytokines and inflammatory signalling pathways, 
and these genes overlap with the genes increased in TLX
-/- 
mice. We showed that 
TLX
-/-
 mice have a blunted transcriptional response to IL-1β after cannulation 
surgery compared to cannulated WT mice and we highlight that TLX may act to 
regulate inflammatory responses via TNF signalling. Finally, we outline that there 
was  no difference in the expression levels of IL-1β and TNFα between TLX-/- and 
WT naïve mice but that these cytokines were significantly increased in TLX
-/- 
mice 
after surgery. Taken together, these data indicate that the absence of TLX results in 
disruption of the hippocampal inflammatory transcriptome response. 
 
There was a large dysregulation in the transcriptional landscape of the hippocampus 
of TLX
-/- 
mice evident with 1542 genes differentially expressed compared to WT 
mice. The majority of these genes (1272 in total) were up-regulated, which is in 
keeping with the current literature describing TLX as a transcriptional repressor (Sun 
et al., 2007, Islam and Zhang, 2014). Similarly, whole transcriptome analysis of 
another strain of TLX knockout mice revealed a large number of differentially 
regulated genes (1721) in NPCs from the subventricular zone of the lateral ventricles 
(Niu et al., 2011). Most likely these genes are not all targets of TLX but rather are 
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up-regulated as a knock-on effect due to a lack of regulation of TLX target genes. 
These genes showed enrichment for GO terms such as the regulation of 
inflammatory processes and included genes such as Tnf, Tlr2, Tlr4, and Il1b. We 
have recently demonstrated that there is a significant increase in microglial cell 
density and activation (increased somal area) in the DG of TLX
-/-
 mice compared to 
WT counterparts under baseline conditions, while there is no change in the number 
of apoptotic cells in the DG of these mice (Kozareva et al., 2017a, Kozareva et al., 
2017b). Thus, there is evidence to suggest that TLX is intrinsically linked with 
inflammatory processes in the hippocampus as the absence of TLX leads to 
increased microglial activation at baseline and a dysregulated inflammatory gene 
expression profile. 
 
As proliferating NPCs are the predominant source of TLX within the hippocampus 
(Shi et al., 2004), it could be suggested that NPCs may function to normalise 
inflammatory gene expression. Moreover, it has been demonstrated that TLX is not 
expressed, or expressed at a very low level within cerebral cortex microglia (EMBL 
gene expression atlas (http://www.ebi.ac.uk/gxa/genes)), and thus it is likely that the 
regulatory role of TLX on inflammation within the hippocampus is mediated by its 
functions within NPCs (Zhang et al., 2014, Li et al., 2012).  To this end, data from 
transplantation studies have demonstrated that NPCs themselves have indirect 
beneficial effects on the surrounding tissue by modulating the inflammatory 
environment (Pluchino et al., 2005, Martino and Pluchino, 2006).  
 
Among the genes that were down-regulated in TLX
-/- 
mice compared to WT mice, a 
significant enrichment for genes involved in synaptic signalling such as Syt4 and 
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Syt17, was observed. This supports a previous report, also using mice with a 
spontaneous deletion of TLX, which demonstrates an impairment in LTP formation 
in the DG in TLX
-/- 
mice compared to WT mice (Christie et al., 2006). Interestingly, 
that study demonstrated that LTP was specifically impaired in TLX
-/- 
mice in the DG 
and not the CA1 region of the hippocampus. As the DG is the primary area where 
NPCs are found, and TLX is primarily expressed in proliferating NPCs, it can be 
suggested that impairments in synaptic plasticity resulting from TLX deletion occurs 
as a results of its disfunction or absence in NPCs. The dysregulation in synaptic gene 
expression and impairment in LTP may also underlie the hippocampal-dependent 
behavioural deficits that we and others have previously observed in these TLX
-/- 
mice (O'Leary et al., 2016a, Christie et al., 2006, Young et al., 2002, O'Leary et al., 
2016b).  
 
Apart from genes involved in the regulation of inflammation, there are a large 
number of genes involved in other processes such as intracellular signal transduction, 
cell chemotaxis, and organ development that are differentially expressed in TLX
-/-
 
mice. These mice have a spontaneous deletion and are thus devoid of TLX from 
embryonic development through to postnatal development and adulthood (Young et 
al., 2002). Therefore, the wide ranging biological processes dysregulated in these 
mice are possibly due to the absence of TLX during critical moments of various 
organ development rather than a specific lack of TLX in adulthood (Monaghan et al., 
1997, Roy et al., 2002). Further studies should assess the inflammatory profile of 
mice with a conditional knockout of TLX in adulthood to address the role that loss of 
TLX during embryonic development has on the development of the immune system 
and its function in adulthood.  
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As we observed a significant dysregulation in inflammatory gene expression in TLX
-
/-
 mice and because we have previously reported enhanced microglial activation in 
the DG of TLX
-/-
 mice, we aimed to assess whether an inflammatory cytokine 
stimulus could induce similar transcriptome changes in WT mice. The pro-
inflammatory cytokine IL-1β, whose receptor is expressed on NPCs in the 
hippocampus (Green et al., 2012), has previously been shown to downregulate TLX 
expression in NPCs in vitro (Green and Nolan, 2012b, Ryan et al., 2013, Farrar et 
al., 1987). In response to hippocampal IL-1β injection in WT mice, we observed a 
significant increase in inflammation and chemotaxis related genes such as Cxcl1, 
Il1b, Tnf, and Tlr2. This is supported by reports that increased cytokine expression or 
administration of exogenous cytokines to the hippocampus can induce further 
endogenous cytokine expression (Anisman et al., 2008, Moore et al., 2009, Shaftel et 
al., 2007, Skelly et al., 2013, Balschun et al., 2004, del Rey et al., 2013). We did not 
observe a significant decrease in TLX expression, However, this may be due to the 
fact that TLX is only expressed in a subset of cells within the hippocampus and as 
we extracted RNA from the whole hippocampus, any changes in specific TLX-
expressing cells may be not be detected.  
 
With regard to the similarity in transcriptome changes in TLX
-/- 
mice and IL-1β-
injected WT mice compared to WT mice, there were 176 genes (of the 1272 genes 
up-regulated in TLX
-/-
 mice) also up-regulated in WT mice in response to IL-1β. It 
should be noted that RNA sequencing analysis only highlighted similarly 
upregulated genes however, and did not compare the magnitude of gene expression 
change between the two groups. Notwithstanding, these data suggest that the absence 
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of TLX expression leads to an inflammatory state in the hippocampus similar to that 
induced by IL-1β in WT mice. KEGG pathway analysis of the overlaping genes 
shared between TLX
-/- 
and WT mice injected with IL-1β compared to WT mice 
reveal that TNF signalling is a common pathway. This then suggests that TLX may 
act to repress TNF signalling, which in turn is increased by knocking down TLX 
expression or by increasing IL-1β expression. It has been established that IL-1β can 
induce the expression of other cytokines such as TNFα, and that TNFα can itself 
suppress proliferation of TLX expressing NPCs and subsequent neuronal 
differentiation (Monje et al., 2003, Ben-Hur et al., 2003, Keohane et al., 2010). 
Likewise, TNFα can induce the expression of other cytokines such as IL-6 and IL-10 
(del Rey et al., 2013, Skelly et al., 2013). Therefore, for future studies on the 
mechanism of the regulatory role of TLX in inflammation, it will be important to 
assess the effects of TLX on various cytokines and their respective signalling 
pathways. From the current study it appears that TLX maintains normal 
inflammatory status in the hippocampus and that the TNF signalling pathway may be 
a major pathway through which TLX carries out this function. 
 
We conducted STRING analysis on the up-regulated genes in TLX
-/- 
compared to 
WT mice enriched for TNF signalling. This analysis predicts potential protein-
protein interactions based on evidence from the literature and from online protein 
databases. The thickness of the interconnecting lines depicted in Figure 3.6 is 
indicative of the amount of evidence supporting the interaction between any two 
proteins. We observed that TLX does not appear to directly interact with TNF 
protein. Rather, TLX may interact with TNF signalling proteins via its potential 
interactions with Top2a and Bcl6b proteins. Both of these genes are up-regulated in 
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our sequencing data suggesting that they may be repressed by TLX signalling. 
However, the evidence for an interaction between TLX and Top2a and Bcl6b 
proteins is not strong, as indicated by the thickness of the connecting lines in Figure 
3.6A. Specifically, STRING analysis highlighted these two proteins due to the fact 
that structural homologs of the proteins (TLX, Top2a, and Bcl6b) have been shown 
to interact in human tissue and there is greater evidence for the interactions between 
protein homologs of TLX and Bcl6b (Ku et al., 2009, Diner et al., 2015). Nuclear 
transrepression is also another potential mechanism by which TLX regulates 
inflammation (Glass and Saijo, 2010). Nuclear transrepression involves the 
‘tethering’ of nuclear receptor to other signalling factors in order to prevent their 
signalling. This is a common mechanism through which glucocorticoid receptors and 
PPARs act to suppress inflammatory-related NF-κB signalling (Glass and Ogawa, 
2006, Glass and Saijo, 2010, De Bosscher et al., 2003, Delerive et al., 1999). It may 
be possible that TLX regulates inflammation via transrepression of TNF signalling 
or other inflammation-related pathways. However, to date no such transrepression 
mechanism has been described for TLX and any component of TNF signalling. 
 
Somewhat surprisingly, we observed a drastically different alteration in the 
transcriptional landscape of TLX
-/- 
mice in response to IL-1β compared to WT mice 
injected with IL-1β. TLX-/- mice have a blunted response with only 38 differentially 
expressed genes compared to 228 genes differentially regulated in the WT mice after 
IL-1β injection. Moreover, enrichment could only be achieved for the down-
regulated genes in the TLX
-/- 
mice in response to IL-1β, and this revealed an 
enrichment in GO terms such as cell chemotaxis  (Cxcl13 and Ccr1). These genes 
are important for NPC-neuron-microglia communication (Cartier et al., 2005, Li, 
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2013). A possible explaination for this blunted response is that the TLX
-/- 
mice 
already have an elevated inflammatory response to the cannulation surgery. 
Specifically, we observed a significant increase in the expression of IL-1β and TNFα 
in TLX
-/- 
mice only after surgery. Thus, it could be suggested that these mice have 
reached an inflammatory plateau after cannulation surgery and are resistant to further 
cytokine stimulus. Additionally, these data indicate that TLX
-/-  
mice may be more 
sensitive to brain injury  compared to WT mice. Despite the fact that we did not see 
any differences in IL-1β or TNFα expression levels between TLX-/- and WT mice at 
baseline, we have previously reported increased microglial activation in TLX
-/-
 mice 
which indicates a heightened inflammatory state in these mice at baseline (Kozareva 
et al., 2017a). It should also be noted that IL-1R1 is expressed on endothelial cells 
throughout the brain (Matsuwaki et al., 2014). These cells also express genes 
involved in the TNF signalling pathway and are thus critical in the regulation of 
neuroinflammation (Liu et al., 2015). Thus mechanistically, it is possible that the 
absence of TLX can disrupt both NPC-endothelial and NPC-microglia 
communication which subsequently results in blunted responses to stimulation by 
inflammatory cytokines as well as an enhanced inflammatory response to 
cannulation surgery.  
 
Disruption of TLX as a result of spontaneous deletion results in abnormalities in 
motor, cognitive and anxiety-related behaviours. The most striking behavioural 
phenotype is increased aggression (Young et al., 2002; O’Leary et al., 2016 review). 
The serotonin2A/C receptor has been shown to mediate the aggressive phenotype of 
TLX
-/- 
mice  (Juarez et al., 2013) and interestingly, from our GO enrichment of genes 
for biological processes we observed an increase in expression in genes associated 
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with serotonin transport and release (Cd300a, Syk, Fcerig, Lgals3 and Fcgr3)  in 
TLX
-/- 
compared to WT mice. Hyperactivity has also been consistently observed in 
TLX
-/-
 mice, and we have recently reported a progressive decline in motor 
performance on the accelerating rotarod (O’Leary et al., 2016) which implicate 
corticostriatal pathways. With regard to hippocampal-associated behaviours, TLX
-/-
 
mice display poor performance in working memory as assessed by spontaneous 
alternations in the Y-maze, as well as and contextual fear conditioning (O'Leary et 
al., 2016a). Extensive evidence in the literature shows that hippocampal 
adminstration of IL-1β results in impairments in hippocampal-associated spatial 
learning and memory tasks and in LTP (Moore et al., 2009, Kohman and Rhodes, 
2013, Vereker et al., 2000).  Although we did not assess behavioural outcomes of IL-
1β administration to TLX-/- mice in the current study, it is possible that IL-1 may 
not exacerbate the already robust deficits in cognitive behaviours due to the 
significant dysregulated and indeed pro-inflammatory transcriptional profile of the 
TLX-/- mice in this study.   
 
In conclusion, this study provides valuable insights into the role of TLX as a 
regulator of inflammation and lays the ground work for future studies assessing the 
effects of TLX on inflammatory and cognitive processes. Moreover, as TLX is a 
nuclear receptor and thus has the potential to be targeted therapeutically (Benod et 
al., 2014b), future studies should aim to identify selective ligands for TLX and 
determine the ability of modulating TLX activity to mitigate the effects of extensive 
inflammation on hippocampal-associated cognition.  
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Experimental group Abbreviation n Pairwise comparison 
Wild type + PBS WT 6 WT vs. WT + IL-1β 
TLX knockout + PBS TLX
-/- 
4 WT vs. TLX
-/-
 
Wild type + IL-1β WT + IL-1β 7 WT + IL-1β vs. TLX
-/- 
+ IL-1β 
TLX knockout + IL-1β TLX
-/-
 + IL-1β 6 TLX-/- + IL-1β vs. TLX-/- 
Table 3.1: Meaningful pairwise comparisons for gene expression changes conducted 
using RNA sequencing (4 unique comparisons). 
 
 
Figure 3.1: Schematic of experimental design and timeline. WT, wildtype; TLX
-/-
, 
TLX knockout; PBS, Phosphate buffered saline; IL-1β, Interleukin-1 beta; WT + 
PBS, Wildtype PBS injected mice; WT + IL-1β, Wildtype IL-1β injected mice; TLX-
/-
 + PBS, TLX knockout PBS injected mice; TLX
-/-
 + IL-1β, TLX knockout IL-1β 
injected mice. 
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Figure 3.2: TLX
-/-
 mice display elevated transcription of inflammatory genes in the 
hippocampus compared to WT controls. A) The number of differentially expressed 
genes (DEGs) between all pairwise comparisons across the groups. B) A volcano 
plot depicting the number of differentially regulated genes between WT and TLX
-/-
 
mice. Each gene is graphed as the fold change (log 2) versus q value (p adjusted 
value) for multiple comparisons. C) Venn diagram outlining the number of DEGs 
either up-regulated (green circles) or down-regulated (blue circles) across all groups. 
D) GO enrichment in biological processes for up-regulated genes comparing TLX
-/-
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to WT mice. Dotted line represents significance level, with values above this line 
deemed significant. E) GO enrichment in biological processes for down-regulated 
genes comparing TLX
-/-
 to WT mice. Dotted line represents significance level, with 
values above this line deemed significant.  
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Figure 3.3: IL-1β induces the transcription of inflammatory-related genes in WT 
mice similar to that in TLX
-/- 
mice. A) Volcano plot of all DEGs when comparing 
WT + IL-1β and WT mice vs. WT and TLX-/- mice. B) Venn diagram of all DEGs 
either up-regulated (green circles) or downregulated (blue circles) and the overlap of 
these genes when comparing TLX
-/-
 and WT mice. C) GO enrichment in KEGG 
pathway for up-regulated genes comparing the overlap of WT vs. WT + IL-1β and 
WT vs. TLX
-/- 
mice. The dotted line represents significance level, with values above 
this line deemed significant. D) GO enrichment in biological processes for up-
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regulated genes comparing the overlap of WT vs. WT + IL-1β and WT vs. TLX-/- 
mice. The dotted line represents significance level, with values above this line 
deemed significant. E) Venn diagram comparing the overlap in gene transcriptional 
changes between WT vs. WT + IL-1β and WT vs. TLX-/- mice. 
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Figure 3.4: String analysis showing interactions between genes similarly increased 
in TLX
-/-
 mice and WT mice injected with IL-1β compared to WT mice that are 
involved in TNF signalling. Line thickness between nodes indicates the strength of 
the evidence to support the interaction.  
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Figure 3.5: TLX
-/- 
mice have a blunted transcriptional response to IL-1β compared 
to WT mice and an increased inflammatory response to cannulation surgery. A) 
Venn diagram showing the total number of DEGs down-regulated when comparing 
WT + IL-1β to TLX-/- + IL-1β mice. B) Venn diagram showing the total number of 
DEGs up-regulated when comparing WT + IL-1β to TLX-/- + IL-1β mice. C) GO 
enrichment in biological processes for down-regulated genes comparing the overlap 
of TLX
-/- 
to TLX
-/- 
+ IL-1β-treated mice. The dotted line represents significant level 
with values above this line deemed significant. 
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Figure 3.6: A) STRING analysis showing interactions between genes increased in 
TLX
-/-
 mice compared to WT mice that are involved in TNF signalling, and how 
TLX interacts with TNF signalling. Thicker lines indicate stronger network 
connections between genes. Line thickness between nodes indicates the strength of 
the evidence to support the integration. B) and C) TNF  and IL-1β mRNA 
expression in non-cannulated and cannulated TLX
-/- 
and WT mice, n.s = non-
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significant (data expressed as mean ± SEM, ***=P<0.001 ANOVA and Tukey’s 
post-hoc test). All data are presented as mean ± SEM. 
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Abstract 
The orphan nuclear receptor tailless homolog (TLX) is an orphan nuclear receptor 
that is highly expressed in proliferating neural progenitor cells (NPCs) in the dentate 
gyrus (DG) of the hippocampus. It is a promoter of cell proliferation and therefore 
plays an important role in regulating hippocampal neurogenesis. However, research 
into the role of TLX in regulating hippocampal function is still in its infancy. Here, 
we describe behavioural and cellular effects of overexpressing TLX in the 
hippocampus of adult rats. We injected a lentivirus into the hippocampus of adult 
rats to induce the overexpression (OEX) of TLX and found that memory retrieval in 
a short term novel object recognition task was impaired. However, memory retrieval 
in a novel location task and hippocampal working memory (spontaneous alternation 
in the Y-maze) was unaffected in these rats. TLX OEX did not alter locomotor or 
anxiety-like behaviour. We also observed an increase in cell proliferation but not in 
cells survival or the birth of new neurons in response to TLX OEX. These data 
suggest that increased hippocampal cell proliferation via TLX OEX may impair 
perirhinal cortex-dependent object recognition and supports the concept that 
enhancement of cell proliferation alone does not promote hippocampal-dependent 
cognition. 
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1: Introduction 
Hippocampal neurogenesis begins during the embryonic period and persists 
throughout adulthood in the dentate gyrus (DG) of the hippocampus (Gage, 2000). 
Successful hippocampal neurogenesis involves the proliferation of undifferentiated 
neural progenitor cells (NPCs), differentiation of the NPCs into neurons, and 
functional integration of those new neurons into the surrounding circuitry (Zhao et 
al., 2008). Hippocampal neurogenesis has been suggested to be involved in various 
hippocampal-associated memory functions including spatial learning and memory as 
well as emotional regulation (Snyder et al., 2005, Deng et al., 2010, Eisch and Petrik, 
2012, Levone et al., 2015). Each stage of hippocampal neurogenesis is under strict 
regulation by a host of cell intrinsic and extrinsic factors (Zhao et al., 2008, O'Leime 
et al., 2017a). A key factor in the regulation of NPC proliferation is the orphan 
nuclear receptor tailless homolog (TLX; Islam and Zhang, 2014, Shi et al., 2004). 
 
TLX (NR2E1) is an orphan nuclear receptor expressed within the mammalian central 
nervous system (CNS; Monaghan et al., 1995). Its expression is largely localised to 
the two neurogenic niches in the adult CNS; the DG and subventricular zone, where 
it is expressed at high levels in proliferating NPCs (Shi et al., 2004, Monaghan et al., 
1997, Monaghan et al., 1995). TLX acts to maintain NPCs in a proliferative state and 
suppresses neuronal differentiation, thus it maintains the NPC pool within the DG. 
Specifically, TLX recruits histone deacetylases (HDACs 3 and 5), and histone 
demethylases (lysine-specific demethylase 1 (LSD1)) to repress the transcription of 
target genes involved in suppressing cell proliferation (Sun et al., 2007, Sun et al., 
2010).  
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There is some evidence to suggest that TLX plays a role in certain hippocampal 
neurogenesis-associated cognitive processes including spatial memory in the Morris 
water maze (MWM) test (Murai et al., 2014, Zhang et al., 2008). For example, 
overexpression of TLX restricted to NPCs in adult mice has been shown to reduce 
the latency to find the hidden platform in the MWM (Murai et al., 2014). This 
suggests that enhancement of TLX function may induce improvements in certain 
forms of hippocampal-associated cognition. Conversely, spontaneous deletion of the 
TLX gene has negative effects on hippocampal-associated cognition such as 
spontaneous alternation in the Y-maze and contextual fear conditioning (O'Leary et 
al., 2016a). In the same strain of mice, absence of TLX also induced impairments in 
hippocampal synaptic plasticity and long-term potentiation (LTP) formation 
(Christie et al., 2006). Additionally, these mice exhibit impairments in non-
hippocampal associated cued fear conditioning indicating that alterations in TLX 
expression may also impact upon non-hippocampal cognitive function (O'Leary et 
al., 2016a).  
 
Most studies to date have investigating TLX gain of function by overexpression 
(OEX) using transgenic approaches in mice. In the current study, we performed a 
targeted delivery of the TLX gene to the hippocampus of rats using lentiviral 
technology. This allowed us to assess potential behavioural changes induced by 
increased TLX expression specifically during adulthood thus removing any effects 
observed as a result of increased TLX expression during development. Additionally, 
it allowed us to carry out behavioural tasks using rats and to rule out any non-
specific effects that may occur with transgenic mouse models. Thus the aim of this 
study is to assess the effects of adult TLX OEX in adult rats on tasks that have been 
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associated with hippocampal and hippocampal neurogenesis-dependent function, 
namely novel object recognition, novel location recognition, and spontaneous 
alternation in the Y-maze (Jessberger et al., 2009b, Johnson et al., 1977, Hughes, 
2004).  
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2: Methods 
2.1: Animals 
Adult male Sprague-Dawley rats obtained from Harlan UK (325-350 grams) were 
pair housed in a colony maintained at 22 ± 1°C, with a 12:12 hour light-dark cycle 
(lights on 0630-1830).  All animal procedures were performed under licenses issued 
by the Health Products Regulatory Authority (HPRA, Ireland), in accordance with 
the European Communities Council Directive (2010/63/EU) and approved by the 
Animal Experimentation Ethics Committee of University College Cork. All rats had 
ad libitum access to food and water for the duration of the study and animal weights 
were recorded weekly. See Fig. 4.1 for the schematic of the experimental design. 
  
2.2 Lentiviral production 
Production of plasmids and lentiviruses to overexpress GFP-tagged TLX (Nr2E1) or 
GFP was carried out by Genecopoeia (GeneCopoeia, MD, USA). Briefly, lentiviral 
particles pseudotyped with the vesicular stomatitis virus (VSV-G) glycoprotein and 
contained plasmids sequences for GFP or GFP-tagged TLX (Nr2e1) on an FIV 
backbone and driven by a cytomegalovirus promoter (CMV) promoter. These 
lentiviral particles were generated using standardised lentiviral production protocols 
and using EndoFectin-Lenti
TM 
and TitreBoost
TM 
reagents. The lentiviral transfer 
vector was co-transfected into 293Ta cells with Lenti-Pac
TM 
FIV packaging mix. 
Viral titres were determined via RT-PCR and were established as 1.63 x 10
7
 
copies/ml for the TLX lentiviral particles and 1.31 x 10
7
 copies/ml for the GFP 
lentiviral particles. The lentivirus particles were then purified and stored at -80°C 
until use. 
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2.3: Stereotaxic Surgery and Lentiviral Injection 
Rats were anaesthetised with isoflurane and placed into a Kopf stereotaxic frame.  
Lentiviruses to overexpress TLX or GFP (Genecopoeia, MD, USA) was injected into 
the dorsal hippocampus using the coordinates AP: -3.5 mm, ML: ± 2.4 mm, DV: -3.8 
mm relative to Bregma (Barrientos et al., 2002) at a volume of 2μl and flow rate of 
1µL/min followed by a 5 min diffusion.  Rats were injected s.c. with carpofen and 
5% glucose prior to anaesthetic recovery.  All rats were allowed to recover for 3 
weeks with ad libitum access to food and water prior to behavioural testing in order 
to allow viral uptake. Animals were administered bromodeoxyuridine (BrdU) 
(1x150mg/kg, i.p.) one week after surgery for immunohistochemical assessment of 
the survival of newly born cells. 
 
2.4 Open field 
Rats were placed in an open field arena (90 cm diameter and 45cm wall height) 
under bright lighting conditions for 10 minutes.  Distance travelled and time in the 
centre of the arena was recorded and calculated using Ethovision software (Noldus).  
The arena was cleaned with a 50% ethanol solution between exposures of animals to 
the arena to remove odour cues. 
 
2.5 Spontaneous Alternation in the Y-maze 
Spontaneous alternation behaviour is used as a measure of hippocampal-dependent 
working memory (Hughes, 2004). The Y-maze consisted of three arms 120° from 
each other (16 cm x 6.5 cm; made in house) (adapted from (Senechal et al., 2007)). 
Each animal was placed into the first arm of the maze facing the wall, and allowed to 
explore the maze for five minutes. The number and order of arm entries were 
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recorded. An arm entry was defined as all four paws entering into the arm (four paw 
criteria). An alternation was determined as the number of consecutive entries into the 
three maze arms. Alternations were then divided by the total number of entries 
during the five minute test period to give the percentage alternation for each animal 
which was plotted as the mean for each experimental group ± standard error of the 
mean (SEM). 
 
2.6 Novel Object Recognition 
Novel object recognition was assessed as previously described (Bevins and Besheer, 
2006). The objects used for this task were either a 250ml Fisherbrand
TM
 glass bottle 
(Thermo Fisher Scientific, MA, USA) or a coffee cup. On day 1 the animals were 
habituated to the testing arena (45cm x 80cm rectangle arena with 45cm wall height) 
for a 10 minute exploration period. On day 2, two identical objects were positioned 
on adjacent corners approximately 5 cm from each wall of the arena and each animal 
was placed in the arena for a 10 minute exploration period. Animals were then 
placed directly back into their home cages. After a 3 hour inter-trial interval, one 
familiar object was replaced with a novel object, and each animal was placed in the 
arena for a 5 minute exploration period. Object exploration was defined as a 2 cm 
radius between the object and the animal’s nose. The testing arena and objects were 
cleaned with a 50% alcohol solution between exposures. Videos were manually 
scored for object exploration and total exploration times with the novel and familiar 
objects were graphed as time (seconds) ± SEM.  
 
2.7 Location recognition task 
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The location recognition task was conducted in the open field arena, covered with 
bedding under dim light conditions (black plastic bags were used to cover the lights 
in the testing room) (adapted from Bekinschtein et al., 2013b, Bekinschtein et al., 
2014, Kent et al., 2015). The objects used were Carlsberg
TM
 330ml glass bottles. The 
testing room had three proximal spatial cues and distal standard furniture.  Objects 
and the arena were cleaned with a 50% ethanol solution between exposures of each 
animal to the arena to remove odour cues.  Rats were habituated to the arena for 10 
minutes per day for 5 consecutive days before testing began.  During the acquisition 
phase, three identical objects were placed 15 cm from the edge of the open field, and 
30 cm from the centre of the arena, and rats were allowed to explore for 10 minutes. 
The three objects were separated by 120° angles during acquisition. The test phase 
was conducted 24 hours following acquisition where one of the objects was removed 
and the two other previously used objects were placed in the arena opposite each 
other.  One was placed in the same position it was in during the acquisition phase 
and the other was placed directly opposite. Rats were allowed to explore for 5 
minutes.  The location of the objects used was counterbalanced within and between 
groups. Time spent exploring the objects was manually scored and total exploration 
times with the novel and familiar objects were graphed as time (seconds) ± SEM. 
 
2.8 Immunohistochemistry and imaging 
Rats were euthanized with an i.p. injection of Euthatal (pentibarbitol; 1.0mL/kg) and 
transcardially perfused using a 0.9% phosphate buffered saline (PBS) solution 
followed by 4.0% paraformaldehyde in PBS.  After perfusion, brains were removed 
and post-fixed in 4% formaldehyde in PBS overnight, then transferred to a 30% 
sucrose solution until they had sunk.  Coronal sections through the hippocampus 
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were cut at 40μm onto slides and stored at -80°C. For analysis of the survival of new 
cells, sections were incubated in HCl (2M) for 45 minutes at 37°C and renatured in 
0.1M sodium tetraborate, and then treated with 3% hydrogen peroxide for 45 
minutes.  Sections were blocked in 10% normal rabbit serum (Sigma) and incubated 
with rat anti-BrdU (Abcam ab6326). Ki67 (Genetex, GTX16667) and DCX (Santa 
Cruz, sc-8066) staining was carried out for analysis of cell proliferation and 
neurogenesis, respectively (see table 4.1 for a list of all primary antibodies and their 
dilutions used in this study). Sections were blocked in 10% normal rabbit serum and 
incubated with the appropriate primary antibody. Detection and visualisation was 
carried out using HRP-linked rabbit-anti-rat secondary and ABC complex (Vector) 
before being placed into DAB and coverslipped with DPX mounting medium. 
Brightfield images across a 1:12 series through the dorsal DG were obtained using 
an Olympus BX53 upright microscope at both 10x and 20x (BioSciences Imaging 
Centre, Department of Anatomy and Neuroscience, UCC).  The total number of 
positively labelled cells were counted and expressed as cells per section within the 
hilus, subgranular zone (SGZ), and granular cell layer (GCL) of the DG. Fluorescent 
images of autofluorescent GFP-tagged TLX transfected cells were taken using an 
Olympus BX53 upright microscope at 20x across a 1:12 series through the 
hippocampus of each animal to confirm successful viral transduction (BioSciences 
Imaging Centre, Department of Anatomy and Neuroscience, UCC). The presence of 
auto-fluorescent cells was deemed to confirm viral transduction. 
 
Target Antibody Source Company Dilution 
BrdU Anti-BrdU Monoclonal 
Rat 
Abcam 1:100 
Ki67 Anti-Ki67 Monoclonal 
Rabbit 
Genetex 1:200 
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DCX Anti-DCX Polyclonal 
Goat 
Santa Cruz 1:100 
Table 4.1: List of antibodies used in chapter 4. 
 
2.9 Statistics 
All data are expressed as mean ± SEM. Student’s t-tests or Two-way ANOVA were 
carried out where appropriate to determine statistical significance and p≤0.05 was 
deemed significant.   
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3: Results 
3.1 Hippocampal TLX OEX did not alter weight, locomotor activity, or thigmotaxis. 
There was no difference in the weight of the animals between both experimental 
groups for the duration of the experiment (Fig. 4.2A). In the open field, both groups 
travelled similar distances and spent similar amounts of time within the centre of the 
arena indicating no differences in locomotor activity or anxiety-like behaviour (Fig. 
4.2B, C). As the TLX overexpression plasmid was tagged with GFP, we confirmed 
the presence viral transduction by visualising auto-fluorescence if the GFP-tagged 
TLX of successfully transduced cells within the hippocampus for each animal (Fig. 
4.2D). In each animal auto-fluorescence of GFP-tagged TLX was evident.  
 
3.2 Hippocampal TLX OEX impairs short-term object recognition memory but does 
not affect long-term location recognition memory or working spatial memory. 
Both control and hippocampal TLX OEX rats had similar exploration times during 
the acquisition phase of the novel object recognition task and neither group showed a 
preference for any particular object used during the test phase (bottle or cup) (Fig. 
4.3A). Rats with hippocampal OEX of TLX showed impaired object recognition 
after a 3 hour delay between acquisition and testing whereas control animals 
successfully identified the novel object (Fig. 4.3A, t(17)=3.393, p=0.0035, *P<0.05). 
However, these same rats performed to a similar extent as control rats in a location 
discrimination task after a 24 hour delay as no impairment or enhancement was 
observed (Fig. 4.3B, Control novel versus familiar t(16)=2.158, p=0.0464; TLX 
novel versus familiar t(18)=3.286, p=0.0041 *P<0.05 and **P<0.01 compared to 
respective familiar object of respective lentiviral treatment group). There were no 
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differences in spatial working memory between the groups as determined by 
spontaneous alternation behaviour in the Y-maze (Fig. 4.3C). 
 
3.3: Hippocampal TLX OEX increases the number of proliferating cells in the 
subgranular zone. 
TLX OEX induced a significant increase in the number of proliferating cells in the 
subgranular zone (SGZ) of the DG (Fig. 4.4A, Ki67 positive cells in the SGZ 
comparing control versus TLX t(6)=3.784, p=0.0091). No change in the number of 
proliferating cells was observed in the granular cell layer (GCL) or the hilus. There 
was no significant difference in the survival of new cells (Fig. 4.4C) or in the 
number of newborn neurons (Fig. 4.4E) in the hippocampus of rats with TLX OEX 
compared to controls. 
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4: Discussion 
In the present study, we utilised lentivirus technology to induce TLX OEX within 
the dorsal hippocampus of adult male rats and assessed changes in hippocampal 
neurogenesis-associated cognition. We did not observe any significant improvement 
in novel location recognition or spontaneous alternation in the Y-maze, however we 
did observe a significant impairment in novel object recognition in these rats. We 
also show that TLX OEX induced a significant increase in cell proliferation in the 
subgranular zone of the hippocampus. We did not observe any changes in cell 
survival or in birth of new neurons in the DG of TLX injected rats. Thus, our results 
suggest that enhancing cell proliferation alone within the neurogenic niche of the 
hippocampus may not be sufficient to promote hippocampal neurogenesis-associated 
cognition, and may in fact impair certain forms of hippocampal cognition. 
 
It is important to bear in mind that the tasks assessed in this study each reflect a 
different aspect of hippocampal-associated cognition. Spatial working memory is 
assessed in the spontaneous alternation task with very little learning involved 
(Gerlai, 2001, Gerlai, 1998). Novel object recognition does involve a minor learning 
component in that the animals must successfully encode or learn the memory of the 
familiar object (Cohen and Stackman, 2015, Aggleton and Brown, 2005, Bevins and 
Besheer, 2006). However, the perihinal cortex is also said to be involved in object 
recognition and depending on the duration if the intertrial-interval, may be more 
responsible for successful completion of the task than the hippocampus (Cohen and 
Stackman, 2015). Location recognition is suggested to be more hippocampal 
dependent than object recognition and provide a greater indication of specific 
hippocampal function (Dupret et al., 2008) 
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Numerous studies have linked the function of adult hippocampal neurogenesis to 
spatial memory and cognition. However, this link is complex as some studies have 
demonstrated the beneficial effects of enhancing neurogenesis (Snyder et al., 2005, 
Deng et al., 2009, Jessberger et al., 2009b) while others have demonstrated that there 
is no effect of manipulating hippocampal neurogenesis on spatial learning and 
memory (Dupret et al., 2008, Zhang et al., 2008, Hernandez-Rabaza et al., 2009, 
Wojtowicz et al., 2008). We demonstrate that enhancing cell proliferation in the 
hippocampus through lentivirus-mediated TLX OEX impairs memory recall in an 
object recognition task. Additionally, neither controls nor TLX OEX group showed 
any bias in exploring any object used in this study (cup or bottle). Object recognition 
involves direct or indirect neuronal inputs the perirhinal cortex to the hippocampus 
(Aggleton and Brown, 2005, Witter et al., 1989, Burwell et al., 1995). In support, it 
has been demonstrated that rats who underwent a location recognition task display 
increased expression of immediate early genes in the hippocampus only whereas rats 
who underwent an object recognition task show increased expression of these genes 
in the perirhinal cortex and not the hippocampus (Aggleton and Brown, 2005). 
Lesion studies have demonstrated that when the perirhinal cortex is damaged, object 
recognition is impaired yet spatial memory performance remains intact and when the 
hippocampus is damaged, spatial memory is impaired but object recognition remains 
intact. However, if the object recognition task is conducted in an open area, salient 
spatial or contextual cues result in the hippocampus being recruited to the neuronal 
circuitry underlying the object recognition task (Aggleton and Brown, 1999, 
Cassaday and Rawlins, 1997, Gaffan, 1994, Zola et al., 2000). This could explain 
why disruption to hippocampal function can impair object recognition. In the context 
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of our results, it could be suggested that this relay of information between the 
hippocampal DG to the peririhinal cortex may be disrupted by the heightened 
proliferative state of the hippocampus as a result of TLX OEX. One important caveat 
to bear in mind when interpreting the results of this study is the intertrial intervals 
used. For the object recognition task a three hour interval was used whereas for the 
location recognition task a 24 hour interval was used. Therefore it is difficult to 
determine whether TLX OEX rats and controls would exhibit equivalent object 
recognition memory after a 24 hour interval or a deficit in place recognition memory 
after a 3 interval. Future studies will aim to address this confounding factor by 
utilising a common intertrial interval between novel object and location recognition 
tasks. 
 
The flow of information between the perirhinal cortex and the hippocampus during 
object recognition has been proposed to be heavily dependent on the duration of time 
that the rodents spend exploring the objects, as well as the length of time between 
acquisition and testing phases. Cohen and Stackman propose that shorter exploration 
times and inter-trial intervals results in the peririhinal cortext being the predominant 
structure involved in processing the task and as these times increase, information 
processing gradually switches to the hippocampus (Cohen and Stackman, 2015). 
They further suggest that the shift from perirhinal cortex to hippocampal information 
processing starts after approximately 30 seconds of object exploration. This time 
frame is similar to the exploration time of the novel object by both the experimental 
groups during the test phase in the current study. Thus, it may be the case that the 
increased cell proliferation in the hippocampus may impair the flow of this 
information from the perirhinal cortex to the hippocampus and thus lead to impaired 
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performance in the object recognition task. However, both groups spent 
approximately 80 seconds exploring the objects during the acquisition phase 
therefore the hippocampus should be sufficiently recruited at that stage for encoding 
the object memory. Notwithstanding these results open an interesting avenue of 
research to assess the detrimental potential of heightened proliferation in the 
hippocampus on hippocampal cognition to determine the mechanism of such 
impairments. 
 
As neurogenesis is a multifactorial process of cell proliferation, differentiation and 
neuronal integration, it may be possible that enhancing just one of these factors is not 
sufficient to enhance hippocampal-associated spatial cognition. Furthermore, 
enhancing one specific component of neurogenesis, such as cell proliferation, may 
dysregulate the entire neurogenic process or not translate to increased neuronal 
differentiation. Indeed it has been demonstrated that when the transcription factor 
sonic hedgehog (Shh) is overexpressed in NPCs, there is a significant increase in cell 
proliferation while there is no effect on differentiation (Lai et al., 2003). Likewise, 
we observed no effect of TLX OEX on the number of DCX cells indicating a lack of 
effect of TLX on neuronal differentiation. Indeed, TLX has previously been shown 
to prevent differentiation by maintaining NPCs in a proliferative state (Niu et al., 
2011, Shi et al., 2004, Li et al., 2008). Our results using a lentivirus-mediated 
approach also show that the increase in cell proliferation induced by TLX occurred 
without altering the differentiation status of these cells. This is in line with the work 
on Shh by Lai et al. (2003) and could explain why we did not see any effect of TLX 
OEX in the novel location test or spontaneous alternation in the Y-maze. These data 
reinforce the notion that for any enhancement in hippocampal cognitive function to 
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be induced by neurogenesis, there must be a robust enhancement of all aspects of 
neurogenesis.  
 
Most studies to date have assessed the functional role of TLX by assessing the 
behaviour of mice in which there is a spontaneous deletion of the TLX gene (Young 
et al., 2002, Roy et al., 2002, O'Leary et al., 2016a).  These studies have shown that 
impairment in TLX expression lead to deficits in locomotor activity, contextual and 
cued conditioning, and reduced anxiety-like behaviour. The broad range of 
behavioural deficits exhibited by these mice is likely a result of the lack of TLX 
expression throughout critical periods of brain development. Thus, to truly assess the 
functional role of TLX in adulthood, targeted manipulation of TLX should be 
assessed specifically during adulthood such as we employed here. Some studies have 
previously attempted to address this issue by transgenic methods to alter TLX 
expression in adulthood (Zhang et al., 2008, Murai et al., 2014). Specifically, it has 
been demonstrated that targeted deletion of TLX in adulthood led to impaired spatial 
navigation in the Morris water maze (MWM) yet did not affect contextual fear 
conditioning (Zhang et al., 2008). Conversely, transgenic overexpression of TLX 
specifically within the hippocampus enhanced spatial memory performance in the 
MWM (Murai et al., 2014). The use of lentiviral vectors is a useful method to either 
enhance or repress the expression of specific genes (Kunitsyna et al., 2016, Escors 
and Breckpot, 2010, Naldini, 1998, van Hooijdonk et al., 2009) and 
immunohistochemical data in this study confirmed that injection of lentiviral 
particles designed to overexpress TLX resulted in increased cell proliferation in the 
DG of the hippocampus. However, as TLX is a nuclear receptor, pharmacological 
manipulation of TLX would ultimately allow for greater control of its activity. 
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Research is currently underway to establish a pharmacological ligand to regulate 
TLX function, and so with the discovery of such ligands it will be possible to probe 
deeper into the role of TLX in hippocampal-associated cognitive processes (Benod et 
al., 2014b, Benod et al., 2016).  
 
In conclusion, we show that TLX overexpression in the hippocampus impaired 
performance in an object recognition task. As TLX functions to promote 
proliferation of NPCs, we also confirmed that lentiviral mediated overexpression of 
TLX had a functional effect by increasing the number of proliferating cells in the 
SGZ of the hippocampus, a region rich in NPCs. Our data suggest that enhanced 
hippocampal cell proliferation may disrupt perirhinal cortex-hippocampal neuronal 
communication and thus impair object recognition memory. However, further 
research is needed to confirm the potential detrimental effect of elevated levels of 
hippocampal cell proliferation on hippocampal cognitive function. Additionally, 
future studies should adopt standardised intertrial intervals to concretely compare 
novel location and novel object recognition tasks without differing intertrial intervals 
being a confounding factor. As we observed no effect of neuronal differentiation, our 
data also supports the concept that enhancement of cell proliferation without 
successful integration of new neurons does not promote hippocampal-dependent 
cognition.  
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Figure 4.1: Experimental timeline. Wk, week; OF, open field; NOR, novel object 
recognition; NLR, novel location recognition; SA, spontaneous alternation dH, 
dorsal hippocampus; OEX, overexpression. 
 
 
Figure 4.2: TLX overexpression in the hippocampus does not alter weight gain, 
locomotor behaviour, or thigmotaxis. A) Body weight of rats for the duration of the 
study. B) Distance travelled in the open field. C) Percentage time spent in the centre 
of the open field. D) Representative image of auto-fluorescence of GFP-tagged TLX 
in the dorsal hippocampus. Image taken at 20x and the scale bar represents 100μm. 
All data are depicted as mean ± SEM (n=9-10).  
  
 Chapter 4 
176 
 
 
Figure 4.3: TLX overexpression in the hippocampus impairs novel object 
recognition but has no effect on novel location recognition or working spatial 
memory. A) Schematic of novel object recognition paradigm (left) and time spent 
with the familiar and novel objects (right). B) Schematic of novel location 
recognition paradigm (left) and time spent with the familiar and novel object 
locations (right). C) Schematic of spontaneous alternation in the Y-maze paradigm 
(left) and percentage alternations in the Y-maze (right). A student’s t-test was used in 
to determine significance where *p<0.05 and **p<0.01 vs respective familiar object 
where n=9-10. Data are depicted as mean ± SEM. 
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Figure 4.4: TLX overexpression in the hippocampus increases cell proliferation in 
the (SGZ) of the DG. Number of Ki67 (A), BrdU (C) and DCX (E) positive cells per 
section in the SGZ, GCL and hilus of control and TLX OEX rats **p<0.01, n=4. 
Representative images of Ki67 (B) and BrdU (D)-positive cells in the DG. The scale 
bar represents 100μm. Representative images of DCX-positive cells in the DG (F). 
The scale bar represents 75μm. Student’s t-test used to determine significance 
p<0.05vs.ctrl. 
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Abstract 
The adolescent period is an important stage of maturation for various brain structures 
and it is during this time that effects of environmental factors such as diet can have a 
particular influence on mood and memory. Diets high in fat and sugar (termed a 
cafeteria diet) have been shown to negatively impact upon cognitive performance. It 
has been suggested that the negative effects of poor diet during adolescence on 
cognition can be reversed by switching to a normal diet during adulthood. However, 
it is unknown whether adolescent exposure to a poor diet potentiates the effects of 
known negative regulators of cognition during adulthood, such as inflammation. To 
address this, we allowed rats access to a cafeteria diet during the adolescent period 
after which time they were injected with a lentivirus in the hippocampus to induce 
chronic low-grade overexpression of the pro-inflammatory cytokine interleukin-1β 
(IL-1β). After viral integration, we assessed performance in a series of hippocampal-
associated cognitive tasks. Our data suggests that adolescent exposure to a cafeteria 
diet does not induce any lasting cognitive deficits when the diet was replaced with a 
normal diet in adulthood. Additionally, IL-1β in the cafeteria diet fed rats did not 
alter this effect. IL-1β in the absence of a prior cafeteria diet impaired spatial 
working memory but enhanced contextual fear learning. In conclusion, we 
demonstrate a complex role of IL-1β in regulating hippocampal-associated 
behaviour.  
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1: Introduction 
A major health concern in developed countries is the over consumption of high 
energy diets rich in saturated fat and sugar (Berthoud et al., 2011, Guyenet and 
Schwartz, 2012, Kearney, 2010). Overconsumption of these ‘cafeteria’ diets have led 
to a drastic increase in the prevalence of obesity and associated cardiovascular and 
metabolic disorders (Bruce-Keller et al., 2009, Haslam and James, 2005). Increased 
consumption of high fat and high sugar diets has also been shown to impair 
cognitive performance and the regulation of emotion (Jacka et al., 2010, Kanoski and 
Davidson, 2011). The hippocampus is a brain region involved in learning and 
memory as well as the regulation of emotional responses and its function is 
particularly affected by increased intake of high fat and/or high sugar diets (Heyward 
et al., 2012, McNay et al., 2010, Ross et al., 2009). For example, it has been 
demonstrated that daily access to sucrose induces impairments in hippocampal-
associated pattern separation in adult rats (Reichelt et al., 2016) and a diet high in 
both fat and sugar has been shown to impair location recognition also in adult rats 
(Beilharz et al., 2014). However, some studies have shown no effect of high fat 
and/or high sugar diets on certain hippocampal dependent tasks in adulthood such as 
spatial navigation and object recognition indicating that the effects of diet may be 
task specific and/or diet specific (Beilharz et al., 2014, Reichelt et al., 2015, 
Valladolid-Acebes et al., 2013).  
 
Increased consumption of cafeteria diets and obesity have been reported across all 
age groups however it is suggested that the adolescent period, a critical period for the 
development of normal cognitive function throughout life (Spear, 2000), is 
particularly susceptible to the cognitive impairments induced by poor diet intake 
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(Ogden et al., 2012, Vendruscolo et al., 2010, Boitard et al., 2014, Boitard et al., 
2012, Reichelt et al., 2015). Consumption of high fat or high sugar in adolescent rats 
have been shown to result in impaired reward pathway regulation as well as 
motivational deficits and these effects are not evident in adult rats (Vendruscolo et 
al., 2010). Additionally, it has been demonstrated in rodents that adolescent 
consumption of a high fat diet impairs a variety of hippocampal-associated cognitive 
processes including spatial memory (Boitard et al., 2012, Boitard et al., 2014) and 
object location recognition (Valladolid-Acebes et al., 2013, Reichelt et al., 2015, 
Beilharz et al., 2014). Interestingly, these behavioural effects are not observed after 
consumption of the same diet in adult rats (Valladolid-Acebes et al., 2013, Reichelt 
et al., 2015, Beilharz et al., 2014). Similar effects have been demonstrated in humans 
where adolescents consuming high fat and high sugar diets have impaired 
visuospatial learning and memory performance which is associated with 
hippocampal function (Nyaradi et al., 2014).  
 
Recent evidence has suggested that the negative effects of high fat diets on 
hippocampal-associated cognition during adolescence can be reversed in adulthood 
by simply reverting to a normal diet (Boitard et al., 2016). Thus, it may be that the 
effects of poor diet during adolescence on cognitive function are not permanent. 
However, it is unknown whether early exposure to a poor diet could exacerbate any 
potential impairment in cognition induced by a negative regulator of hippocampal 
function during adulthood. Interleukin-1β (IL-1β) is a pro-inflammtory cytokine 
which is prevalent in the hippocampus after infection and is responsible for 
mediating cellular processes associated with the cognitive and affective symptoms of 
neurodegenerative diseases and stress-induced major depression (Hauss-Wegrzyniak 
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et al., 1998, Ransohoff, 2016, Heppner et al., 2015, Müller, 2014, Salim et al., 2012). 
However, there are conflicting reports on the effects on hippocampal function with 
some studies demonstrating improved performance by rodents in certain 
hippocampal-associated tasks and others demonstrating an impaired performance 
(Goshen et al., 2007, Moore et al., 2009, Barrientos et al., 2002). Thus, the study 
described herein consisted of three main aims. Firstly, we aimed to determine 
whether adolescent exposure to a cafeteria diet high in both sugar and fat induces 
hippocampal-associated cognitive impairments in adulthood. Secondly, we aimed to 
determine the effects of lentiviral-mediated sustained overexpression (OEX) of IL-
1β during adulthood on hippocampal associated cognition. Finally, we sought to 
determine whether adolescent cafeteria diet consumption could exacerbate IL-1β-
induced effects on cognition during adulthood. Hippocampal cognitive performance 
was determined by assessing short-term spatial working memory, recognition 
memory, and fear memory tasks and associated neuroplasticity gene expression 
changes in the hippocampus were determined.  
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2: Methods 
2.1: Animals 
Male Sprague-Dawley rats were bred in-house (Biological Services Unit, UCC) and 
were weaned at postnatal day (PND) 21. Weaned rats were pair housed in a colony 
maintained at 22 ± 1°C with a 12:12 hour light-dark cycle (lights on 0639-1830). All 
animal procedures were performed under licenses issued by the Department of 
Health and Children (Ireland) and the Health Products Regulatory Authority (HPRA, 
Ireland), in accordance with the European Communities Council Directive 
(2010/63/EU) and approved by the Animal Experimentation Ethics Committee of 
University College Cork.  
 
2.2: Experimental design and diet 
Rats were randomly divided into four experimental groups; control chow fed animals 
injected with an mCherry expressing lentivirus (Ctrl) (n=8), cafeteria diet fed 
animals injected with an mCherry expressing lentivirus (caf. diet) (n=10), control 
chow fed animals injected with an IL-1β expressing lentivirus (Ctrl + IL-1β) (n=10), 
and cafeteria diet fed animals injected with an IL-1β expressing lentivirus (caf. diet + 
IL-1β) (n=10). The cafeteria diet consisted of high fat and high sugar components 
and was given in addition to standard chow to diet fed rats (blue and green 
highlighted columns in figure 5.1 represent high fat and high sugar foods 
respectively). Each day, rats were given one high fat food and one high sugar food as 
well as regular chow. The combination of foods given was randomised such that rats 
had equal exposure to each food type across the length of the study. Foods were 
weighed prior being placed in the cages and were given in excess and the leftover 
amount of each component was weighed after 24 hours to determine the amount 
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consumed by rats in each cage. Standard chow was also weighed daily to determine 
consumption by rats in all cages (See table 5.1 for list of all foods given and 
nutritional information). Cafeteria diet began one week after weaning (PND28) and 
ended at PND56 when the animals underwent sterotaxic sugery. Standard chow was 
given for the remainder of the study. Behaviour testing started 3 weeks later to allow 
for lentiviral uptake. The animals were culled at PND98/99 and tissue collected for 
ex vivo analysis. Left and right hippocampus tissue was collected. Tailblood samples 
were taken before the start of the diet, immediately at the end of the diet, and truck 
blood was taken at cull to measure metabolic hormone levels. See fig. 5.1A for 
experimental schematic. 
 
2.3 Lentiviral production 
Production of plasmids and lentiviruses to overexpress mCherry or mCherry-tagged 
IL-1β was carried out by Genecopoeia (GeneCopoeia, MD, USA). Briefly, lentiviral 
particles pseudotyped with the vesicular stomatitis virus (VSV-G) glycoprotein and 
contained plasmids sequences for mCherry or mCherry-tagged IL-1β on an FIV 
backbone and driven by a cytomegalovirus promoter (CMV) promoter. These 
lentiviral particles were generated using standardised lentiviral production protocols 
and using EndoFectin-Lenti
TM 
and TitreBoost
TM 
reagents. The lentiviral transfer 
vector was co-transfected into 293Ta cells with Lenti-Pac
TM 
FIV packaging mix. 
Viral titres were determined via RT-PCR and were established as 1.93 x 10
7
 
copies/ml for the IL-1β lentiviral particles and 2.42 x 108 copies/ml for the GFP 
lentiviral particles. The lentivirus particles were then purified and stored at -80°C 
until use. 
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2.4: Sterotaxic surgery 
Rats were anaesthetised with isoflurane and placed into a Kopf stereotaxic frame.  
Lentiviruses to overexpress mouse IL-1β or mCherry (Genecopoeia, MD, USA) 
were injected into the dorsal hippocampus using the coordinates AP: -3.5 mm, ML: 
± 2.4 mm, DV: -3.8 mm relative to Bregma (Barrientos et al., 2002) at a volume of 
2μl and a flow rate of 1µL/min followed by a 5 min diffusion.  Rats were injected 
s.c. with carpofen and 5% glucose prior to anaesthetic recovery.  All rats were 
allowed to recover for 3 weeks with ad libitum access to regular chow and water to 
allow viral uptake prior to beginning behavioural testing. 
 
2.5: Open field 
Rats were placed in an open field arena (90 cm diameter and 45cm wall height) 
under bright lighting conditions for 10 minutes.  Behaviours were recorded, and 
distance travelled, velocity, and time in the centre of the arena were calculated using 
Ethovision software (Noldus).  The arena was cleaned with a 50% ethanol solution 
between exposures of each animal to the arena to remove odour cues. 
 
2.6: Spontaneous Alternation in the Y maze 
Spontaneous alternation behaviour is the tendency of rodents to alternate their 
exploration of maze arms (such as those of the Y maze) and is used as a measure of 
hippocampal-dependent short-term working memory (Hughes, 2004). The Y maze 
consisted of three arms 120° from each other (16 cm x 6.5 cm; made in house). The 
protocol was adapted from (Senechal et al., 2007). Each animal was placed into the 
first arm of the maze facing the wall, and allowed to explore the maze for five 
minutes. The number and order of arm entries were recorded. An arm entry was 
 Chapter 5 
187 
 
defined as all four paws entering into the arm (four paw criteria). An alternation was 
determined as the number of consecutive entries into the three maze arms. 
Alternations were then divided by the total number of entries during the five minute 
test period. 
 
2.7 Novel Object Recognition 
Novel object recognition was assessed as described (Bevins and Besheer, 2006). The 
objects used for this task were either a 250ml Fisherbrand
TM
 glass bottle (Thermo 
Fisher Scientific, MA, USA) and/or a coffee cup. On day 1, the animals were 
habituated to the rectangular testing arena (45cm x 80cm with 45cm wall height) for 
a 10 minute exploration period. On day 2, two identical objects were positioned on 
adjacent corners approximately 5 cm from each wall of the arena and each animal 
was introduced for a 10 minute exploration period. Animals were then placed 
directly back into their home cages. After a 3 hour inter-trial interval, one familiar 
object was replaced with a novel object, and each animal was introduced for a 5 
minute exploration period. Object exploration was defined as when the animal’s nose 
comes within a 2 cm radius of the object. The testing arena and objects were cleaned 
a 50% alcohol solution in between each exposure. Videos were then manually scored 
for object exploration.  
 
2.8 Contextual and cued fear conditioning 
We utilised contextual and cued fear conditioning paradigms to determine the effects 
of our experimental interventions on hippocampal and amygdala-associated function, 
respectively (Maren, 2001, Pattwell et al., 2011). During the acquisition phase, rats 
were placed into fear conditioning context A (Med Associates, VT, USA) which 
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consisted of a rectangular chamber with a grid floor and scented with a lemon and 
ginger tea bag (Twinings
TM
). Animals were acclimatised to the chamber for 2 
minutes after which they received three tone and shock pairs (30 s tone; 5 kHz; 70 
dB; 1 s foot shock; 0.35 mA DC current) separated by 30 s intervals. Animals 
remained in context A for 1 minute after the final shock at which point they were 
returned to their home cage. Contextual fear memory was assessed 24 hours when 
animals were returned to context A chamber but did not receive a paired tone/shock. 
Time spent freezing was measured during a total 5.5 min protocol using specialized 
software (Video freeze, Med Associates, USA). Cued fear conditioning and memory 
extinction was measured 24 h after the contextual test in the same chambers but with 
contextual cues altered so that the animals experienced a novel context (context B). 
Context B consisted of a white floor, black wall insert at 60°, and scented with 
almond extract (1% in water). Animals were allowed 2 minutes to acclimatize to 
context B followed by 10 tone presentations (30 s; 5 kHz; 70 dB) separated 30 
seconds apart. Freezing behaviour during the 30 second tone presentations was 
recorded (Video freeze,MedAssociates, USA) to assess cued memory recal and 
extinction of the cued memory.  
 
2.9: Quantitative real-time PCR (qRT-PCR) 
Total RNA was extracted from hippocampal tissue using the mirVana
TM
 total RNA 
extraction kit (Ambion/Life Technologies, Dublin, Ireland) and and DNase treated  
using Turbo DNA-free kit (Ambion/life technologies) as per the manufacturer’s 
instructions. The total concentration of extracted RNA was quantified using a 
Nanodrop 2000 (Thermo Scientific, UK) and was stored at -80°C. cDNA was 
reversed transcribed using the high capacity cDNA reverse transcription kit (Applied 
 Chapter 5 
189 
 
Biosystems) using the SureCycler
®
 8800 (Agilent Technologies) and diluted to a 
final concentration of 10ng/μl. All qRT-PCR was performed in 3 technical replicates 
for each biological sample on a LightCycler
®
 480 Instrument II (Roche) using the 
following primers: Synaptophysin F: CCCTTCAGGCTGCACCAA, R: 
TTGGTAGTGCCCCCTTTGAC; PSD95 F: ACGCCGAAGAGTCAGAGAAA, R: 
ACTGTTGGACCGAGTGAACC; R: CCCATTTGGGAACTTCTCCT, CXCL1: F: 
CTCCAGCCACACTCCAACAG, R: GACTTCGGTTTGGGTGCAGT and SHDA 
F: CCCACTAACTACAAGGGACAGG, R: TTGGCACCATGCACTGAG. The 
PCR consisted of the following steps: 95°C for 2 minutes to denature the cDNA 
followed by 40 cycles of 95°C for 5 seconds and 60°C for 20 seconds. Each reaction 
consisted of 1μl of sample (5ng/ul), 5μl of Sybr MasterMix (KiCqStart® SYBR® 
Green qPCR ReadyMix™ with ROX™ for ABI instruments, Sigma-Aldrich), 0.1μl 
of both forward and reverse primers, and 3.8μl of RNase free H2O. Results were 
normalised to succinate dehydrogenase (SDHA). Quantification of gene expression 
was analysed using the ΔΔ Ct method (Livak and Schmittgen, 2001).  
 
2.10: Western Blot 
Total protein was extracted from hippocampal tissue, separated using SDS-
polyacrylamide gel electrophoresis, and electrophoretically transferred to a 
nitrocellulose membrane as previously described (Green and Nolan, 2012a, Nolan et 
al., 2005). The membrane was then incubated with primary antibodies for IL-1β 
(R&D systems, goat anti-mouse IL-1β polyclonal, 1:500) and β-actin (Sigma, mouse 
polyclonal, 1:1000) and subsequently incubated with the appropriate secondary HRP 
tagged secondary antibodies. Proteins were then visualised on exposure film using 
ECL detection kit (GE healthcare). Densitometry analysis of the developed 
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immunoblot bands was carried out using ImageJ software. Intensity readings for 
each band were expressed as arbitrary units relative to normalised to controls 
(standard chow fed non-IL-1β injected rats).  
 
2.11: ELISA 
ELISA was carried out on serum collected from cafeteria diet fed animals before the 
start of the diet, immediately after the end of the diet, and at culling. Leptin and 
insulin concentrations were determined by following the manufacturers’ guidelines 
(Millipore).  
 
2.12: Statistics 
One way or Two-way analysis of variance (ANOVA) tests were used where 
appropriate to determine statistical significance followed by the Bonferoni post-hoc 
test. Results were expressed as mean ± SEM and deamed significant when P≤0.05.  
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3: Results 
3.1 Animals fed a cafeteria diet during adolescence consume foods with significantly 
larger energy content but no change in body weight. 
Neither adolescent cafeteria diet consumption nor IL-1β (in combination or alone) 
induced any significant change in body weight of the rats throughout the study (Fig. 
5.1B). Animals receiving the cafeteria diet consumed foods with a significantly 
larger energy content than control animals (Main diet effect during diet phase of the 
study F(1,28)=474.004, P=0.0001; main effect of time F(1, 21)=353.8, P=0.0001; 
Interation between diet and time F(1,27)=9.211, P=0.0004; ***P<0.001 diet vs. 
controls, Fig. 5.1C). Immediately after the end of the cafeteria diet, animals 
consumed foodstuffs amounting to lower energy content than control chow fed 
animals and this was mirrored by the amount of chow intake by animals that were 
previously fed the cafeteria diet (Main diet effect F(3,120) = 31.53, P=0.0003; main 
effect of time F(9,120)=106.4, P=0.0001; interaction between diet and time 
F(27,120)=31.53, P=0.0001; ***P<0.001 compared to controls, Fig. 5.1D, E). This 
effect normalised within two weeks of cessation of the cafeteria diet. The component 
of the cafeteria diet for the duration of the study predominantly consumed was high 
fat foodstuffs (Fig. 5.1F). 
 
 3.2 Lentivirus overexpression of IL-1β induced significantly increase levels of 
hippocampal IL-1β at 6 weeks post surgery. 
Confirmation of lentiviral mediated overexpression of IL-1β was carried out by 
determining IL-1β protein expression in the hippocampus. There was a significantly 
elevated expression of IL-1β protein in the hippocampus 6 weeks after animals were 
injected with a lentivirus overexpressing IL-1β compared to rats injected with a 
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lentivirus overexpressing mCherry and this effect was not altered by the diet 
(Significant virus effect F(1,26)=28.319, P=0.0002; Diet effect F(1,26)=1.443, 
P=0.240; Interaction F(1,26)=1.451, P=0.239; ***P<0.001 vs ctrl, Fig. 5.2A). 
 
3.3 Adolescent cafeteria diet consumption leads to sustained elevation in serum 
leptin and insulin concentrations 
The serum concentration of the metabolic hormones leptin and insulin were 
measured in the cafeteria diet fed animals using ELISA prior to the start of the diet 
(baseline), immediately after the diet ended (T1), and again at the time of culling 
(cull). Consumption of the cafeteria diet induced a significant increase in both leptin 
and insulin serum concentrations at T1 and cull compared to baseline for both diet 
fed groups and this result was not affected by virus (Main effect of timepoint on 
leptin F(2,20)=35.85, P=0.0001; and insulin F(2,16)=8.66, P=0.0028; No effect of 
virus on leptin F(2,20)=0.041, P=0.949 or insulin F(2,16)=0.109, P=0.749 *p<0.05 
compared to baseline counterparts, Fig. 5.2C, D). In animals in which IL-1β was 
overexpressed within the hippocampus, there was a higher insulin concentration 
maintained at cull compared to animals injected with a control lentivirus however 
after repeated-measures two-way ANOVA analysis this difference did not reach 
significance (Fig. 5.2D).  
 
3.4 Adolescent cafeteria diet consumption and/or IL-1β does not alter anxiety-like 
behaviour 
Animals fed the cafeteria diet during adolescence with or without hippocampal IL-1β 
overexpression or animals with IL-1β overexpression alone did not show any 
changes in anxiety-like behaviour as all groups of animals spent a similar percentage 
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of time within the center of the open field arena (Fig. 5.2E). Additionally, all animals 
travelled similar distances within the open field demonstrating no changes in 
locomotor activity across the groups (Fig. 5.2F). 
 
3.5 IL-1β impairs spatial working memory but enhances contextual fear memory 
recall  
Adolescent cafeteria diet consumption did not induce any changes in spontaneous 
alternation behaviour in the Y-maze, object recognition memory, contextual fear 
conditioning, or cued fear conditioning (Fig. 5.3A, D, F-H). There was a main effect 
of IL-1β observed on spontaneous alternation in the Y-maze (Main effect of IL-1β 
F(1,31)=5.571; no effect of diet F(1,31)=0.135, P=0.716; no interaction effect 
F(1,31)=1.996, P=0.171; *p<0.05, Fig. 5.3A) while it had no effect on novel object 
recognition (Fig. 5.3D). All animals successfully acquired a freezing response to the 
tone stimulus (Fig. 5.3F). IL-1β significantly enhanced contextual fear memory 
recall compared to controls (Main effect of IL-1β F(3,12)=12.14, P=0.004; no effect 
of diet F(3,12)=2.9, P=0.24; No interaction effect F(3,34)=1.118, P=0.3505; *p<0.05 
vs Ctrl/mCherry and #p<0.05 vs Diet/IL-1β Fig. 5.3G) whereas no effect was 
observed on cued fear memory recall (IL-1β effect: F(3,34)=0.1671, P=0.9178; diet 
effect F(3,34)=0.2164, P=0.8843 Fig. 5.3H). All groups display similar memory 
extinction rates in response to multiple tones in the absence of shock stimuli (Fig. 
5.3H). 
 
3.6 IL-1β significantly increases post-synaptic synaptic but not pre-synaptic 
plasticity genes in the hippocampus.  
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After two-way ANOVA analysis, there was no significant difference in 
syanpatophysin (Diet effect F(1,26)=1.966, P=0.173; virus effect F(1,26)=1.082, 
P=0.308) or PSD95 (Diet effect F(1,26)=0.01, P=0.986; virus effect F(1,26)=0.995, 
P=0.328) mRNA expression across any of the groups (Fig. 5.4C, E). There was a 
significant effect of diet on CXCL1 expression (F(1,26)=5.632, P=0.025; #p<0.05 
between Ctrl/IL-1β and Diet/IL-1β , Fig. 5.4B).   
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Discussion 
There is a wealth of evidence to suggest that consumption of a high fat and/or high 
sugar diet during adolescence can have detrimental effects on hippocampal 
associated cognition (Vendruscolo et al., 2010, Boitard et al., 2014, Boitard et al., 
2012, Reichelt et al., 2015). However, more recent data suggests that the effect of a 
high fat only diet on hippocampal cognition may be reversed by removal of the diet 
and replacement with normal chow in adulthood (Boitard et al., 2016). Our data 
supports the later finding. We demonstrate that three weeks of cafeteria diet 
consumption high in both sugar and fat during the adolescent period (PND28 – 
PND56), does not result in cognitive deficits in adulthood when the animals were 
switched to a normal chow diet at adulthood for three weeks prior to testing. 
However, the cafeteria diet fed animals still maintained altered levels of leptin and 
insulin in the serum six weeks after the diet had been replaced with standard chow. 
Additionally, we demonstrate that hippocampal overexpression of the 
proinflammatory cytokine IL-1β during adulthood does not induce any cognitive 
impairments in cafeteria diet fed animals. Surprisingly, we demonstrate that 
overexpression of IL-1β during adulthood after normal diet intake during 
adolescence, induces impairments in spatial working memory and an enhancement in 
fear memory. This behavioural effect was complemented with increases in markers 
of synaptic plasticity and chemokine expression in the hippocampus.  
 
Previous work has shown that high fat/high sugar diets induce impairments in 
cognition during adolescence (Boitard et al., 2014, Boitard et al., 2012, Vendruscolo 
et al., 2010). These impairments have predominantly been demonstrated in 
hippocampal-associated spatial learning and memory tasks in rodents. For example, 
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Boitard et al demonstrated that after one or two months of high fat diet consumption 
starting at weaning, there was a significant impairment in long-term memory 
retention in the Morris water maze (despite no effect on acquisition or short-term 
memory retention) (Boitard et al., 2014). That study maintained the high fat diet 
throughout behavioural testing whereas in our study, the animals had been switched 
to a regular chow diet three weeks prior to the start of behavioural testing. This then 
may explain why we saw no effect on diet on any behavioural paradigm. 
Additionally, we assessed behaviour in different hippocampal-associated tasks than 
the ones used by Boitard et al and so adolescent cafeteria diet may only affect certain 
hippocampal-associated cognitive processes. Indeed this has been previously 
suggested as rats tested in a location recognition task after 20 days of high fat and 
high sugar diet consumption showed impairments in this task whereas no 
impairments were observed in an object recognition task (Beilharz et al., 2014) 
similar to what we observed. However, as with the work by Boitard et al, this study 
maintained the diet throughout behavioural testing. Therefore, the discrepancies in 
these studies compared to ours are most likely due to the fact that any effects that the 
diet may have had on hippocampal-associated cognition are likely reversed after a 
washout period. In this regard, that when rats that had consumed a high fat diet for 
three months starting at weaning, were switched to a regular chow diet and given a 
three month washout period before behavioural testing, no effect of adolescent high 
fat diet was observed in adulthood (Boitard et al., 2016).  
 
It has previously been demonstrated that consumption of a high fat diet can induce 
an increase in the expression of pro-inflammatory cytokines such as IL-1β and TNFα 
as well as increased microglial activation in brain regions including the 
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hypothalamus and hippocampus (Hansen et al., 1998, Beilharz et al., 2014, Pistell et 
al., 2010, Boitard et al., 2014). Thus, we hypothesised that adolescent exposure to a 
high fat cafeteria diet could increase the susceptibility of the hippocampus to 
inflammation during adulthood even after the cafeteria diet has been switched to a 
regular chow. IL-1β itself has been demonstrated to have robust effects (both 
positive and negative) on hippocampal function such as impairments spatial 
navigation in the Morris water maze and increase contextual fear memory recall 
(Farrar et al., 1987, Yirmiya et al., 2002, Goshen et al., 2008, Goshen et al., 2007, 
Avital et al., 2003, Moore et al., 2009). However, in the current study, we found that 
overexpression of IL-1β during adulthood did not unmask any behavioural 
phenotype induced by adolescent cafeteria diet consumption. Despite this, IL-1β 
alone during adulthood impaired spontaneous alternation in the Y-maze and 
enhanced contextual recall in a fear conditioning paradigm. Thus, it would appear 
that adolescent diet consumption negated the cognitive effects of IL-1β-induced 
changes in fear learning.  
 
A potential explanation is that alterations in factors induced by the cafeteria diet such 
as metabolic hormone and/or inflammatory markers may be impairing the ability of 
IL-1β to modulate cognition. For example, the expression of the IL-1RA has been 
shown to be significantly increased in the serum of obese patients (Meier et al., 
2002). Additionally, mice fed a high fat diet (albeit for 35 weeks) have been shown 
to have elevated serum IL-1RA expression (Somm et al., 2006). As IL-1RA is 
known to cross the blood brain barrier (Gutierrez et al., 1994) this could impair IL-
1β signalling within the hippocampus thus negating the IL-1β-induced changes in 
fear learning. However, this is rather simplistic view as high fat and high sugar diets 
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have been known to induce the expression of a plethora of inflammatory mediators 
such as IL-10, IL-6, and TNFα (Pistell et al., 2010, Boitard et al., 2014) as well as 
peripheral metabolic hormones that can regulate cognition. Indeed, we demonstrated 
significant main effect of diet on CXCL1 expression. CXCL1 is a chemoattractant 
(Johnson et al., 2011) and it may induce the migration of inflammatory cells such as 
astrocytes and microglia to the hippocampus which in turn can release inflammatory 
regulators (e.g. IL-1RA and IL-6) that could impact upon IL-1β-induced changes in 
hippocampal function.  
 
Both spontaneous alternation in the Y-maze and contextual fear conditioning are 
reliant on some aspect of hippocampal function as studies where the hippocampus is 
lesioned or damaged demonstrated impairments in these tasks (Gerlai, 1998, Johnson 
et al., 1977, Saxe et al., 2006, Anagnostaras et al., 2001, Maren and Fanselow, 1997, 
Maren et al., 1997). Increased expression of IL-1β has been shown to impair 
performance in hippocampal-associated tasks such as spatial navigation in the water 
maze (Moore et al., 2009). However, there is also evidence available to suggest that 
IL-1β is required for certain forms of hippocampal-associated memory. Initially it 
was demonstrated that interleukin-1 receptor type 1 (IL-1R1) knockout (KO) mice 
have longer latencies to find the hidden platform in the Morris water maze test of 
spatial navigation and reduced contextual fear conditioning responses (Avital et al., 
2003). IL-1R1 KO mice in that study also had reduced hippocampal long-term 
potentiation (LTP) formation however there were no deficits observed in 
hippocampal-independent tasks such as guided spatial navigation and cued fear 
conditioning. Subsequently it was demonstrated in rats that underwent fear 
conditioning based contextual learning that there is an increase in hippocampal IL-1β 
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expression during the learning phase (Goshen et al., 2007). Our data closely 
resembles the results found in these studies in that we see and enhancement in 
contextual fear conditioning as well as synaptic plasticity markers in rats exposed to 
IL-1β only. There is a strong argument that IL-1β at lower concentrations may 
enhance certain hippocampal-associated memory formation (Goshen et al., 2007, 
Avital et al., 2003), particularly in fear based learning paradigms, whereas it may 
impair spontaneous spatial memory performance as suggested from our data. 
However, determining the exact concentration and duration of IL-1β required to 
either enhance or impair cognition are largely unknown and would be an interesting 
avenue for future research. 
 
It must also be acknowledged that we did not observe any difference induced by IL-
1β on novel object recognition. Thus some, but not all, hippocampal associated tasks 
are sensitive to changes in hippocampal IL-1β expression. It is important to bear in 
mind that the tasks assessed in this study each reflect a different aspect of 
hippocampal-associated cognition. Spatial working memory is assessed in the 
spontaneous alternation task with very little learning involved (Gerlai, 2001, Gerlai, 
1998). Fear conditioning involves a strong learning or acquisition aspect to 
successfully complete the task (Phillips and LeDoux, 1992, Anagnostaras et al., 
2001). Novel object recognition does involve a minor learning component in that the 
animals must successfully encode or learn the memory of the familiar object (Cohen 
and Stackman, 2015, Aggleton and Brown, 2005, Bevins and Besheer, 2006). 
However, the perihinal cortex is also said to be involved in object recognition and 
depending on the duration if the intertrial-interval, may be more responsible for 
successful completion of the task than the hippocampus (Cohen and Stackman, 
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2015). Therefore, whether IL-1β negatively, positively or has any affect on 
hippocampal cognition depends on the neuronal circuitries recruited, the intertrial-
interval used, or even the degree to which learning is involved in performing the task 
(Goshen et al., 2007, Barrientos et al., 2002, Gonzalez et al., 2013, Hein et al., 2010). 
 
We assessed the expression of the pre-synaptic plasticity marker synaptophysin and 
the post-synaptic plasticity marker PSD95 in an attempt to determine whether the 
effects of IL-1β on cognition are associated with synaptic changes. Although we 
observed an increase in PSD95 expression it did not reach significance after two-
ANOVA analysis. Additionally, we saw no significant effect on synaptophysin 
expression. Increased expression of these markers is considered an indication of 
increased synaptic plasticity (Janz et al., 1999, El-Husseini et al., 2000). For 
example, it has been demonstrated that after environmental enrichment, a process 
known in enhance synaptic plasticity rodents (Moser et al., 1994, Rampon et al., 
2000), there is also an increase in both synaptophysin and PSD95 in the 
hippocampus (Nithianantharajah et al., 2004). It could be possible that PCR analysis 
is not sensitive to detect significant change in the mRNA expression of 
synaptophysin or PSD95 and so more work is needed to determine the role of 
lentiviral mediated enhancement of IL-1β expression on regulating hippocampal 
synaptic plasticity. As IL-1β at low concentrations has been suggested to promote 
LTP (a functional read-out of synaptic plasticity) (Di Filippo et al., 2008), it would 
be of value to determine the exact concentration of IL-1β is being produced in our 
lentiviral approach and whether other measures of synaptic plasticity such as LTP 
are affected. 
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In conclusion, we demonstrated that three weeks of cafeteria diet consumption 
during adolescence does not induce impairments in hippocampal-cognitive 
performance in adulthood and this is not affected by increased hippocampal IL-1β 
expression in adulthood. IL-1β in adulthood impairs spatial working memory and 
enhances fear memory coupled thus highlighting the complex role of IL-1β in 
regulating hippocampal-associated cognitive processes. Further studies should aim to 
address how adolescent cafeteria diet consumption may impair IL-1β-mediated 
regulation of hippocampal cognitive processes by determining the dietary-induced 
changes in expression of metabolic or inflammatory factors that can impact upon IL-
1β signalling. Taken together, although poor diet consumption during adolescence 
may not induce lasting negative effects on cognition, it may negatively impact upon 
potential facilitators of learning and memory during adulthood.  
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Product Brand Energy 
(kJ/100g) 
Fat (g/100g) Sugar 
(g/100g) 
Frosted 
Shreddies 
Nestle 1556 1.5 27.0 
Marshmallow 
Mateys 
MaltOMeal 1611 3.5 41.0 
Ripple Swiss Roll Gateaux 1538 11.1 42.5 
Jaffa Cakes Sondey 1605 11.3 47.0 
Custard Cream 
Biscuits 
Tesco 2066 20.9 28.5 
KitKat (Regular) Nestle 2141 24.8 52.7 
Digestive Biscuits Tesco 2057 22.4 18.5 
Toffee Cake Tesco 1773 18.6 39.0 
Peanut Butter 
Oreos 
Mondelez 2014 21.0 34.0 
Magic Stars Milkyway 2330 34.7 53.6 
Mini Rolls Cadbury 1810 23.0 42.4 
Battenberg Cake Gateaux 1779 12.0 56.9 
Plain M&Ms Mars 2017 19.3 67.7 
Jelly Babies Sugarland 1445 0.1 69.3 
Jelly Beans Tesco 1548 0.7 60.2 
Jelly Snakes Natural Foods 1380 0.2 65.5 
Cocoa Pops SuperValu 1654 2.8 33 
Buttersalt 
Popcorn 
Perri 2252 36.4 0.1 
Mild White 
Cheddar Cheese 
Tesco 1725 34.9 0.1 
Frankfurters Dulano 1295 28.0 1.0 
Everyday Value 
Ham 
Tesco 1116 4.1 2.6 
Sausage Rolls  1420 19.5 2.1 
California 
Walnuts 
Alesto 2938 69.1 3.0 
BBQ Rib Flavour 
Doritos 
Doritos 2060 25.6 3.4 
Cheezit Sunshine 2090 26.7 0.0 
Jumbo Dry 
Roasted Peanuts 
Tesco 2448 46.5 4.8 
Chopped Pork 
and Ham 
Dulano 1103 22.0 1.3 
Ready Salted 
Crisps 
Tesco 2270 33.2 0.4 
Hula Hoops 
Cheese + Onion 
KP Snacks 2137 27.0 2.0 
Chow Envigo 1300 6.2  
Table 5.1: Food list with nutritional information used for cafeteria diet and chow 
given to rats. 
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Figure 5.1: A) Experimental timeline. B) Body weight in of rats across the duration 
of the dietary intervention. C) Energy in kilojoules (kJ) of consumed foodstuffs 
across the duration of the dietary intervention. D) Energy in kilojoules (kJ) of 
consumed foodstuffs across the duration of the study. E) Regular chow intake by all 
animals averaged across each cage after surgery. F) Proportion of each cafeteria diet 
component consumed across the duration of the dietary intervention and as a 
percentage of total food eaten. PND, post-natal day. All data are expressed as mean 
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± SEM, n=8-10 for all groups, ***P<0.001 compared to controls, Two-way 
ANOVA and Bonferoni post hoc.  
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Figure 5.2: Administration of lentivirus induces significant increase in IL-1β 
expression and cafeteria diet consumption results in persistent elevated metabolic 
hormone concentration. A) Confirmation of IL-1β protein overexpression in the 
hippocampus (n=6-8). B) Representative immunoblot of mouse IL-1β protein 
expression from hippocampal tissue. C) Serum leptin concentration before (baseline) 
and immediately after (T2) diet and at cull (Cull) (n=5-7). D) Serum insulin 
concentration before (baseline) and immediately after (T2) diet and at cull (Cull) 
(n=5-7). E) Percentage time spent in the centre of the open field arena (n=8-10). F) 
Distance travelled in the open field (n=8-10). All data are expressed as mean ± SEM. 
Fig 2A, ***P<0.001 compared to controls; Fig 2C, D, *P<0.05 compared to 
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respective baseline, #P<0.05 compared to adolescent diet at cull, Two-way ANOVA 
and Bonferoni post hoc. 
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Figure 5.3: Cafeteria diet has no effect on hippocampal cognitive processes in 
adulthood whereas IL-1β impairs spatial working memory and enhances contextual 
fear conditioning. A) Percentage alternation in the Y-maze (*p<0.05 between ctrl 
and ctrl + IL-1β, Two-way ANOVA and Bonferoni post hoc). B) Number of arm 
entries in the Y-maze. C) Schematic of spontaneous alternation task. D) Novel object 
recognition depicted as discrimination ratio (DR) between novel (N) and familiar (F) 
objects. E) Schematic of novel object recognition task. F) Acquisition phase of fear 
conditioning paradigm. G) Freezing behaviour during contextual recall  (*P<0.05 
compared to control, and #P<0.05 compared to Diet/IL-1β, Two-way ANOVA and 
Bonferoni post hoc). H) Freezing behaviour during contextual recall. All data are 
expressed as mean ± SEM, n=8-10. 
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Figure 5.4: The effects of cafeteria diet and/or IL-1β overexpression and 
hippocampal gene expression. A) Relative expression of hippocampal 
synaptophysin. B) IL-1β induces a significant increase in PSD95 expression. C) 
Relative expression of hippocampal CXCL1 (#P<0.05 vs Caf. Diet + IL-1β). All 
data are expressed as mean ± SEM, n=6-8. 
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Chapter 6: General discussion 
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Over the past two decades there has been increasing evidence supporting the notion 
that hippocampal neurogenesis is involved in certain types of hippocampal cognitive 
function, particularly learning and memory and pattern separation (van Praag et al., 
2002, Kempermann et al., 2004b, Zhao et al., 2008, Clelland et al., 2009). Indeed it 
has been suggesting that hippocampal neurogenesis may also interfere with the 
stability of existing memories and thus may have a function in the process of 
forgetting (Frankland et al., 2013, Akers et al., 2014, Epp et al., 2016). As our 
understanding of the functional roles of hippocampal neurogenesis in both health and 
disease continues to be refined (Groves et al., 2013, Glover et al., 2017, Levone et 
al., 2015, O'Leary and Cryan, 2014), a greater comprehension of the regulators of 
neurogenesis is required. Some of the most common positive regulators of 
neurogenesis include exercise (van Praag et al., 1999b), environmental enrichment 
(Kempermann et al., 1997b), learning (Gould et al., 1999), and healthy diet (Valente 
et al., 2009). Conversely, common negative regulators of neurogenesis include stress 
(Malberg and Duman, 2003), poor diet (Lindqvist et al., 2006), and 
neuroinflammation (Monje et al., 2003). It has been suggested that decreases in 
hippocampal neurogenesis could be responsible for some of the cognitive deficits 
observed in many neurodegenerative and psychiatric disorders (Balu and Lucki, 
2009, Horgusluoglu et al., 2017, Winner et al., 2011, Lie et al., 2004, Lazarov et al., 
2010) and a common factor in many of these disorders is the presence of 
hippocampal inflammation (Ransohoff, 2016, Heppner et al., 2015, Rao et al., 2010, 
Khansari and Sperlagh, 2012). However, whether intrinsic regulators of neurogenesis 
could be targeted therapeutically to mitigate cognitive deficits remains to be 
elucidated.  
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Neuroinflammation is a well established suppressor of hippocampal neurogenesis 
and a key component of neuroinflammation is the pro-inflammatory cytokine IL-1β 
(O'Leime et al., 2017a, Goshen et al., 2007, Yirmiya and Goshen, 2011). It is 
generally understood that IL-1β is detrimental to hippocampal neurogenesis however 
some studies have demonstrated that IL-1β can indeed enhance certain forms of 
hippocampal neurogenesis-associated cognition namely contextual fear conditioning 
(Yirmiya et al., 2002, Goshen et al., 2007). Whether IL-1β has positive or negative 
effects on hippocampal neurogenesis-associated cognition largely depends on the 
concentration present in the hippocampus. However, whether the negative effects of 
IL-1β could be exacerbated by pre-exposure to a negative regulator of neurogenesis 
such as poor diet merited further research. 
 
TLX is a nuclear receptor expressed in NPCs within the hippocampus (Niu et al., 
2011, Li et al., 2012, Shi et al., 2004, Islam and Zhang, 2014). As a regulator of gene 
expression, TLX acts to maintain NPCs in a proliferative state thus maintaining the 
NPC pool within the neurogenic niche of the hippocampus (Niu et al., 2011, Shi et 
al., 2004). It has previously been shown that enhancing TLX expression can promote 
certain hippocampal-associated cognitive processes in mice including spatial 
memory in the MWM (Zhang et al., 2008, Murai et al., 2014). TLX expression has 
been suggested to be negatively impacted by neuroinflammation. Specifically, the 
pro-inflammatory cytokine IL-1β has been shown to reduce proliferation and TLX 
expression in proliferating hippocampal NPCs (Ryan et al., 2013, Green and Nolan, 
2012b). However, whether modulation of TLX expression could prevent IL-1β-
induced effects on neurogenesis was not previously determined. Likewise, the effects 
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of modulating TLX expression on hippocampal-associated behaviours in animal 
models other than mice were not assessed prior to this thesis. 
 
The present series of studies are divided into three main themes. Firstly, chapters 2 
and 3 assessed the interactions between TLX and IL-β both in hippocampal NPCs in 
vitro and in the hippocampus using in vivo approaches. Specifically, these chapters 
aimed to determine the functional role of TLX in mitigating IL-1β-induced effects 
on neurosphere expansion and the transcriptional role of TLX in regulating IL-1β 
target genes, respectively. Secondly, chapter 4 aimed to determine the effects of over 
expressing TLX within the hippocampus of adult rats on hippocampal-associated 
cognitive tasks. Finally, chapter 5 deals with the impact of a diet high in fat and 
sugar during adolescence on IL-1β-induced changes in hippocampal-associated 
cognition. 
 
Chapter 2 of this thesis described the inhibitory role of IL-1β on TLX expression in 
proliferating hippocampal NPCs and the role that NF-κB signalling had in mediating 
this effect. Additionally, this chapter outlines the potential protective capacity of 
TLX in mitigating the negative effects of IL-1β on neurosphere expansion. We 
ensured that our data was in line with previously published data (Green and Nolan, 
2012b) by confirming that treatment of hippocampal neurosphere cultures with IL-1 
β for 6 days produced a significant reduction in neurosphere expansion as well as 
TLX expression. We also demonstrated an increase in the expression of the TLX 
target gene p21 after IL-1β treatment for up to 6 days. p21 expression was 
suppressed by TLX and when its expression was increased it induced cell cycle 
arrest and reduced proliferation (Waga et al., 1994, Pechnick et al., 2011, Sun et al., 
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2007). From this result, our data suggested that the increase in p21 expression may 
be involved in the impairment in neurosphere expansion, as expansion has been 
closely correlated with NPC proliferation (Widera et al., 2006, Murai et al., 2014).  
 
In several cell types including rat hippocampal NPCs, mouse embryo fibroblasts, and 
human epithelial cells (Seitz et al., 2000, Chen et al., 2006, Koo and Duman, 2008), 
activation of the NF-κB pathway has been shown to suppress cell proliferation. As 
IL-1β has been shown to recruit this pathway in the hippocampus of rodents (Koo 
and Duman, 2008, Koo et al., 2010), we chose to determine whether it is activated in 
response to IL-1β specifically within hippocampal NPCs. We observed rapid 
translocation of the p65 subunit to the nucleus (an indicator of NF-κB activation (Xie 
et al., 2016, Zhu et al., 2015)) after IL-1β administration, which was coupled with 
activation of the NF-κB target gene, IκBα. JSH-23 is a well characterised inhibitor of 
NF-κB signalling (Koo and Duman, 2008, Arias-Salvatierra et al., 2011, de Vries et 
al., 2014, Kesanakurti et al., 2013), and in our study, co-treatment of NPCs with this 
compound and IL-β prevented the IL-1β-induced decrease in TLX expression and 
also reduced the increase in IκBα mRNA expression. Thus, the NF-κB pathway 
appeared to be a potential mediator of IL-1β-induced changes, not only on NPC 
proliferation as previously shown (Koo et al., 2010, Koo and Duman, 2008) but also 
on TLX expression. We did not observe any significant effect of JSH-23 on the TLX 
target gene, p21. JSH-23 has been established as a selective NF-κB inhibitor (Shin et 
al., 2004, Kumar et al., 2011, Arias-Salvatierra et al., 2011) however, as this 
compound had not previously been used specifically in hippocampal NPCs, we 
cannot rule out the fact that JSH-23 may have non-specific effects in these cells that 
could affect the expression of p21. That being said, as this compound attenuated 
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IκBα expression, our data are a proof of concept that NF-κB signalling is at least 
partially responsible for the effects of IL-1β on TLX expression. 
 
Loss of TLX expression has been shown to result in both impaired NPC proliferation 
and neurogenesis (Islam and Zhang, 2014, Niu et al., 2011, Li et al., 2012, Shi et al., 
2004). Conversely, it has been shown that over expressing or restoring TLX 
expression can rescue these proliferative defects (Murai et al., 2014, Zhang et al., 
2008). From these studies we hypothesised that overexpression of TLX could rescue 
the effects of IL-1β on neurosphere expansion. We generated a lentivirus to over 
express TLX and used GFP as a control vector. In the GFP transfected neurospheres, 
expansion was impaired after IL-1β administration whereas TLX overexpression 
prevented this effect. Thus, these data suggest that an enhanced TLX function may 
have a protective effect against IL-1β on hippocampal NPC proliferation. However, 
these beneficial effects may only be evident when there is a potential insult such as 
neuroinflammation present as TLX was only maintained at a higher level in the cells 
co-treated with IL-1β and TLX overexpression compared to control NPCs treated 
with IL-1β. 
 
Our data suggest that IL-1β acts at least in part via NF-κB to suppress TLX 
expression. However, it may be that TLX does not suppress NF-κB signalling to 
prevent the effects of IL-1β on neurosphere expansion. This suggestion comes from 
the fact that we did not observe any differences between GFP and TLX transfected 
NPCs with regards to IL-1β-induced increase in IκBα. If TLX were to suppress NF-
κB signalling we would expect to see a differential response in NF-κB target genes 
in TLX OEX NPCs versus GFP OEX NPCs after IL-1β treatment. Thus, more 
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research is required to determine the exact signalling interaction between IL-1β and 
TLX. Additionally, it has been demonstrated that IL-1β can recruit signalling 
pathways other than NF-κB to exert its effects on neurogenesis (Wang et al., 2007, 
Zunszain et al., 2012a, O'Leime et al., 2017a). To follow on from our study, it may 
be beneficial to determine how TLX may associate with some of these IL-1β 
associated pathways to get a clearer picture as to how TLX and IL-1β interact.  
 
RNASeq is a powerful tool to assess global transcriptome changes. In chapter 3 we 
took a sequencing approach to assess the regulatory role of TLX in IL-1β-induced 
changes within the hippocampus of mice. Specifically, we assessed these 
transcriptome changes in a mouse model in which there is a spontaneous deletion of 
the TLX gene (Young et al., 2002, Roy et al., 2002, O'Leary et al., 2016b). These 
mice lack TLX throughout development and as a result have impaired neurogenesis 
and associated cognition (Shi et al., 2004, O’Leary et al., 2016). In this chapter, we 
assessed the hippocampal transcriptome changes induced in these mice compared to 
WT control mice with normal expression of TLX. Our main finding from this study 
was the fact the TLX acts to maintain a normal inflammatory profile within the 
hippocampus as the absence of TLX leads to increased transcription of inflammatory 
related genes. We also highlighted the TNF pathway as a potential pathway through 
which TLX may act to assert its effects on hippocampal inflammatory gene 
transcription. Finally, we outline the vastly different transcription responses TLX 
KO mice have compared to WT controls in response to IL-1β. 
 
Of the 1269 genes increased in TLX KO mice compared to WT mice, there was a 
strong enrichment in genes relating to inflammation. These genes included 
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transcripts for cytokines, cytokine receptors and markers of microglial activation. A 
recently published paper by our lab described that absence of TLX in a similar strain 
of mice induces a significant increase in hippocampal microglial activation and an 
increase in the level of pro-inflammatory cytokine IL-1β in the hippocampus 
(Kozareva et al., 2017a). The RNASeq data described in this thesis supports these 
cellular effects by confirming a robust transcriptional shift towards an inflammatory 
response within the hippocampus of TLX KO mice. Additionally, we identified a 
larger number of downregulated genes in TLX KO mice compared to WT mice, and 
the majority of these genes were involved in the regulation of synaptic signalling. 
Our data is again supported by previously published work where it was demonstrated 
in the same strain of TLX KO mice that there is a significant impairment in LTP 
formation within the DG (Christie et al., 2006). 
 
As RNASeq projects generate vast amounts of data, we wished to utilise online 
network analysis platforms to gain an insight as to how TLX could be regulating 
inflammatory gene transcription. Using DAVID, we conducted KEGG pathway 
analysis on the upregulated genes identified in TLX KO mice to assess what cellular 
signalling pathways they are associated with. This analysis revealed that TNF 
signalling was strongly associated with the genes we identified as upregulated in 
TLX KO mice. Thus, from our data we hypothesise that TLX can regulate TNF 
signalling in some manner to repress the induction of an inflammatory profile. To 
further explore this hypothesis, we conducted STRING analysis which produces a 
network map of protein-protein interactions based on the differentially expressed 
genes identified from or sequencing data. STRING analysis highlights potential 
protein-protein interactions based on evidence from the literature and from online 
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protein databases. From this analysis, we identified some evidence that TLX may 
indirectly regulate TNF signalling via its protein interaction with Top2a and Bcl6b. 
However, STRING analysis highlighted that the evidence for an interaction between 
TLX and Top2a and Bcl6b is not strong as only structure homologs of these proteins 
have been shown to interact (Ku et al., 2009, Diner et al., 2015). As there is little 
research available into the role of TLX and the regulation of inflammation, STRING 
analysis software has little evidence to suggest potential interactions between TLX 
and inflammatory pathways. In this regard, more research is required to determine 
protein-protein interactions between TLX and inflammatory-related proteins. 
However, our data suggest that TNF signalling may be a potential candidate through 
which TLX represses inflammation. 
 
A surprising finding from this study was the vastly different response to IL-1β 
between TLX KO mice and WT mice. TLX KO
 
mice have a more blunted response 
with only 38 differentially expressed genes compared to 228 genes differentially 
regulated genes in the WT mice after IL-1β injection. We hypothesise that due to the 
fact the TLX KO mice have elevated transcription of inflammatory genes at baseline, 
these mice have reached an elevated inflammatory plateau and are unresponsive to 
further cytokine stimulus. Another consideration that must be made when discussing 
data generated from the strain of mice used in this study, is the fact that these mice 
are devoid of TLX throughout embryonic development and adulthood (Young et al., 
2002). Thus, the alterations observed in inflammatory response to a cytokine 
stimulus are potentially due to the absence of TLX during critical stages in immune 
system and organ developmen (Monaghan et al., 1997, Roy et al., 2002). Therefore, 
future studies should aim to assess the regulatory role of TLX in models where TLX 
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is only absent in adulhood (Zhang et al., 2008). In conclusion, the data from this 
chapter positions TLX as a potential regulator of the inflammatory response with 
deficits in TLX expression leading to an elevated inflammatory response similar to 
that which occurs after a cytokine stimulus. 
 
Previous work assessing the role of TLX in cognitive function utilised mouse models 
in which there was either a decrease or increase in TLX expression (Zhang et al., 
2008, O'Leary et al., 2016b, Murai et al., 2014). The consensus from these studies is 
that TLX promotes neurogenesis-associated spatial learning and memory in the 
MWM (Murai et al., 2014, Zhang et al., 2008), while in a mouse strain where there is 
a spontaneous deletion in the TLX gene, impairments in contextual fear conditioning 
and spatial working memory were evident (O'Leary et al., 2016b). In chapter 4, we 
aimed to assess the role of enhanced TLX expression in promoting hippocampal-
associated cognitive processes in rats. Firstly, we demonstrated that enhanced cell 
proliferation via OEX of TLX in the dorsal hippocampus does not induce anxiety-
like behaviours. This is in line with some studies that also show that modulation of 
neurogenesis does not result in anxiety-like behaviours (Shors et al., 2002, Santarelli 
et al., 2003, Saxe et al., 2006, Leasure and Jones, 2008, Holick et al., 2008, Bessa et 
al., 2009). As TLX OEX was targeted at the dorsal hippocampus and it has been 
suggested that the ventral hippocampus is responsible for the regulation of emotion 
(Felice et al., 2012, O'Leary et al., 2012, Levone et al., 2015, O'Leary and Cryan, 
2014), this then could explain why we did not observe any anxiety-like behaviours.  
 
Secondly, we demonstrated that increased proliferation induced by TLX OEX 
impaired object recognition while it had no effect on location recognition or 
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spontaneous alternation in the Y-maze. Object recognition has previously been 
shown to rely on both the hippocampus and the perirhinal cortex with the ‘flow’ of 
information from one structure to the other being a critical factor in successful object 
recognition (Aggleton and Brown, 2005, Cohen and Stackman, 2015). Short term 
object exploration is thought to result in the perirhinal cortex being responsible for 
information processing during the object recognition task. It has been suggested that 
after approximately 30 seconds of object exploration, information processing begins 
to flow to the hippocampus with this region of the brain becoming increasingly 
involved in successful completion of the task (Cohen and Stackman, 2015). This 30 
second exploration time is similar to the exploration time observed in our study and 
so it may be possible the flow of information from the perirhinal cortex to the 
hippocampus may be disrupted by the highly proliferative state of the hippocampus 
leading to impaired object recognition performance.  
 
The involvement of neurogenesis in hippocampal-associated cognition is complex. 
However, it has been suggested that for neurogenesis to be implicated, the 
behavioural task being assessed needs to be sufficiently difficult (Curlik and Shors, 
2011). From our work, it could be suggested that novel location recognition and 
spontaneous alternation do not sufficiently recruit hippocampal neurogenesis or are 
reliant upon it. Therefore, our TLX-induced enhancement in proliferation does not 
produce a behavioural phenotype that is detectable in the tasks we assessed. As the 
tasks we utilised for this current study rely on the natural preference for rats to 
explore novelty, there is very little learning involved in these tasks. As learning is a 
robust inducer of all aspects of neurogenesis, it may be more beneficial to assess the 
impact of TLX OEX in rats on other behavioural paradigms in which there is a 
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stronger role for learning or training such as spatial navigation tasks or contextual 
fear conditioning (Gould et al., 1999, Deng et al., 2010). Additionally, it should be 
noted that in our study, we only observed increased proliferation with no significant 
effect on neuronal differentiation or cell survival. As successful neurogenesis 
requires all stages of neurogenesis (proliferation, neuronal differentiation, and 
survival/integration) to be completed, the lack of improvement in location 
recognition or spatial working memory from our study may be due to the fact that 
there was no overall increase in neurogenesis. 
 
Future in vivo TLX OEX studies must be carried out with extreme caution as 
overexpression of TLX can lead to hyperproliferation of NPCs and increased glioma 
formation (Liu et al., 2010, Park et al., 2010). However, efforts have been made to 
identify ligands for this orphan nuclear receptor in order to target and manipulate 
TLX function (Benod et al., 2014b). With the advent of selective TLX ligands, it 
may be possible to have more controlled regulation of TLX function and avoid the 
potential side-effects of enhanced TLX expression. Therefore, ligand based 
regulation of TLX function will vastly improve our understanding of its function in 
vivo. 
 
IL-1β has been shown to have conflicting effects on hippocampal-associated 
cognition (Avital et al., 2003, Goshen et al., 2007, Ben Menachem-Zidon et al., 
2008) and so in chapter 7 we aimed to determine whether the negative effects of IL-
1β could be exacerbated by pre-exposure to another proposed negative regulator of 
hippocampal neurogenesis, namely poor diet intake. The adolescent period has 
previously been shown to be a particularly vulnerable period to the negative effects 
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of poor diet on cognition (Hueston et al., 2017, Boitard et al., 2014, Boitard et al., 
2012, Vendruscolo et al., 2010). Indeed, it has been demonstrated that rats fed a high 
fat diet during adolescence show impairments in hippocampal-associated relational 
memory and neurogenesis whereas when the same diet is given in adulthood there 
was no significant impairments in these tasks (Boitard et al., 2012). Thus, we chose 
to expose rats to a diet high in both fat and sugar during adolescence and assess their 
performance in hippocampal-associated cognitive processes in adulthood. The diet 
mimics a cafeteria diet which is consumed in high levels in the western world and is 
associated with increased obesity as well as cardiovascular and metabolic disorders 
(Bruce-Keller et al., 2009, Haslam and James, 2005). Similar diets in rodent studies 
have been shown to induce hippocampal inflammation as well as impairments in 
hippocampal neurogenesis and associated cognitive processes (Hansen et al., 1998, 
Martire et al., 2014, Beilharz et al., 2014). However, from our data we did not 
observe any impairment in behaviours at adulthood induced by the adolescent 
cafeteria diet. The likely cause of this is the fact that the rats were switched to a 
regular chow diet three weeks prior to behavioural testing, thus any effects induced 
by the diet would have been normalised in that time. This theory is supported as it 
has been shown that switching from a high fat diet to a regular chow diet and 
allowing a 3 month washout period resulted in no changes in hippocampal-
associated spatial navigation in the MWM (Boitard et al., 2016). However, we 
observed a lasting effect of increased levels of the metabolic hormones leptin and 
insulin in serum indicating that there may be lasting effects on metabolism in 
adolescent cafeteria diet fed rats. 
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High fat diets have been shown to induce hippocampal inflammation in the form of 
increasing expression of pro-inflammatory cytokines IL-1β and TNFα (Hansen et al., 
1998, Beilharz et al., 2014, Pistell et al., 2010, Boitard et al., 2014). Thus, our main 
aim for this chapter was to determine whether pre-exposure to a cafeteria diet during 
adolescence could exacerbate any potential effects of IL-1β on cognition in 
adulthood. However, we did not observe any significant differences in hippocampal-
associated behaviours induced by IL-1β in cafeteria diet fed rats compared to non-
IL-1β injected cafeteria diet fed rats. Interestingly, IL-1β OEX alone impaired spatial 
working memory in the Y-maze and enhanced contextual fear conditioning both of 
which are hippocampal-associated. However, it has been shown that IL-1β at low 
expression levels is required for successful completion of certain hippocampal-
associated tasks such as spatial navigation in the MWM and contextual fear 
conditioning (Avital et al., 2003, Goshen et al., 2007). From our data, it may be that 
spontaneous alternation is more sensitive to elevated levels of IL-1β in the 
hippocampus. However, contextual fear conditioning is enhanced by similar 
expression levels of IL-1β. Therefore, our data supports the complex role of IL-1β in 
regulating hippocampal-associated cognition.  
 
Interestingly, the only effect that the adolescent cafeteria diet appeared to have was 
to attenuate the effects of IL-1β on hippocampal-associated cognition. As we 
observed similar levels of IL-1β in the hippocampus of both cafeteria diet and 
standard chow fed rats, viral uptake is not affected by the cafeteria diet. What is a 
more likely explanation is that alterations in factors induced by the cafeteria diet 
such as in metabolic hormone levels and/or inflammatory levels may be impairing 
the ability of IL-1β to modulate cognition. In support of this theory, IL-1RA has 
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been shown to be significantly increased in the serum of obese patients (Meier et al., 
2002). Additionally, mice fed a high fat diet (albeit for 35 weeks) have been shown 
to have elevated serum levels of IL-1RA (Somm et al., 2006). As IL-1RA is known 
to cross the BBB (Gutierrez et al., 1994) it could impair IL-1β signalling in the 
hippocampus thus negating the IL-1β-induced cognitive changes we observed. 
 
Despite the insights gained into the role of TLX and IL-1β in hippocampal 
neurogenesis and associated cognition, the limitations encountered throughout the 
course of this work are worth discussing. Firstly, although lentiviral technology is a 
valuable to enhance the expression of specific proteins, the lack of precise control as 
to exactly how much protein is expressed is a limitation. For example, although we 
could alter the concentration of the viruses we used in terms of transfection units 
(TU) which in theory should alter the amount of overexpressed protein is produced, 
variables such as subsequent inflammatory response to the virus, or stress levels of 
the animals after surgery can impact optimal viral uptake which would affect any 
results obtained using this technology (Escors and Breckpot, 2010, Naldini, 1998). 
The field of viral vector mediate gene transfer has advanced greatly and significant 
progress has been made to reduce inflammatory responses to viruses by minimising 
viral gene expression in these vectors (Escors and Breckpot, 2010). However, the 
lack of control of the expression or activation state of the overexpressed protein is 
still a factor that needs to be considered when designing studies using lentiviruses. 
Another limitation with the work described herein relates to our use of mice with a 
spontaneous deletion of TLX. These mice are devoid of TLX throughout 
development (Young et al., 2002) and so although our data strongly suggest a role 
for TLX in regulating the inflammatory transcriptional profile within the 
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hippocampus in adulthood, it may be that this effect is due to the fact that TLX is 
absent during critical stages of immune system development in early life. To address 
this limitation, future studies should aim to utilise rodents with a conditional knock-
out of TLX in adulthood. 
 
In conclusion, data in the present thesis adds to the current knowledge of how TLX 
and IL-1β interact and how these two factors independently or in combination can 
regulate hippocampal-associated cognition. We utilised hippocampal neurosphere 
cultures to identify the NF-κB pathway as a potential mediator of the effects of IL-1β 
on TLX expression, and also showed that restoration of TLX expression can prevent 
the suppressive effects of IL-1β on neurosphere expansion. Using RNASeq 
technology, we highlighted the potential a role for TLX in regulating and 
inflammatory transcriptional profile within the hippocampus both at baseline and in 
response to IL-1β stimulus. These data positions TLX as a potential transcriptional 
regulator of neuroinflammation within the hippocampus. We report that lentiviral 
mediated OEX of TLX did not promote hippocampal-associated cognition but rather 
impaired hippocampal-associated object recognition. We demonstrated that 
adolescent cafeteria diet consumption does not produce lasting effects on 
hippocampal-associated tasks. Finally, lentiviral-mediated overexpression of IL-1β 
represents a promising method to highlight the various effects of IL-1β on 
hippocampal-associated cognition. Specifically we outlined that this approach 
induced impairments in spontaneous alternation in the Y-maze and promoted 
contextual fear recall in adult rats. Interestingly, we demonstrated that these effects 
were attenuated by adolescent consumption of a cafeteria diet indicating that pre-
exposure to a poor diet can impact upon the ability of IL-1β to modulate 
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hippocampal-associated cognition. From the in vitro and RNASeq evidence 
described herein, it appears that TLX represents a promising pharmaceutical target to 
mitigate the anti-neurogenic effects of IL-1β and regulate neuroinflammation within 
the hippocampus. However, more work is needed to ascertain the functional role of 
TLX in hippocampal-associated cognitive processes. Specifically, it should be 
addressed whether increased proliferation in the hippocampus can negatively impact 
upon neuronal signals entering the hippocampus from brain structures such as the 
perihinal cortex. Additionally, behavioural paradigms involving a strong learning 
component such as spatial navigation in the MWM or fear conditioning should be 
utilised to determine whether increase cell proliferation in the hippocampus of rats 
can enhance performance in these tasks. With the advent of pharmaceutical ligands 
which regulate TLX function, greater strides can be made to determine the protective 
role and therapeutic potential of TLX in IL-1β and neuroinflammatory-induced 
changes in hippocampal-associated cognition. 
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Chapter 7: Future Studies 
 
 
 
 Chapter 7 
227 
 
In vitro studies 
1. a) Assess the interaction between TLX and various components of the NF-κB 
pathway in proliferating hippocampal NPCs after IL-1β stimulation.  
b) Determine which components of the NF-κB pathways are responsible for 
the effects of IL-1β on TLX expression by using different selective inhibitors 
of specific components of the NF-κB pathway. 
 
2. Determine whether members of the mitogen activated protein kinase 
(MAPK) pathways are involved in IL-1β-induced suppression of TLX 
expression and/or neurosphere expansion. 
 
3. Further characterise the effects of TLX overexpression on neuronal 
differentiation and survival of hippocampal NPCs. 
 
4. Assess whether viral-mediated knockdown of TLX expression impairs 
neurosphere growth.  
 
5. Determine the role of p21 in IL-1β-induced suppression of neurosphere 
expansion.  
 
6. Assess whether a similar lentiviral transfection methodology can be 
employed to overexpress TLX in adult hippocampal neurosphere cultures. 
 
7. Assess the interaction of TLX with TNF signalling in hippocampal NPCs in 
vitro.  
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In vivo studies 
1. Determine whether IL-1β (either lentiviral-mediated overexpression or 
injection of recombinant protein) can induce alterations in behaviour of TLX 
KO mice. 
 
2. Utilise selective TLX ligands to modulate the activation state of TLX and 
assess its role on hippocampal-associated cognitive function. 
 
3. a) Maintain a longer period of cafeteria diet consumption to assess whether 
cafeteria diet can induce impairments in fear conditioning 
b) Determine whether chronic lentiviral-mediated IL-1β overexpression 
impairs or protects performance. 
 
4. Determine what factors are released within the hippocampus as a results of a 
cafeteria diet during adolescence that may impact upon the IL-1β-induced 
changes in cognition. 
 
5. Assess whether TLX modulation by selective ligands can modulate the 
effects of a diet high in fat and sugar on hippocampal associated cognition. 
 
6. Investigate whether TLX activation by a selective ligand can alter IL-1β-
induced-induced changes in behaviour. 
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1.1: Chapter 2 methods 
Aseptic technique 
All tissue culture procedures were carried out in a Class II Biological Safety Cabinet 
(Astec, AGB, Ireland). Gloves and specific tissue culture lab coats were worn at all 
times. All surfaces were sprayed with 70% ethanol prior to commencing work and 
all equipment and reagent bottles were sprayed with 70% ethanol before being put 
under the hood. All glassware, water, microcentrifuge tubes and pipette tips were 
autoclaved prior to use. 
 
Epidermal growth factor 
EGF (25μg) (Sigma, Ireland) was reconstituted using 0.2μm filtered sterile 10mM 
acetic acid (Sigma, Ireland) containing 0.01% Bovine serum albumin (BSA) (Sigma, 
Ireland) to give a stock of 20μg/ml. 50μl aliquots were stored at -20°C. 
 
1, 4-Dithiothreitol (DTT) (100mM) 
DTT (0.31g) (Sigma, Ireland) was dissolved in 20ml of sterile PBS (10mM). The 
solution was sterile filtered and stored at 4°C 
 
 Heparin (50mg/ml) 
Heparin (50mg) (Sigma, Ireland) was dissolved in 1ml of sterile PBS (10mM). The 
solution was sterile filtered and stored at 4°C  
 
FGF 
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bFGF (25μg) (Millipore) was reconstituted using 0.2μm filtered sterile PBS (10mM) 
containing 0.1% BSA, 1mM DTT, and heparin (5μg/ml), to give a stock solution of 
20μg/ml. 50μl aliquots were stored at -20°C. 
 
Complete tissue culture proliferation media for E18 rat hippocampal NPCs 
A solution of Dulbeccos Modified Eagles Medium/F12 (Sigma Ireland) containing 
200mM L-Glutamine (Sigma Ireland), 1% Penicillin/Streptomycin (Sigma Ireland), 
and 33mM D-Glucose (Sigma Ireland) was prepared and stored at 4°C. Complete 
tissue culture media was supplemented with 2% B27 without vitamin A (Invitrogen, 
UK) and 10ng/ml of both EGF (Sigma Ireland) and bFGF (Millipore) according to 
(Ray et al., 1993). This media was made up on the day of culture and kept at 37°C in 
an incubator (Binder, Germany). 
 
IL-1β preparation 
A stock solution of 10μg/ml of IL-1β (R&D systems) was made up by dissolving 
50μg of IL-1β in 4.995ml sterile PBS (10mM) and 5μl of BSA (7.5%) (Sigma, 
Ireland). This solution was stored in 100μl aliquots at -80°C. This concentration was 
found to be lowest concentration of IL-1β to significantly alter NPC proliferation 
without affecting viability or cellular phenotype (Green et al. 2012). 
 
JSH-23 preparation 
A stock solution of 25mM of JSH-23 (Sigma, Ireland) was made up by dissolving 
3.004mg of JSH-23 in 0.5ml dimethyl sulphoxide (DMSO) (Sigma, Ireland). This 
solution was store in 10μl aliquots at -20°C.  
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Poly-D-Lysine and coating of 13mm coverslips 
0.1mg/ml poly-D-lysine (Sigma, Ireland) was prepared by dissolving 5mg of poly-
D-lysine in 50ml of sterilised distilled water (dH2O) and stored at -20°C in aliquots 
of 3.5ml (1 aliqout = 1x24 well plate). 13mm glass coverslips were placed in a glass 
petri dish and sterilised under UV radiation for 45mins. The sterilised coverslips 
were placed one per well in a 24 well plate under the laminar flow hood. 130μl of 
0.1mg/ml poly-D-lysine was placed on each coverslips and the plate was left in the 
incubator at 37°C for 30mins. The 24 well plate with the coverslips was removed 
from the incubator and the coverslips were washed 3 times in dH2O and left to dry 
for 1hr in the laminar flow hood. Coated coverslips were stored at -20°C until use. 
 
Isolation of E18 rat hippocampal tissue 
Time mated Sprague Dawley rats were provided by the Biological Services Unit 
(University College Cork, Ireland). Female rats were anaesthetised in a bell jar using 
isofluorane (Abbeyville Veterinary, Ireland) and then sacrificed by decapitation. An 
incision was made along the abdominal midline through the abdominal wall 
exposing the embryos. The embryos were removed from the female, placed in a petri 
dish and sacrificed by hypothermia on ice. The individual embryos were removed 
from their amniotic and chorionic sacks and decapitated. Under a dissecting stereo 
zoom microscope (Leica, Milton Keynes, UK), whole brains were then removed 
using two Dumont forceps and placed in a 20ml tube Hank’s Balanced Salt Solution 
(HBSS) (Sigma, Irealnd) on ice. The hippocampi from each embryo were 
subsequently micro-dissected out and placed in a 20ml tube in HBSS on ice. All 
dissecting instruments were sterilised in 70% ethanol and rinsed in sterile HBSS. 
Hippocampi from one litter were pooled and represented an individual culture. 
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Preparation of E18 rat hippocampal neurosphere culture 
All work from here was carried out under sterile conditions. Hippocampal tissue was 
transferred to a 35mm petri dish containing ice cold HBSS under a sterile microflow 
cabinet (Astec, AGB, Ireland). The tissue was then minced using a sterile scalpel 
blade. The tissue was then transferred to a 15ml tube and centrifuged for 5mins at 
200rcf at room temperature (Beckman Coulter Allegra 21R). The supernatant was 
removed and pre-warmed 0.1% trypsin-EDTA (2ml trypsin-EDTA and 3ml HBSS) 
(Sigma, Ireland) was added for 5mins at 37°C. Soya bean trypsin inhibitor 
(0.5mg/ml, Sigma, Ireland) was added to inhibit the enzymatic reaction and the tube 
was inverted 3 times. Mechanical dissociation was carried out by triturating the 
tissue gently for approximately 1min using a flame polished Pasteur pipette 
(Sarstedt, Ireland) and followed once by a 23G needle and syringe (Sarstedt, 
Ireland). This suspension was centrifuged again at 200rcf for 5mins. The supernatant 
was removed and 1ml of pre-warmed proliferation media was added to the tube. The 
pellet was dissociated gently by brief trituration using a P1000 pipette. The solution 
was filtered by being passed through a 40μm cell strainer (BD Falcon, Ireland) into a 
new 15ml tube. 10μl of this cell suspension was placed in a 0.5ml microcentrifuge 
tube for cell counting. 10μl of trypan blue was added to the microcentrifuge tube and 
this mixture was added to a haemocytometer (Alkem, Ireland). The total number of 
live cells (cells which did not take up the trypan blue die) was counted under a 
microscope and a concentration of cells/ml was calculated using the following 
equation: 
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Cells/ml = (Number of cells counted in 4 fields) x (Dilution factor) x 10
4 
     4 
 
Cells were seeded at a concentration of 2 million cells per flask in T25 flasks 
(Sarstedt, Ireland). Cells were cultures as neurospheres at 37°C in a humidified 
incubator containing 5% CO2 and 95% air for up to 6 days. The growth factors EGF 
and FGF (both 20ng/ml) were added on the 2
nd
 day and half the media in the flasks 
was replaced with fresh proliferation media on the 3
rd
 and 5
th
 days of culture. 
 
IL-1β treatment timeline of E18 rat hippocampal neurospheres 
Cell treatments were carried out after 6 days in vitro (6DIV). Prior to treatments, 
neurospheres were dissociated into a single cell suspension. Neurospheres were 
collected into a 15ml tube and centrifuged at 1100rpm for 5mins. The supernatant 
was removed and the neurospheres were resuspended in 1ml of 0.1% trypsin-EDTA 
for 5min at 37°C in an incubator. Neurospheres were removed from the incubator 
and 400μl of soya bean trypsin inhibitor was added to the tube. Mechanical 
dissociation, cell filtering, and cell counts were carried out as described above. Cells 
were then plated down onto 13mm poly-D-lysine coated coverslips. To do so, 40-
60μl of cell suspension in proliferation media at a concentration of 
50,000cells/coverslip was added to each well and left in the incubator for 1hr to 
adhere. After 1hr every well was flooded with proliferation media to give a final 
volume of 500μl per well. IL-1β was added to each well at specific timepoints 
(10min, 30min, 1h, 2h, or 4h) with a final concentration of 10ng/ml in each well. All 
wells were assigned at random. After the 4hrs (the final timepoint), the cells were 
washed in warmed HBSS then fixed for further immunocytochemistry analysis. 
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NPCs for PCR analysis were seeding in 24 well plates without poly-D-lysine coated 
coverslips and suspended in complete proliferation media with or without IL-1β 
treatments. 
 
JSH-23 treatment of E18 rat hippocampal NPCs 
2μl of stock solution of JSH-23 (25mM) was added to 2ml of culture media 
containing proliferating dissociated NPCs to give a final concentration of 25μM. 
This concentration had previously used to determine the effects of NF-κB signalling 
on cell proliferation within the hippocampus (Koo et al., 2010). Cells were incubated 
with IL-1β with and without JSH-23 or vehicle (0.001% DMSO) for 3 hours in 24 
well plates before cell viability or TLX, p21 and IκBα mRNA expression was 
assessed. Cells were also attached to poly-D-lysine coated coverslips as described 
above to conduct immunocytochemical analysis of JSH-23 treated NPCs. 
 
Lentiviral treatment of E18 rat hippocampal neurospheres 
Mouse TLX (Nr2e1) was cloned into a pCDF-CMV-IRES-GFP lentiviral backbone. 
Transgene expression of TLX was driven by a cytomegalovirus (CMV) promoter. 
Lentiviral particles were produced by transfecting a HEK 293T producer cell line 
with the lentiviral Nr2e1 plasmid or lentiviral GFP control plasmid and pPACKF1
TM
 
Lentivector Packaging Kit (System Biosciences, 2438 Embarcadero Way, Palo Alto, 
CA, 94303, USA). Harvested viral supernatant was aliquoted and stored at -80°C 
until use. Packaged viruses had titres of approximately 1x10
6
 TU/ml. On the first day 
of cultures, 5x10
5 
dissociated NPCs were plated in each well of a 6 well plate along 
with 7x10
4 
TU/ml of lentivirus overexpressing either TLX or GFP. After 24 hours, 
recombinant rat IL-1β (10ng/ml) or PBS was added. Cells were allowed to 
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proliferate as neurospheres and were kept under proliferative conditions for a further 
6DIV. 
 
Neurosphere expansion analysis 
Floating neurospheres were observed under an Olympus IX70 inverted microscope 
at 10x magnification each day the cells were in culture. Phase contrast images were 
taken using the attached Olympus DP70 digital camera. For each flask five images 
were taken and saved. Within each image, the diameter of four spheres was 
measured using ImageJ. 
 
Immunocytochemistry of treated NPCs 
After cells were treated with IL-1β, they were washed in warmed in HBSS. The 
HBSS was removed and cells were fixed by adding ice cold methanol for 10mins at -
20°C. The fixative was removed and cells were washed 3x5min in 0.02% triton-X in 
PBS. Following this, the cells were incubated overnight at 4°C in 5% donkey serum 
made in 0.02% triton-X 100 as a blocking agent. After an overnight incubation, the 
blocking solution was removed and the primary antibodies made in blocking solution 
were added overnight at 4°C. For each experiment, at least one well was designated 
as a negative control where only blocking solution without primary antibody was 
added. After an overnight incubation in primary antibody, 3x5min 0.02% triton-X 
washes were carried out followed by 2hr incubation in the dark at room temperature 
with secondary antibody. The secondary antibody was removed and 3x5min 0.02% 
triton-X washes were carried out followed by 5min incubation with the nuclear stain 
4’, 6-diamidino-2-phenylindole (DAPI). The cells were washed in PBS once for 
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10mins and the coverslips were mounted onto 76x26mm microscope slides using 
mounting media (DAKO). 
  
Target Antibody Source Company Dilution 
TLX Anti-TLX Polyclonal 
Rabbit 
Santa Cruz 1:100 
p65 Anti-p65 Polyclonal 
Rabbit 
Santa Cruz 1:100 
Table 1.1: List of primary antibodies used for in vitro study 
 
Secondary antibodies Company Dilution 
AlexaFluor 488-conjugated donkey anti-
rabbit 
Invitrogen, UK 1:2000 
Table 1.2: Secondary antibody used for in vitro study 
 
Imaging 
Immunocytochemically stained cells were viewed using and Olympus Provis AX70 
upright fluorescent microscope. Green and blue fluorescent images were taken at 
40X magnification using the attached Olympus DP40 digital camera. Five random 
fields of view per coverslip were imaged and two pictomicrographs for each filter 
(green and blue) were taken per field of view. The results were merged and analysed 
using ImageJ. 
 
Fluorescence measurements 
The fluorescent intensity of TLX and p65 was calculated on ImageJ. Each TLX 
positive and p65 positive cell was highlighted using the draw tool on ImageJ and the 
fluorescent intensity was measured. For each pictomicrograph, ten immuno-positive 
cells were measured for their fluorescent intensity. Also for each pictomicrograph, 
three background measurements were taken. An average background value for each 
 283 
 
image was calculated and subtracted from each cell value to obtain a corrected 
fluorescent intensity measurement. 
 
Collection of NPCs for mRNA analysis 
After IL-1β, JSH-23 or lentiviral treatments, proliferating NPCs were harvested as 
whole neurospheres (i.e. after expansion analysis with IL-1β and lentiviral 
treatments), or dissociated NPCs (i.e. after IL-1β timeline and JSH-23 treatments) as 
described above. Neurospheres or dissociated NPCs were collected into 15ml tubes 
and centrifuged at 200rcf for 5mins and room temperature. Neurospheres were then 
re-suspended in 1ml of warmed HBSS and transferred to a sterile 1.5ml 
microcentrifuge tube. These tubes were centrifuged (Eppendorf Minispin centrifuge) 
at 14,000rcf for 5mins. The supernatant was removed and the neurospheres or NPCs 
were flash frozen and stored at -80°C. 
 
Ribonucleic Acid (RNA) extraction 
Neurospheres used for PCR experiments were collected as described above. Cell 
pellets were defrosted on ice and total cellular RNA was extracted using GenElute™ 
Mammalian Total RNA Miniprep Kit (Sigma). Cell pellets were lysed by adding 
250μl of lysis buffer and resuspending the cell pellet. This lysate was then passed 
through a filtration column within a 2ml collection tube and centrifuged at 14,000rcf 
for 2 minutes to remove cellular debris and shear DNA. Equal volume of 70% 
ethanol was added to the filtrate. The filtrate is then added to an RNA binding 
column and the RNA was washed by adding 500μl of Wash Buffer I and centrifuged 
at 14,000rcf for 30 seconds. The flow through was discarded and the binding column 
was placed in a new collection tube and 500μl of Wash Buffer II was added to the 
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column. The column was then centrifuged at 14,000rcf for 30 seconds. The flow 
through was discarded and a second 500μl of Wash Buffer II was added and the 
column was centrifuged at 14,000rcf for 1 minute to dry the column. The RNA was 
then eluted by adding 30μl of elution solution and centrifuged at 14,000 rcf for 1 
minute. Any DNA left in the eluted RNA sample was removed using DNase I 
amplification grade kit (Sigma). RNA in 30 ml of elution solution was treated by 
adding 3μl of 10X Reaction Buffer and 5μl of DNase I Amplification Grade 
(Sigma), and incubating at room temperature for 15 minutes. Inactivate the DNase 
by adding 5μl of the Stop Solution and heating at 70 °C for 10 minute. The eluted 
RNA was then stored at -80°C until use.  
 
RNA quantification 
RNA was quantified using a Nano drop 3300 (Thermo Scientific, UK). 1μl of 
undiluted sample was placed on the nano drop electrode and the RNA concentration 
was calculated in ng/μl. The 260/280 and 260/230 ratio were also calculated to 
assess RNA purity. 
 
cDNA Synthesis 
RNA was reverse transcribed into cDNA using the ReadyScript® cDNA Synthesis 
Mix (Sigma). RNA concentration was normalised to 0.1μg/reaction by diluting in 
RNase free H2O. In each 200μl cDNA reaction tube, 4μl of ReadyScript® cDNA 
Synthesis Mix was added along with varying volumes of RNA and RNase free H2O 
to give a final volume of 20μl/tube with 0.1μg of RNA. The tubes were then placed 
in a thermal cycler (Sure Cycler 8800, Agilent Technologies) and underwent the 
following cycle: 5 minutes at 25°C, 30 minutes at 42°C, 5 minutes at 85°C, and held 
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at 4°C. The samples were then diluted 1:4 to give 80μl of diluted sample within the 
1pg threshold of the Sybr Master Mix used for RT-PCR. The cDNA samples were 
then either stored at -20°C or used immediately for RT-qPCR. 
 
Real Time Quantitative PCR (RT-qPCR) 
RT-qPCR was carried out using a StepOnePlus Real-Time PCR Machine (Applied 
Biosystems). Each run was carried on 96 well plates (Applied Biosystems). For each 
run, the samples were run in triplicate for each target gene and the housekeeping 
gene which was B-actin. Negative controls were also run for each target gene. Each 
reaction was carried out in 20μl volume containing 10μl of Sybr Master Mix 
(KiCqStart
®
 SYBR
®
 Green qPCR ReadyMix
™ 
with ROX
™
 for ABI instruments, 
Sigma), 0.2μl of both forward and reverse primers (Eurofins Genomics), 4.6μl of 
RNase-free H2O, and 5μl of sample. Primers for the target genes were carried out 
using the primer designing tool on Pubmed 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). The RT-PCR reaction was carried 
out as follows. The samples were heated to 95°C for 3mins to denature the cDNA. 
The samples then underwent 45 cycles of 95°C for 10 seconds and 60°C for 30 
seconds. The fluorescence data was collected at the end of each cycle. The raw data 
generated was exported as an excel file and the Cycle Threshold (CT) values were 
analysed using the Livak method (Livak & Schmittgen 2001). 
 
Gene Primers 
(From Pubmed Primer Blast) 
NCBI Reference 
SDHA F cccactaactacaagggacagg NM_130428.1 
R ttggcaccatgcactgag 
TLX F gctttcttcacagcggtcac NM_001113197.1 
R gcagacacagcggtcaact 
IkBa F tgaagtgtggggctgatgtc NM_001105720.2 
R agggcaactcatcttccgtg 
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p21 F gtatgccgtcgtctgttcgg U09793.1 
R gcagaagaccaatcggcgct 
Table 1.3: List of primers used for in vitro study 
 
1.2: Chapter 3 methods 
Preparation of WT and TLX
-/-
 mouse hippocampal tissue for RNASeq 
Anesthesia 
All surgery to implant the guide cannula (Plastics1, Gauge:22, Pedestal 
Length:4mm, Projection:1.5mm) was conducted on WT and TLX
-/-
 mice at p52 
under general anaesthesia induced by a mixture of ketamine (0.25ml), xylazine 
(0.2ml) and sterile 0.9% saline (2.05ml) at a dose of 0.1mls/10g injected 
intraperitoneally (i.p). 
 
Carprofen 
A 50mg/ml stock solution of carprofen (Abbeyville Veterinary, Ireland) was diluted 
in sterile saline to give a final concentration of 1mg/ml. Mice were injected 
subcutaneously (SC) with carprofen at a volume of 0.1ml/30g post-surgery.  
 
Glucose 
Glucose (Sigma, Ireland) was dissolved in sterile saline to give a final concentration 
of 5%. Glucose was administered SC at a volume of 1.25ml/100g post-surgery. 
 
Stereotaxic surgery for hippocampal cannulation 
Animals were placed in a stereotaxic frame (Kopf, Tujunga, CA). The guide cannula 
was implanted unilaterally at the following co-ordinates for the dorsal hippocampus, 
AP -1.7, ML -1.2 and DV -1.5 relative to bregma (Haettig et al., 2013). Animals to 
be implanted on the left or right hemisphere were chosen at random within the WT 
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and TLX
-/-
 groups. The cannula was then secured in place using superglue as a base 
layer followed by dental cement. After the dental cement had hardened sufficiently, 
recovery injections were administered (carprofen and glucose). Animals were 
returned to their home cage when recovered and 4 days later where taken for IL-1β 
or saline microinjections. 
 
Intrahippocampal microinjections and hippocampal dissections 
At p56, WT and TLX
-/-
 mice received intrahippocampal injections of either IL-1β or 
PBS. The injection cannula used projected a further 0.5mm past the guide cannula to 
give a total depth of 2.0mm. Unilateral dorsal hippocampal injections of either 
recombinant mouse IL-1β or PBS at a volume and rate of 1ul at 0.5ul/min were 
performed using an automated microinjector 1h prior to sacrifice. The injection 
cannula was left in place for 2mins after the injection to allow diffusion of the 
injected volume. Mice were sacrificed by decapitation and hippocampal tissue from 
each mouse was isolated and snap frozen in 1.5ml microcentrifuge tubes on dry ice. 
The hippocampal tissue was then stored at -80°C.  
 
RNA extraction 
Hippocampal tissue was defrosted on ice and total RNA was extracted using 
mirVana
TM
 total RNA extraction kit (Ambion/Life Technologies, Dublin, Ireland) as 
per the manufacturer’s instructions. Hippocampal tissue was lysed by adding 300μl 
of lysis buffer and mechanically dissociated using pestles. Equal volume of phenol 
was added to the lysis buffer/tissue mix and left to incubate on ice for 10mins. 
Samples were then vortexed for 60 seconds and centrifuged for 5min at 10,000rcf. 
The upper aqueous solution was withdrawn and transferred to a fresh tube. 1.25 
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times volume of 100% ethanol was added to the aqueous solution which was then 
added to an RNA binding column and the RNA was washed by adding 700μl of 
Wash Buffer I and centrifuged at 14,000rcf for 30 seconds. The flow through was 
discarded and the binding column was placed in a new collection tube and 500μl of 
Wash Buffer 2/3 was added to the column. The column was then centrifuged at 
14,000rcf for 30 seconds. The flow through was discarded and a second 500μl of 
Wash Buffer 2/3 was added and the column was centrifuged at 14,000rcf for 1 
minute to dry the column. The RNA was then eluted by adding 100μl of elution 
solution at 95°C and centrifuged at 14,000rcf for 1 minute. Total extracted RNA was 
DNAse treated using Turbo DNA-free kit (Ambion/life technologies). The total 
concentration of extracted RNA was quantified using a Nanodrop 2000 (Thermo 
Scientific, UK) and was stored at -80°C until sent for sequencing or prepared for 
cDNA synthesis and PCR analysis.  
 
mRNA sequencing  
Sequencing was carried out as described in chapter 3. 
 
1.3: Chapter 4 methods 
Carprofen 
Carprofen (50mg/ml) (Abbeyville Veterinary, Ireland) stock solution was diluted to 
a final concentration of 2.5mg/ml in sterile saline and administered SC in a volume 
of 1.5ml/kg post-surgery. 
 
Glucose 
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Glucose (Sigma, Ireland) was dissolved in sterile saline to give a final concentration 
of 5%. Glucose was administered SC at a volume of 3ml/kg post-surgery. 
 
Stereotaxic surgery and lentiviral injection 
Rats were anaesthetised with isoflurane (Abbeyville Veterinary, Ireland) and placed 
into a Kopf stereotaxic frame (Kopf, Tujunga, CA).  Lentiviruses to overexpress 
TLX (1.63 x 10
7
 copies/ml) or GFP (1.31 x 10
7
 copies/ml) (Genecopoeia, MD, USA) 
was injected into the dorsal hippocampus using the coordinates AP: -3.5 mm, ML: ± 
2.4 mm, DV: -3.8 mm relative to Bregma (Barrientos et al., 2002) at a rate of 
1µL/min followed by a 5 min diffusion.  Rats were injected SC with carpofen and 
5% glucose prior to anaesthetic recovery.  All rats were allowed to recover for three 
weeks with ad libitum access to food and water prior to behavioural testing in order 
to allow viral uptake.  
 
BrdU 
A 30mg/ml solution of BrdU was prepared by dissolving 1.5g of BrdU (Sigma) in 
50mls of sterile saline. The solution was incubated at 37°C and sonicated to dissolve 
the BrdU. BrdU was administered intraperitoneally (i.p.) at a volume of 5ml/kg. 
Animals were administered BrdU one week after surgery for immunohistochemical 
assessment of the survival of newly born cells. 
 
Behavioural testing 
Behavioural testing was carried out as described in chapter 4. 
 
Sacrifce and perfusion 
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Rats were euthanized with an i.p. injection of Euthatal (pentibarbitol) (1.0ml/kg). 
Once anaesthetised, the thoracic cavity was opened and a 26G needled connected to 
tubing filled with ice cold 0.9% PBS was inserted into the left ventricle. The right 
atrium was cut and the PBS was pumped at a flow rate of 23ml/min to flush the 
blood out of the circulatory system. Once the out-flowing blood ran clear, the tubing 
was and transferred to pump 4.0% paraformaldehyde (PFA) until a sufficient level of 
fixed tissue was observed in the neck area.  After perfusion, rats were decapitated 
and the brains were removed and post-fixed in 4% formaldehyde in PBS overnight, 
then transferred to a 30% sucrose solution until they had sunk.  The brains were then 
snap frozen using isopentane as a freezing medium and liquid nitrogen and 
subsequently stored at -80°C until sectioned. 
 
Brain sectioning and immunohistochemistry 
Coronal sections through the hippocampus were cut at 40μm onto slides and stored 
at -80°C. For analysis of cellular survival with BrdU, sections were incubated in HCl 
(2M) for 45 minutes at 37°C and re-natured in 0.1M sodium tetraborate, and then 
treated with 3% hydrogen peroxide for 45 minutes. Sections were blocked in 10% 
normal rabbit serum and incubated with the appropriate primary antibody (See table 
4.4). Detection and visualisation was carried out using HRP-linked rabbit-anti-rat, 
goat anti-rabbit, or rabbit anti-goat secondary antibodies from ABC complex kits 
(Vector) before being placed into DAB and coverslipped with DPX mounting 
medium. Brightfield images across a 1:12 series through the dorsal DG were 
obtained using an Olympus BX53 upright microscope at both 10x and 20x 
(BioSciences Imaging Centre, Department of Anatomy and Neuroscience, UCC).  
The total number of positively labelled cells were counted and expressed as cells per 
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section within the hilus, subgranular zone (SGZ), and granular cell layer (GCL) of 
the DG. Images of autofluorescent TLX overexpressed as a result of the lentiviral 
injection were also captured across a 1:12 series throughout the hippocampus using 
an Olympus BX53 upright microscope at 20x (BioSciences Imaging Centre, 
Department of Anatomy and Neuroscience, UCC).  
 
1.4: Chapter 5 methods 
Stereotaxic surgery and lentiviral injections 
Rats were anaesthetised with isoflurane (Abbeyville Veterinary, Ireland) and placed 
into a Kopf stereotaxic frame (Kopf, Tujunga, CA).  Lentiviruses to overexpress 
mouse IL-1β (1.93 x 107 copies/ml) or mCherry (2.42 x 108 copies/ml) 
(Genecopoeia, MD, USA) was injected into the dorsal hippocampus using the 
coordinates AP: -3.5 mm, ML: ± 2.4 mm, DV: -3.8 mm relative to Bregma 
(Barrientos et al., 2002) at a rate of 1µL/min followed by a 5 min diffusion.  Rats 
were injected SC with carpofen and 5% glucose prior to anaesthetic recovery as per 
appendix section 1.3 above.  All rats were allowed to recover for three weeks with 
ad libitum access to standard chow and water prior to beginning behavioural testing 
to allow viral uptake. 
 
Behavioural testing 
Behavioural testing was carried out as described in chapter 5. 
 
Hippocampal RNA extractions 
Total RNA was extracted as described in appendix section 1.2. 
 
 292 
 
Quantitative real-time PCR (qRT-PCR) 
cDNA was reversed transcribed using the high capacity cDNA reverse transcription 
kit (Applied Biosystems) using the SureCycler
®
 8800 (Agilent Technologies) and 
diluted to a final concentration of 10ng/μl. All qRT-PCR was performed in 3 
technical replicates for each biological sample on a LightCycler
®
 480 Instrument II 
(Roche). See table 1.5 for a list of primers used. The PCR consisted of the following 
steps: 95°C for 2 minutes to denature the cDNA followed by 40 cycles of 95°C for 5 
seconds and 60°C for 20 seconds. Each reaction consisted of 1μl of sample (5ng/ul), 
5μl of Sybr MasterMix (KiCqStart® SYBR® Green qPCR ReadyMix™ with 
ROX™ for ABI instruments, Sigma-Aldrich), 0.1μl of both forward and reverse 
primers, and 3.8μl of RNase free H2O. Results were normalised to succinate 
dehydrogenase (SDHA) and quantification of gene expression was analysed using 
the ΔΔ Ct method (Livak and Schmittgen, 2001).  
 
Gene Primers 
(From Pubmed Primer Blast) 
NCBI Reference 
SDHA F cccactaactacaagggacagg NM_130428.1 
R ttggcaccatgcactgag 
TLX F gctttcttcacagcggtcac NM_001113197.1 
R gcagacacagcggtcaact 
IL-1β F aaagaagaagatggaaaagcggtt NM_031512.2 
R gggaactgtgcagactcaaactc 
Synaptophysin F cccttcaggctgcaccaa NM_012664.3 
R ttggtagtgccccctttgac 
PSD95 F acgccgaagagtcagagaaa NM_019621.1 
R actgttggaccgagtgaacc 
NeuroD1 F acaacaggaagtggaaacatgac NM_019218.2 
R gctgggacaaacctttgcag 
TNFα F gtctgtgcctcagcctcttc X66539 
R cccatttgggaacttctcct 
CXCL1 F ctccagccacactccaacag NM_030845.1 
R gacttcggtttgggtgcagt 
Table 1.5: List of primers used in chapter 5. 
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Protein extraction 
Total protein was extracted from hippocampal tissue using a lysis solution of RIPA 
buffer (Thermo Fisher) with a protease and phophotase inhibitor tablet (Pierce, 
Thermo Fisher) along with mechanical dissociation using a pestle. The samples were 
centrifuged at 12,000 rpm for 12 minutes to remove tissue debris. The supernatant 
was then frozen at -80°C until required. 
 
Protein concentration determination 
The concentration of the extracted protein was determined by Bradford assay. A 
standard curve was prepared by making the following standards of bovine serum 
albumin (BSA) (Sigma) dissolved in distilled H2O (dH2O): 0.1, 1, 10, 100, 1000, 
10000, 100000μg/ml. Standards and samples were vortexted prior to loading at 
100μl onto the 96-well plate (Sarstedt). Bradford reagent was diluted 1:10 in dH2O 
and loading at an equal volume to the standards and samples and incubated for 15 
minutes and room temperature. The absorbance was measured at 600nm using a 
spectrophotometer plate reader (Multiskan, Thermo Fisher). The absorbance values 
of the standards were used to produce a log standard curve of known concentrations 
relative to absorbance values. This standard curve was then used to determine the 
concentrations of the samples. 
 
Western blotting 
Prior to western blotting the following buffer solutions were made as per table 1.5 
below. Protein samples were mixed in a 1:1 ratio with sample buffer and incubated 
at 95°C for 5 minutes before being rapidly placed on ice. A 12% SDS resolving gel 
was first poured and left to solidify for 30mins prior to pouring a 4% SDS stacking 
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gel on top. Once the stacking gel had solidified, samples were loaded onto this gel. 
Gels were placed into a vertical western blot rig (Atto, Japan) and electrophoresis 
was started by applying 150V at room temperature (Bio-Rad power pack). 
Electrophoresis was ended just before the migrating protein line reached the bottom 
of the gel. The gels were then placed onto a transfer buffer soaked nitrocellulose 
membrane and the gel and membrane were sandwiched between layers of filter 
paper. The wet transfer was carried out for 75 minutes at 75 volts at 4°C (Trans Blot 
Cell, Bio-Rad). Once the transfer was complete, the membrane was then incubated 
with primary antibodies for IL-1β (R&D systems, goat polyclonal, 1:500) and β-
actin (Sigma, mouse polyclonal, 1:1000) and subsequently incubated with the 
appropriate secondary HRP tagged secondary antibodies. Proteins were then 
visualised using ECL detection kit (GE healthcare). Densitometry for the developed 
immune blots was carried out using ImageJ software. 
 
Buffer Preparation 
 
Sample buffer (2x in dH2O) 
Made 1:1 ratio with samples 
 
12.5% Tris-HCl (Sigma) 
20% Glycerol (Sigma) 
2% Sodium dodecyl sulphate (SDS) (Sigma) 
5% β-mercaptoethanol (Sigma) 
0.05% w/v Bromophenol blue (Sigma) 
Running buffer (10x in dH2O) 
1x prepared for electrophoresis 
250mM Tris-base (Sigma) 
1.92M Glycine (Sigma) 
1% SDS (Sigma) 
Transfer buffer 
Prepared in dH2O on day of 
electrophoresis 
25mM Tris-base (Sigma) 
192mM Glycine 
5% v/v methanol 
Tris-buffered saline (TBS) 
Prepared in dH2O, pH 7.2-7.4 
200mM Tris-HCL 
1.5mM NaCl 
TBS-Tween (TBS-T) 0.05% Tween in 1L TBS 
Ammonium persulphate (APS) 1g APS 
10ml dH2O 
4% SDS stacking gel 1.87ml 0.5M Tris-HCL 
975μl 30% acrylamide (Sigma) 
4.5ml dH2O 
75μl 10% SDS 
37.7μl 10% APS 
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15μl Tetramethylethylenediamine (TEMED) 
12% SDS separating gel 3.75ml 1.5M Tris-HCl 
6ml 30% acrylamide (Sigma) 
5.1ml dH2O 
150μl 10% SDS 
75μl 10% APS 
15μl TEMED 
Table 1.6: List of buffers and details of preparation used for western blotting.  
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TLX is an intrinsic regulator of the negative effects of IL-1b
on proliferating hippocampal neural progenitor cells
Ciara´n S. O´’Le´ime,* Danka A. Kozareva,* Alan E. Hoban,* Caitriona M. Long-Smith,*,† John F. Cryan,*,†
and Yvonne M. Nolan*,†,1
*Department of Anatomy and Neuroscience and †Alimentary Pharmabiotic Centre (APC) Microbiome Institute, University College Cork, Cork,
Ireland
ABSTRACT: Hippocampal neurogenesis is a lifelong process whereby new neurons are produced and integrate into
the host circuitry within the hippocampus. It is regulated by a multitude of extrinsic and intrinsic regulators and is
believed to contribute to certain hippocampal-dependent cognitive tasks. Hippocampal neurogenesis and associ-
ated cognition have been demonstrated to be impaired after increases in the levels of proinflammatory cytokine
IL-1b in the hippocampus, such as that which occurs in various neurodegenerative and psychiatric disorders. IL-1b
alsosuppresses theexpressionofTLX(orphannuclear receptor taillesshomolog),which isanorphannuclear receptor
that functions topromoteneuralprogenitor cell (NPC)proliferationandsuppressneuronaldifferentiation; therefore,
manipulationofTLXrepresentsapotential strategywithwhich toprevent theantiproliferativeeffectsof IL-1b. In this
study, we assessed the mechanism that underlies IL-1b–induced changes in TLX expression and determined the
protective capacity ofTLX tomitigate the effects of IL-1b on embryonic rat hippocampal neurosphere expansion.We
demonstrate that IL-1b activated the NF-kB pathway in proliferating NPCs and that this activation was responsible
for IL-1b–induced changes in TLX expression. In addition, we report that enhancing TLX expression prevented the
IL-1b–induced suppression of neurosphere expansion. Thus, we highlight TLX as a potential protective regulator of
the antiproliferative effects of IL-1b on hippocampal neurogenesis.—O´’Le´ime, C. S., Kozareva, D. A., Hoban, A. E.,
Long-Smith, C. M., Cryan, J. F., Nolan, Y. M. TLX is an intrinsic regulator of the negative effects of IL-1b on
proliferating hippocampal neural progenitor cells. FASEB J. 32, 000–000 (2018). www.fasebj.org
KEY WORDS: neurogenesis • nuclear receptor • inflammation • Nr2e1
Hippocampal neurogenesis is a process by which new
neurons are born from neural progenitor cells (NPCs) in
the hippocampus. This process begins during embryonic
development and persists into adulthood, when it is
thought to contribute to hippocampal-dependent cogni-
tive function (1, 2). Evidence of the functional role of hip-
pocampalneurogenesis in theadulthasbeenshown invivo
as a result of its involvement in various cognitive tasks,
such as the Morris water maze (3–6), novel object and
novel location recognition (7–9), and pattern separa-
tion in rodents (10–13). In addition, adult hippocampal
neurogenesis has been demonstrated to be impaired in
conditions in which there is a subsequent impairment
in hippocampal cognition, such as stress, depression,
aging, and neurodegeneration (14–18). Many of these
conditions have been associated with increased in-
flammation and expression of proinflammatory cyto-
kine IL-1b in the brain (19–22).
Inflammation has been well established as having
negative consequences on CNS function and hippo-
campal neurogenesis. Release of IL-1b occurs from
activated microglia as a result of stress, infection,
neurodegeneration, or, indeed, with aging (18, 21, 23,
24). IL-1 receptor type 1 (IL-1R1) is the cognate re-
ceptor for IL-1b and this receptor is highly expressed
on glia, neurons, and NPCs in the hippocampus of the
rodent brain (25–28). After binding to IL-R1, IL-1b
induces an intracellular signaling cascade that leads to
altered gene transcription and a heightened proin-
flammatory response (29–31). In most cell types, liga-
tion of IL-1b to IL-1R1 activates the NF-kB signaling
pathway (32). NF-kB is composed of homo- or heter-
odimeric combinations of the Rel family of proteins,
which consists of p52, p65 (nuclear factor NF-kB p65
subunit; RelA), c-Rel, Rel B, andp50. Theseproteinswork
in combination or with other cofactors, such as CREB
binding protein, to regulate the transcription of NF-kB
target genes (33). The consequences of the sustained
ABBREVIATIONS:DIV, day in vitro; GFP, green fluorescent protein; GSK-b,
glycogen synthase b; IkBa, nuclear factor of k light polypeptide gene
enhancer in B-cell inhibitor a; IL-1R1, IL-1 receptor type 1; NPC, neural
progenitor cell; Nr2e1, nuclear receptor subfamily 2 group E member 1;
p21, cyclin-dependent kinase inhibitor 1; p65, nuclear factor NF-kB p65
subunit; TLX, orphan nuclear receptor tailless homolog
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elevation of IL-1b in the hippocampus include impaired
synaptic plasticity and hippocampal-dependent learn-
ing and memory (28, 30, 34–36). Indeed, the NF-kB
pathway has been suggested to mediate the effects of
IL-1b on long-term potentiation (34, 37, 38). It has also
been demonstrated that IL-1b can recruit the NF-kB
pathway to suppress hippocampal neurogenesis. For
example, it has been demonstrated that inhibition of the
NF-kB pathway before the extrinsic administration of
IL-1b to hippocampal NPCs in vitro prevented the
IL-1b–induced suppression of proliferation in these
cells (39); however, it is uncertain how the activation of
this pathway can affect intrinsic regulators of hippo-
campal neurogenesis.
The study of the signaling mechanism within embry-
onic NPCs provides valuable insight into signaling
mechanisms that may occur within adult NPCs (40–43).
IL-1R1 is expressed on both embryonic and adult NPCs
(27, 28), and IL-1b has been shown to negatively impact
various aspects of hippocampal neurogenesis, such as
proliferation, differentiation, and survival (27, 28, 39). TLX
(orphan nuclear receptor tailless homolog)—or Nr2e1
(nuclear receptor subfamily 2 group E member 1)—is an
orphan nuclear receptor and an intrinsic regulator of
neurogenesis that is required tomaintain the pool ofNPCs
within the hippocampus by promoting NPC proliferation
and suppressing differentiation (44, 45). Studies that use
transgenic models have shown that TLX can contribute to
hippocampal-dependent learning and memory (44, 46,
47). For example, impairments in hippocampal-associated
cognitive function and hippocampal neurogenesis have
been reported in TLX2/2 mice (48, 49). It has also been
demonstrated that IL-1b negatively regulates the expres-
sion of TLXwithin both adult and embryonic NPCs, with
subsequent impairment in NPC proliferation (28, 30, 50;
however, the associated signaling remains largely un-
known. Likewise, whether TLXmanipulation can prevent
the effects of IL-1b on NPC expansion has not been in-
vestigated. Here, we identify the NF-kB signaling path-
way as a key mediator of the effects of IL-1b on TLX
expression and demonstrate that the restoration of TLX
expression is sufficient to prevent the negative effects of
IL-1b onNPC expansion in vitro. These data, alongwith
previous data from studies by us and others, highlight
TLX as a potential regulator of IL-1b–induced impair-
ment in hippocampal neurogenesis.
MATERIALS AND METHODS
Preparation and treatment of rat
hippocampal NPCs
Embryonic day 18 rat hippocampi (Biologic Services Unit, UCC,
Cork, Ireland) were cultured for 6 d in vitro (DIV) as previously
described [Green et al. (27) andKeohane et al. (51)].Neurospheres
werekeptunderproliferative conditions inT25 flasks at adensity
of 23 106 cells/10ml of proliferationmedia [DMEM:F12 (Sigma-
Aldrich, St. Louis,MO,USA), 2%B27 supplement (ThermoFisher
Scientific, Waltham, MA, USA), 1% penicillin/streptomycin
(Sigma-Aldrich), 10 ng/ml epidermal growth factor (Sigma-
Aldrich), 10 ng/ml fibroblast growth factor (Millipore, Billerica,
MA, USA), 200 mM L-glutamine (Sigma-Aldrich), and 33 mM
D-glucose (Sigma-Aldrich). At 6 DIV, neurospheres were dissoci-
ated by using 0.1% trypsin-EDTA enzyme (Sigma-Aldrich) and
treated as a single-cell suspension. Cells (53 104)wereplated in
proliferationmedia ontopoly-D-lysine (Sigma-Aldrich)–coated
coverslips for immunocytochemical analysis, and cells (5 3
105)were seededperwell in proliferationmedia in 6-well plates
for PCRanalysis. In the first set of experiments, recombinant rat
IL-1b (10 ng/ml; R&D Systems, Minneapolis, MN, USA) was
added to media for 10 and 30 min, 1, 2, and 4 h, or 6 DIV to
measure the mRNA expression levels of TLX, p21 (cyclin-
dependent kinase inhibitor 1), and IkBa (nuclear factor of k
light polypeptide gene enhancer in B-cell inhibitor a), and p65
and TLXprotein levels. A second series ofNPC cultureswere
treated with IL-1b (10 ng/ml) for 8, 16, and 24 h to assess the
effects of longer-term treatment of IL-1b on TLX and p21
mRNA expression. In a subsequent series of experiments, IL-1b
(10 ng/ml)was added toproliferationmediawith orwithout the
NF-kB inhibitor, JSH-23 (25 mM; Sigma-Aldrich), for 3 h in vitro,
and the mRNA expression levels of TLX, p21, and IkBa, as well
as protein levels of TLX were assessed.
Lentiviral production and transduction of NPCs
with TLX lentivirus
Mouse TLX (Nr2e1) was cloned into a pCDF–cytomegalovirus–
IRES–green fluorescent protein (GFP) lentiviral backbone by
using standard cloning methods. Transgene expression of TLX
was driven by a cytomegalovirus promoter. Lentiviral particles
were produced by transfecting an HEK293T producer cell line
with the lentiviral Nr2e1 plasmid or lentiviral GFP control plas-
mid and pPACKF1 Lentivector Packaging Kit (System Biosci-
ences, Palo Alto, CA, USA). Harvested viral supernatant was
aliquoted and stored at 280°C until use. Packaged viruses had
titers of approximately 13 106 transfectionunits/ml. On the day
of seeding, 53 105dissociatedNPCswereplated in eachwell of a
6-well plate, along with 73 104 transfection units/ml of lentivi-
rus that overexpressed either TLX or GFP. After 24 h, recombi-
nant rat IL-1b (10 ng/ml) or PBSwas added. Cells were allowed
to proliferate as neurospheres and were kept under proliferative
conditions for an additional 6 DIV.
PCR
Total cellular RNA was extracted from dissociated NPCs that
were derived from neurospheres by using a Total Mammalian
RNA extraction kit (Sigma-Aldrich) according to manufacturer
instructions. Extracted RNA was treated with DNase (Sigma-
Aldrich) to remove any DNA contamination. cDNA was pre-
pared by using the high-capacity cDNA reverse-transcription kit
(Applied Biosystems, Foster City, CA, USA). PCR was carried
out on a 96-well plate by using a StepOnePlus Real-Time PCR
machine (AppliedBiosystems) using the followingprimers: TLX,
(forward) GCTTTCTTCACAGCGGTCAC, (reverse) GCAGA-
CACAGCGGTCAACT; IkBa, (forward) TGAAGTGTGGGGC-
TGATGTC, (reverse) AGGGCAACTCATCTTCCGTG; p21,
(forward) GTATGCCGTCGTCTGTTCGG, (reverse) GCA-
GAAGACCAATCGGCGCT; and succinate dehydrogenase,
(forward) CCCACTAACTACAAGGGACAGG, (reverse)
TTGGCACCATGCACTGAG. PCR consisted of the following
steps: 95°C for 3 min to denature the cDNA, followed by 45
cycles of 95°C for 10 s and 60°C for 30 s. Each reaction con-
sisted of 1 ml of sample (5 ng/ml), 10 ml of Sybr MasterMix
(KiCqStart SYBR Green quantitative PCR ReadyMix with
ROX reference dye for ABI instruments; Sigma-Aldrich),
0.1 ml of both forward and reverse primers, and 8.8 ml of
RNase-free H2O. RNA elution solution was used instead
of samples to ensure that no amplification occurred as a result
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of self-complimentary primers. Results were normalized to
succinate dehydrogenase and analyzed by using the DDCt
method (52).
Immunocytochemistry
Cells were incubated in 5% donkey serum overnight at 4°C to
block nonspecific Ab binding. Cells were then incubated with
Abs against nestin (1:200, donkey anti-goat; Santa Cruz Bio-
technology, Santa Cruz, CA, USA), TLX (1:100, donkey anti-
rabbit; Santa Cruz Biotechnology), and/or p65 (1:100, donkey
anti-rabbit; Abcam, Cambridge, MA, USA) at 4°C overnight.
Cells were subsequently incubated with the appropriate fluo-
rescently tagged secondary Ab (Alexa Fluor; Thermo Fisher
Scientific) for 2 h at room temperature in the dark. Cells were
counterstained with DAPI (1:2500) to identify nuclei. For each
protein, a sample of cells was incubated with blocking solution
and secondary Ab, but without prior incubation with primary
Ab, as a negative control.
Neurosphere diameter analysis, cell counts,
and densitometry
Neurospheres were imaged by using an inverted microscope
(IX70;Olympus, Tokyo, Japan)at310magnification eachday for
5DIV.At 6DIV,neurospheresweredissociated to assess changes
in TLX andp21 expression as previously described. For diameter
analysis, images of 5 individual neurospheres were captured per
field of view from 4 fields of view per flask per time point.
Neurosphere diameter was measured by using ImageJ (v.1.47;
National Institutes of Health, Bethesda, MD, USA). At least 20
spheres were analyzed per condition. Each experiment was re-
peated at least 3 times. Immunolabeled cells were imaged by
usinganuprightmicroscope (BX53;Olympus).Positively stained
cells were counted from 5 random fields of view per coverslip.
For each condition, cells from 4 coverslips were counted, and
each experiment was repeated 3 times. Merged images of DAPI
with TLX or p65 immunolabeled cells were used to analyze the
densitometryofnuclear staining from10 randomlyselectedTLX-
or p65-positive cells per field of view by using ImageJ. Twenty
micrographs per condition were analyzed from 3 independent
experiments. Background fluorescence intensity was controlled
for by thresholding.Datawere expressed as arbitraryunits of the
intensity ratio of nuclear to nuclear+cytoplasmic TLX, and each
data set that resulted from IL-1b treatmentwas normalized to its
respective control.
Statistical analysis
An unpaired Student’s t test and 1- or 2-way ANOVA, followed
by Bonferroni post hoc test was performed, when appropriate, to
determine which conditions were significantly different from
each other. Results are displayed as means 6 SEM and deemed
significant at values of P, 0.05.
RESULTS
IL-1b suppresses neurosphere expansion
Two-way ANOVA revealed a main effect of IL-1b
(10 ng/ml) treatment [F(1, 20) = 15.805; P , 0.001] and
treatment duration [F(4, 20) = 53.093; P, 0.001]. Post hoc
analysis demonstrated that IL-1b suppressed neuro-
sphere expansion under proliferative conditions after 4
and5DIV (P,0.05vs. control;Fig. 1A,B).Under the same
conditions at 6 DIV, IL-1b induced a significant increase in
the mRNA expression of the tumor suppressor gene, p21,
in dissociated NPCs (P , 0.01 vs. control; Fig. 1C). IL-1b
also induced a significant decrease in the mRNA expres-
sion of TLX—a known promoter of cell proliferation in
NPCs—at this time point (P , 0.01; Fig. 1D). This is con-
sistentwith a previous report that demonstrated that IL-1b
reduced protein expression levels of TLX in hippocampal
NPCs after 7 DIV (30). IL-1b did not induce a reduction in
cell viability at this dose and over this timeframe (data not
shown), which is in agreement with previous data (27).
IL-1b induces rapid activation of NF-kB
To assess whether IL-1b administration induced the
translocation of the NF-kB subunit, p65, to the nucleus in
hippocampal NPCs—an indicator of NF-kB activation—
we assessed the ratio of nuclear to cytoplasmic expression
of p65 (Rel A), a key signaling component of the NF-kB
pathway. As NF-kB signaling has been shown to be rap-
idly activated in human glial cells after IL-1b exposure
(53), we assessed p65 translocation to the nucleus from
10 min to 4 h after IL-1b administration. IL-1b adminis-
tration induced a significant increase in the nuclear trans-
location of p65 protein at 10 min after IL-1b, indicating
increased NF-kB activation [F(5, 114) = 19.21; P, 0.001 vs.
control; Fig. 2A, C]. A negative feedback mechanism was
evident because of the fact that mRNA expression of
IkBa—a negative regulator and target gene of p65—was
significantly increased 10min after IL-1b [F(5, 18) = 6.56;
P, 0.001; P, 0.05 vs. control; Fig. 2B)]. The increase in
IkBa expression was maintained for up to 4 h, which
coincided with a decrease in nuclear p65 protein ex-
pression at 4 h after IL-1b (P, 0.01 vs. control; Fig. 2A).
IL-1b induces suppression of TLX expression
As we observed NF-kB activation that was induced by
IL-1b in hippocampal NPCs, we next assessed the effects
of IL-1b onTLXexpression inhippocampalNPCsover the
same time period. After 30 min of IL-1b exposure, there
was decreased mRNA expression of TLX in proliferating
NPCs [F(5, 12) = 3.17; P, 0.05; Fig. 3A]. This resulted in a
significant decrease in TLX protein after 1 h of IL-1b ex-
posure [F(5, 114) = 20.75; P , 0.001; Fig. 3B, C]. We
assessed TLX mRNA expression after an extended treat-
ment with IL-1b and demonstrated that it remained re-
duced after 8 h of IL-1b exposure, normalized at 16 h, and
was significantly lower than control again at 24 h after
IL-1b treatment [F(3, 3) = 18.88; P , 0.001; P , 0.01; Fig.
3D]. This corroboratespreviousdata that showareduction
in TLXprotein expression at 24 h in response to IL-1b (28).
As TLX functions as a transcriptional suppressor, we
assessed the effect of IL-1b on the expression of the TLX
target gene and the suppressor of proliferation, p21. IL-1b
induced a significant increase in p21 mRNA expression
after 2 h [F(5, 18) = 3.25;P, 0.01 vs. control]; however, this
effect was not significant after 4 h (Fig. 3E). Therefore, we
extended our treatment times and observed that after 8 h
TLX IS AN INTRINSIC REGULATOR OF THE NEGATIVE EFFECTS OF IL-1b 3
 Vol.,  No. , pp:, October, 2017The FASEB Journal. 194.27.18.18 to IP www.fasebj.orgDownloaded from 
of IL-1b exposure, there was no change in p21 expression
compared with control; however, after 16 and 24 h, p21
mRNA expression was significantly higher than controls
[F(3, 8) = 12.16; P, 0.01; Fig. 3F].
IL-1b mediates its effects on TLX expression
via NF-kB pathway activation
To assesswhether the IL-1b–induced activation of theNF-
kB pathway is responsible for the IL-1b–induced decrease
inTLXexpression,wepretreatedhippocampalNPCswith
JSH-23, an inhibitor of NF-kB activation (54). We demon-
strated that when this pathway is inhibited, the IL-1b–
induced reduction in TLXmRNAexpression is attenuated
[F(3, 8)= 12.14;P, 0.001 vs. control;P, 0.05 vs. IL-1b;Fig.
4A]. Changes in TLXmRNA expressionweremirrored by
those in TLX protein expression [F(3, 796) = 75.57; P ,
0.001 vs. control; P , 0.001 vs. IL-1b; Fig. 4B, C]. Attenu-
ation of the IL-1b–induced decrease in TLX by JSH-23was
not a result of a reduction in total cell viability, as neither
IL-1b, nor JSH-23 reduced cell viability compared with
control during this acute incubation period (data not
shown). Treatment of NPCs with JSH-23 had no effect on
the IL-1b–induced increase in mRNA expression of the
TLX target gene, p21 (Fig. 4D), but attenuated the IL-1b–
inducedactivationof theNF-kB targetgene, IkBa (Fig. 4E).
Increased TLX expression prevents
IL-1b–induced suppression of
neurosphere expansion
To assess whether TLX could prevent the IL-1b–induced
decrease in neurosphere expansion, we transduced neu-
rospheres with lentiviruses that expressed either GFP or
TLX and demonstrated that they did not significantly
impair neurosphere expansion compared with control
nonlentiviral-transduced neurospheres across all time
points (Fig. 5A, B). Two-way ANOVA revealed a main
effect of treatmentwith lentiviruswith orwithout IL-1b
[F(5, 216) = 29.575; P , 0.001] and treatment duration
[F(5, 216) = 120.422; P, 0.001], and an interaction effect
of treatment 3 treatment duration [F(25, 216) = 1.780;
P , 0.05]. Post hoc analysis demonstrated that IL-1b
treatment of GFP-transduced neurospheres impaired
neurosphere expansion to an extent that was similar to
nonlentiviral-transduced neurospheres that were treated
with IL-1b at 4, 5, and 6 DIV (P , 0.05; Fig. 5A), whereas
IL-1b treatment of TLX-transduced neurospheres did not
(Fig. 5B). Moreover, neurospheres that were transduced
with lentivirus that overexpressed TLX significantly atten-
uated IL-1b–induced impairment in neurosphere expan-
sion at 4, 5, and 6 DIV (P, 0.01; Fig. 5B, C). IL-1b–treated
GFP-transduced neurospheres demonstrated impaired ex-
pansion compared with GFP-transduced controls at 6 DIV
Figure 1. IL-1b–induced suppression of hippocampal neurosphere expansion is associated with increased p21 expression and
reduced TLX expression. A) Neurosphere diameter from IL-1b–treated and untreated cultures (n = 3; 2-way ANOVA with
Bonferroni post hoc test). B) Representative images of control and IL-1b–treated neurospheres at 5 DIV. Scale bars, 100 mm. C)
Relative mRNA expression of p21 in untreated and IL-1b–treated cultures after 5 DIV under proliferative conditions (n = 8;
Student’s t test). D) Relative mRNA expression of TLX in untreated and IL-1b–treated cultures after 5 DIV under proliferative
conditions (n = 8). AU, arbitrary units; Ctrl, control. Data are expressed as means 6 SEM *P , 0.05, **P , 0.01 (Student’s t test).
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(P, 0.001; Fig. 5D), and this effect was not apparent in IL-
1b–treated TLX-transduced neurospheres compared with
TLX-transduced controls (Fig. 5D, E). To confirm the effi-
cacy of lentiviral transduction, we assessed TLX mRNA
expression in GFP- and TLX-transduced neurospheres at 6
DIV. In the absence of IL-1b, there was no significant dif-
ference in TLX mRNA expression between TLX- and
GFP-transduced neurospheres (Fig. 5F); however, after
treatment with IL-1b for 6 DIV, TLX-transduced neuro-
spheresmaintainedasignificantlyhigher expressionofTLX
mRNA compared with GFP-transduced neurospheres
[F(3, 25) = 7.73;P, 0.05 betweenGFP+ IL-1b andTLX+
IL-1b;P, 0.01 betweenGFPandGFP+ IL-1b[P, 0.001
between TLX and GFP + IL-1b; Fig. 5F]. Both GFP- and
TLX-overexpressing cells display an increase in mRNA
expression of IkBa in response to IL-1b treatment; how-
ever, the increase in expression only reaches significance in
TLX-transducedneurospheres [F(3, 19) = 5.71;P, 0.001 vs.
TLX; Fig 5G].
DISCUSSION
The present study demonstrates that TLX may protect
against the IL-1b–induced suppression of hippocampal
NPC proliferation, and, therefore, TLX is an important
regulator of neuroinflammatory-induced changes in hip-
pocampal neurogenesis. Specifically, we show that IL-1b
induces a decrease in hippocampal NPC neurosphere ex-
pansion,which is consistentwith previous reports (28, 30).
This decrease is associated with a significant reduction in
TLX expression—a regulator of NPC proliferation—and
an increase in p21 expression, a mediator of cell-cycle ar-
rest and reduced proliferation (55–57). In addition, we
demonstrate that IL-1b recruits the NF-kB pathway in
embryonic hippocampal NPC neurospheres and that
pharmacologic inhibition of this pathway is sufficient to
reverse the negative effects of IL-1b on TLX expression.
Finally, we show that the restoration of TLX expression in
the presence of IL-1b protects against the IL-1b–induced
suppression of neurosphere expansion. This suggests that
TLX can mitigate the antiproliferative effects of IL-1b on
hippocampal NPCs.
We and others have previously established that IL-1b
induces a decrease in hippocampal NPC proliferation in
cultures of embryonic and adult neurospheres (28, 30, 39),
and neurosphere expansion has been correlated with in-
creased proliferation ofNPCs fromboth the hippocampus
and the subventricular zone of the lateral ventricles (46,
58). We also observed that IL-1b at the dosage and dura-
tion of treatment that were used in the current study does
not affect cell viability; however, we did demonstrate that
Figure 2. A, B) IL-1b induces the rapid activation of NF-kB signaling in proliferating hippocampal NPCs. Ratio of nuclear to
cytoplasmic p65 staining intensity [arbitrary units (AU); n = 3; A] and relative mRNA expression of IkBa (B) in untreated and
IL-1b–treated NPCs (n = 3). C) Representative images of p65 staining. Scale bars, 5 mm. Ctrl, control. Data are expressed as
means 6 SEM *P , 0.05, **P , 0.01, ***P , 0.0001 (ANOVA with Bonferroni post hoc test).
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IL-1b decreased mRNA expression of TLX after a short
treatment duration for up to 24 h as well as after a longer
treatment duration of 5 d. This supports previously
published data that report an IL-1b– induced decrease in
the protein expression of TLX at both 24 h (28) and
7 d (30). As TLX promotes cell proliferation, suppression
of neurosphere expansion in response to IL-1b is po-
tentially mediated via reduced expression levels of TLX.
In addition, we observed an increase in mRNA expres-
sion of the TLX target gene, p21, after IL-1b treatment for
up to 5 d. p21 expression in suppressed by TLX, and
when its expression is increased, it induces cell-cycle
Figure 3. IL-1b suppresses TLX expression. A, B) Relative mRNA expression of TLX (n = 3; A) and ratio of nuclear to cytoplasmic
TLX staining intensity [arbitrary units (AU); n = 3; B) in untreated and IL-1b–treated NPCs at 10 min, 30 min, 1 h, 2 h, and 4 h
post–IL-1b treatment. C) Representative images of TLX staining. Scale bars, 5 mm. D) Relative mRNA expression of TLX in
untreated and IL-1b–treated NPCs at 8 h, 16 h, and 24 h post–IL-1b treatment (n = 3). E) Relative mRNA expression of p21 in
untreated and IL-1b–treated NPCs at 10 min, 30 min, 1 h, 2 h, and 4 h post–IL-1b treatment (n = 3). F) Relative mRNA
expression of p21 in untreated and IL-1b–treated NPCs at 8 h, 16 h, and 24 h post–-1b treatment (n = 3). Ctrl, control. Data are
expressed as means 6 SEM. **P , 0.01; ***P , 0.0001 compared with control (ANOVA with Bonferroni post hoc test).
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arrest and reduces proliferation (55, 57, 59). Therefore, on
the basis of the current study and previous reports (28,
30), the ability of IL-1b to reduce neurosphere expansion
is likely a result of a reduction in NPC proliferation
rather than an induction of cell death.
The NF-kB pathway has been shown to be responsible
for the inhibition of cell proliferation in vitro and in vivo
in several cell types, including rat hippocampal NPCs,
mouse embryo fibroblasts, and human epithelial cells
(39, 60, 61). IL-1b has previously been shown to recruit
the NF-kB pathway to suppress hippocampal NPC
proliferation in vivo (39). NF-kB is rapidly activated in
response to IL-1b in human glial cells (53) and, there-
fore, we hypothesized that a rapid activation may also
occur in hippocampal NPCs. Indeed, we observed that
translocation of the p65 subunit to the nucleus [an
Figure 4. Inhibition of NF-kB signaling prevents the IL-1b–induced decrease in TLX expression. A, B) Relative mRNA expression
of TLX (A) and nuclear TLX protein expression (B) in untreated, IL-1b–treated, JSH-23–treated, and IL-1b+JSH-23–treated
hippocampal NPCs. C) Representative images of TLX staining. Scale bars, 5 mm. D, E) Relative mRNA expression of p21 (D) and
IkBa (E) in untreated, IL-1b–treated, JSH-23–treated, and IL-1b+JSH-23–treated hippocampal NPCs. AU, arbitrary units; Ctrl,
control. Data are expressed as means 6 SEM. *P , 0.05, ***P , 0.001 compared with vehicle; +P , 0.05, +++P , 0.001 compared
with IL-1b (ANOVA with Bonferroni post hoc test).
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Figure 5. TLX overexpression (OEX) protects the IL-1b–induced suppression of neurosphere growth. A) Effect of GFP OEX on
IL-1b–induced changes in neurosphere growth. *P , 0.05; **P , 0.01, control (Ctrl) compared with GFP+IL-1b; $$$P , 0.001,
Ctrl compared with IL-1b; ++P, 0.01 GFP compared with GFP+IL-1b; ##P, 0.01; ###P, 0.001 GFP compared with IL-1b (2-way
ANOVA with Bonferroni post hoc test; n = 7). B) Effect of TLX OEX on IL-1b–induced changes in neurosphere growth. $$P , 0.01;
$$$P , 0.001, Ctrl compared with IL-1b; +P , 0.05 Ctrl compared with TLX; ##P , 0.01; ###P , 0.001 TLX compared with IL-1b;
(continued on next page)
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indicator of NF-kB activation (62, 63)] of hippocampal
NPCs within 10 min of IL-1b administration. We also
demonstrated the activation of the NF-kB target gene,
IkBa, within this timeframe. Inhibition of NF-kB acti-
vation by using JSH-23 (39, 64–66) abrogated the
IL-1b–induced decrease in TLX mRNA and protein
expression in hippocampal NPCs after 3 h of exposure
to IL-1b and also attenuated the IL-1b–induced increase
in IkBa mRNA expression. Thus, the NF-kB pathway
seems to be a potential mediator of IL-1b–induced
changes, not only on NPC proliferation as previously
shown (39, 54), but also on TLX expression. It is tempting
to speculate that the suppression of TLX by IL-1b via en-
hanced NF-kB activation is the predominant mechanism
that determines the outcome of IL-1b–induced changes in
the proliferation of NPCs. The data herein would suggest
that the IL-1b–induced activation of NF-kB results in the
suppression of TLX gene expression, which results in a
subsequent decline in TLX protein expression and NPC
proliferation. This mechanistic pathway would be more
likely than a direct protein interaction between TLX and
NF-kB signaling because of the fact that changes in TLX
and p65 expression occur at largely different time points
and locations within NPCs.
We did not observe an effect of NF-kB inhibition on
the expression of the TLX target gene, p21, in response
to IL-1b. JSH-23 has been established as a selective NF-
kB inhibitor, but any nonspecific signaling effects that
JSH-23 treatment may have on hippocampal NPCs that
may impact target genes cannot be ruled out (64, 67, 68).
However, we observed that JSH-23 treatment attenu-
ated the IL-1b–induced increase in the NF-kB target
gene, IkBa; therefore, our data are a proof of concept
that NF-kB signaling, at least in part, is responsible for
the effects of IL-1b on TLX expression. It should be
noted, though, that IL-1b does not exclusively recruit
NF-kB signaling pathway components to mediate its
effect on hippocampal NPC proliferation (69–71). Spe-
cifically, it has previously been demonstrated that IL-1b
treatment for 48 h induced the activation of SAPK/JNK
signaling in embryonic rat forebrain NPCs in vitro and
that SAPK/JNK signaling, not the NF-kB pathway,
mediated the IL-1b–induced decrease in the prolifera-
tion of these NPCs (69). Differences reported in that
study may be related to brain region, embryonic age of
NPCs, or treatment duration of IL-1b. Results also
suggest that, at specific stages in development, IL-1b
may recruit different pathways to exert its effects on
NPCs, or, indeed, longer incubations with IL-1b may
result in different signaling pathway activation. We
have previously shown that IL-1b can increase the ac-
tivity of glycogen synthase kinase 3 b (GSK-3b), a
negative regulator ofWnt signaling pathway (72), in the
proliferation of hippocampal embryonic NPCs with
subsequent reductions in proliferation (30). In addi-
tion, that study demonstrated that when GSK-3b was
inhibited, the IL-1b–induced suppression of NPC pro-
liferation and TLX expression were ameliorated; how-
ever, that study assessed the effects of chronic IL-1b
administration, and, hence, GSK-3b—and potentially
Wnt signaling—may regulate the chronic effects of IL-1b
on TLX and NPC proliferation. Of interest, GSK-3b can
interact with NF-kB signaling to regulate cytokine pro-
duction; therefore, the protective effects of the inhibition
of GSK-3b after IL-1b exposure may be indirectly medi-
ated by the subsequent effect on NF-kB signaling (73, 74).
Assessment of the differential activation of specific path-
ways in response to individual activators as NPCs pro-
liferate, differentiate, and integrate into the surrounding
neuronal circuitry provides an interesting avenue for fu-
ture research.
An interesting insight into the transcriptional effects of
IL-1b in NPCs is the increase in p21 expression after IL-1b
treatment of proliferating NPCs that is demonstrated in
this study. p21 is a potent suppressor of the cell cycle, and,
subsequently, is an important regulator of cell pro-
liferation (56). TLXhaspreviously been shown to suppress
the expression of p21 in neural stem cell cultures (un-
known source), which is correlated with an increase in
NPCproliferation (55); however, the studydidnotattempt
to manipulate the increase in p21 expression—either by
knockdownoranothermethodof inhibition—to assess the
direct role of p21 on neural stem cell proliferation (55). The
importance of p21 in regulating the proliferation of hip-
pocampalNPCshas sincebeenestablished inp212/2mice
for which there is a significant increase in NPC pro-
liferation (59); therefore, it is reasonable to suggest that the
mechanismbywhichTLX regulates proliferation involves
the regulation of p21 expression. We demonstrate here
that when TLX expression is suppressed by IL-1b, there is
a concurrent increase in p21 expression, which suggests
that IL-1bmay suppress NPC proliferation by enhancing
p21 expression. This theory is supported by findings that
show an increase in hippocampal IL-1b expression, a
subsequent increase in hippocampal p21 expression, and
reduced hippocampal NPC proliferation and neuronal
differentiation in a mouse model of inflammatory bowel
disorder (75).
Deficits in neurogenesis in TLX-null mice have been
reported by several research groups (46, 55, 76, 77). For
**P , 0.01; ***P, 0.001 TLX+IL-1b compared with IL-1b (2-way ANOVA with Bonferroni post hoc test; n = 7). C) Comparison of
GFP OEX and TLX OEX on IL-1b–induced changes in neurosphere growth. *P , 0.05 GFP compared with TLX; $$P , 0.01
GFP compared with GFP+IL-1b; ++P , 0.01; +++P , 0.001 TLX compared with GFP+IL-1b; ##P , 0.01; ###P , 0.001 TLX+IL-1b
compared with GFP+IL-1b (2-way ANOVA with Bonferroni post hoc test; n = 7). D) Comparison of GFP OEX and TLX OEX on
IL-1b–induced changes in neurosphere growth at 6 DIV. ***P , 0.001 GFP compared with GFP+IL-1b (1-way ANOVA with
Bonferroni post hoc test; n = 7). E) Representative images of GFP OEX and TLX OEX neurospheres, untreated or IL-1b
treated. Scale bars, 100 mm. F, G) Relative mRNA expression of TLX (F) and IkBa (G) after lentiviral treatment of
neurospheres with and without IL-1b treatment. AU, arbitrary units; Ctrl, control. Data are expressed as means 6 SEM. **P , 0.01
GFP compared with GFP+IL-1b; $$$P , 0.001 TLX compared with GFP+IL-1b; #P , 0.05 GFP+IL-1b compared with TLX+IL-1b
(Student’s t test; n = 7).
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example, Shi and colleagues have demonstrated that
NPCs of TLX2/2 mice have prolonged cell cycles and
impaired proliferation during embryonic development
(77). This was also demonstrated in adult hippocampal
NPCs, in which there was impairment in NPC pro-
liferation within the hippocampus of adult mice with an
induced recombination of theTLX gene (78). Functionally,
deficits inTLXexpression and the subsequent suppression
of hippocampal neurogenesis have been demonstrated to
impair spatial memory inmice, which is a hippocampal-
associated cognitive process (78). More recently, it has
been shown that overexpressing TLX can rescue the
proliferative defects in mice that lack TLX and improve
hippocampal neurogenesis-associated cognition, as
evidencedby improvedperformance in theMorriswater
maze (46). Taken together, these data show that TLX can
be manipulated to positively regulate hippocampal
neurogenesis and associated cognition; however, little
has been done to assess whether TLX can mitigate the
negative effects of an external insult, such as in-
flammation on hippocampal neurogenesis. In the cur-
rent study, we show that the overexpression of TLX
rescued the negative effects of IL-1b on hippocampal
neurosphere expansion. Thus, TLX may act as a regula-
tor of IL-1b–induced deficits in NPC expansion, but
whether this effect translates in vivo remains to be de-
termined. As we have demonstrated that NF-kB signal-
ing maymediate the suppressive effects of IL-1b on TLX
expression, the ability of TLX to counter the effects of
IL-1b on neurosphere expansion may not be mediated
by the suppression ofNF-kB signaling. This is because of
the fact that both GFP- and TLX-overexpressing neuro-
spheres both demonstrate a similar increase in IkBa ex-
pression after IL-1b treatment. As previously discussed,
IL-1b can recruit multiple pathways to regulate NPC
proliferation; therefore, TLX may potentially interact
with pathways other than NF-kB to mitigate the effects
of IL-1b on neurosphere expression (69, 71, 79). Not-
withstanding, our study demonstrates that TLX can
prevent the functional effects of IL-1b on neurosphere
expansion, and future studies will involve the identifi-
cation of specific signaling interactions between these 2
regulators of NPC proliferation. It should be noted,
however, that overexpression of TLX can lead to the
hyperproliferation of NPCs and increased glioma for-
mation in vivo (80, 81); however, this may be overcome
with the advent of pharmacologic ligands for TLX. In-
deed, efforts have been made to identify ligands for this
orphan nuclear receptor to target and manipulate TLX
function (82). Moreover, ligands may provide a control-
lable regulation of TLX function, thereby avoiding the
potential adverse effects of enhanced TLX expression.
In conclusion, the current studyprovides evidence that
IL-1b–induced down-regulation of TLX is mediated by
the NF-kB pathway, and that enhanced TLX expression
prevents IL-1b–induced reduction in NPC neurosphere
expansion, potentially via an NF-kB–independent mech-
anism. We propose that the IL-1b–mediated suppression
of TLX results in increased p21 expression, which leads
to reduced cell proliferation. Additional research on the
role of TLX in modulating neuroinflammatory-induced
deficits in hippocampal neurogenesis will pave theway
to the development of new therapeutic strategies for
hippocampal-dependent cognitive disorders.
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a b s t r a c t
Hippocampal neurogenesis, the process by which new neurons are born and develop into the host cir-
cuitry, begins during embryonic development and persists throughout adulthood. Over the last decade
considerable insights have been made into the role of hippocampal neurogenesis in cognitive function
and the cellular mechanisms behind this process. Additionally, an increasing amount of evidence exists
on the impact of environmental factors, such as stress and neuroinflammation on hippocampal neuroge-
nesis and subsequent impairments in cognition. Elevated expression of the pro-inflammatory cytokine
interleukin-1b (IL-1b) in the hippocampus is established as a significant contributor to the neuronal
demise evident in many neurological and psychiatric disorders and is now known to negatively regulate
hippocampal neurogenesis. In order to prevent the deleterious effects of IL-1b on neurogenesis it is nec-
essary to identify signalling pathways and regulators of neurogenesis within neural progenitor cells that
can interact with IL-1b. Nuclear receptors are ligand regulated transcription factors that are involved in
modulating a large number of cellular processes including neurogenesis. In this review we focus on the
signalling mechanisms of specific nuclear receptors involved in regulating neurogenesis (glucocorticoid
receptors, peroxisome proliferator activated receptors, estrogen receptors, and nuclear receptor subfam-
ily 2 group E member 1 (NR2E1 or TLX)). We propose that these nuclear receptors could be targeted to
inhibit neuroinflammatory signalling pathways associated with IL-1b. We discuss their potential to be
therapeutic targets for neuroinflammatory disorders affecting hippocampal neurogenesis and associated
cognitive function.
 2017 Elsevier Inc. All rights reserved.
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1. Introduction
Hippocampal neurogenesis is a process by which neurons are
born from neural progenitor cells (NPCs), and it is now known to
occur from embryonic development throughout adulthood. Evi-
dence of adult hippocampal neurogenesis first began to emerge
as early as the 1960s when radiolabelling studies in adult rats
showed that there was an increase in newborn cells within the
dentate gyrus (DG) of the hippocampus (Altman and Das, 1965).
More recently, it has been estimated that approximately 700 new
neurons are generated in the hippocampus of humans daily
(Spalding et al., 2013). Functionally, hippocampal neurogenesis
has been associated with hippocampal-dependent behaviours such
as episodic and spatial learning and memory, as well as regulation
of emotion (Deng et al., 2010; Aimone et al., 2014; Zhao et al.,
2008; O’Leary and Cryan, 2014). Indeed, reductions in hippocampal
neurogenesis have been associated with neurological and psychi-
atric disorders such as Alzheimer’s disease and major depression,
as well as with aging (Verret et al., 2007; Sahay and Hen, 2007;
Kuhn et al., 1996). This then raises the question; can therapies
aimed at protecting hippocampal neurogenesis be used to subse-
quently improve cognitive function in these diseases?
A common denominator in these conditions is the elevation in
the expression of a key pro-inflammatory cytokine interleukin-1b
(IL-1b) within the hippocampus (McGeer et al., 1994; Sluzewska
et al., 1996; Leonard and Myint, 2006). IL-1b has been shown to
negatively affect various stages of hippocampal neurogenesis from
the proliferation of NPCs to their differentiation into neurons or
astrocytes (Green and Nolan, 2012; Ben Menachem-Zidon et al.,
2008; Goshen et al., 2008). Therefore, targeting regulators of these
processes in NPCs could potentially mitigate the effects of IL-1b on
hippocampal neurogenesis and associated cognition. In this regard,
nuclear receptors (NR) are suitably poised as ideal therapeutic tar-
gets due to the fact that many are expressed within NPCs where
they regulate aspects of neurogenesis. However, the question
remains – can manipulating these regulators of neurogenesis pre-
vent the negative effects of IL-1b on hippocampal neurogenesis
and associated cognitive function? This review aims to address this
question by firstly highlighting aspects of hippocampal neurogen-
esis that are regulated by both NRs and IL-1b, and secondly by
exploring any signalling overlap between NRs and IL-1b with a
view to identifying therapeutic targets for neurological or psychi-
atric disorders where deficits in hippocampal associated cognition
is evident.
2. Hippocampal neurogenesis
Within the adult brain of many mammalian species including
rodents and non-human primates, neurogenesis occurs in two
specific regions known as neurogenic niches, namely the subven-
tricular zone (SVZ) of the lateral ventricles and the subgranular
zone (SGZ) of the DG in the hippocampus (Suh et al., 2009;
Eriksson et al., 1998; Alvarez-Buylla and Lim, 2004). In these niches
it has been shown that NPCs have the ability to replenish them-
selves via symmetrical division, or differentiate into specialized
cells of the CNS such as mature neurons or astrocytes via asymmet-
rical division (Gage et al., 1995; Fisher, 1997; Zhao et al., 2008). In
humans, while there is clear evidence to show ongoing neurogen-
esis in the DG of the hippocampus, there appears to be negligible
levels of SVZ neurogenesis (Bergmann et al., 2012; Spalding
et al., 2013). More recently, it has been proposed that neurogenesis
occurs within the striatum of humans (Ernst et al., 2014). Hip-
pocampal neurogenesis has been widely studied in terms of both
its mechanism and functional role and will be the focus of this
review. Multipotent neural stem cells (NSCs) reside within the
embryonic and adult hippocampus and can give rise to NPCs
(Gage, 1998; Kriegstein and Alvarez-Buylla, 2009; Eriksson et al.,
1998). The distinctions between NPCs and NSCs are not yet clearly
defined yet it is thought that NPCs are an intermediary between
NSCs and differentiated cells and have a more limited capacity
for self-renewal compared to NSCs (Gage, 1998, 2000; Sohur
et al., 2006; Olynik and Rastegar, 2012). For simplicity, in this
review NPCs will refer to all undifferentiated cells that have the
ability to self-replicate and differentiate into various cellular lin-
eages of the central nervous system (CNS) such as neurons, astro-
cytes or oligodendrocytes.
2.1. Developmental vs adult hippocampal neurogenesis
Development of the DG begins at embryonic day (E) 14 in the
rat (Schlessinger et al., 1978; Laplagne et al., 2007). By E18, prolif-
erating neuroblasts have formed the granular cell layer (GCL) with
mature granule neurons evident 2–3 days before birth. The DG
then continues to form until it is fully developed by postnatal
day (P) 30. At this point NPCs are established in the SGZ where
neurogenesis occurs throughout adulthood (Gage, 2000; Altman
and Bayer, 1990). In the DG of the human brain, the granule neu-
rons are identifiable at gestational week 11.5 (Humphrey, 1967).
Using the proliferation marker Ki67 it has been shown that prolif-
erating cells are widespread at the 14th week of gestation in vari-
ous hippocampal regions, and as gestation progresses these
proliferating cells become more restricted to the hilus region of
the DG (Seress, 2007). It should be taken into account that humans
have a much longer gestational period as well as having a larger
hippocampal formation than rodents. Thus, taking rodent gestation
to be approximately three weeks and human gestation to be on
average 40 weeks, the appearance of granule neurons appear rela-
tively much earlier in humans than rodents. However, this may
also be due to the evolutionary differences between rodents and
humans.
The cellular processes involved in embryonic and adult neuro-
genesis are very similar with the two main differences between
each primarily arising from differences in the tissues that the NPCs
are situated (Kempermann et al., 2004). Firstly, adult NPCs require
a microenvironment conducive to neurogenesis (the neurogenic
niche) within a larger non-neurogenic environment. In effect, adult
NPCs need to be protected from the wide range of potential anti-
neurogenic influences, which may reside within the surrounding
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brain tissue. In this regard, it has been shown that adult rat NPCs
derived from the spinal cord, a non-neurogenic region, show self-
renewal and multipotentiality properties once transplanted into
the DG, indicating that the microenvironment in the DG is crucial
for providing support for neurogenesis to occur (Shihabuddin
et al., 2000). Secondly, adult neurogenesis is an individualistic pro-
cess with cells at all stages of development present in the same
microenvironment at the same time, whereas embryonic neuroge-
nesis is a highly coordinated process with large groups of cells
undergoing the same developmental process at the same time
(Kempermann et al., 2004). Despite these differences, individual
adult NPCs have been shown to undergo all of the same cellular
processes as embryonic NPCs during developmental neurogenesis
i.e. proliferation, differentiation, and functional integration of new-
born neurons (Kempermann et al., 2004; Zhao et al., 2008). Addi-
tionally, the intracellular mechanistic features that regulate each
stage of neurogenesis in the DG are suggested to be the same
throughout all stages of development (Pleasure et al., 2000). There-
fore, promoters and inhibitors of neurogenesis are likely to have
similar effects on intracellular signalling mechanisms in both
embryonic NPCs and adult derived NPCs.
2.2. Function of hippocampal neurogenesis
A growing body of evidence over the past two decades suggests
that newly born neurons in the adult hippocampus contribute to
hippocampal dependent learning and memory (Deng et al.,
2010). Techniques to manipulate neurogenesis in rodents have
provided direct evidence of the role of hippocampal neurogenesis
in behaviour. These include irradiation of the hippocampus (Huo
et al., 2012; Madsen et al., 2003; Saxe et al., 2006), as well as trans-
genic animal models (Snyder et al., 2016; Cummings et al., 2014;
Saxe et al., 2006) and viral mediated techniques targeting neuro-
genic promoters specifically within NPCs (Murai et al., 2014;
Jessberger et al., 2009; Taliaz et al., 2010) to ablate or enhance neu-
rogenesis. The majority of these techniques have been used to
ablate hippocampal neurogenesis and have demonstrated impair-
ments in hippocampal associated behaviours, such as novel object
and novel location recognition, fear conditioning, long-term spatial
memory in a Morris water maze test, and pattern separation (an
ability to distinguish two similar contexts) (Jessberger et al.,
2009; Saxe et al., 2006; Clelland et al., 2009; Snyder et al., 2005;
Dupret et al., 2008; Deng et al., 2009; Sahay et al., 2011;
Winocur et al., 2006; Tronel et al., 2012). It should be noted that
it has also been reported that alterations in hippocampal neuroge-
nesis had no effect on some of these hippocampal-dependent tasks
(Hernandez-Rabaza et al., 2009; Wojtowicz et al., 2008; Groves
et al., 2013). Furthermore, a meta-analysis of the relevant literature
revealed no significant effects of ablation of adult neurogenesis on
spatial memory or cued fear conditioning (Groves et al., 2013),
although the meta-analysis showed high levels of heterogeneity
among the studies. Overall, while there is general consensus that
hippocampal neurogenesis is required for pattern separation, the
functional role of hippocampal neurogenesis has not yet been
clearly demonstrated. It has been suggested that the heterogeneity
in the findings to date may be due to differences in species, method
of ablation, behavioural test used or in the variation in stress levels
(Groves et al., 2013; Dranovsky and Leonardo, 2012; Glasper et al.,
2012). For example, it has been suggested that the environment
that the new neurons are born into will determine their functional
significance (Dranovsky and Leonardo, 2012; Glasper et al., 2012)
in that neurons born in conditions of low stress contribute to learn-
ing and memory while neurons born in conditions of high stress
contribute to anxiety like behaviours (Glasper et al., 2012). Indeed,
evidence now suggests that there is a critical role for hippocampal
neurogenesis in the stress response and in the regulation of emo-
tion (Cameron and Glover, 2015; Levone et al., 2015; Snyder
et al., 2011). Moreover, recent evidence indicates that there is over-
lap between the role of neurogenesis in learning and emotion by
demonstrating that inhibition of adult neurogenesis in the mouse
DG reduces defensive behaviour to ambiguous threat cues but does
not if the same negative experience is reliably predicted (Glover
et al., 2017).
One proposed cellular mechanism for learning and memory is
via changes in hippocampal synaptic plasticity. Long term potenti-
ation (LTP) is an electrophysiological correlate of changes in synap-
tic plasticity and it has been shown that adult born neurons
contribute to LTP formation within the DG of rats (Snyder et al.,
2001). Ablation of neurogenesis by use of either transgenic mice
or hippocampal irradiation inhibited LTP formation in the DG
(Wang et al., 2008; Garthe et al., 2009). Interestingly, stress has
been shown to impair DG LTP (Vereker et al., 2001) while LTP itself
can increase the proliferation of NPCs in the DG if it is induced in
the medial perforant pathway, which relays synaptic input to the
DG (Bruel-Jungerman et al., 2006).
Another insight into the functional role of hippocampal neuro-
genesis emerged when it was shown that ablation of neurogenesis
by irradiation blocked the behavioural effects of antidepressants in
mice (Santarelli et al., 2003). This coupled with the discovery in the
late 1990s of a pro-neurogenic effect of antidepressants (Malberg
et al., 2000; Malberg and Duman, 2003; Gur et al., 2007) has led
to the theory that some antidepressants work by altering neuroge-
nesis (O’Leary and Cryan, 2014; Tanti and Belzung, 2013; Eisch and
Petrik, 2012). It has been shown that neurogenesis and its func-
tional consequences can be selectively enhanced by promoting cell
survival. Specifically, a subsequent improvement in pattern separa-
tion has been reported in transgenic mice where NPC survival was
enhanced by selectively ablating the pro-apoptotic gene Bax in
NPCs (Sahay et al., 2011). It has also been established that increas-
ing hippocampal neurogenesis via physical exercise induces an
improvement in cognitive performance (Voss et al., 2013; van
Praag et al., 2005; Ryan and Kelly, 2016). However, enhancing neu-
rogenesis is complex due to its multifactorial process of prolifera-
tion, differentiation, and survival of the newborn neurons and thus
it may be difficult to definitively uncover the role of enhanced neu-
rogenesis by manipulating one aspect of the process.
2.3. Regulation of hippocampal neurogenesis
Hippocampal neurogenesis is regulated by a wide range of
intrinsic signalling molecules as well as by external factors influ-
enced by the surrounding environment (Aimone et al., 2014).
Intrinsic regulators of hippocampal neurogenesis include intracel-
lular signalling pathways within NPCs, such as Wnt, Notch, nuclear
factor kappa B alpha (NF-jB) and mitogen activated protein kinase
(MAPK) (Johnson et al., 2009; Aimone et al., 2014; Mu et al., 2010;
Lie et al., 2005; Breunig et al., 2007; Faigle and Song, 2013). These
intrinsic factors regulate gene expression within NPCs in order to
control their proliferation, differentiation and maturation into neu-
rons or glia (Mu et al., 2010). Expression and function of these
intrinsic regulators can be altered by external environmental fac-
tors, which subsequently lead to altered hippocampal neurogene-
sis. The main external environmental factors that influence
hippocampal neurogenesis include stress, exercise, diet, learning,
environmental enrichment, and environmental toxins (Besnard
and Sahay, 2016; van Praag et al., 1999a, Stangl and Thuret,
2009; Deng et al., 2010; Brown et al., 2003). Voluntary exercise,
learning, environmental enrichment, and a healthy diet have all
been shown to promote neurogenesis (van Praag et al., 1999a,b,
Gould et al., 1999; An et al., 2008). However, the mechanism
underlying their positive effects on neurogenesis is the subject of
much research. For example, enhanced serum concentration of
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brain derived neurotrophic factor (BDNF) and increased levels of
dietary nutrients, such as flavonoids (enriched in foods such as
cocoa and blueberries) have been proposed as mediators of the
pro-neurogenic effects of diet and exercise, respectively (Erickson
et al., 2011; An et al., 2008). Environmental factors that negatively
regulate neurogenesis include stress, an unhealthy diet, and envi-
ronmental toxin exposure (Gould et al., 1998; Lindqvist et al.,
2006; Sava et al., 2007; Desplats et al., 2012). Interestingly, these
negative regulators are all associated with neuroinflammation as
evidenced by increased microglial activation and increased pro-
inflammatory cytokine release (Tynan et al., 2010; Goshen et al.,
2008; Goshen and Yirmiya, 2009; Boitard et al., 2014; Purisai
et al., 2007). Pro-inflammatory cytokines released from activated
microglia can affect many aspects of hippocampal neurogenesis
including the proliferation, differentiation, andmaturation of NPCs,
thus they are robust manipulators of hippocampal neurogenesis
(Green et al., 2012; Green and Nolan, 2012; Ryan et al., 2013;
Keohane et al., 2010; Yirmiya and Goshen, 2011; Borsini et al.,
2015). While microglia are the predominant source of pro-
inflammatory cytokines within the brain (Hanisch and
Kettenmann, 2007), it should be noted that astrocytes are also sus-
ceptible to stimulation and can release cytokines. However, they
produce relatively low levels of cytokines but have been shown
to potentiate the release of cytokines from microglia in response
to an inflammatory insult (Barbierato et al., 2013; Chen et al.,
2015).
3. Regulation of hippocampal neurogenesis by IL-1b
It is now well established that neuroinflammation induced by
injury, neurodegeneration, aging, as well as environmental factors,
such as stress, unhealthy diet, and toxins (e.g. 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) and paraquat) can negatively
affect hippocampal neurogenesis, (Fig. 1) (Ekdahl et al., 2003;
Monje et al., 2003; O’Leary et al., 2012; Heine et al., 2004; Green
and Nolan, 2014; Hueston et al., 2017; Klein et al., 2016; Li et al.,
2017). Neuroinflammation contributes to the pathophysiology of
many psychiatric and neurodegenerative disorders where cogni-
tive dysfunction and reductions in hippocampal neurogenesis are
evident including Alzheimer’s disease (AD), Parkinson’s disease
(PD), and depression as well as aging (Raison et al., 2006;
Leonard, 2007; Tang et al., 2016; Höglinger et al., 2004). Indeed,
in aged individuals and in both patients and animal models of
AD, PD, and depression there is evidence of a heightened inflam-
matory state including increased pro-inflammatory cytokine
expression within the hippocampus (Monson et al., 2014;
Heppner et al., 2015; Heneka et al., 2015; Ryan and Kelly, 2016;
Nolan et al., 2013, 2005). For example, heightened expression of
pro-inflammatory cytokines in the cerebrospinal fluid of AD
patients becomes evident in the preclinical stages of the disease
concurrent with mild cognitive impairments (Monson et al.,
2014). Additionally heightened expression of inflammatory cytoki-
nes have been demonstrated specifically within hippocampal tis-
sue of AD patients and rodent models (Sheng et al., 1995; Hauss-
Wegrzyniak et al., 1998). Levels fluctuate as the disease persists
with elevated expression again evident in post-mortem hippocam-
pal tissue (Monson et al., 2014; Heppner et al., 2015). Similarly in
PD, pro-inflammatory cytokine expression is predominantly
chronically elevated in brain tissue and it is proposed that a persis-
tent inflammatory microenvironment around the susceptible neu-
rons potentiates the disease progression (Herrero et al., 2015;
Collins et al., 2012). Evidence from both human and animal studies
show that both peripheral and hippocampal chronic low grade
inflammation plays an important role in the pathology of depres-
sion, and it is particularly apparent in patients with treatment-
resistant depression, and in patients who have experienced some
form of early life trauma (Pariante, 2017; Kim et al., 2016) .
IL-1b is a pro-inflammatory cytokine that plays a role in hip-
pocampal neuroinflammation due to its heightened receptor
expression profile in the hippocampus (Farrar et al., 1987). While
there is evidence to suggest that low expression levels of IL-1b
are required for hippocampal-related learning and memory it is
well established that chronically elevated IL-1b has detrimental
effects on memory and cognition (Yirmiya and Goshen, 2011;
Lynch, 2015). IL-1b is produced predominantly by microglia but
also by pyramidal neurons and astrocytes in the hippocampus
(Bandtlow et al., 1990; Lechan et al., 1990; Eriksson et al., 1999;
Barbierato et al., 2013) and is released into the extracellular matrix,
where it binds to its cognate receptor interleukin receptor type 1
(IL-1R1), which is expressed on NPCs in the hippocampus
(Hanisch and Kettenmann, 2007; Rothwell et al., 1996; Green
and Nolan, 2012). Thus, as well as influencing the function of
mature neurons, IL-1b can directly influence NPCs via interaction
with IL-1R1 on both embryonic and adult NPCs (Green and
Nolan, 2012; Ryan et al., 2013). It should be noted that IL-1b may
differentially influence NPCs or respond to changes in neurogenesis
depending on the time during the lifespan at which changes in
either inflammatory insult or neurogenesis occur. For example,
an increase in hippocampal IL-1b was demonstrated in juvenile
rats but not in adult rats subjected to whole brain irradiation
(Blomstrand et al., 2014), which ablates neurogenesis, and thus
suggests that different inflammatory mechanisms may be involved
in regulating hippocampal neurogenesis at different ages. Likewise,
inflammatory-induced changes in neurogenesis during embryonic
or postnatal development may result in overall changes in the
number of proliferating cells in the adult DG, which may conse-
quently cause structural changes in the hippocampus, and ulti-
mately lead to changes in behaviour (Green and Nolan, 2014).
Development of anti-inflammatory interventions to circumvent
inflammatory-induced impairments in neurogenesis and associ-
ated hippocampal functions should also take into consideration
the timing during the lifespan of the intervention. Taken together,
the evidence to date suggests that the mechanism underlying IL-
1b-induced changes in neurogenesis during both development
and in the adult hippocampus represents an important avenue
for future research.
Upon binding to IL-1R1, IL-1b induces an intracellular signalling
cascade, which ultimately leads to altered gene expression of IL-1b
target genes and a heightened pro-inflammatory response (Sims
et al., 1993). Alternatively, IL-1b can bind to IL-1R2, which is a
decoy receptor and does not produce a physiological response
(McMahan et al., 1991). The expression of IL-1R2 has not been
demonstrated on NPCs. However, it has been shown to be mainly
expressed on microglia, which suggests it plays a role in dampen-
ing cytokine-induced activation of microglia (Pinteaux et al., 2002).
IL-1b signalling is inhibited by the IL-1 receptor antagonist (IL-
1RA), which binds with almost equal affinity as IL-1b to IL-1R1
(Seckinger et al., 1987; Hannum et al., 1990). IL-1RA is expressed
and produced by both pyramidal neurons and microglia within
the hippocampus (Eriksson et al., 1999). IL-1b has been shown to
negatively impact upon the proliferation, differentiation, and sur-
vival of hippocampal NPCs in cultures of rat hippocampal NPCs
(Green et al., 2012; Ryan et al., 2013). There is further in vitro evi-
dence to suggest that IL-1RA can reverse IL-1b-induced suppres-
sion of NPC proliferation as well as its promotion of astrogenesis
in cultures of rat hippocampal neurospheres (Green and Nolan,
2012; Ryan et al., 2013; Koo and Duman, 2008).
It has also been shown that IL-1b can suppress neuronal differ-
entiation in a human hippocampal progenitor cell line (Zunszain
et al., 2012). While this study reported an increase in cell prolifer-
ation in response to IL-1b, which is contrary to what has been
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shown in rodent cell models, the increase in cell proliferation does
not necessarily indicate enhanced neurogenesis. It is possible that
an increase in cell proliferation in response to IL-1b leads to a phe-
notypic shift towards astrocyte rather than neuronal production, as
has been previously demonstrated in response to IL-1b in primary
cultures of rat NPCs (Green et al., 2012). It is also possible that the
signalling mechanisms underlying IL-1b-induced changes in cell
proliferation in human and rodent NPCs are not comparable but
this has yet to be explored in more detail. In addition, it is likely
that immortalised cells such as the human hippocampal progenitor
cell line, may respond differently to cytokine stimulation than cul-
tured primary cells or indeed than NPCs in vivo, due to genotypic
and phenotypic variation which can come about due to serial pas-
saging of cell lines over time (Pan et al., 2009). Notwithstanding,
these discrepancies highlight the importance of assessing not only
the proliferation status of NPCs but also their differentiation phe-
notype as only the complete progression from proliferating NPCs
to integrated mature neurons represents successful neurogenesis.
In vivo studies have provided evidence that there are functional
implications of neurogenesis as a mediator of IL-1b-induced
changes in cognitive behaviours. For example, impairments in
performance in the Morris water maze (MWM) and reduced
Fig. 1. IL-1b, nuclear receptors, and neurogenesis. IL-1b is released within the hippocampus in response to a host of factors, such as an unhealthy diet, increased age, brain
injury, stress, environmental toxin exposure, and neurodegeneration. This can lead to suppression of neurogenesis and an impairment of hippocampal-dependent behaviours.
Nuclear receptors (NRs) are known to regulate neurogenesis and are commonly targeted by small molecule therapeutics. As there is evidence to link NR signalling with
signalling pathways activated by IL-1b, there is potential to therapeutically manipulate NRs to mitigate IL-1b-induced impairments in neurogenesis and hippocampal
dependent cognition.
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neurogenesis due to elevated levels of hippocampal IL-1b in
rodents can be rescued by administration by of IL-1RA (Ben
Menachem-Zidon et al., 2014). Thus, IL-1RA is an important tool
to examine the effects of IL-1b signalling on hippocampal neuroge-
nesis and associated behavioural tasks. See Table 1 for a summary
of evidence showing the effects of IL-1b on hippocampal neuroge-
nesis and associated cognition.
3.1. IL-1b signalling pathways in NPCs
Downstream from IL-1R1, the NF-jB signalling pathway is one
of the major mediators of the IL-1b intracellular response (Fig. 2).
NF-jB is composed of homo- or heterodimeric combinations of
the Rel family of proteins consisting of p52, p65 (Rel A), c-Rel, RelB,
and p50. These proteins work in combination or with other co-
factors, such as creb binding protein (CBP) to regulate the tran-
scription of NF-jB target genes (Sheppard et al., 1999). The expres-
sion of p52, p65, p50, and CBP has been reported in NPCs from
embryonic and rat forebrain where they have been shown to be
involved in a range of processes, such as proliferation of NPCs
and regulation of the effects of environmental enrichment on neu-
rogenesis (Shingo et al., 2001; Lopez-Atalaya et al., 2011;
Kaltschmidt and Kaltschmidt, 2009). RelB and c-Rel are expressed
on migratory NPCs involved in SVZ neurogenesis and thus may
play a role in the regulation of NPC migration (Denis-Donini
et al., 2005). Evidence for the role of NF-jB signalling in neuroge-
nesis comes from the fact that inhibition of NF-jB pathway by a
specific pharmacological NF-jB signalling inhibitor impaired NPC
neuronal differentiation in mouse NPCs in vitro (Rolls et al.,
2007). Additionally, it has been shown in vitro that inhibition of
NF-jB signalling impaired mouse NPC proliferation and neuronal
differentiation (Zhang et al., 2012). A limited number of research
studies have been carried out using human NPCs to highlight the
signalling pathways employed by IL-1b. Zunszain and colleagues
have shown that IL-1b increases the expression of enzymes
involved in the kynurenine pathway in differentiating human hip-
pocampal NPCs (Zunszain et al., 2012). This metabolic pathway is
responsible for the enzymatic catabolism of tryptophan, the main
amino acid involved in serotonin production, into kynurenine,
which is known for its immunomodulatory effects (Nguyen et al.,
2010). Dysregulation of this pathway has been associated with
immune activation and it has been demonstrated to be activated
during cytokine-induced depression (Dantzer et al., 2011; Davis
and Liu, 2015). Interestingly, mice lacking the enzyme
tryptophan-2,3-dioxygenase (TDO), which is involved in the cata-
bolism of tryptophan, display enhanced hippocampal neurogenesis
(Kanai et al., 2009). Moreover, it has been shown that the kynure-
nine pathway is activated by NF-jB in human placental cells
(Dharane Nee Ligam et al., 2010). Thus, it is tempting to speculate
that IL-1bmay impair neurogenesis in the human hippocampus via
NF-jB-mediated enhancement of kynurenine pathway activation.
Functional associations have also been made between impaired
NF-jB signalling and deficits in hippocampal neurogenesis-
associated cognition. It has been reported that reduced neuronal
differentiation and impairments in spatial memory were evident
in p50-deficient mice (Denis-Donini et al., 2008). Despite this evi-
dence on the role of NF-jB signalling in neurogenesis, the direct
interaction between IL-1b and NF-jB activation in NPCs has not
been well studied. The main evidence for a role of NF-jB signalling
in IL-1b-induced effects on hippocampal neurogenesis has shown
Table 1
IL-1b and neurogenesis. Summary of the effects of IL-1b on hippocampal neurogenesis, signalling mechanisms and function. Embryonic day (E), postnatal day (P), Morris water
maze (MWM), overexpression (OEX), intracerebroventricular (ICV), Alzheimer’s disease (AD).
Species IL-1b Manipulation IL-1b
Signalling
Mechanism
Effects in vitro Effects in vivo Gross effect on
neurogenesis
Reference
E18 rat 10 ng/ml in culture media Upregulation
of GSK-3b
; NPC proliferation
" Astrocytic
differentiation
; Neuronal differentiation
– ; Green and Nolan
(2012) Green et al.
(2012)
Adult rat 10 ng/ml in culture media IL-1R1 binding ; NPC proliferation
; Neuronal differentiation
– ; Ryan et al. (2013)
Adult rat Interferon alpha mediated
increase in IL-1b
IL-1R1 binding ; NPC proliferation – ; Kaneko et al. (2006)
1 rats 5, 10, and 10 ng/ml in
culture media
IL-1R1 binding ; Neuronal differentiation
(Serotonergic neurons)
– ; Zhang et al. (2013)
Human
hippocampal
progenitor cells
10 mg/ml in culture media – " NPC proliferation
; Neuronal differentiation
– ; Zunszain et al. (2012)
E16 rat 0.8–500 ng/ml in culture
media
" SAPK/JNK ; NPC proliferation
; Neuronal differentiation
– ; Wang et al. (2007)
Aged adult mice Inhibition of IL-1b
activation by caspase-1
cleavage
– – " proliferation " Gemma et al. (2007)
Adult mice MyD88 knockout
(disruption of IL-1R1
dependent signalling)
IL-1R1
independent
– ; NPC proliferation ; Wu et al. (2013)
Adult rat 20 ng/ml or 200 ng/ml ICV "NF-jB – ; Cell proliferation ; Koo and Duman (2008)
Mice OEX of IL-1RA – – Impaired MWM
performance
; Goshen et al. (2007)
Mice Transplantation of NPC OEX
IL-1RA
– – Prevention of stress
induced impairments
in fear conditioning
" Ben Menachem-Zidon
et al. (2008)
Mice Transplantation of NPC OEX
IL-1RA
– – Improved MWM
performance in model
of AD
Ben Menachem-Zidon
et al. (2014)
Rats Intrahippocampal IL-1b
infusion (5 ng/0.25 ll)
" MAPK (p-
ERK)
– Impaired fear
conditioning
Prevented by MAPK
inhibition
Gonzalez et al. (2013)
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that activation of the NF-jB pathway is responsible for the anti-
neurogenic effects of IL-1b in adult rats in vivo and in vitro (Koo
and Duman, 2008; Koo et al., 2010). In these studies, both stress
and IL-1b induced a significant suppression of the proliferation of
NPCs, which was prevented by NF-jB inhibition.
Another pathway thatmaymediate IL-1b-induced effects onhip-
pocampal neurogenesis is the MAPK pathway (Fig. 2) (Tong et al.,
2012; Huang et al., 2011). The MAPK pathway is a signal transduc-
tion pathway that can be activated by various cytokines and growth
factors that act on cell surface kinase-linked receptors (Johnson and
Lapadat, 2002). Once this pathway is activated there is a cascade of
protein phosphorylation, which ultimately leads to altered gene
expression and regulation of cell division, apoptosis, and tissue
regeneration (Rang et al., 2012). IL-1b has been shown to regulate
the MAPK pathway to produce various hippocampal neurogenesis
associatedcognitiveeffects. Forexample, in thehippocampusof rats,
IL-1b decreases the activation of extracellular signal-regulated
kinases 1 and 2 (ERK1/2), a component of theMAPK pathway,which
correlates with impairments in fear conditioning (Gonzalez et al.,
2013). This study assessed MAPK signalling in hippocampal tissue
as a whole rather than in any cell type in the hippocampus, and so
the specific cell or cells mediating these effects remains unknown.
A previous study employing neurosphere cultures prepared from
embryonic rat forebraindemonstrated that the stress-activatedpro-
tein kinase SAPK/JNK, a subfamily of MAPK signalling pathway, is
activated in response to IL-1b, and that inhibition of JNK can prevent
IL-1b-induced impairments in proliferation and apoptosis in these
cultures of forebrain NPCs (Wang et al., 2007). This study also
reported that IL-1b did not induce activation of p38MAPK in NPCs
(Wang et al., 2007). However, a role for any of the MAPK subtypes
in IL-1b-induced changes in proliferation or lineage fate specifically
in hippocampal NPCs has yet to be determined.
It is worth noting that IL-1b-induced activation of either NF-jB
or MAPK have different roles within the various cells types of the
hippocampus (Srinivasan et al., 2004). For example, in microglia
or astrocytes, IL-1b activates NF-jB and p38MAPK to promote fur-
ther cytokine production (Pinteaux et al., 2002; McManus et al.,
1998), whereas in hippocampal pyramidal glutamatergic neurons
IL-1b regulates synaptic functions via activation of the p38MAPK
pathway and promotes neuronal death via JNK activation
(Katsuki et al., 1990; Bellinger et al., 1993; Murray and Lynch,
1998; Kelly et al., 2001). As hippocampal NPCs possess the ability
to differentiate into either neuronal or glial cells, there may be dif-
ferential pathway activation in response to IL-1b in these younger
cells. Recent evidence into the mechanisms of IL-1b-induced
changes in NPC proliferation has highlighted that the suppression
of proliferation by IL-1b may be mediated by activation of the
p53 tumour suppressor gene within NPCs (Guadagno et al.,
2015). Interestingly, this gene has been shown to be regulated by
both NF-jB and MAPK signalling in other cell types (Shi et al.,
2014; Ryan et al., 2000; Fujioka et al., 2004) and thus provides a
rational for research into IL-1b-induced activation of these path-
ways in NPCs. The general consensus is that elevated expression
of IL-1b acts to impair hippocampal neurogenesis as shown by its
ability to repress proliferation and impair neuronal differentiation
(Ryan et al., 2013; Koo and Duman, 2008; Zunszain et al., 2012;
Green et al., 2012). However, whether the effects of IL-1b on the
various stages of neurogenesis are predominantly NF-jB or MAPK
mediated is yet to be fully resolved and provides an interesting
avenue for future research.
4. Nuclear receptors as modulators of IL-1b-induced changes in
neurogenesis
NRs are a superfamily of ligand regulated transcription factors
and are common drug targets: approximately 13% of all Food and
Drug Administration (FDA) approved drugs target NRs
Fig. 2. Schematic of IL-1b signalling cascades. Within neurogenic cells, IL-1b signals via either NF-jB or MAPK pathways. interleukin-1 beta (IL-1b), interleukin receptor type
1 (IL-1R1), interleukin receptor type 2 (IL-1R2), creb binding protein (CBP), long term potentiation (LTP), nuclear factor of kappa light polypeptide gene enhancer in B-cells
inhibitor, alpha (IjBa).
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(Rask-Andersen et al., 2011). The NR superfamily shares a similar
three domain structure. These domains include a highly conserved
DNA binding domain, a ligand binding domain, and a variable N-
terminal transactivation domain, which binds various co-
activators and co-repressors. Functionally, NRs govern many
aspects of development, reproduction, and metabolism (Sun and
Shi, 2010). As transcriptional regulators, NRs may represent conve-
nient targets to mitigate the inflammatory effects of IL-1b in the
hippocampus. Moreover, research into the effects of NRs on neuro-
genesis and how they respond to IL-1bmay highlight possible ther-
apeutic intervention targets to prevent IL-1b-associated deficits in
adult hippocampal neurogenesis and related cognitive impair-
ments. Of particular note in this regard is the glucocorticoid recep-
tor (GR), peroxisome proliferator-activated receptors (PPAR),
estrogen receptor (ER), and NR2E1 receptor (Fitzsimons et al.,
2013; Lehmann et al., 2013; Quintanilla et al., 2014; Wada et al.,
2006; Li et al., 2011; Bowers et al., 2010; Green and Nolan, 2012;
Islam and Zhang, 2014). We have selected to discuss the expression
profile, regulation, and functional role of these four key NRs in
adult hippocampal neurogenesis. We will highlight the potential
signalling overlap between these NRs and IL-1b and whether this
overlap could be exploited to regulate IL-1b-induced changes in
hippocampal neurogenesis.
5. Glucocorticoid receptor
Glucocorticoid receptors (GRs) have a pivotal role to play in the
stress response and immune function (Garcia et al., 2004; Busillo
and Cidlowski, 2013). The main activators of GRs are adrenal glu-
cocorticoid hormones or stress hormones. Corticosterone (CORT),
or cortisol in humans, is a lipophilic glucocorticoid hormone pro-
duced from cholesterol that readily passes the blood brain barrier
and can enter neuronal cells through the cell membrane. CORT is
produced mainly by the adrenal glands however there is evidence
to suggest that it is also produced within the hippocampus where
there is an abundance of enzymes required for its production
(Beyenburg et al., 2001; Gomez-Sanchez et al., 1996; Stromstedt
and Waterman, 1995). Its release is classically triggered after psy-
chological or physical stress (Sapolsky et al., 1986; Droste et al.,
2003, 2007). Once inside the cell, CORT can bind to two types of
receptor, the mineralocorticoid receptor (MR) and the GR. Activa-
tion of these receptors results in receptor dimerisation and translo-
cation to the nucleus where they regulate gene transcription. This
can lead to several physiological responses including repression of
the immune system, neuronal death, and/or neuronal maturation
and survival (Fig. 3) (Coutinho and Chapman, 2011; Reagan and
McEwen, 1997). The GR is expressed in nearly all cell and tissue
types of the body although the regulation of its expression can dif-
fer across different tissue types (Lu et al., 2006; Oakley et al., 1996;
Lu and Cidlowski, 2005). In relation to its expression within the
hippocampus, the GR has been reported to be highly expressed
within the hippocampus of both rodents and humans, particularly
within the CA1 and DG (Roland et al., 1995; Reul and De Kloet,
1985).
Fig. 3. Nuclear Receptor signalling. A) Glucocorticoid receptor (GR) signalling. B) peroxisome proliferator-activated receptor (PPAR) signalling. C) Estrogen receptor (ER)
signalling. D) NR2E1 (TLX) receptor signalling. GRs are be activated by ligands such as corticosterone in rodents. Once activated they form homodimers and regulate gene
transcription. PPARs are activated by a wide variety of synthetic and endogenous ligands and can form heterodimers with the retinoid x receptor (RXR) to regulate gene
transcription. ERs form either homo or heterodimers with other ER subtypes when activated by ligands such as estradiol. NR2E1 is an orphan nuclear receptor and as such has
no known ligand, yet it recruits various co-signalling molecules, such as HDAC3/5 and LSD1 to repress gene expression.
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5.1. GR and neurogenesis
In the hippocampus, CORT regulates information processing in
neuronal networks associated with emotion, cognition, and mem-
ory (de Kloet et al., 2009; De Kloet et al., 1998). It has also been
demonstrated that NPCs in the DG are located within close proxim-
ity to blood vessels and so are very susceptible to changes in circu-
lating CORT levels (Wurmser et al., 2004). GRs are expressed in
approximately 50% of proliferating NPCs in rodent hippocampus
while MR expression is below detectable levels (Cameron et al.,
1993; Boku et al., 2009; Garcia et al., 2004). As NPCs begin to
express the immature neuronal marker doublecortin (DCX), the
expression of GR within these cells is significantly reduced but is
restored again once the NPCs mature into neurons (Garcia et al.,
2004). This suggests that GRs initially mediate the effects of CORT
on NPCs and are then subsequently involved in the regulation of
NPC proliferation. Indeed, GR modulation has been shown to
reduce the proliferation of hippocampal NPCs with subsequent
alterations in differentiation and hippocampal network circuitry
(Fitzsimons et al., 2013; Chetty et al., 2014). For example, it has
been shown that administration of CORT to rats significantly
reduced the number of proliferating cells in the DG (Cameron
and Gould, 1994). Increased circulating CORT in rats also reduced
neuronal differentiation of hippocampal NPCs (Wong and
Herbert, 2006). Conversely, adrenalectomy, which reduces circu-
lating CORT, significantly increased the number of proliferating
cells in the rat DG (Cameron and Gould, 1994; Cameron et al.,
1993). Suppression of GR function can also lead to impairments
in hippocampal neurogenesis. For example, suppression of GR
expression has been shown to reduce the proliferation of NPCs,
accelerate their differentiation into neurons and induce abnormal
neuronal integration and excitability in new born neurons
(Fitzsimons et al., 2013). Moreover, in GR+/ mice where there is
a reduction in GR expression by 50%, there is a reduction in the
number of newborn neurons in the hippocampus, indicating that
even partial suppression of GR expression can result in neurogen-
esis deficits (Kronenberg et al., 2009). Thus, the association
between GR function and neurogenesis is complex (for an in-
depth review please see (Egeland et al., 2015)). This is especially
evident from studies showing that exercise, which is a potent pro-
moter of hippocampal neurogenesis, also increases circulating
CORT levels (Adlard and Cotman, 2004). However, a host of other
pro-neurogenic factors are released after exercise. For example,
BDNF, whose mRNA and protein expression has been shown to
be increased within neurons of the DG and CA3 of the hippocam-
pus after exercise (Cotman and Berchtold, 2002), may overcome
the suppressive effects of CORT and enhance neurogenesis
(Vaynman et al., 2004). Acute CORT administration has been
shown to enhance plasma BDNF expression (Yau et al., 2012). This
then may explain how acute stress, which elevates CORT, may sub-
sequently either increase peripheral and/or DG neuronal BDNF
expression, and in turn increase hippocampal NPC proliferation
through the expression of BDNF receptor TrkB on NPCs (Horch
and Katz, 2002; Choi et al., 2009; Bergami et al., 2008). Many of
these discrepancies may also be explained by the type of stress
induced. For example, social defeat stress negatively impacts upon
hippocampal neurogenesis whereas environmental enrichment,
which is known to increase adrenal activity in rodents (Moncek
et al., 2004), positively affects hippocampal neurogenesis
(Lehmann et al., 2013). In addition, the evidence to date suggests
that acute stressors increase neurogenesis while chronic stress
suppresses it (Pham et al., 2003; Kirby et al., 2013; Cheng et al.,
2015). In summarising these complicated interactions between
GR function and neurogenesis, it appears that strict regulation of
GR activation is important for maintaining neurogenesis.
Mice lacking GR display impairments in hippocampal
neurogenesis-associated behaviours. For example, deficits in con-
textual fear conditioning in GR knockdown mice is coupled with
reduced NPC proliferation and accelerated neuronal differentiation
(Fitzsimons et al., 2013). Interestingly, in this study no effects of GR
knockdown were observed in amygdala-associated cued fear con-
ditioning. This suggests that GR knockdown may lead to deficits
in hippocampal function only due to the GR knockdown effects
on neurogenesis. Conversely, activation of GR by systemic admin-
istration of CORT under baseline conditions has been shown to
impair hippocampal neurogenesis-associated spatial memory in a
water maze task (de Quervain et al., 1998). This reiterates that nor-
mal GR regulation is beneficial to neurogenesis and associated cog-
nition while hyperactivation or suppression of GR activity leads to
impairments in neurogenesis and cognitive function. In adrenalec-
tomised rats, where there is reduced CORT and hippocampal GR
activation, the impairment in hippocampal neurogenesis-
associated spatial memory in the water maze was reversed by
administration of CORT for 5–10 days prior to the start of beha-
vioural testing (McCormick et al., 1997). However, chronic (5–
6 weeks) CORT administration after adrenalectomy is not sufficient
to restore spatial memory performance in the water maze and
indeed it also impairs hippocampal NPC proliferation (Lee et al.,
2011; Spanswick et al., 2007). This indicates that chronic disrup-
tions in GR signalling may have long lasting effects on
neurogenesis-associated cognition. Interestingly, it has been
demonstrated that inhibition of GR signalling using the GR antag-
onist mefipristone in an AD mouse model rescued impairments in
hippocampal neurogenesis associated novel object recognition
(Lante et al., 2015; Dong et al., 2004). Indeed, mefipristone has
been shown to reverse CORT-induced suppression of human hip-
pocampal NPC proliferation (Anacker et al., 2013). Therefore, it
may only be when deregulation of neurogenesis occurs, e.g. during
neuroinflammation, that short-term GR manipulation may prove
therapeutically viable to regain normal levels of neurogenesis.
5.2. GR and IL-1b signalling interaction in hippocampal NPCs
Due to the immunosuppressive consequences of GR activation,
GR agonists, such as dexamethasone and prednisolone are well
established anti-inflammatory agents (Sundahl et al., 2015). Despite
awealth of research outliningGR signalling interactionwith IL-1b in
post-mitotic cells, the interaction of these signalling cascades has
not been explored in hippocampal NPCs. However, using the evi-
dence to date, one can postulate as to howGRand IL-1bmay interact
in NPCs. Activation of GR signalling inmousemacrophages has been
shown to interact with the IL-1b-associated NF-jB signalling path-
way and to repress the expression of various inflammatory genes
including IL-1b itself (Uhlenhaut et al., 2013). There are several
mechanisms throughwhich GR activation impairs NF-jB signalling.
Specifically, GR can physically interact with p65, a member of the
NF-jB family of proteins which is expressed in NPCs, and suppress
its interaction with DNA in a monkey fibroblast cell line (Liden
et al., 1997). GR activation has been shown to suppress the expres-
sionofNF-jB target genes by inducing thebindingof p65with inter-
feron regulatory transcription factor 3 (IRF3) in a mouse
macrophage cell line, thus preventing its transcriptional activity of
p65 (Reily et al., 2006). Additionally, GR-mediated inhibition of IL-
1b signalling can also occur through recruitment of histone deacety-
lases (HDACs) to NF-jB dependent promoters and consequent sup-
pression of gene transcription in a human lung adenocarcinoma cell
line (Ito et al., 2006). These studies, provide valuable insights into
possible interactions between GRs and NF-jB signalling molecules
and provide solid rational for further research intoGRmediated reg-
ulation of NF-jB signalling in NPCs.
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There is little evidence for the relationship between GR activity,
MAPK, and IL-1b within hippocampal NPCs and therefore this rep-
resents an open field of research. It has been demonstrated that in
response to a prolonged increase in CORT-induced activation of GR,
there is an exacerbation in both MAPK and NF-jB activation within
the whole hippocampus of rats after lipopolysaccharide (LPS)
exposure, a known inducer of inflammation and pro-
inflammatory cytokine expression including IL-1b (Munhoz et al.,
2010). Thus, in terms of IL-1b-mediated inflammation, chronic
GR activation may elicit a stronger inflammatory response by IL-
1b on NPCs by enhancing both MAPK and NF-jB pathway activa-
tion. This is in line with the overarching concept that chronic stress
can induce a priming effect on immune activity such that exposure
to stress can enhance pro-inflammatory cytokine expression and
neuronal death after an inflammatory insult (for review see
(Sorrells et al., 2009)) (de Pablos et al., 2006). Thus, the duration
of GR activation in response to increased IL-1b expression is impor-
tant in understanding the signalling connection between GR and
IL-1b. It appears that prolonged activation of GR induces both
MAPK and NF-jB activation and thus may potentiate IL-1b-
induced changes, potentially on hippocampal neurogenesis.
6. PPAR receptors
Peroxisome Proliferator Activated Receptors (PPARs) consist of
three main subtypes; PPARa, PPARb/d, and PPARc. Functionally,
PPARs are involved in the regulation of lipid metabolism and glu-
cose homeostasis (Cimini and Cerù, 2008). They can be activated
by endogenous lipid compounds, such as prostaglandins and other
fatty acids, as well as synthetic compounds from the diabetic drug
class thiazolidinediones (Ahmadian et al., 2013). Activated PPARs
form a heterodimer complex with retinoic X receptors (RXRs)
and then translocate to the nucleus where they modulate the
expression of different target genes involved in processes, such
as fatty acid metabolism (Fig. 3) (Forman et al., 1996; Cimini
et al., 2007). RXRs, which are activated by retinoic acid, have been
shown to be ubiquitously expressed within the hippocampus
including in NPCs (Androutsellis-Theotokis et al., 2013;
Zetterstrom et al., 1999). This heterodimer complex like most NR
complexes can interact with various co-activators and co-
repressors of gene expression (Quintanilla et al., 2014; Ahmadian
et al., 2013; Forman et al., 1996). PPARa is highly expressed in
the liver, heart, kidneys, and other metabolically active tissues
(Rosen and Spiegelman, 2001; Forman et al., 1996). PPARb is ubiq-
uitously expressed but at different levels depending on the tissue
(Coll et al., 2009). PPARc is expressed mostly in fatty tissue and
in the vasculature. However, it has been detected in the heart
and brain tissue where its activation has been shown to be associ-
ated with reduced cardiovascular damage and reduced neurode-
generation, respectively (Barak et al., 1999; Tontonoz and
Spiegelman, 2008).
6.1. PPARs and neurogenesis
Much of the focus on the role of PPARs in hippocampal neuro-
genesis to date has focused on PPARc, although all PPAR subtypes
have been shown to be expressed in the DG of the hippocampus of
rodents (Bordet et al., 2006; Sun and Shi, 2010; Moreno et al.,
2004; Cimini et al., 2007). Additionally, it should be noted that
much of the research into PPAR function in neurogenesis has
focused on embryonic neurogenesis rather than adult neurogene-
sis. However, many of the cellular processes of proliferation, differ-
entiation, and survival are common to both embryonic and adult
neurogenesis (Pleasure et al., 2000), and so these embryonic stud-
ies provide useful clues as to how PPARs may regulate these
processes in adult hippocampal neurogenesis. PPARc has been
shown to play a role in cell proliferation and differentiation of NPCs
derived from whole brain E13-14 mice embryos. Specifically, PPAR
deficient NPCs failed to proliferate whereas treatment with the
PPARc agonist rosiglitazone induced cell growth and inhibited dif-
ferentiation of NPCs into neuronal cells (Wada et al., 2006). Both
PPARc and PPARb/d activation in NPCs in the SVZ of adult mice
leads to increased proliferation in these cells (Bernal et al., 2015).
These authors also demonstrated that PPARc activation increased
the expression of PPARb/d, suggesting that these receptor isotypes
work in tandem to promote proliferation of NPCs. Stimulation of
PPARc by pioglitazone, a synthetic PPARc agonist, enhanced neu-
rite outgrowth in SHY-SY5Y cells, which indicates its role in neu-
ronal maturation (Miglio et al., 2009). Additionally, it has been
demonstrated that PPARc is important in the development of neu-
ronal cells from a pluripotent embryonic stem cell line derived
from mouse embryos. This indicates that PPARc signalling sup-
ports preferential differentiation of neurons (Ghoochani et al.,
2012). It should be noted however, that the variation of PPAR
effects on neurogenesis may be due to the wide variety of com-
pounds used to modulate their activity with each one having dif-
fering dosage and time dependent effects (Ghoochani et al.,
2012; Wada et al., 2006). Indeed, it has been shown that with doses
of the PPARc agonists rosiglitazone or pioglitazone in excess of
30 lM, cell proliferation of embryonic NPCs is significantly
reduced (Wada et al., 2006).
Synthetic PPAR agonists have been shown to have beneficial
effects on hippocampal neurogenesis-associated cognitive function
under inflammatory, stress and neurodegenerative conditions. For
example, LPS-induced impairments in spatial memory in the Mor-
ris water maze as well as decreased levels of hippocampal neuro-
genesis were reversed by administration of rosiglitazone in
female mice (Ormerod et al., 2013). Interestingly, there was no
improvement in spatial memory performance or in neurogenesis
induced by rosiglitazone in the absence of an LPS insult
(Ormerod et al., 2013). Similarly, the protective effects of rosiglita-
zone have been reported in the Tg2576 and APP/PS1 mouse models
of AD as assessed by radial arm maze and Morris water maze tasks
(Pedersen et al., 2006; O’Reilly and Lynch, 2012). While impaired
neurogenesis has been previously demonstrated in mouse models
of AD (Ben Menachem-Zidon et al., 2014; Hsiao et al., 1996; Zeng
et al., 2016), neurogenesis was not assessed in these studies. How-
ever, a direct effect of rosiglitazone on neurogenesis has been
observed in that 3 weeks administration of rosiglitazone induces
an increase in the number of immature neurons in the hippocam-
pus (Cheng et al., 2015) although no cognitive behavioural corre-
lates have been reported. Taken together, it is likely that, similar
to studies on GR modulation, the beneficial effects of PPAR modu-
lation are only evident in the presence of an insult that impairs
neurogenesis and associated cognition.
6.2. PPARs and IL-1b signalling interaction in hippocampal NPCs
PPAR activation has been predominantly associated with anti-
inflammatory effects (Blanquart et al., 2003). For example, activa-
tion of PPARa and PPARc by the endogenous agonist 9-
hydroxyoctadecadienoic acid (a major fatty acid in oxidized low
density lipoprotein) in a mouse macrophage cell line inhibits IL-
1b-induced NF-jB pathway activation (Chung et al., 2000). Addi-
tionally, activation of PPARa by fibrates (agonists of PPARa) has
been shown to directly interact with p65 in mouse and human vas-
culatures after LPS or IL-1b induced inflammation and increases
the expression of IkB, a negative regulator of NF-jB signalling
(Delerive et al., 2000, 1999). PPARc activation by rosiglitazone
leads to reduced phosphorylation of p65 in mouse hippocampal
neuronal cultures (Du et al., 2011). Thus, while it has not been
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specifically reported to date, it is likely that PPAR inhibition of IL-
1b-induced effects on hippocampal neurogenesis involves suppres-
sion of the NF-jB pathway. PPAR activation by either pioglitazone
or rosiglitazone has also been suggested to inhibit MAPK signalling
within whole hippocampal tissue of rats in response to increased
neuroinflammation induced by an ischemia model of stroke, which
increases pro-inflammatory cytokine expression (Collino et al.,
2006b,a) However the exact mechanism has not been definitively
demonstrated, nor has the interaction between PPARs and MAPK
signalling been explored within NPCs. Nevertheless, evidence that
PPARs can suppress MAPK signalling after a neuroinflammatory
insult, such as ischemic injury within the hippocampus as
described above suggests that modulating PPARs in NPCs may have
protective effects against neuroinflammation on these cells yet this
requires further research. It should be noted that targeting PPAR
signalling in NPCs to prevent the effects of IL-1b on hippocampal
neurogenesis poses several problems. The first is the lack of speci-
fic ligands for PPARs as every currently available ligand is not
specific for any individual PPAR (Grygiel-Górniak, 2014). This cou-
pled with the ubiquitous nature of PPAR expression in the CNS
leads to the potential of many side effects of PPAR modulation
(Bordet et al., 2006). Nevertheless, PPAR activation possesses sig-
nificant anti-inflammatory properties including an ability to
impede IL-1b-associated signalling. With the advent of new ligands
and technologies for modulating receptor expression (Niu et al.,
2014; Brooks et al., 2015; Liu et al., 2016), assessing this interac-
tion in NPCs warrants further research.
7. Estrogen receptor
The estrogen receptor (ER) family represents another group of
nuclear receptors that can regulate neurogenesis and may interact
with IL-1b signalling. Two types of ER exist; ERa and ERb. Both are
expressed within the hippocampus of rodents and humans with
ERa displaying a slightly higher expression profile in rodents and
ERb being suggested to be the primary ER in humans (Mitterling
et al., 2010; Pérez et al., 2003; Towart et al., 2003; Osterlund
et al., 2000; González et al., 2007). Upon activation, these receptors
form dimers of the ER subtypes and translocate to the nucleus to
alter gene transcription (Fig. 3) (Hall et al., 2001). Cell surface G-
protein coupled receptor ERs also exist within the hippocampus
of rodents, however this review will focus on the nuclear receptor
ERs (Brailoiu et al., 2007; Hazell et al., 2009). The sex or estrogen
hormones estradiol, estrone, and estriol bind to ERs. Estradiol is
the most potent and has been the focus of most research to date
on the role of the ERs in hippocampal function (McEwen et al.,
2012; McEwen and Milner, 2007; Vasudevan and Pfaff, 2008).
Estradiol is synthesised from cholesterol mainly in the ovaries in
females and estrogen has also been shown to be locally produced
by hippocampal neurons in male rats (Hojo et al., 2004). Its level
fluctuates during puberty and over the menstrual cycle and
decreases after the menopause. It is also produced in bone, adipose,
and nervous tissue in both females and males. The primary func-
tions of estradiol in the CNS include regulation of stress, anxiety,
feeding behaviour, aggression, and sexual behaviour (Arevalo
et al., 2015; Do Rego et al., 2009).
7.1. ERs and neurogenesis
It has been shown in rats that ERs are expressed within adult
and postnatal hippocampal NPCs (Mazzucco et al., 2006; Pérez
et al., 2003). Administration of estradiol to female rats or meadow
voles has been shown to increase NPC proliferation however this
effect was only observed after 4 h of treatment whereas with
48 h of treatment there was a suppression of cell proliferation
within the DG (Ormerod and Galea, 2001; Ormerod et al., 2003).
One possible explanation for this effect is the immediate and latent
side effects of estradiol. Estradiol induces a rapid increase in sero-
tonin levels that has been suggested to mediate estradiol effects on
NPC proliferation in the DG of rats (Banasr et al., 2001). With pro-
longed estradiol exposure, adrenal activity is increased and so sup-
pression of the proliferation of NPCs within the DG ensues
(Ormerod et al., 2003). In line with the role of ER in regulating
sex hormones, there is evidence to suggest that there are sex differ-
ences in neurogenesis. Female rats have been shown to have higher
levels of cell proliferation in the DG than males depending on
which stage of the menstrual cycle they are in (Chow et al.,
2013; Bowers et al., 2010; Marques et al., 2016; Tanapat et al.,
1999), but this has not been observed in mice (Lagace et al.,
2007). However, in this mouse study cell proliferation in females
during the proestrus stage of the menstrual cycle were not com-
pared with with males, which is when a difference in cell prolifer-
ation in rats was observed. There is also evidence to suggest that
ER modulation after brain injury in mice enhances proliferation
of cells in the DG (Li et al., 2011). Thus, it may be that ER-
induced regulation of neurogenesis under baseline conditions is
minimal but where there is an insult (such as in brain injury)
and a consequent increase in pro-inflammatory cytokine expres-
sion, ERs play a role in recovery. Aging is associated with both
decreased hippocampal neurogenesis and decreased circulating
levels of estrogens (Lamberts et al., 1997; Kuhn et al., 1996;
Kempermann et al., 1998). Indeed, there is some evidence to sug-
gest that estrogen replacement in women can ameliorate age-
related cognitive decline (Gibbs and Gabor, 2003; Sherwin,
2006). Thus, it would appear that the effect of estrogen signalling
on neurogenesis is dose, time, sex and age-dependent.
Modulation of ERs by estrogen hormones, particularly estradiol,
has been demonstrated to have beneficial effects on hippocampal
neurogenesis-associated cognition. For example, estradiol induced
significant improvements in spatial memory impairments in the
radial arm maze and in the water maze in ovariectomised rats
(which effectively reduces levels of circulating estrogens) (Luine
et al., 1998; Daniel et al., 1997; Sandstrom and Williams, 2004),
as well as in object location recognition in ovarectomised mice
(Li et al., 2004). Similar improvements in spatial memory (object
location recognition) have been demonstrated in male orchidec-
tomised rats who received estradiol injections (Jacome et al.,
2016). However, it has been demonstrated that ovarectomy itself
does not appear to alter neurogenesis as no differences in cell pro-
liferation were reported in rodents 3–4 weeks post ovarectomy
(Green and Galea, 2008; Lagace et al., 2007; Tanapat et al., 1999).
As estradiol can be produced locally within the hippocampus, there
may be compensatory mechanisms at play to protect new neurons
from any detrimental effect of ovarectomy (Hojo et al., 2004). It
would be interesting to determine whether estradiol administra-
tion in the absence of ovarectomy or orchidectomy can rescue
impairments in hippocampal-associated behaviours induced by
suppression of neurogenesis (either transgenic models or hip-
pocampal irradiation). It may be the case that estradiol treatment
may only be beneficial for hippocampal neurogenesis-associated
cognition when deficits in neurogenesis are present. Furthermore,
little work has been carried out on the potential role of ER modu-
lation in regulating inflammatory-induced changes in hippocampal
neurogenesis-associated cognition, and so this represents another
interesting avenue for future research.
7.2. ERs and IL-1b signalling interaction in hippocampal NPCs
It has largely been shown that estrogen acts antagonistically on
IL-1b-induced changes in hippocampal function. For example, in
mice that have been ovariectomised there is a significant increase
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in the expression of pro-inflammatory cytokines including IL-1b
within the hippocampus (Benedusi et al., 2012). It has also been
shown that estradiol treatment of rat hippocampal slice cultures
reduced an ischemia-induced increase in cell death as well as IL-
1b expression (Choi et al., 2008). The effect of estradiol on IL-1b
may be due to the reduction in cell death however, estradiol also
increased the expression of IL-1RA, which directly suppresses the
potential negative effects of IL-1b in the hippocampus (Choi
et al., 2008). Estradiol treatment has been shown to reduce IL-
1b-induced apoptosis by inhibiting caspase 3 activation in mouse
embryonic hippocampal NPC cultures in vitro, thus indicating that
estrogen signalling may also have indirect effects on IL-1b-induced
changes in NPC viability (Kajta et al., 2006). However, the mecha-
nisms underlying this interaction have not been investigated to
date, in NPCs or any other cell type. Understanding the mecha-
nisms of interaction between ERs and IL-1b will not only provide
better rationale for therapeutically targeting ERs to prevent IL-
1b-associated impairments in neurogenesis and associated cogni-
tion, but it may also highlight any potential differences between
the sexes in their response to inflammatory-induced changes in
hippocampal neurogenesis.
8. NR2E1 (TLX)
NR2E1 is an orphan nuclear receptor, which (also known as
TLX) is predominantly expressed in the eye and forebrain
(Monaghan et al., 1995). Indeed, the expression of NR2E1 is mainly
restricted to the mammalian CNS (Li et al., 2012). In the adult,
NR2E1 is predominantly expressed in the DG in the hippocampus
and in the SVZ zone of the lateral ventricles. Like most nuclear
receptors, NR2E1 has at least three structural domains, a DNA
binding domain, an N-terminal transactivation domain and a mod-
erately conserved ligand-binding domain (LBD) (Yu et al., 1994;
Bain et al., 2007; Benod et al., 2014). NR2E1 functions primarily
as a transcriptional repressor of downstream target genes. To do
so, NR2E1 recruits transcriptional co-repressors, such as the epige-
netic modulators lysine-specific histone demethylase 1 (LSD1), and
HDACs 3 and 5, which repress gene expression and in turn sup-
press the expression of anti-proliferative genes to regulate NPC
proliferation (Sun et al., 2007, 2010, 2011). Genes regulated by
NR2E1 include Ascl1, Pou5f1, Pax2, Mir9, Mir137, Pten, p21, Cdkn1a,
Sirt1, and Wnt7a (Islam and Zhang, 2014). Importantly, repression
of cyclin dependent kinase inhibitor p21 and the tumour suppres-
sor gene Pten by NR2E1 activation, promote the proliferation of
NPCs (Sun et al., 2007).
8.1. NR2E1 and neurogenesis
At a cellular level, NR2E1 has been demonstrated to be critical
for maintaining neural stem cell proliferation in both the develop-
ing embryonic forebrain and dorsal midbrain, and within the neu-
rogenic niches of the adult brain (Monaghan et al., 1995; Shi et al.,
2004; Sun et al., 2007). NR2E1 expressing NPCs from the SGZ, SVZ,
and olfactory bulb proliferate and are capable of differentiating
into all neural cell types whereas NPCs lacking NR2E1 fail to prolif-
erate (Shi et al., 2004). The importance of NR2E1 was further
demonstrated by the fact that reintroduction of NR2E1 into NPCs
restored all of the deficits in proliferation observed in the cells
lacking NR2E1 (Shi et al., 2004). Moreover, overexpression of
NR2E1 within hippocampal NPCs has been shown to enhance the
proliferation phase of neurogenesis and subsequently improve
learning and memory processes in mice (Murai et al., 2014).
NR2E1 knockout mice show deficits in hippocampal neurogenesis
and impaired learning and memory as well as a heightened stress
response (Monaghan et al., 1997; Young et al., 2002; O’Leary et al.,
2016a). More recently, it has been demonstrated that mice with a
spontaneous deletion of NR2E1 display impairments in hippocam-
pal neurogenesis-associated cognitive tasks (O’Leary et al., 2016a).
Specifically, this study demonstrated that NR2E1/ mice dis-
played impaired short term spatial memory as tested by sponta-
neous alternations in the Y-maze. Furthermore, male adolescent
mice displayed impaired contextual fear conditioning performance
suggesting a role for NR2E1 in sex- and age-related effects on cer-
tain hippocampal neurogenesis-associated tasks (O’Leary et al.,
2016a). It should be noted however that most work to date assess-
ing the relevance of NR2E1 in hippocampal neurogenesis-
associated cognition has focused on models of genetic reductions
(germline knockouts or inducible knockouts) of NR2E1 expression
(O’Leary et al., 2016b). For example, NR2E1 knockout in mice (cre-
lox deletion) resulted in impaired performance in the Morris water
maze spatial memory task (Zhang et al., 2008) which was associ-
ated with impaired hippocampal neurogenesis. Interestingly, it
has been demonstrated that enhancing NR2E1 expression specifi-
cally in NPCs can promote hippocampal neurogenesis and enhance
performance in the Morris water maze task (Murai et al., 2014).
This study demonstrated the potential for NR2E1 as a therapeutic
target to selectively enhance hippocampal neurogenesis and asso-
ciated cognition. Thus, it would appear the NR2E1 is intrinsically
linked with both the cellular mechanisms and functional outcomes
of hippocampal neurogenesis and as such its role in mitigating
neuroinflammation-induced deficits in neurogenesis will be of
interest for future research.
8.2. NR2E1 and IL-1b signalling interaction in hippocampal NPCs
The link between IL-1b signalling and NR2E1 is only beginning
to be studied. So far, it has been shown that IL-1b decreases NR2E1
expression in both adult and embryonic hippocampal NPCs (Green
and Nolan, 2012; Ryan et al., 2013). Furthermore, co-treatment of
hippocampal NPCs with IL-1b and IL-1RA or siRNA to inhibit IL-
1R1 expression restored NR2E1 expression in hippocampal NPCs
(Ryan et al., 2013). Little is currently known about the molecular
interactions between IL-1b and NR2E1 signalling, however some
theories can be postulated based on evidence from the literature.
For example, many of the target genes of NR2E1, such as Cdkn1a
and Pten are also regulated by NF-jB signalling in embryonic
mouse fibroblasts. NF-jB targets these genes to enhance their
expression while NR2E1 represses their expression (Xia et al.,
2007). NR2E1 has also been shown to suppress the MAPK pathway.
In NR2E1 null progenitor cells from mouse retina, there was a sig-
nificant increase in the activation of p38MAPK (Zhang et al., 2006).
This was also shown by signalling pathway analysis of RNA
sequencing data of NR2E1 knockdown in NPCs from the SVZ (Niu
et al., 2011). None of these signalling interactions have been
demonstrated in hippocampal NPCs however and this represents
an important area for future research.
Currently there is no known endogenous ligand for NR2E1.
Therefore, drug discovery efforts are underway to identify selective
synthetic ligands for this orphan nuclear receptor (Benod et al.,
2014). Using medium throughput screening and thermal shift
assays to assess the binding capabilities of a catalogue of com-
pounds, Benod et al. demonstrated that the NR2E1 ligand binding
domain (LBD) can be selectively targeted by three potential
NR2E1-modulating synthetic ligands (Benod et al., 2014). Current
research is establishing the efficacy of these ligands in modulating
the function of the full length NR2E1 protein in cell lines (Benod
et al., 2016). The discovery of ligands that can selectively modulate
NR2E1 function will greatly enhance our understanding of the
interaction of NR2E1 with IL-1b as well as the impact selective
pharmacological manipulation of NR2E1 may have on
neurogenesis-associated cognition. Moreover, the fact that NR2E1
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is selectively expressed within proliferating NPCs of the neuro-
genic niches of the adult brain will serve to limit any potential side
effects of a selective ligand. On the other hand, enhanced NR2E1
expression is associated with increased tumorigenesis (Zou et al.,
2012; Park et al., 2010; Liu et al., 2010) and thus caution should
be taken when manipulating NR2E1 within NPCs. Notwithstand-
ing, although the data is still in its infancy, it is tempting to spec-
ulate that NR2E1 may be a potential therapeutic target for IL-1b-
induced changes in hippocampal neurogenesis and related impair-
ments in cognition.
9. Conclusions
Hippocampal neurogenesis has been shown to be functionally
associated with hippocampal learning and memory processes
and is known to be impaired in various neuropathologies affecting
the hippocampus. Increased expression of IL-1b is evident in the
hippocampus under neuropathological conditions and with age.
Along with the high expression of its cognate receptor on hip-
pocampal neurons and hippocampal NPCs, it is positioned as a
major mediator of neuroinflammation and consequent decline in
cognitive function. As such, determining the cellular signalling
pathways responsible for mediating the detrimental effects of IL-
1b on hippocampal neurogenesis is necessary. This review has
highlighted two pathways that are activated downstream of IL-
1b in NPCs; NF-jB and MAPK pathways. We speculate that IL-1b
activation of NF-jB or MAPK pathways in NPCs may depend on
the stage of neurogenesis that the cells are engaged in. In this
regard we propose that NF-jB signalling may mediate IL-1b-
induced changes on earlier stages of neurogenesis (e.g. during pro-
liferation) with MAPK signalling mediating the IL-1b-induced
changes in more mature NPCs and synaptic integration.
Evidence for IL-1b-induced NF-jB signalling in proliferating
NPCs has been demonstrated due to the fact that inhibition of
the NF-jB pathway, and not p38MAPK, in mice was sufficient to
prevent the anti-proliferative effects of IL-1b in hippocampal NPCs
in vivo (Koo and Duman, 2008; Koo et al., 2010). Other studies have
demonstrated that IL-1b-mediated changes in NPC proliferation
and differentiation are mediated in part by the kynurenine path-
way and by GSK-3b activation (Green and Nolan, 2012; Zunszain
et al., 2012). Interestingly, NF-jB activation has been suggested
to be downstream of GSK-3b in the hippocampus (Bali and Jaggi,
2016) and moreover, the kynurenine pathway can be activated
downstream of NF-jB activation, albeit in the human placenta
(Dharane Nee Ligam et al., 2010). It has also been demonstrated
that IL-1b activates both the NF-jB and p38MAPK pathways in hip-
pocampal astrocytes but that only the p38MAPK pathway is acti-
vated in hippocampal neurons in response to IL-1b (Srinivasan
et al., 2004; Huang et al., 2011). Therefore, as NPCs begin to differ-
entiate into either glial cells or neuronal cells it appears that there
is a diverging point at which they recruit either the MAPK or the
NF-jB pathway in response to IL-1b depending on the cellular phe-
notype they adopt as they differentiate. It must been noted how-
ever that activation of SAPK/JNK (part of the MAPK signalling
family but not encompassing p38MAPK) has also been demon-
strated to mediate the effects of IL-1b on proliferation (albeit in
whole embryonic forebrain tissue) (Wang et al., 2007) and so
may play a contributing role to IL-1b-induced changes in hip-
pocampal neurogenesis. Of course it is also possible that IL-1b
may recruit either or both NF-jB and MAPK pathways in NPCs at
any given stage of neurogenesis depending of the concentration
of IL-1b, the duration of its exposure or indeed the time during
the lifespan at which IL-1b is exposed to the hippocampal NPCs.
These questions can only be answered with further research.
As IL-1b appears to regulate different signalling pathways
within NPCs depending on what stage of neurogenesis they are
in, mitigating these effects will require manipulating factors that
can also regulate multiple processes and pathways within NPCs.
It is clear that the four NRs discussed, namely the GRs, PPARs,
ERs, and NR2E1, play a key role in a host of physiological processes
including several aspects of neurogenesis (Fig. 4). However, the
question remains as to whether these NRs can be targeted to pre-
vent or reverse impairments in hippocampal neurogenesis induced
by IL-1b. The NRs reviewed herein may be of value in exploring
NPC based therapies for neuroinflammatory associated cognitive
dysfunction. Due to their expression in hippocampal NPCs, their
functional role in regulating neurogenesis, and their interaction
with neuroinflammatory pathways, they position themselves as
promising therapeutic targets. Moreover, as NRs function as ligand
regulated transcription factors, they represent valuable targets for
pharmacological manipulation. All except NR2E1 can currently be
selectively targeted by numerous synthetic ligands to either acti-
vate or repress their activity. However, more work is needed to
assess the effect of targeting these receptors on IL-1b-mediated
suppression of neurogenesis. To this end, specific ligands for each
NR discussed in this review and/or knockdown or overexpression
studies will be invaluable in determining the potential of these
receptors in mitigating the IL-1b-induced effects on neurogenesis.
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